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Abstract 
The prevalence and use of medical devices in the home environment continues to 
grow in the United Kingdom (UK) and Worldwide. It is recognised that such devices 
offer significant benefits to both patients and the National Health Service in the UK.  
The design of home use medical devices however represents a considerable 
challenge to designers and manufacturers alike. Developing devices that are usable 
and understandable by inexperienced, lay or dexterity impaired users requires an 
understanding across a breadth of disciplines. Previous research in this field has 
explored these challenges in attempt to offer support for developers of home use 
medical devices. 
There have been very few studies however that have explored whether the design 
community actually need, want or use such guidance, before considering whether 
this literature is adopted correctly.   
Through case studies, an online survey and in depth interviews this thesis suggests 
that industry practitioners are sceptical of the value of design guidance towards user 
involvement in home use medical device design. Consequently the practitioners in 
this research make little or no use of the formal design methods and supportive 
guidance documents available to them. More typically, practitioners in the home use 
medical device field use their own personal experiences and knowledge from 
working in the industry to adapt their own approaches to design.  
This thesis reports that the greatest challenge to involving users in the design of 
home use medical devices are the internal corporate and traditionally hierarchical 
barriers between stakeholders within the design process. In contrast to previous 
research offering support for designers and developers of home use medical devices 
this thesis calls for a wider change in design practice to facilitate the application of 
usability principles. 
As a conclusion to this thesis, recommendations for further research to address these 
changes in practice are proposed to industry professionals in the medical device 
industry. This thesis is submitted as part of the requirement for the Degree of Doctor 
of Philosophy at Loughborough University.  
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Glossary 
The following terms are used repeatedly throughout this thesis and their context and 
definitions are integral to the reportage of this document. For clarity to readers, the 
definitions of these terms in the context of this research are provided here.  
Designer – A person who plans the look or workings of something prior to it being 
made, by preparing drawings or plans (Oxford Dictionaries, 2013). In the context of 
this research the term ‘designer’ extends to individuals involved in the design and 
development process that ultimately influence the appearance, function and 
performance of a home use medical device. 
Home Use Medical Device - A device intended for use in a non-clinical or transitory 
environment, is managed partly or wholly by the user, requires adequate labelling for 
the user, and may require training for the user by a health care professional in order 
to be used safely and effectively.”(FDA, 2013). 
Human Factors Engineering – The application of knowledge about human 
capabilities (physical, sensory, emotional and intellectual) and limitations to the 
design and development of tools, devices, systems, environments, and organisations 
(ANSI/AAMI HE75: 2009).  
Medical Device – Any instrument, apparatus, appliance, software, material or other 
article, whether used alone or in combination, together with any accessories, 
including the software intended by its manufacturer to be used specifically for 
diagnostic and/or therapeutic purposes and necessary for its proper application, 
intended by the manufacturer to be used for human beings for the purpose of:  
 diagnosis, prevention, monitoring, treatment or alleviation of disease,  
 diagnosis, monitoring, treatment, alleviation of or compensation for an injury 
or [disability],  
 investigation, replacement or modification of the anatomy or of a 
physiological process,  
 control of conception,  
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and which does not achieve its principal intended action in or on the human body by 
pharmacological, immunological or metabolic means, but which may be assisted in 
its function by such means. (EC, 2007; in accordance with Council Directive 
2007/47/EC).  
Usability – Characteristic of the user interface that establishes effectiveness, 
efficiency, ease of user learning and user satisfaction (IEC BS EN 62366: 2007). 
Usability Engineering – Application of knowledge about human behaviour, 
abilities, limitations, and other characteristics related to the design of tools, devices, 
systems, tasks, jobs and environments to achieve adequate usability (IEC BS EN 
62366: 2007).  
Use Error – Act or omission of an act that results in a different medical device 
response that intended by the manufacturer or expected by the user (IEC BS EN 
62366: 2007).   
User – Person using, i.e. operating or handling, the medical device. Note one: This 
includes, but is not limited to, cleaners, maintainers and installers. Note two: Patients 
or other laypersons can be users (IEC BS EN 62366: 2007).  
User Involvement – The involvement of ‘representative intended users’ within the 
design process of a home use medical device (IEC BS EN 62366: 2007).  
User Centred Design – A philosophy based on the needs of and interests of the user, 
with an emphasis on making products usable and understandable (Norman, 1998).   
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Chapter 1  
Introduction 
 
1.1 Background 
 
In recent years patient use of medical devices in the home environment has grown 
considerably. Changes in the age demographics of society and a cultural shift 
towards early discharge from hospital are recognised as key contributors to this 
recent trend (FDA, 2010). The trend is expected to continue into the future with the 
use of increasingly complex and sophisticated medical devices finding their way into 
patient’s homes (National Research Council, 2011).  
It is reported that home healthcare can provide significant benefits to both patients 
and society due to an improved quality of life and financial savings that can be made 
by providing care outside of the institutional environment (FDA, 2010). For 
ventilator-dependent adults savings of up to 66% can be achieved per month when 
care is delivered in the home (NAHC, 2008). These savings not only apply to high-
risk devices such as complex therapeutic and respiratory devices. The increased use 
of monitoring and diagnostic equipment in the home can reduce the number of 
hospital visits and re-admissions, which provides significant savings to the National 
Health Service (NHS) in the United Kingdom (UK). 
Aside from the cost savings that can be made, home healthcare provides increased 
comfort and convenience to patients and their families (FDA, 2010). In many cases 
patients are able to remain independent through the use of home healthcare devices 
and equipment (National Research Council, 2011). Advances in technology and 
miniaturisation have enabled devices that were previously only used by experienced 
and trained healthcare professionals to be used by inexperienced and lay users in the 
home environment (Cifter, 2011; FDA, 2010; Gupta, 2007).  
It is recognised however that market migration in any field of design presents 
challenges to the role of the designer, and the medical device industry is no exception 
(Martin et al, 2008). It has been argued that home use medical devices are often 
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simplistic and smaller, more ‘colourful’ versions of medical equipment used by 
professionals in the hospital (Bogner, 1999 Wilcox, 2005). The key therefore to 
design in this sector is making the technology accessible, usable and understandable 
by patients who are often vulnerable and inexperienced.  
In the past decade there has been an increased focus on research towards 
understanding the interaction between users and medical devices. Usability has been 
one of the primary foci in this research movement. In 2008, the British Standards 
Institute (BSI) introduced IEC BS EN 62366: 2008, an internationally harmonised 
standard under current medical device regulation, which refers to the Application of 
Usability Engineering to Medical Devices. (IEC BS EN 62366: 2008).  
In the US, the Food and Drug Administration (FDA) refer to usability as one of the 
unique challenges in their guidance document the Medical Device Home Use 
Initiative (FDA, 2010). The initiative, first introduced by the FDA in the US in 2010, 
was developed to address the safety and safe use of medical devices used in the home 
environment. Within this document the FDA outline the benefits of the cultural shift 
towards home care whilst also recognising the challenges this rapidly growing 
market presents.   
1.2 Motivation 
 
It is recognised that a number of key contributing factors are driving the rise in the 
increased use and development of home use medical devices. Cifter posited that the 
three most cited reasons within the literature behind the rise in home use medical 
devices are (Cifter, 2011); 
I. The increased proportion of older people in the adult population.  
II. The trend towards reducing the patient time in hospitals.  
III. The advances in technology.  
The Ageing Population 
It is widely understood that the demographics of society are changing and in recent 
times have encountered a cultural shift. Population changes are attributable to births, 
deaths and migration. In a recent publication by the Office for National Statistics 
(ONS) the national census for England and Wales revealed that there were 6.6 
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million births and 5.0 million deaths representing an increase in population of 1.6 
million (ONS, 2012). The statistics show a decline in birth rates and increase in life 
expectancy as people are living longer. The figures from the ONS report a decline in 
the younger population between the ages of 0-14 years and increase in population of 
persons aged 65 and over.  
In 2011, the percentage of the population aged 65 and over was the highest seen in 
any census at 16.4 per cent, denoting one in six people in the population were 65 and 
over (ONS, 2012). This represents a dramatic change in population demographics 
over the last century. In 1911, the data for England and Wales suggested that one in 
twenty residents were aged 65 and over (ONS, 2012). The percentage increase in 
population aged 65 and over has increased by approximately 10.6% between 2001 
and 2011.  
With a recognised ageing population there is subsequent demand for relevant health 
services and devices to accommodate for conditions associated with ageing. It is 
estimated that by the year 2050 in Europe, the population over 60 years of age will 
be approximately 253 million in comparison to 96 million under the age of 14.  
Early Patient Discharge from Hospitals 
Increasingly hospitals are discharging patients earlier than in previous years. The 
impact of early discharge presents the need for increased devices and technologies to 
treat patients outside of the hospital environment. Currently there are on-going 
changes to the NHS in the UK that have seen the introduction of targets to reduce the 
time patients spend in hospitals (e.g. Length of Stay) resulting in patients being 
discharged early from hospital to continue complex care regimes in the home 
environment (NHS Improving Quality, 2013).  
The Advancements in Technology 
Arguably a driving factor for all industrial development, from the automotive 
industry to mobile telecommunications, is the ever-increasing sophistication and 
capability of modern technology. New technologies enable consumers to perform 
tasks that were not possible in previous years. A consequence of this phenomenon 
being the associated level of expectation of technology available on the market 
today. With a rapid growth in the capability of technology, users become more 
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educated and aware of the technologies available to them. Thus there can be a rise in 
expectations for products and services. In the foreseeable future this may also be true 
and applicable to medical devices as increasing numbers of previously recognised 
professional use devices find their way into the home environment (Bogner, 1999 
Wilcox, 2005).  
The Rising Costs of Healthcare in Hospitals 
The cost of healthcare is under the continuous scrutiny of government and media. It 
is widely understood that the cost of healthcare is rising globally (Bodenheimer, 
2005). Simultaneously, cut backs on spending are occurring in all industry sectors 
since the economic downturn in 2008. These two compounding issues facing society 
today represent significant business drivers and incentives behind the transition 
towards home use medical devices.  
Adverse Incidents are on the Rise 
In a recent device bulletin by the Medicines and Healthcare products Regulatory 
Agency (MHRA), it was reported that adverse incidents (see Section 2.3.4) have seen 
a rise by approximately 13% for 2009-2010 (MHRA, 2011). According to the 
MHRA this figure has been increasing year on year in recent times (MHRA, 2011). 
A range of contributing factors need to be considered with these figures, however it 
is believed that the design of medical devices has a pivotal role to play moving 
forward in order to see a reduction in these incidents; particularly where home use 
medical devices are concerned. Further information regarding adverse incidents and 
their reporting is presented in Chapter Two. 
The Prevalence of Chronic Conditions 
There has been a significant increase in the prevalence of chronic conditions across 
the entire age spectrum particularly for conditions related to obesity such as diabetes. 
Consequently, there is an increasing demand placed upon healthcare services and the 
devices for patients. In light of the increasingly ageing population, people are now 
living longer with complex medical and social needs that foreseeably require 
treatment within the home environment (Gupta, 2007).  
 
 
 
19 
 
Lifestyle Choices 
Increasing emphasis is now placed upon improving the overall wellbeing and quality 
of life across all ages and into older age. There is a drive towards improved health 
management with the goal of improved independence to monitor one’s own health. 
Marketing campaigns for sports and health brands typically target this phenomenon 
that again could be argued contribute to the expectations of users for home use 
medical devices.  
The range of tasks performed by patients in the home varies significantly in 
complexity and care requirements. Devices are used for monitoring, diagnostics, 
drug delivery and even emergency care. It is estimated that there are at least 10,000 
different families of medical device types (Quotec, 2012). Given the variations in 
features of each of these device families, it is believed there are over 400,000 
different medical devices on the market today (Quotec, 2012).  
The combination of all of the factors described above demonstrates the rise in 
demand for home use medical devices. The dependence of society globally upon 
home use medical devices in the future is without question. In light of this, the 
intention of this thesis is to explore the practice of design by industry towards 
making home use medical devices usable and understandable for their users.  
1.3 Existing Knowledge 
 
It is recognised that there is currently a wealth of on-going research in the field of 
medical device design.  Much of the previous research in this space has addressed the 
challenges of designing and delivering professional use medical devices (Brigdelal 
Ram et al, 2008; Martin et al, 2008; MATCH, 2003; Money et al, 2011; Sharples et 
al, 2012).  
 
The specific focus of this research is upon home use medical device design. The 
most notable and in-depth of studies within this field in the UK is the work of Suresh 
Gupta (2007) and Abdusselam Cifter (2011). Both completed PhD theses in the 
home use medical device arena and the following section provides a brief 
introduction to their findings and how this research aims to build on their 
contributions to knowledge. 
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In his thesis, Design and Delivery of Medical Devices for Home-Use: Drivers and 
Challenges, Gupta explored the challenges to designing home use medical devices 
(Gupta, 2007). Gupta carried out a study with industrial design consultants and 
manufacturers to determine why the process of designing home use medical devices 
is both unique and challenging. Table 1.1 below presents the range of challenges 
identified by Gupta towards the development of home use medical devices (Gupta, 
2007).  
Table 1.1: Range of challenges to home use medical device design and 
development (Adapted from Gupta, 2007). 
 
 
 
 
 
 
 
 
Gupta identified that designing home use medical devices requires a depth of 
understanding across a broad range of issues. The range of issues presented in Table 
1.1, reflect the unique nature of home use medical devices holistically. The 
recognised trend towards increasing home use medical devices has resulted in a rapid 
period of growth for the field and a shift in paradigm towards commercialisation and 
consumerism. This change in paradigm has seen a blurring between the end users 
(i.e. typically patients for home use medical devices), as customers, which highlights 
the pertinence of commerciality in a medical context. Gupta referred to this shift as 
the crossing of boundaries between consumer products and home use medical 
devices. Gupta posited that while home use medical devices by necessity have to 
fulfil the legal regulatory requirements of medical devices, they may have to 
simultaneously meet the requirements of consumer products (Gupta, 2007).  
Regulatory Issues 
Manufacturing Issues 
Point-of-provision Issues 
Use Issues 
Support Issues 
Liability Issues 
Disposal Issues 
Business Issues 
Technological Issues 
Design and Development Issues 
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The work of Abdusselam Cifter also explored home use medical device design in the 
thesis titled: An Inclusive Approach Towards Designing Medical Devices for Use in 
the Home Environment (Cifter, 2011). Cifter’s work suggests three significant 
challenges specific to home use medical devices (Cifter, 2011).  
 The knowledge level of lay users when using products. 
 The usability of home use medical devices. 
 The context of use of home use medical devices. 
The themes highlighted by Cifter address a multitude of issues that increase the list 
of challenges and considerations for designers and developers of home use medical 
devices. Further challenges have also been cited within the literature, adding to the 
complexity of the field and the role of the designer. Some of these themes are 
introduced below: 
 The use of out-dated equipment – Inexperienced and vulnerable users are 
increasingly using what is referred to as ‘legacy’ equipment in the home 
environment without technical support or instructions. The avenues for which 
medical equipment can now be accessed in the home are so vast that it would 
be almost impossible to monitor and control such movements (National 
Research Council, 2011; Turieo et al, 2004). It is becoming increasingly 
common for people to pass on devices and equipment to friends and family 
removing the healthcare professional out of the device provision process. 
This is compounded by the fact that these devices are often provided without 
instructions or packaging to offer guidance to the users and a reference of 
whom to seek when difficulties occur. Furthermore where instructions are 
available they are often not written for a lay audience and it is widely 
recognised that people do not refer to instruction manuals.  
  Usability – Presently the user rarely chooses many of the devices used in the 
home themselves (UL, 2012). Devices are regularly prescribed or selected by 
healthcare professionals based on clinical effectiveness and purchasing 
decisions, with little consideration for the needs of the end users (UL, 2012). 
 The unpredictability of the home environment – The hospital environment 
is regarded as predominantly controlled and hygienic. In contrast, the home 
environment can be the antithesis. The performance of devices is impeded or 
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compromised by noise, poor lighting, glare-producing surfaces, heat, dirt, 
improper cleaning products, electrical interference, humidity and moisture 
(Sawyer, 1996). The compounding of such factors and the interactions with 
users become integral considerations when designing a medical device for 
use in the home. The safe use of medical devices can only be achieved 
through careful consideration of the operating environment, user capabilities, 
device design and the interactions between them.    
To counteract the challenges of designing home use medical devices it is advocated 
that users are involved early and often in the design process (IEC BS EN 62366: 
2008). Sawyer posits that the end user population should be involved early and 
throughout the design process with ‘hands-on’ testing at the development stage 
(Sawyer, 1996). Sawyer states that the correct application of methods and attention 
focused on the needs of users leads to safer, more usable devices that consequently 
deliver reduced user errors (Sawyer, 1996). Good design practice for home use 
medical devices therefore can deliver considerable benefits to patients, the NHS and 
government in the United Kingdom.  
The purpose of this thesis is to build on this existing knowledge of the field and 
make contributions to new knowledge that is of practical value to industry. 
Both the works of Cifter and Gupta shared the overall aim of supporting designers in 
the design and development of home use medical devices. In his thesis, Gupta set out 
to ‘support’ product developers in designing ‘better home use medical devices’ 
(Gupta, 2007). In contrast, the aim of Cifter’s thesis called for ‘supportive 
information and suggestions regarding lay users’ and how designers should address 
their needs and expectations (Cifter, 2011). In this respect, both bodies of research 
assert that designers need support in the design of home use medical devices.  
However, both researchers identified that some designers in the context of their 
research were sceptical of the value of ‘academic’ design guidance, stating that they 
would not use such guidance in practice. Therefore, this research steps back from the 
position of offering designers further guidance and pursues whether designers do, in 
fact, require support in the design of home use medical devices. After all, developing 
further design guidance that is not utilised by practicing designers will not influence 
a change in current design practice.  
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To this end, the research described in this thesis aims to identify ways in which 
incentivising a change in industry’s approach to design can be realistically achieved. 
In contrast to the work of Gupta and Cifter, this research seeks to identify designers’ 
perspectives on the available guidance and information relating to the involvement of 
users in the design process of a home use medical device. The research aspires to 
ascertain whether practicing designers do in fact need support in the design of home 
use medical devices and whether they use the types of supportive information and 
guidance currently available. In addition, should it be found that designers do not 
make use of the available design guidance, the research explores what approaches 
can realistically be taken in order to change current design practice by industry 
towards home use medical devices.  
1.4 Scope 
 
The scope of this research is to identify current designer and developer perspectives 
towards usability guidance, specifically relating to user involvement, in the design of 
home use medical devices. This research is focused specifically on companies based 
within the United Kingdom (UK). The reason for this being that each country 
(Member State) has specific regulations and guidance towards medical device 
development. The locality of this research is in the UK and it is not within the scope 
of this research to address home use medical device design globally. That said, the 
findings of this research may possibly have implications for other member states and 
could be applicable to other fields. Where appropriate, any such findings will be 
indicated and described.  
With this scope in mind the following section will now outline the aim of the 
research, the research questions and objectives of this thesis.  
1.5 Research Aim, Questions and Objectives 
 
It is understood that designing medical devices for use in the home is both a growing 
and challenging market. Previous research has addressed the need to support 
designers in this process (Cifter, 2011 Gupta, 2007). Much less research however has 
explored whether designers need, want or use such support.  
The increasing body of research advocating user involvement in the design process 
of home use medical devices has not been matched by an increase in studies 
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addressing the practicalities of adopting such principles. Previous research has 
suggested that informal processes of user requirements research are still dominant in 
this field (Cifter, 2011; Gupta, 2007; Martin et al, 2008; Money et al, 2012). There is 
a need to explore and understand the design practice for home use medical devices 
more holistically prior to the development of any further support for designers. 
The purpose of this research is to explore current design practice by home use 
medical device companies within the United Kingdom to understand their 
perceptions and application of current guidance and information.  
With this is mind the aim of this research is: 
To incentivise the adoption of usability principles and the practice of user 
involvement in home use medical device design in the United Kingdom. 
To achieve the aim of this research, three research questions and corresponding 
objectives have been identified.  
Research Question One: How do designers consider and involve users in home 
use medical device development? 
Objectives: To ascertain how home use medical devices are designed for the needs 
of their users it is necessary to understand current design practice. This will be 
achieved through the following objectives: 
I. Conducting a literature review of user involvement in home use medical 
device design. 
II. Conducting a case study within industry to understand idealised practice for 
home use medical devices in the UK. 
III. Identifying the design processes and methods currently used by industry in 
the UK.  
Research Question Two: What are the challenges for industry to involving users 
in the design process of home use medical devices?  
Objectives: To understand the challenges faced by designers it is necessary to both 
explore existing research and current practice on the nature of user involvement 
within Industry. This will be achieved through the following objectives:    
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I. Conducting a literature review on the challenges of usability for home use 
medical devices. 
II. Conducting a case study to identify the range of stakeholders involved in 
home use medical device development. 
III. Conducting an in-depth study with practicing designers to identify the 
challenges towards involving users in the design process of home use medical 
devices. 
Research Question Three: How can usability for home use medical devices be 
incentivised for industry?  
Objectives: In order to increase the uptake of usability principles for home use 
medical devices it is necessary to understand the perceived value of usability by 
industry. This research question will be answered through the following objectives: 
I. Identifying the challenges for adopting usability principles and involving 
users in practice. 
II. Developing intervention(s) based on these challenges to incentivise a 
change in industry’s approach to design. 
III. Evaluating the interventions with industry experts for future development 
opportunities. 
The following section will now present a brief overview of the research methodology 
and introduce the structure of the thesis. 
1.6 Overview of Research Methodology 
 
This research follows a theory building methodology that applies the findings of each 
study to draw conclusions and add to the existing knowledge of the field. The 
principles of Design Research Methodology (DRM) were adapted for the context of 
this research and form the basis of the thesis structure and methodology (Blessing & 
Chakrabarti, 2009). A combination of exploratory, descriptive and prescriptive 
studies were used in this thesis to develop recommendations for current practice 
towards home use medical device design with respect to user involvement. A 
schematic of the thesis structure is presented in Section 1.8. Chapter Three of this 
thesis describes in detail how the methodology of this research was identified, 
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selected and developed. The following section provides a summary of each chapter 
presented in this thesis. 
1.7 Thesis Structure 
 
This thesis is comprised of ten chapters that support the recommendations and future 
work presented as a conclusion. The following section presents a short summary of 
the individual chapters as a quick reference for the reader: 
Chapter One  Introduction: Provides a brief synopsis of the topics and 
themes presented throughout this thesis. This chapter provides an overview of the 
research, a summary of the research methodology and a description of the research 
aims and objectives.  
Chapter Two  Literature Review: Presents a review of existing research 
relevant to the field of home use medical device design. The review explores medical 
device design as a practice from the perspectives of design processes, user centred 
design and current regulation. This chapter forms the foundation and context of the 
thesis.  
Chapter Three Research Methodology: Describes the research designs, 
methods and strategies employed within this thesis. The epistemology and ontology 
of the researcher are described in relation to the theory within this thesis. The nature 
of quantitative and qualitative research is explored before the final design 
methodology is presented. 
Chapter Four Case Study One: Towards Idealised Design Practice: 
Presents a theoretical idealised approach towards home use medical device design. 
The case study presents a range of preliminary challenges to involving users in the 
design process of a home use medical device. A series of step factors (drivers) 
behind the raised expectations for usability of home use medical devices are 
identified. A verified model for idealised practice towards home use medical device 
design is presented as a conclusion to the chapter. 
Chapter Five  Case Study Two: Home Use Medical Device Stakeholder 
Network: Provides an example of a current home use medical device stakeholder 
network from the diabetes market in the United Kingdom. The case study identifies 
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the range of stakeholders within a hierarchical structure that have different influences 
on the design and delivery of home use medical devices to their patients.  
Chapter Six  Designers’ and Manufacturers’ Perspectives: Presents the 
descriptive study of the thesis. The chapter presents an online survey of practicing 
designers’ perspectives towards user involvement in home use medical device design 
in the United Kingdom. The chapter presents the methodology, analysis, results and 
discussion in relation to current literature. The chapter concludes with a summary of 
the main findings and the relevance to existing knowledge.  
Chapter Seven Understanding Current Practice: Presents the explanatory 
study of the thesis. This chapter builds on the findings of Chapter six through in-
depth interviews with participants from the previous study. Content analysis was 
performed on the interview transcripts using Nvivo software. The chapter presents a 
detailed description of the challenges towards user involvement in home use medical 
device design. The chapter concludes with the identification of three incentives to 
address current challenges towards the adoption of usability principles in home use 
medical device design.  
Chapter Eight Proposed Interventions: Presents the validation study of the 
thesis. The chapter describes a stakeholder workshop conducted with a range of 
professionals from the field of home use medical devices. The chapter describes 
three interventions explored with stakeholders to identify improvements and 
potential for adoption in current practice. The chapter concludes with a discussion on 
the leading intervention identified during the workshop. 
Chapter Nine  Overview and Synthesis: Presents a discussion chapter on the 
findings and implications of this research on the wider research arena. The synthesis 
explores the implementation of the proposals within this research on a regional, 
national and international level.  
Chapter Ten  Conclusions and Future Work: Presents the conclusions of 
the thesis. The chapter describes the research contributions to knowledge in the field 
of home use medical device design and provides a summary of each of the chapters 
within the thesis. Finally the chapter concludes with a summary of future work to be 
conducted by others.  
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1.8 Thesis Framework 
 
Figure 1.1: Thesis Framework 
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Chapter 2  
Literature Review 
 
In the previous chapter, an overview to the context of the research was presented. 
The research aim, questions and objectives were identified. The following chapter 
explores the existing literature on home use medical device design. The review will 
go into more depth behind the reasons for current practice in the Medical Technology 
(MedTech) sector and provide the foundation for the research methodology as a 
whole.  
2.1 Introduction 
 
Medical device design is a field of design that will affect us all at some point in our 
lifetimes. Almost everyone will experience the effects of ageing and capability loss 
when it comes to physical interaction with products and equipment. Furthermore, in 
recent years there has been a recognised cultural shift towards home healthcare that 
has seen a significant increase in the diversity and quantity of home use medical 
devices now available on the market. Recent estimates suggest there are 
approximately 400,000 different medical devices currently available on the market 
(Quotec, 2010). This figure demonstrates the considerable choice and variety for 
both professional and lay use of medical devices.   
To understand the context of home use medical device design and usability it is 
necessary to explore topics such as industrial design, medical device regulation, user 
centred design and product design and how they all relate to the design of medical 
devices. This literature review is an essential component of the thesis framework to 
provide preliminary answers to the research questions.  
For the purpose of this review a search strategy was applied to identify the relevant 
research papers, articles, journals and theses in the field. A summary of the 
methodology is provided here to bring clarity to the reader on how the literature was 
accessed and the search terms and sources used throughout this review.   
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2.2 Literature Review Methodology 
 
The literature in this review was predominantly accessed through online databases 
that consist of peer reviewed full text articles. Initial searches for background reading 
and context of the field were conducted using the Loughborough University Library 
Catalogue. This online service provided by Loughborough University’s library 
consists of resources available in the library and online in the University’s repository.  
The search process was then expanded using the Catalogue Plus facility, which 
broadens the literature access to a series of online databases consisting of peer-
reviewed journals, articles and E-books. While some search terms used in one online 
database may have provided few or no results, the same terms in another database 
could be much more fruitful. Where specific and relevant sources were found the 
references within that article were explored further. The use of citation maps was 
considered particularly useful for this research to explore one article’s relationship 
with other literature. An example of one such citation map is provided in the 
screenshot shown in Figure 2.1.  
Figure 2.1 is an example of a backwards style citation map in which the cited 
references by the target article can be easily viewed to discover the wider 
relationships to other research. The particular screenshot shown in Figure 2.1 is a 
citation map developed during the very early stages on this research dated March 
2011.  
 
Figure 2.1: Example of a Citation Map used within this Literature Review. 
In some cases, backward and forward citation maps were developed to explore not 
only cited articles and their relationships, but also more recent articles citing a 
particular target article. This method of literature searching helped develop a wide 
review of relevant literature for home use medical device design.  
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Search Terms and Sources 
The broad range of topics and themes covered within home use medical device 
design called for an in-depth and expansive search of literature. By definition this 
need for a breadth of knowledge required the exploration of a multitude of literature 
sources and directories to inform the literature review. Table 2.1 presents a list of 
some of the additional online sources used throughout this research. While this list is 
by no means exhaustive, it does present of the main sources of information presented 
in this review. Note that the additional online sources of literature not present on the 
list were located through research avenues from the sources shown in Table 2.1. 
Table 2.1: Additional Online Resources. 
 
  
  
 
 
Using these various sources of information the domain of home use medical device 
design was divided into specific research topics to simplify the process of searching. 
For the purpose and scope of this research seven research areas were defined: 
Design, Design Process, Design Research, Home Use Medical Devices, Medical 
Device Design, Usability and User Centred Design. 
Table 2.2 presents a list of some of the search terms used for each research area 
within the online sources previously described. Note this list is not exhaustive and is 
provided to give an indication of how the literature in this review was found.   
www.bsigroup.co.uk 
www.fda.gov 
www.mendeley.com 
www.mhra.gov.uk 
www.nice.org.uk 
www.sciencedirect.com 
www.webofknowledge.com 
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Table 2.2: Examples of Search Terms used with the Online Databases and 
Library Catalogue. 
Research Area Concerned Search Terms (Including Boolean 
Operators and Wildcards) 
Design Design, Design* (Designing, 
Designers, Designs, Designed etc.) 
Design Process Design Process* (Design Processes) 
Design Research Design Research, Research Design, 
Research Method* (Research 
Methods, Research Methodologies 
etc.) 
Home Use Medical Devices Medical Devices AND Home, Home 
use Medical Devices, Design AND 
Medical Devices AND Home. 
Medical Device Design Medical Devices, Medical Devices 
AND Design, Medical Device 
Design, Medical Device AND 
Usability. 
Usability Usability, Ergonomics, Human 
Factors. 
User Centred Design User Centred Design, User Centered 
Design, UCD.  
 
The review will now be presented in accordance with the seven themes previously 
described. 
2.2 Design 
 
“Design is the conscious and intuitive effort to impose meaningful order.” 
(Papanek, 1984). 
Many throughout history have defined the discipline of design. Pananek’s definition 
refers to a state of order which design as a process aims to achieve. The term 
‘intuitive’ used by Papanek is arguably one of the fundamental and desirable aspects 
of design today, particularly with the wealth of research on going in the field of User 
Centred Design (UCD). Furthermore, one could argue that intuitive design is even 
expected by users of modern products. 
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If products are intuitive to use then there are a range of associated benefits for the 
users themselves. The attainment of truly intuitive design however is undeniably a 
difficult task from the perspective of the designer.   
A phrase familiar to many, whether involved in design or not, is that of ‘Form 
Follows Function’ first coined by Horatio Greenough in 1739 (Papanek, 1984). The 
definition however is often misinterpreted and the meaning behind the original 
statement is lost through modern translations. ‘Form Follows Function’ implies that 
as long as the functional requirements of a design are satisfied, form will follow and 
seem pleasing (Papanek, 1984). In contrast however, others have interpreted the 
phrase to mean that ‘ideal’ form will always work well. Papanek posited that this 
notion of thinking was responsible for many of the ‘sterile, operating-room-like 
furniture and implements’ from the early 20th century (Papanek, 1984). Simply 
designing for functionality does not result in good aesthetic or vice versa. As 
Papanek described design must be meaningful, which goes far beyond satisfying one 
aspect of a product’s design (Papanek, 1984). Generating meaningful designs 
therefore must appeal to the users on a deeper level.  
Designs that are meaningful to users evoke emotional responses or attractions to 
products. Concepts such as brand loyalty and the power of social image and 
acceptance have researched this topic considerably. More specific design research 
has addressed the concept of User Experience. Donald Norman explored the 
emotional effects of products on users in his book Emotional Design (Norman, 
2004). Norman suggests that there are three levels of design namely: Visceral, 
Behavioural and Reflective (Norman, 2004). A description of the ‘Three Levels of 
Design’ are presented in Table 2.3.  
Table 2.3: Three Levels of Design (Norman, 2004). 
Level of Design Description 
Visceral Appearance, Automatic, Prewired emotional reaction. 
Behavioural Performance, Pleasure and effectiveness of use, Controls everyday 
behaviour. 
Reflective Self-image, Personal Satisfaction, Memories. Contemplative 
reaction. 
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While Norman admits the description is perhaps a simplification of design and 
emotion, it raises the issues of ‘trade-offs’ in requirements and the translation of 
emotions into a final product (Norman, 2004). The level of importance attributed to 
each level evidently sits with the manufacturer, yet the outcome of the decisions will 
have the most significant impact on the end user. The principles of emotional design, 
user experience and design as a practice are important considerations in the design of 
home use medical devices.  
Mary Beth Privitera et al posit that medical device design feature ‘cross-functional 
properties which relate to function, appearance and value (Privitera et al, 2009a). 
According to Privitera et al these values are not necessarily equally weighed as there 
is an obvious emphasis upon clinical utility. Nevertheless the authors argue that there 
is an increasing awareness amongst user groups of the requirements relating to 
perceptions of value and appearance (Privitera et al, 2009a).    
An example of a poor design in relation to Norman’s Three Levels of Design is the 
Exubera inhaled insulin device, launched by Pfizer in July 2006. Exubera failed to 
meet the needs of the end user on a Visceral and Reflective level (Johnson, 2007; 
Norman, 2004). At the time, inhaled insulin devices were considered a dramatic leap 
forward in innovation and highly desirable by patients with Diabetes. In many 
respects the potential for this technology is still unattainable by manufacturers and 
the demand very much remains.  
The prospect of administering insulin in a quick and pain free manner when 
compared with injectable devices meant that Pfizer’s new product was highly sort 
after by patients and clinicians. When Pfizer launched the new device onto the 
market, the aesthetics of the final product was presented to healthcare professionals; 
including General Practitioners and Diabetes specialists, which instantly revealed 
problems. Note that these issues occurred following a challenging regulatory process 
for approval in which the efficacy and safety of the device was questioned.  
The aesthetic of the device is provided Figure 2.2. At the final design stage prior to 
launch, medical devices represent a considerable financial investment to the 
company and shareholders. It is therefore often considered critical to attain approval 
and acceptance by the healthcare community at the early stage of the design process.  
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The Exubera device was criticised by healthcare professionals (HCPs) on an 
aesthetic and visceral level. The device invoked a negative emotional reaction to 
HCPs, which represent the medium between the designer and ultimate end users, the 
patients.  
It is recognised that one of the aspects patients like about injectable insulin devices is 
their discrete nature due to the associated stigma of a medical condition. The visceral 
aspects of the Exubera device failed to consider and meet the expectations and needs 
of device users. Similarly, with respect to Norman’s reflective element of design 
appeal, the ‘self-image’ of patients was not addressed in the device design (Norman, 
2004).  
“…the unwieldy device, a tube about the size of a flashlight, drew unfavorable 
reviews from the outset from doctors and investors.” (Johnson, 2007) 
It would appear that during the conception and design stage of the Exubera device 
there was little consideration for the context and environment of device use. As a 
portable device intended for use in the home and public environments the design had 
failed to cater for the needs of its users. The look of the device had detrimental 
effects on the social image of patients making them feel uncomfortable in public.    
Figure 2.2: Pfizer Exubera Inhaled Insulin Device (Johnson, 2007). 
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“The Exubera device, which some compared unflatteringly to a bong for smoking 
marijuana, could also be embarrassing to use in public” (Johnson, 2007) 
Aside from the aesthetical issues concerning Exubera, there were considerable safety 
concerns surrounding the device that resulted in a tough regulatory process for the 
company. At issue, only 10% of the insulin inhaled by the patient would get into the 
bloodstream (Johnson, 2007). The regulators took a strong stance against the device 
and when Pfizer finally received approval, the device had to be launched with a 
cautionary warning label against use of the device by smokers and asthmatics 
(Johnson, 2007). Furthermore, use of the Exubera device required patients to have 
regular lung examinations to ensure they were suitable to use the device and would 
be capable to inhale sufficient doses of insulin.  
There were further issues surrounding the training of patients to use the device. One 
endocrinologist believed it could take up to one (1) hour to train a patient how to use 
inhaled insulin, significantly longer than that of insulin pens which would typically 
take around 5 minutes (Johnson, 2007). Alas, the costs to provide inhaled insulin 
devices are far greater than that of existing devices on the market.  
From a functional and performance perspective, the aspects Norman describes as the 
behavioural level of design, Exubera also failed its users. Patients were required to 
insert packets of powder into the device measured in three or nine milligrams, which 
are not the units doctors typically used (Johnson, 2007). Consequently Pfizer had 
difficulty getting insurance to cover the treatment at a favourable rate and one British 
medical committee felt that the British health authorities should not pay for the 
device at all because it failed to offer any advantages over existing and less 
expensive therapies (Johnson, 2007). This example of medical device failure is 
particularly unique as it represents one of the few drug delivery products pulled from 
the market through lack of sales (Johnson, 2007). More typically this scenario would 
be seen for safety critical devices where reported incidents had been received and a 
subsequent device recall or alert had been called. 
Evidently there were multiple failings with the Exubera device which were not 
limited to just the design and interactions with users. However, the failings in the 
design of the device resulted in a poor uptake and acceptance by both the healthcare 
sector and patients. The project is an example of a technology driven process that 
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perhaps with further consideration for the task, the users and the environment could 
have resulted in a final product more suited to the needs of end users. Reflecting on 
such a failing in the design of a medical device, and more specifically a home use 
medical device by definition, raises the question of how the design community 
prioritise the different levels of design. 
This research aims to ascertain where the needs of end users sit alongside the other 
technical and commercial requirements for home use medical device development. 
One lesson that can be taken from the Exubera example is the essential requirement 
to satisfy relevant regulations in the design and development of any medical device. 
The following section will now explore the current regulations in relation to medical 
devices and home use medical devices before exploring the specific implications for 
design.   
2.3 Medical Device Regulation 
 
The medical device industry is arguably the most heavily regulated industry in the 
world today. The following section reviews the regulatory process for medical 
devices and in particular looks at the regulation of home use medical devices. To 
provide clarity for the reader the definition of a medical device is presented as a 
starting point to this section.  
Due to the scope of this research, the definition used throughout this thesis is in line 
with the European Medical Device Directive 2007/47/EC or MDD as it shall now be 
referred.  
According to the MDD, the definition of a medical device is as follows: 
Any instrument, apparatus, appliance, software, material or other article, whether 
used alone or in combination, together with any accessories, including the software 
intended by its manufacturer to be used specifically for diagnostic and/or therapeutic 
purposes and necessary for its proper application, intended by the manufacturer to 
be used for human beings for the purpose of:  
 diagnosis, prevention, monitoring, treatment or alleviation of disease,  
 diagnosis, monitoring, treatment, alleviation of or compensation for an injury 
or [disability],  
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 investigation, replacement or modification of the anatomy or of a 
physiological process,  
 control of conception,  
And which does not achieve its principal intended action in or on the human body by 
pharmacological, immunological or metabolic means, but which may be assisted in 
its function by such means. (EC, 2007; in accordance with Council Directive 
2007/47/EC).  
The definition by the MDD is very broad in its context and as previously described 
covers an estimated 400,000 different devices on the market today (Quotec. 2010). 
The role of the MDD is to harmonise the regulations for all medical devices sold 
within the European market (EC, 2007). The directive outlines essential safety and 
administrative requirements for all medical devices that fall into the scope of the 
directive. Compliance with the directives requirements must be shown through CE 
marking and only then can a medical device be freely sold throughout the European 
market without being subject to other national regulations.   
Within Europe, medical devices are currently regulated and controlled through three 
directives known as the; Active Implantable Medical Devices Directive (AIMDD) 
90/385/EEC, Medical Devices Directive (MDD) 93/42/EEC and the In-Vitro 
Diagnostic Medical Devices Directive (IVDMDD) 98/79EC. In recent years these 
directives have been supplemented with updates in the form of modified and 
implemented directives with the most recent publication, at the time of writing, being 
the development of a technical revision Directive 2007/47/EC (EC, 2012). 
As of the 26th September 2012 the European Commission announced a series of 
revisions for the regulatory framework (EC, 2012). The changes to the regulations, 
including home use devices, aim to ensure the products are safe and can be freely 
sold and fairly traded throughout the EU. It should be noted that changes and updates 
to the regulation of medical devices is an on-going process due to the evolving 
market shifts and capabilities of technology. The most recent updates aim to address 
the identified issues of medical device traceability to their suppliers, which is not 
always possible, and a lack of transparency on the evidence assessing medical device 
safety and efficacy (EC, 2012).  It is proposed that the new regulations will be 
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implemented in 2014 however there is a recognised transition time during which the 
current regulations will remain in force (EC, 2013).  
A Competent Authority (CA) ultimately determines the assessment of whether a 
medical device meets the applicable regulations. The recognised CA in the United 
Kingdom is the Medicines and Healthcare Products Regulatory Agency (MHRA). If 
a manufacturer is to consider developing a medical device to be distributed globally, 
for example outside of Europe, they must address international regulatory 
requirements. 
The regulation of medical devices in the United States (US) is entirely separate of 
European regulatory system and comes with its own legislation and requirements. 
The recognised CA in the US is the Food and Drug Administration (FDA). The FDA 
uses the code of Federal Regulations to enforce the Federal Food, Drug and 
Cosmetic Act in the regulatory control of medical devices in the US market. The 
significance of the FDA for this research is particularly pertinent due to the size of 
the home use market in the US. As such, the impact of these regulations has global 
significance, particularly to the design community in the UK as many companies 
look to invest in this market demand. The following section will address the key 
differences between these two regulatory bodies and the necessary requirements to 
seek regulatory approval.  
2.3.1 The Differences between EU and US Regulation 
 
The regulatory authoritative bodies responsible for medical devices in EU and the 
US share some principles, however there are noticeable differences between them. 
Alexander and Clarkson refer to the differences in objectives established by the EU 
and US regulations (Alexander, K. & Clarkson, P.J, 2000). The objective of the EU 
regulations is to ensure that devices are safe and perform as the manufacturer 
intended. In contrast, the FDA’s objective is to ensure finished devices will be safe, 
effective and thus present a benefit to the user (Alexander, K. & Clarkson, P.J, 
2000).  
One aspect that is shared by both regulatory bodies is the acknowledgement that 
safety and effectiveness in medical device development is an evolutionary process 
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and therefore cannot be simply assessed through final inspections or testing 
(Alexander, K. & Clarkson, P.J, 2000).  
Due to the scope of this research, the review will not go into greater depth on the 
regulatory process adopted by the US and the FDA. Rather, the review will discuss 
the relevant similarities and where applicable refer to guidance developed by the 
FDA that is referred to in the UK guidance. For those interested in further 
information on FDA regulation, this can be found through the FDA website 
(http://www.fda.gov/).  
2.3.2  Medical Device Classification 
 
Within the EU, medical devices fall into one of four classifications that each has 
slightly different approaches for European Conformance (CE marking). These 
classifications are broadly dependent on the level of risk associated with a device and 
its use. The classifications for medical device regulation are as follows; Class I 
(including Is and Im), Class IIa, Class IIb and Class III. 
The classification of any medical device will depend on the following factors: 
 How long the device is intended to be in continuous use.  
 Whether or not the device is invasive or surgically invasive. 
 Whether the device is implantable or active.  
 Whether or not the device contains a substance, which in its own right is 
considered to be a medicinal substance and has action ancillary to that of the 
device. 
The intended purpose for use, defined by the manufacturer, will determine the 
classification of a medical device and ultimately the regulatory approval process 
necessary for conformity (EC, 2007). This was highlighted earlier in the definition of 
a medical device in the MDD whereby the medical purpose or ‘intended use’ is a 
statement assigned by the manufacturer (EC, 2007). Arguably, this presents an 
opportunity for manufacturers to avoid higher classifications through clearly defined 
purpose and device labelling. Such an approach would enable an easier route to 
market from a regulatory perspective and subsequently a quicker device launch.  
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Due to the size of the European conformance procedures copies of diagrams are 
presented in the appendix of this thesis (see Appendix 1) (MHRA, 2008). What 
follows is a description of the various approaches towards the attainment of a CE 
mark for a medical device.  
The Classifications 
The classifications and associated risks are presented in Table 2.4. Essentially, the 
conformity assessment procedures are more stringent for higher risk device 
classifications (MHRA, 2010).  
Table 2.4: Medical Device Classifications (Adapted from MHRA, 2013). 
Medical Device Classifications 
Class I – generally regarded as low risk 
Class IIa – generally regarded as medium risk 
Class IIb – generally regarded as medium risk 
Class III – generally regarded as high risk 
 
 
Class I Medical Devices 
For Class I medical devices, the initial responsibility falls upon the manufacturer to 
comply with all the essential requirements outlined in the MDD (MHRA, 2008). The 
manufacturer provides a self-declaration to this effect and records this in a written 
statement. The manufacturer must then follow a conformity assessment as shown in 
the flow diagram in Appendix 1 and compile a technical file for the declaration of 
conformity (MHRA, 2008). Finally, the manufacturer must register with a CA, the 
MHRA in the UK and only then can a CE mark be affixed to the medical device.   
For medical devices that feature measuring functions or require sterilisation there are 
further considerations for the manufacturer:  
 Is Medical Devices (Sterility) 
The manufacturer must apply for certification through a Notified Body (NB) on 
aspects of manufacture relating to the securing and maintaining of a sterile barrier.  
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 Im Medical Devices (Metrology)  
The manufacturer must apply for certification through a NB on aspects of 
manufacture relating to metrology for devices with a measuring function. 
 
For those Class I medical devices without a measuring function or sterile 
requirement, certification by a NB is not necessary and conformity with the 
International and European standard ISO EN 13485 Medical Devices is voluntary 
(MHRA, 2008). For reference, ISO EN 13485 outlines requirements for a 
comprehensive quality management system for the design and development of 
medical devices, but is not a mandatory requirement for manufacturers to satisfy.   
Note the role of notified bodies will be discussed later in this review. 
Class IIa and IIb Medical Devices 
In contrast to Class I devices, Class IIa requires further assessment in the form of a 
quality assurance audit by a NB. The declaration must be backed in all cases through 
a conformity assessment conducted by the chosen and qualified NB (MHRA, 2008).  
Typically, the manufacturer has two potential routes to demonstrate compliance, 
what is referred to as an EC declaration of conformity. One approach is to follow the 
guidance set out in Annex II of the MDD, for a full quality assurance route 
incorporating an audit by a notified body to ISO EN 13485. The alternative route is 
to follow the declaration of conformity set out in Annex VII of the MDD coupled 
with one of the following options, defined in the MDD, at the manufacturer’s 
discretion: 
 EC Verification set out in Annex IV. 
 Product Quality Assurance set out by the EC declaration of conformity in 
Annex V. 
 Annex VI Product Quality Assurance declaration of conformity. 
To further support the declaration of conformity, Class IIa devices must be assessed 
by a NB at all stages to assess and ultimately prove whether the manufactures claims 
are supported. 
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In many respects the route for class IIa and IIb are very similar as can be seen from 
the diagrams provided in Appendix 1.  
In the case of Class II medical devices, the manufacturer has two potential routes to 
market. One approach as outlined in Annex II of the MDD is a full quality assurance 
audit. Alternatively manufacturers can follow an EC type examination outlined by 
Annex III of the MDD combined with one of the options described below: 
 Examination and testing of each product or homogenous batch of products 
(Annex IV).  
Or 
 Audit of the production quality assurance system (Annex V) ISO 13485:2003 
(excluding Design).  
Or 
 Audit of final inspection and testing (Annex VI) ISO 13485:2003 (excluding 
Design & Manufacture). 
 
Class III Medical Devices 
Class III medical devices represent the highest risk to device users and this is 
reflected in their regulatory approval process. Unquestionably such devices present 
considerable challenges to the manufacturer to gain conformance and approval. This 
is due to their complexity, invasiveness and in most cases risk to a patient’s life. For 
these reasons the conformance route for Class III devices requires an additional 
design dossier examination by a notified body if the manufacturer opts for a full 
quality assurance audit by a NB in accordance with ISO 13485:2003. The alternative 
route is similar to a class II medical device through an Annex III of the MDD with an 
examination by a NB followed by either; a full production quality assurance audit or 
having every device/batch verified by a NB. The difference between class II and III 
being that class III medical device conformance does not allow manufacturers the 
route of mere inspection as described in Annex VI of the MDD, making the 
requirements and standards for medical devices, deservedly high. 
Further information on the regulatory assessment procedures can be found in 
Appendix 1 of this thesis or by visiting the MHRA website at 
(http://www.mhra.gov.uk/Howweregulate/Devices/). 
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Competent Authorities 
To reiterate, in the United Kingdom, the MHRA is the competent authority qualified 
to ensure medical devices comply with relevant regulations. There are currently four 
sets of Medical Device Regulations implementing all of the MDD amendments to 
date; Statutory Instrument No.618 Medical Device Regulations 2002 (Consolidated 
Legislation), 2003 No. 1697 (Amendments to cover the re-classification of breast 
implants and additional requirements covering devices utilising materials from TSE 
susceptible animal species), Medical Devices Regulations 2007 No.400 (Amendment 
to cover the re-classification of total hip, knee and shoulder joints) and the Medical 
Devices (Amendment) Regulations 2008 No. 2936 which transposes Directive 
2007/47/EC into UK law (MHRA, 2013).  
This section of the review has revealed that an integral aspect of the regulatory 
process is the role of the NB. The following section will address what notified bodies 
do and how they sit alongside the regulatory framework for medical devices. 
2.3.3  Notified Bodies 
 
Notified Bodies or NBs are certification organisations designated by the National 
authority (Competent Authority) of a Member State to carry out one or more of the 
conformity assessment procedures described in the annexes of the MDD (MHRA, 
2006). The previous section highlighted that with the exception of some Class I 
medical devices, all medical devices require the intervention of a NB.  
The chosen NB must be qualified to perform all the functions set out in any annex 
for which it is designated (MHRA, 2006). The designation may be restricted to 
specific types of devices and/or Annexes (MHRA, 2006). It is worth noting however 
that the NB might not necessarily conduct every part of the testing process. Third 
parties or subcontractors may be employed into the certification process to conduct 
testing in external laboratories or by specialists. In such cases the NB must be 
qualified and competent to analyse the results of any tests or audits conducted.  
Despite this, the final responsibility very much sits with the NB concerned and 
therefore the competence of any subcontractors must be ensured by the NB 
themselves (MHRA, 2006).   
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What will a Notified Body do? 
The tasks of the NB will vary according to the classification of the device concerned 
and the preferred assessment route selected by the manufacturer. Typical activities 
performed by notified bodies are described in Table 2.5. 
Table 2.5: Current Roles of Notified Bodies (Adapted from MHRA, 2006). 
Full Quality Assurance – The NB will carry out an assessment of the 
manufacturer’s quality system, including design. They will sample across the 
range of products and processes to ensure that the requirements are being met.  
Examination of the Design – The NB will assess the full design dossier relating 
to each type of product to ensure that they meet the requirements. 
Type Examination – The NB will assess the full technical information relating to 
each type of product and carry out appropriate testing of a representative sample of 
production to ensure that it meets the requirements. 
Verification – The NB will either test every unit or every batch of product to 
ensure that they are meeting the requirements before the manufacturer can place 
them onto the market. 
Production and Product Quality Assurance – The NB will carry out an 
assessment of either the manufacturer’s quality system covering production and 
inspection (Production QA) or final inspection (Product QA). They will sample 
across the range of products to ensure that relevant technical files are available as 
well as ensuring that the relevant processes being undertaken meet the 
requirements. 
 
Evidently, medical device regulation is critical to successful design in the sector. It 
has been argued however that regulation or rather over regulation can limit the ability 
and innovation of the designer (Braungart & McDonough, 2008). This can be drawn 
from the legislative procedures within the available guidance documents themselves, 
which are predominantly prescriptive, outlining a framework for the design process.  
In contrast, design is inherently a creative and innovative process that could be 
considered the antithesis to the prescriptive requirements laid out in current 
legislation and guidance for designers.  
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Braungart and McDonough argue that regulation can be a sign that the design 
process has failed.  
“In a world where designs are unintelligent and destructive, regulations can reduce 
immediate deleterious effects. But ultimately a regulation is a signal of design 
failure.” (Braungart & McDonough, 2008).  
Regulations therefore have potential to both mitigate risks from potentially 
hazardous devices but simultaneously inhibit the role of the designer to deliver 
devices that are truly innovative. 
It has believed that if the process of design is sufficiently understood and 
implemented then regulation should not be so restrictive to innovation. Braungart 
and McDonough posited that ‘good design can require no regulation at all’ 
(Braungart & McDonough, 2008). This does not mean to say that there is no place 
for regulation in the control of medical device design. To the contrary, regulation of 
medical devices is unquestionably necessary in this expansive and diverse market 
where the needs of users and capabilities of technology are ever changing.  
There is however a need to consider the shift in market demands for current and 
future devices used within the home environment, including the implications for 
medical device regulation (Cifter, 2011, Gupta, 2007). Modern devices used in the 
home environment represent a form of cultural shift towards commercially available 
‘consumer medical devices’ (Cifter, 2011; Gupta, 2007). The implications of this 
shift have profound effects on device design, which will be discussed throughout the 
content of this thesis. 
Devices that are now recognised as ‘consumer medical devices’, in that the consumer 
or user has the choice of which device to purchase, calls for additional design 
considerations beyond meeting the safety and efficacy requirements (Cifter, 2011; 
FDA, 2010; Gupta, 2007). Arguably, the designer needs an element of freedom and 
creativity to deliver designs that offer a greater experience for the end user.  
Where regulations are too prohibitive to design then ultimately there will be no 
variation in the availability of devices to users. Perhaps for instances of safety critical 
devices such an approach is necessary and apposite.  
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Norman describes how a ‘standardised’ approach may be necessary when products 
cannot be designed without arbitrary mappings and difficulties to device users 
(Norman, 1998). By standardising the system, the problem or the task, the potential 
for error and requirement for learning is reduced. This approach does have the 
negative consequence however of stagnating innovation and designs that are 
desirable to their users. Furthermore, overregulation can have a negative 
consequence on industry’s perception towards regulation and subsequently have a 
detrimental effect on industry as a whole.  
Aside from assessing regulatory approval, the MHRA also monitor medical devices 
post launch. Once a device is launched onto the market, issues of device use are put 
to real tests with potential users. The following section explores the importance and 
role of adverse incident reporting.  
2.3.4 Adverse Incidents 
 
As the UK’s CA the MHRA are responsible for the monitoring and regulation of any 
adverse incidents involving the use of medical devices. The MHRA define an 
adverse incident as follows (MHRA, 2011a):  
An adverse incident is an event that causes, or has the potential to cause, 
unexpected or unwanted effects involving the safety of device users (including 
patients) or other persons.  
 
Causes of adverse incidents involving devices may include:  
 
• Design or manufacturing problems  
• Inadequate servicing and maintenance  
• Inappropriate local modifications  
• Unsuitable storage and use conditions  
• Selection of the incorrect device for the purpose  
• Inappropriate management procedures  
• Poor user instructions or training (which may result in incorrect user practice).  
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Conditions of use may also give rise to adverse incidents:  
 
• Environmental conditions (e.g. electromagnetic interference)  
• Location (e.g. devices designed for hospitals may not be suitable for a community 
or ambulance setting).  
 
Each year the MHRA produce a report that provides an overview of medical device 
related adverse incidents that are received during the preceding calendar year. The 
report presents the most recent incidents and significant actions taken in that year.  
 
The most recent report available at the time of writing presents the data recorded in 
2010 (MHRA, 2011b). In 2010 the MHRA received 10,280 adverse incidents reports 
involving medical devices, which represents a 13% increase on the previous year 
(see Table 2.6).  
 
Table 2.6: Adverse Incident Reports Received in the UK (MHRA, 2011b). 
Data 2008 2009 2010 
Incident Reports Received 8,902 9,099 10,280 
% change over previous year +3.1 +2.2 +13.0 
 
The figures show a 42% increase over the past decade, which is in line with a global 
rise in adverse incidents. In the US, serious adverse events have tripled in as many 
years (QMED, 2012). As shown in Figure 2.3 below, the FDA received over 400,000 
adverse events with more than 50,000 reported serious patient outcomes in 2011 
(QMED, 2012). Serious patient outcomes are defined by hospitalisation or worse, 
including deaths. These figures represent an annual growth of 45% for adverse 
events associated with device malfunctions or defects in 2011 (QMED, 2012). 
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Figure 2.3: Adverse Event Reports Submitted to the FDA (QMED, 2012). 
 
To refer back to the definition of an adverse incident by the MHRA it is evident that 
the design of medical devices plays a crucial role in these figures. From experience, 
the MHRA suggest that ‘user error’, as it is traditionally known, is sometimes the 
cause of adverse incidents or at least contributes to their cause (MHRA, 2011b). 
However the error on the users’ part is often the result of underlying issues, such as 
device management, maintenance or the adequacy of training for users (MHRA, 
2011b). As such, adverse incidents relating to ‘user error’ are considered a failure of 
the ‘system’ surrounding the use of medical devices, which includes all of training, 
maintenance and the delivery of the device to the patient. In a device bulletin 
available on the MHRA website, the organisation explicitly states the following 
(MHRA, 2011a): 
 
“…the MHRA is concerned with preventing the occurrence of adverse incidents, not 
with assigning blame or liability.” 
 
It is believed that a blame neutral culture to adverse incident reporting will lead to 
increased accuracy and reporting of events involving medical devices through honest 
and open reporting. The failing of the system rather than the user is mirrored by the 
current definition of ‘use error’ adopted by the British Standards Institute (BSI) in 
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the internationally harmonised standard IEC BS EN 62366:2007. The standard 
adopts the term ‘use error’ as opposed to ‘user error’ within the usability standard for 
medical devices which is presented below: 
 
“Act or omission of an act that results in a different medical device response than 
intended by the manufacturer or expected by the user.”(IEC BS EN 62366:2007) 
 
Use error is preferred by the usability standard, as it is blame neutral on behalf of 
device users. Thus, the occurrence of errors is attributable to the use of the device as 
opposed to the user themselves. It has been identified that the number of errors 
attributable to use error caused by inadequate medical device usability are an 
increasing cause for concern (IEC BS EN 62366:2007). Typical examples of use 
errors can include slips, lapses and mistakes by the user (IEC BS EN 62366:2007).  
 
The concept of use error is currently preferred over terms such as ‘user error’ and 
‘human error’ as it is believed that not all errors associated with the use of medical 
devices are attributable to oversight or carelessness on the part of the user (IEC BS 
EN 62366:2007). Rather, as is more commonly the case, use errors are the direct 
result of poor user interface design. Here, the interface represents the point at which 
the user physically interacts with a device to achieve a desired, or as the case may be 
undesired, outcome. One of the most significant contributors to use error is attributed 
to non-intuitive or counter-intuitive displays and controls on devices.  
 
In the US, the notion of a blame neutral term is shared by the American National 
Standards. The American National Standard ANSI/AAMI HE75:2009 defines use 
error as follows:  
 
“Undesirable or unexpected events resulting from the interaction between a user and 
a device; use error accurately indicates error but does not attribute fault to the 
user.” (ANSI/AAMI HE75:2009). 
 
Use error however is not the same as abnormal use by users who actually intend to 
use a device correctly (ANSI/AAMI HE75, 2009). The American National Standard 
explores this topic further and refers to the different types of use errors that are 
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encountered with medical devices. They represent a mismatch between the needs of 
users and the design of the device and/or user interface. As such the consideration of 
the needs and expectations of users during the design process is advocated to develop 
safe and usable devices (IEC BS EN 62366:2007; ANSI/AAMI HE75:2009).  
 
Ward and Clarkson posited that the concept of user errors raises the question of how 
the designer ensured ‘trouble free use’ through good design practice (Ward & 
Clarkson, 2004). It has long been understood that the there is a direct link between 
poor device design and what has traditionally been classified and understood as user 
error (Ward & Clarkson, 2004). IEC BS EN 62366, covered in more detail later in 
this review, outlines three types of use error that can occur with medical devices. The 
diagram shown in Figure 2.4 presents the relationships between the different types of 
use errors.  
 
Actions performed by users can be either intended or unintended. Intended actions 
can refer to abnormal or correct use and mistakes, whereas unintended actions can be 
classified as either slips or lapses. Mistakes by users are intended but incorrect 
actions and therefore constitute use error. Use error specifically can be the result of 
mistakes, lapses or slips as shown in Figure 2.4. A slip or lapse is the result of some 
form of failure in the execution and/or memory recall when performing an action. 
Mistakes on the other hand are failures in judgement and/or inferential processes 
used to select an objective (ANSI/AAMI HE75:2009). 
 
Abnormal use is generally the result of a malevolent action, actions that are intended 
that result in undesirable outcomes. Typically, this form of device use is not 
associated with use scenarios that designers can reasonably anticipate or prevent 
through application of risk control measures (ANSI/AAMI HE75, 2009). This makes 
reference to the regulatory requirement to make devices as safe as is reasonably 
practicable. It is important however for the designer to consider that abnormal does 
occur and ANSI/AAMI HE75:2009 recommends ‘follow-up’ assessments to 
determine whether instances of abnormal use and associated hazards can be avoided. 
This is again supported by IEC BS EN 62366:2007 and is mandated in ISO 14971 
for Medical Devices and the Application of Risk Management (IEC 62366:2007; 
ISO 14971).  
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Figure 2.4: Types of Use Error (Adapted from BSI 62366:2007 and ANSI/AAMI 
HE75:2009). 
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The introduction of the harmonised usability standard in the UK represents the 
increased drive towards improved design in the Medical Technology (MedTech) 
sector (IEC BS EN 62366:2007). The standard and other supportive guidance 
represent ‘push’ factors upon manufacturers to develop intuitive and usable designs 
that meet the needs of end users. 
 
For clarity to readers, the terms incident and event are used interchangeably in this 
section. Under the MHRA definition in the UK, such cases are referred to as 
‘Adverse Incidents’ as per the definition shown previously. Under FDA regulation in 
the US however the term ‘Adverse Event’ is used to describe such cases. For clarity 
from this point forward and due to the context of this research, the MHRA term 
‘Adverse Incident’ will be used throughout the thesis. 
 
While there has been a recognised increase in the number of adverse incidents 
received by the regulatory authorities in both the UK and US, it does not necessarily 
mean that devices are less safe today than they have been previously. There is a 
range of hypotheses as to why recent figures have seen such a significant rise in the 
past decade and these are discussed below.  
 
Drivers in the Rise of Adverse Incident Reporting 
According to a report by the Qualified Suppliers to the Medical Device Industry 
(QMED) there are four recognised key drivers that are responsible for the growth in 
adverse event reports received by the FDA in the US (QMED, 2012). While these 
drivers specifically address figures for the US market they refer to general principles 
that are arguably applicable to the overall rise in the adverse incidents with medical 
devices and therefore have implications for the UK market.  
 
Driver One: Improved Reporting Compliance and Procedures 
The increasing regulation of medical devices, specifically focused on user error as 
previously described, has resulted in an increased emphasis on the reporting of 
adverse incidents. While many argue that adverse incidents are vastly underreported 
it is believed that a significant proportion of the growth in adverse incidents is 
indicative of improved reporting (QMED, 2012). The MHRA have developed an 
online facility through their website for anyone, whether manufacturer, clinician or 
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patient to report an incident at any time. There has also been an increase in device 
bulletins published by the MHRA each year that has led to a raised awareness 
amongst industry to report incidents.   
 
Driver Two: More Devices in Use 
The number of medical devices that can be bought directly in a commercial 
environment or over the internet is increasing (MHRA, 2013). There are more 
medical devices in circulation now than there ever has been and the variety and 
complexity continues to grow. Chapter One introduced some of the drivers for the 
home use market and these trends certainly look set to continue into the future (FDA, 
2010). With more devices in use it can be expected that there will be a rise in the 
numbers of adverse incidents involving devices due to the significant increase in 
their prevalence.  
 
Driver Three: Increased Medical Device Complexity  
As devices become increasingly complex, errors will inevitably rise. Devices that 
were previously used by trained healthcare professionals are now accessible in the 
home environment for use by lay users with a lack of experience and familiarity with 
the technologies (Cifter, 2011). Inappropriate or poor design for the end user leads to 
a mismatch in the expectations of users and the use of a device. Affordances are a 
fine example of this in such cases where ‘pull’ handles are featured on a ‘push’ door. 
In this oversimplified example, the product (a door) is very simple to use however 
the poor consideration for users and their interaction with the product make use 
unnecessarily complex. Device complexity therefore does not only refer to the 
technological capability of a medical device but the interface with which the user 
interacts.     
 
Driver Four: Higher Risk Patient Groups and Procedures 
The final driver recognised for increased adverse incident reporting is the rise in 
high-risk patient groups now using medical devices (QMED, 2012). As 
manufacturers and designers alike attempt to innovate and expand markets, devices 
are increasingly targeting the most vulnerable users (QMED, 2012). In such cases the 
perceived benefits to the patient are considered ‘worth the risk’ for device use and as 
such the potential for adverse incidents to occur is considerably high. 
 
 
55 
 
With the current regulatory framework now presented the focus of this review will 
turn to home use medical devices specifically. The following section opens with a 
brief overview of home use medical devices, including definitions and a taxonomy of 
home use medical devices. 
2.4 Home Use Medical Devices  
 
Until recent times, designers of medical devices designed products that were 
intended largely for use in formal clinical environments by trained professionals 
(National Research Council, 2011). This allowed designers the opportunity to make 
numerous design related assumptions (ANSI/AAMI HE75:2009). These design 
assumptions included the environmental conditions, where typically the device 
would be used and the skills and abilities of the expected device users. It is now 
widely understood that medical devices originally designed for such instances are 
now migrating into the home (Gupta, 2007; Cifter, 2010; Martin et al, 2008). These 
devices present considerable challenges to the role of the designer and numerous 
additional considerations that need to be accounted for in the design and 
development process (Gupta, 2007; Cifter, 2010; Martin et al, 2008). One example 
of such challenges includes the defining and characteristics of home use medical 
device users.  
The cognitive and physical abilities of home use medical device users are hugely 
diverse (Gupta, 2007; Cifter, 2010). To compare such users with healthcare 
professionals, for whom many of these migrated devices were originally designed, 
results in very different levels of training, experience and expectations of device use 
(ANSI/AAMI HE75:2009). Increasingly untrained and inexperienced users of 
medical devices in the home are interacting with complex and sophisticated medical 
technology.  This is further compounded by the symptoms and capability loss that 
are associated with particular conditions.  
In the FDA publication, Do it By Design, Sawyer et al posited that the population of 
home use medical device users represent a special challenge to designers (Sawyer, 
1996). Sawyer et al explained that illness, poor reading ability, inadequate facilities, 
insufficient assistance and inexperience all add to this additional complexity of 
designing a medical device for home use (Sawyer, 1996). It is recognised that one of 
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the factors driving the increased complexity of devices used in the home is the push 
towards shorter stays in hospital and consequently patients are discharged with 
complex care regimens and thus require further care in the home (ANSI/AAMI 
HE75:2009). The very nature of the technology and considerations for the design 
process makes designing medical devices for this market particularly challenging for 
designers (Martin et al, 2008). The conditions of home use medical devices set the 
stage for problems in terms of usability and use errors that both compromise patient 
safety (ANSI/AAMI HE75:2009). Chapter One of this thesis introduced two 
significant bodies of research that have explored the topic of home use medical 
device design (Cifter, 2011; Gupta, 2007). The following section highlights some of 
the findings of these works in more detail before defining the term ‘home use 
medical device’ for the context of this research.  
It has been posited that home use medical devices are particularly unique in the sense 
that they simultaneously represent forms of consumer products and medical devices 
(Gupta, 2007). As previously explained these devices sit between the boundaries of 
consumer products and medical devices (Asl, 2004; Gupta, 2007; Cifter, 2010). This 
connection between consumer products and medical devices forms part of the 
cultural shift towards commercialisation in the medical world. Figure 2.5 is an 
adaptation of the diagram developed by Gupta that demonstrates the relationship 
between medical devices and consumer products (Gupta, 2007). 
 
In his thesis, Gupta found that the majority of designers did not distinguish between 
designing home use medical devices and consumer products (Gupta, 2007). In fact, 
the majority of designers in his study disagreed that home use medical devices are 
any different from either professional use medical devices or consumer products in 
terms of how their design process works (Gupta, 2007). From a purely design 
perspective this finding is concerning as home use medical devices represent a 
significantly safety critical domain.  
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It would appear from the findings of this literature review that there is a real push 
towards commercial issues and much less emphasis put upon device usability. 
Previous research has reported that the consideration of usability within the design 
process is often an afterthought (Martin et al, 2008). Furthermore, the perceived 
costs in time and money outweigh the benefits gained by manufacturers, reportedly 
delaying the time to market (Martin et al, 2008, Money et al, 2011). Alas, the 
incentives for manufacturers to implement such practices within their own design 
process fail to be adopted, despite regular advocacy from researchers. Gupta’s study 
identified that designers believed home use medical devices come with their own 
unique challenges and design issues. These challenges specifically related to device 
usability and risk management (Gupta, 2007). Interestingly, Cifter’s research into 
home use medical device design found a contrasting view. In his thesis, Cifter found 
that designers did distinguish between designing home use medical devices and 
consumer products. Cifter identified four main aspects of design that were unique to 
home use medical devices. These are summarised in Table 2.7 (Cifter, 2011).  
  
Figure 2.5: Gupta's Relationship between Medical 
Devices and Consumer Products (Gupta, 2007). 
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Table 2.7: Cifter's Unique Aspects to Home Use Medical Devices (Cifter, 2011). 
Home use medical devices, by their nature require an intrinsically greater attention 
to matters of lay users’ safety and risks to the lay users.  
A considerable amount of attention should be given to lay users and their 
characteristics, in relation to demographic variety and diverse capabilities.  
Home use medical devices are subject to medical device regulations. 
The functionality and usability of home use medical devices should be optimised 
in order to prevent user errors, because misuse may have more serious implications 
than that of everyday products.  
 
Where Gupta and Cifter agree is that home use medical device design is a complex 
field that is comprised of numerous challenges for the designer (Gupta, 2007; Cifter, 
2011). Delivering a device that is usable, safe and provides a benefit to the user is a 
very difficult task. Cynically, one could argue that any product is the result of 
compromises made throughout the design process to satisfy stakeholders and this is 
particularly interesting for medical device design and this research. By understanding 
designers and stakeholder perspectives of home use medical devices this research 
will ascertain how such compromises are prioritised to deliver safe, usable and 
effective medical devices for end users. This knowledge forms the basis of research 
question one of this research. Both the works of Gupta and Cifter revealed that 
defining a home use medical device in itself is difficult. Evidently there are a host of 
(consumer) products and devices that fall into the scope of home use medical 
devices. Certainly far too many to list here, however for clarity a taxonomy of 
medical devices currently used in the home is presented in Section 2.4.2. 
  
As consumer products and medical devices merge, the expectations of users change. 
Traditionally home use medical devices would wholly have been developed to serve 
the purpose of a clinical need. However as described by the National Research 
Council in their ‘Health Care Comes Home’ report, medical devices are now 
expected to meet the demands of modern lifestyles and consider the implications of 
consumer choice (National Research Council, 2011).  
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“Some types of medical devices have become de facto consumer products, and more 
and more individuals expect to be able to choose products that suit their lifestyles 
and are convenient and easy to use.” (National Research Council, 2011) 
 
For clarity purposes it is necessary to establish what is specifically meant by the term 
‘home use medical device’ within the context of this thesis. The following section 
looks towards a recognised definition.  
2.4.1 Defining Home Use Medical Devices 
 
In order to identify potential users of home use medical devices it is necessary to 
establish a clear definition of what the term ‘home use medical device’ means. This 
is essential for the scope and context of this research. During this review a number of 
definitions were found in the literature.  
In his thesis, Gupta explored the definition of a home use medical device. At the time 
of his research there was no recognised definition of a home use medical device 
(Gupta, 2007). As such Gupta developed a definition of a home use medical device 
within his literature review based on previous examples from the Global Medical 
Device Nomenclature and the FDA (Gupta, 2007). Gupta’s definition of a home use 
medical device used within the context of his thesis was as follows: 
“A home-use medical device is a medical device that is or can be used and/or 
operated by non-professional users, such as patients and their carers, independently 
in the home environment or other non-clinical environments such as people’s cars 
and places of work, etc.”(Gupta, 2007). 
 
This definition recognises the multitude of potential users and environments that fall 
under the term ‘home use medical device’ (National Research Council, 2011). 
Compounding this issue is the recognition that medical devices currently used in the 
home may not have been originally designed for that intention (IEC BS EN 62366: 
2007; Martin et al, 2008). The concept of independence in this definition implies that 
in some contexts of device use it will be necessary for users to be unsupervised. 
Therefore the designer must consider the expectations of device users to develop a 
device that is understandable and operable without assistance. 
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Gupta’s definition makes another reference to the use of mobile or portable medical 
devices that are taken everywhere by their users. This represents a growing trend in 
medical device use. The Exubera device presented in Section 2.2 described an 
example of a portable device and some of the considerations for design. 
Over the years that have passed since the publication of Gupta’s work in this area 
there have been developments in the regulatory definitions of a home use medical 
device. This is largely attributable to the increasing recognition from the regulatory 
bodies of the rise in home use medical devices (Turieo et al, 2004; FDA, 2010; FDA, 
2012).   
One example of more recent research in this field was the thesis conducted by Cifter 
(Cifter, 2011). In the context of his research and the exploration of lay users for 
home use medical devices, Cifter refers to the current definition adopted by the 
Centre for Devices and Radiological Health (CDRH) in the US. The CDRH Home 
Health Care Committee (HHCC) was set up in 2001 to look at medical devices 
through the Total Product Life Cycle (FDA, 2013). Their current definition of a 
home use medical device is: 
“A device intended for use in a non-clinical or transitory environment, is managed 
partly or wholly by the user, requires adequate labelling for the user, and may 
require training for the user by a health care professional in order to be used safely 
and effectively.”(FDA, 2013). 
This definition expands on the issues raised in Gupta’s definition and makes specific 
reference to device labelling and training that may be required to use a device as 
intended by the manufacturer. Furthermore, there are four specific references to 
device use and users in a variety of contexts that ultimately impact on device safety. 
These are briefly summarised in Table 2.8.  
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Table 2.8: References to Users within the CDRH Definition of a Home Use 
Medical Device (FDA, 2013). 
1. Environment of Use - The first context refers to the environment of use 
and where the device is likely to be used by users. 
2. Task - The second context refers to the task directly. This demonstrates 
the importance of identifying the target users for whom the device is 
intended and addressing their needs.  
3. Instructions and Labelling - The third reference relates directly to 
instructions and labelling which must be readily accessible and legible for 
a lay audience. 
4. Training - The final reference refers to the necessary training, 
particularly by healthcare professionals, necessary to use a device safely 
and effectively. The need for training on the use of a device demonstrates 
a need for a level of required knowledge and experience beyond that of 
the capabilities of the user. Essential to designing home use medical 
devices effectively is the understanding of user needs and capabilities to 
make devices usable, safe and of benefit to the user. The design of home 
use medical devices in this context goes beyond designing a product 
alone and more specifically refers to the design of a system that 
compensates for user inexperience or capability loss.  
One final definition of a home use medical device was found during this review on 
the FDA website. On their specific Home Use Devices page, accessible from the 
FDA website, the definition of a home use medical device is as follows: 
 “A home use medical device is a medical device intended for users in any 
environment outside of a professional healthcare facility. This includes devices 
intended for use in both professional healthcare facilities and homes.” (FDA, 2013). 
Perhaps this last definition presents most clearly that a home use medical device has 
the potential to be vast array of devices used anywhere, by anyone. Thus the 
implications for design of such devices are significant. It is the role of this research 
to explore how such devices are designed in practice to deliver benefits to device 
users. 
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2.4.2 Taxonomy of Home Use Medical Devices 
 
The range of definitions for home use medical devices revealed that there are a 
multitude of available devices that are potentially used in the home today. These 
devices could range from simple, understandable and common devices through to 
complex, rare and incomprehensible devices to a vast majority of device users. For 
the purpose of this research it was deemed necessary to gain an understanding of the 
range and complexity of devices that are currently used and are migrating into the 
home environment. As part of this review, a taxonomy of home use medical devices 
was constructed to benefit both the researcher and the readers build a visual 
understanding of the types of devices currently made available to the home use 
market (see Table 2.9).  
The taxonomy structure is adapted from previous literature and taxonomies found 
while conducting this literature search. In particular the works of Gupta and the 
National Research Council were predominantly used to provide a basis for this 
taxonomy (Gupta, 2007; National Research Council, 2011). The taxonomy presented 
here is not exhaustive of all devices currently used in the home. Due to the nature in 
which devices are accessed today it would be almost impossible to determine every 
device that is used in the home environment. Therefore the list presented here 
provides a summary of the range of devices that are known to be in current use 
within the home environment. As such this taxonomy provides a context for the 
definitions of home use medical devices previously described.  
For simplicity and legibility, the range of devices presented in this taxonomy have 
been categorised into three simplistic groups. The categories selected and presented 
in Table 2.9 include: Diagnostics and Monitoring, Therapeutic and Assistive 
Technology.  
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Table 2.9: Home Use Medical Device Taxonomy (Adapted from Gupta, 2007 
and National Research Council, 2011). 
Category Devices 
Diagnostic and Monitoring – For 
home use these devices largely refer to 
test kits used in the self-diagnosis of a 
condition or devices used to monitor 
one’s own health. 
Allergy Test 
Apnoea Monitor 
Bladder Infection Test 
Blood Coagulation Meter 
Blood Glucose Meter 
Blood Pressure Monitor 
Cholesterol Test 
Doppler 
Drug, Alcohol, Nicotine Test 
Electrocardiogram (ECG)/Heart 
Monitor 
Electrocardiogram Monitor 
Fetal Monitor 
Gonorrhoea Test 
Hepatitis C Test 
HIV Test 
Male Fertility Test Kits 
Male/Female/Stress Hormone Test 
Menopause Test 
Ovulation Test 
Peak Flow Meter 
Pregnancy test 
Pulse Oximeter 
Stethoscope 
Thermometer 
Vaginal pH Test 
Weight Scales 
Therapeutic – In the context of the 
home these refer to devices and 
equipment used to treat or prevent a 
condition which may be delivered by 
the patient themselves or healthcare 
professional depending on the device. 
Breast Pump 
CPM 
Defibrillator 
Dosing Equipment 
Feed Pump 
First Aid Kit 
Haemodialysis Equipment 
Inhalers 
Insulin Pens 
Manual Resuscitation Bags 
Massager 
Medication Patches 
Nasal Sprays 
Nebulisers 
Nebulisers  
Oxygen Cylinders 
Oxygen Therapy System 
Suction Pumps 
Syringe Drivers 
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Category Devices 
Syringe Pumps 
Syringes 
TENS (Transcutaneous Electrical Nerve 
Stimulation) Machine 
Tracheostomy Care 
Ventilators 
Volumetric Pumps 
Wound Dressings 
Assistive Technology – Within the 
home assistive technologies largely 
refer to aids that benefit patients with 
mobility issues and physical disabilities.   
Bathing Aids 
Beds, Mattresses and Cushions 
Communication Aids 
Eyeglasses 
Hearing aids 
Hoists 
Incontinence Aids 
Medicine Management Kits 
Orthotic Devices 
Prosthetics  
Scooters 
Stair Lifts 
Vision Aids 
Walking Aids 
 
The review will now discuss the current usability standard IEC BS EN 62366:2007 
which is harmonised under the current Medical Device Directive (MDD). 
2.4.3 IEC BS EN 62366:2007 - Application of Usability Engineering to 
Medical Devices 
 
Recent developments in the literature and academic research have led to the 
increased recognition of usability and in 2007 IEC BS EN 62366 – Application of 
Usability Engineering to Medical Devices was harmonised. The internationally 
recognised standard details the application of usability engineering to medical 
devices (IEC 62366:2007).  
 
The standard was first introduced to counteract the reported rise in use related errors 
caused by poor device usability. It was recognised that medical devices designed 
prior to the introduction of more formal processes were ‘non intuitive, difficult to 
learn and to use’ (IEC BS EN 62366:2007). As a result the standard describes a 
Usability Engineering Process (UEP) for manufacturers and designers alike to follow 
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as a methodology to improve device usability and minimise use related errors. The 
scope of the standard specifies a process for a manufacturer to analyse, specify, 
design, verify and validate usability, and how it relates to the safety of a medical 
device (IEC BS EN 62366:2007). The definition of the term ‘usability’ will now be 
discussed. Within IEC BS EN 62366:2007, usability is recognised as a particular 
characteristic of device design itself. Thus usability is defined as a: 
 
“…characteristic of the user interface that establishes, effectiveness, efficiency, ease 
of user learning and user satisfaction” (IEC BS EN 62366:2007) 
 
However if the concept of usability is broadened out, the International Standards 
Organisation (ISO) also define usability as: 
 
“The effectiveness, efficiency and satisfaction with which specified users can achieve 
specified goals in particular environments” (ISO DIS 9241:2011) 
 
Therefore usability refers to a range of factors specific to design that determine the 
interactions made by users. Consequently good design is paramount to achieve 
improved and usable products for users.   
 
Both ISO definitions make reference to three specific terms that define usability; 
Effectiveness, Efficiency and Satisfaction. To understand usability it is necessary to 
have a greater understanding of what these terms specifically mean and how they 
related to the use of a device.  
 
Patrick Jordan, a renowned usability professional and researcher, defines these terms 
within his book, An Introduction to Usability (Jordan, 1998).  
 
 “Effectiveness refers to the extent to which a goal, or task, is achieved” 
 “Efficiency, meanwhile, refers to the amount of effort required to accomplish 
a goal” 
 “Satisfaction refers to the level of comfort that the users feel when using a 
product and how acceptable the product is to users as a means of achieving 
their goals”  
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Jordan argues that it is possible to make the general assumption that users of 
products that are used voluntarily regard satisfaction as the most significant aspect of 
usability (Jordan, 1998).  In the context of medical devices, the use of devices is 
predominantly mandatory as opposed to voluntary. It is typically more common for 
users of home use medical devices to be required to use a device for a particular 
condition rather than their own choice to do so. Alas, the subject of satisfaction or the 
‘pleasurability’ of medical devices is often an issue for debate.  
That is not to say that satisfaction for medical devices is not an important issue. To 
the contrary, as increasing numbers and varieties of professional medical devices 
migrate into the home the topic of satisfaction will become increasingly important. 
Particularly when we consider that user satisfaction is widely regarded as one of the 
critical factors behind medical adherence and commercial brand loyalty. For over-
the-counter medical devices, where device users are both the purchasers and end 
users of the device, user satisfaction is both more an important and powerful 
consideration for manufacturers. If users are fond of a particular type of device 
produced by one manufacturer they are much more likely to repeat purchase or in the 
case of prescribed devices request them from their general practitioner. This model 
of accessing devices supports the commercial argument and business case for 
companies to invest in usability for medical devices. 
For a manufacturer to meet the internationally harmonised standard there are certain 
steps that must be followed as part of the Usability Engineering Process (UEP) (IEC 
BS EN 62366:2007). A significant part of this process is the collation of the 
‘Application Specification’ (IEC BS EN 62366:2007). This specification includes 
fundamental proponents of a ‘User Centred’ approach to design such as; the intended 
patient (user) population and an intended user profile.  
 
The contents of an application specification include: 
 Intended medical indication. 
 Intended patient population – Examples include; age, weight, health and 
condition. 
 Intended user profile. 
 Intended conditions of use – Examples include; environment of use, hygienic 
requirements, frequency of use, location and mobility. 
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 Operating principle. 
The standard requires that manufacturers identify characteristics that are related to 
safety, including the consideration of the user profile and the features previously 
described that form the application specification.  
The aim of the UEP outlined in the standard is to assess and mitigate risk caused by 
usability problems associated with correct use and use errors (IEC BS EN 
62366:2007). It is believed that by following the UEP, ‘reasonable usability’ can be 
achieved which in turn will lead to a reduction in use errors and minimise use-
associated risk (IEC BS EN 62366:2007). With this in mind, research question one of 
this research aims to establish how usability guidance, specifically IEC BS EN 
62366:2007 is received by practitioners in industry. To ascertain the perceived value 
of such guidance it is necessary to understand how designers consider and involved 
users in the design of home use medical devices, a fundamental principle of a 
usability engineering approach. The review will now turn towards the identification 
of specific design methods currently recognised and used to capture the needs and 
requirements of device users.  
2.5 Design Methods for Medical Device Development 
 
It is acknowledged that designing medical devices is a complex and multi-layered 
process that involves a diverse and skilled team (Lehoux et al, 2011). Understanding 
how individuals from different disciplines and perspectives come together is integral 
to any design process. Each member of the design team brings their own perspective 
to design based on their experience, knowledge and opinions. To ensure that the 
approaches and methods advocated by each member of the design team are 
considered and harnessed the correct design method must be chosen. Similarly, the 
research methods chosen in relation to identifying user needs must be suited to the 
context of the product being designed. This section explores previously used design 
methods in the development of medical devices specific to improving usability.  
To explore the range of methods used in the development of home use medical 
devices, a review of the design method literature was conducted.  
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Martin et al conducted a literature review of methods used to capture user 
requirements to determine the value of such approaches for medical device 
development (Martin et al, 2008). A total of 120 papers were found and over thirty 
(30) methods were reviewed in relation to ergonomics and applications in medical 
device development. Many of the methods highlighted in the review shared 
similarities with one another and featured only slight variations from more 
established or well-known methods (Martin et al, 2008).  
Martin et al presented methods, which were repeated in more than five (5) papers in 
terms of; the types of data generated, the specific considerations for medical device 
development and their potential for improved usability and user satisfaction (Martin 
et al, 2008). The list discussed by Martin et al included: Contextual Inquiry, 
Cognitive Task Analysis, Cognitive Walkthrough, Delphi Technique, Focus Groups, 
Heuristics and Usability Tests (Martin et al, 2008).  
A brief summary of these techniques is presented below: 
Contextual Inquiry (CI) – refers to a specific form of interview conducted within 
the context of use. Participants are asked to perform a task while an interviewer aims 
to extract as much raw data and information as possible through observation. The 
method is regarded as an adapted form of ethnographic research to meet the time and 
budget constraints of engineering (Holtzblatt & Beyer, 1993). Thus, some prefer 
contextual ‘observation’ in place of inquiry as the method refers to a form of 
ethnography. Martin et al believe the method to be particularly suited for medical 
device development during the design of a new, or re-design of an existing, medical 
device (Martin et al, 2008).  
Cognitive Task Analysis (CTA) – refers to a method of data capture that studies the 
mental processes involved for a particular activity. The addition of ‘cognitive’ 
changes the focus of a simple task analysis to that of the mental processes involved 
(Cacciabue, 2004). Cacciabue defines CTA as ‘a method that attempts to specify the 
interaction of mental procedures, factual knowledge, and task objectives in the 
process of job performance.’ (Caccibue, 2004). Martin et al posit that CTA has 
potential value for medical device design. They suggest that through an 
understanding of the cognitive workload and identification of critical decision points, 
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the designs of devices can be informed and supportive of the tasks performed by 
users (Martin et al, 2008).   
Cognitive Walkthrough – refers to a form of expert evaluation specific to the 
usability of a product or device. This method therefore does not include actual end 
users but rather evaluators, typically members of the development team or usability 
specialists, who look for usability issues through the sequence of a performed task 
(Martin et al, 2008). One limitation of this method is the use of experienced 
evaluators who may not necessary represent the actual end users and their likely 
interactions. Martin et al suggest that cognitive walkthrough may be more suited to 
the early stages in the design process whereby obvious usability issues could be 
identified before testing later with actual end users (Martin et al, 2008). 
Delphi Technique – refers to a technique that aspires to gain a consensus of opinion 
from a group of people. This approach is particularly beneficial for prioritising 
requirements that may have been established through other user requirements 
research (Martin et al, 2008).  Delphi Technique, shares some similarities with that 
of Nominal Group Technique in that individual estimates or data is initially collected 
prior to a group discussion on the subject and previous data collected (Robson, 
2011). Revisions are then made to reach a ‘group view’ or consensus (Robson, 
2011). Typically such an approach would involve a number of rounds in which 
questions are revised based on previous responses to clarify issues raised before the 
final round of questions which looks to establish a consensus on the relative 
importance or priority of issues raised in the previous rounds (Martin et al, 2008). 
Focus Groups – are a widely recognised and adopted method for data capture in 
research and commercial business worldwide. Their application in medical device 
development is particularly attractive to designers due to relative low investments in 
time and money to collect data and information from device users (Martin et al, 
2008). Robson defines focus groups as a ‘group interview on a specific topic’ 
featuring ‘open-ended’ discussions guided by the researcher (Robson, 2011). There 
are challenges associated with their use however. For example it can be common for 
one or two persons to dominate a discussion restricting involvement from 
participants who are less willing to share information (Robson, 2011). Furthermore, 
as with interviews, participants are only able to discuss issues that they are aware of 
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and that they can recall or articulate at the time of the interview (Martin et al, 2008). 
To combat these issues Martin et al suggest combining focus groups with 
observational techniques, such as those described in CI, to assess the contextual 
issues of device use (Martin et al, 2008). 
Heuristics – refer to an evaluative usability technique, typically conducted by 
experienced individuals in Human Factors or Human Computer Interaction (HCI), 
which examines the user interface of a product or device against a set of established 
usability heuristics (Usability Net Website, 2003). According to Zhang et al, one 
reviewer can detect up to 35% of usability problems through a heuristics evaluation 
and add that using five reviewers will result in approximately 65-70% of usability 
issues being identified (Zhang et al, 2003). Thus, such an approach is not sufficient 
alone to capture all of the usability issues of a medical device. Martin et al add that a 
heuristics evaluation is potentially more valuable during the early stages as part of an 
iterative design approach (Martin et al, 2008).   
Usability Tests – perhaps the most ubiquitous method associated with the 
development of medical devices today. They refer to the testing of device 
performance in terms of task completion times and rates, ease of use and amount of 
errors (Martin et al, 2008). Usability tests are commonly used during the medical 
device validation stage to demonstrate regulatory compliance (IEC BS EN 
62366:2007). They have been shown to add value for design during the early stages 
of the design process however. Martin et al describe how usability tests can inform 
and help generate usability goals during the early stages and through iteration can 
lead to the refinement of device design (Martin et al, 2008).  
Aside from the seven commonly cited methods for medical device development 
identified by Martin et al, there are alternative approaches available to designers. As 
Martin and Barnett posit it is not suitable to assume that cited methods in the 
literature necessarily reflect those used in practice (Martin & Barnett, 2012).  They 
state: 
“It is difficult to know to what extent the published ergonomics research in this area 
reflects current industrial practice, given the heterogeneous nature of the medical 
device industry and the understandable reluctance of companies to publicise details 
of their development processes.”(Martin & Barnett, 2012). 
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Thus one of the aims of this research is to determine the current methods adopted by 
industrial practitioners operating in the home use medical device market today.  
One alternative approach identified during this literature search for design methods 
includes the possibility of approaching a specialist design consultancy, such as IDEO 
for example.  IDEO is a globally recognised design consultancy that specialise in 
‘human centred’ design for the public and private sectors. Since previous research 
has reported that it is not uncommon for external companies or consultancies to 
conduct specific usability research, it could be considered foreseeable that a 
manufacturer might consider such an approach to identify design research methods 
(Gupta, 2007). Practicing designers could therefore approach IDEO to identify 
relevant or suitable methods for the design of a new or upgrade of an existing home 
use medical device.  
To address this market need, IDEO developed a range of method cards that aim to 
simplify the process of data capture and improve the understanding of designers on 
usability issues. The IDEO method cards were developed as part of a research project 
that aimed to inspire practicing and/or aspiring designers to keep people at the centre 
of the design process (IDEO, 2002). The methods are grouped into four simplistic 
themes; Learn, Look, Ask and Try defined by the nature of the approach. The 
researcher reviewed the cards based on particular references suggested for improving 
the usability of a product. Table 2.10 lists the range of potential methods that might 
be considered suitable during the process of designing and developing a home use 
medical device.  
It was recognised during this review that a range of the methods refer to techniques 
that are similar to those discussed by Martin et al (Martin et al, 2010). The IDEO 
method cards provide ‘snippets’ of information relating to a method offering 
suggested further reading for designers or developers to become more 
knowledgeable about a particular technique. The cards are admittedly intended as a 
guide or reference to the design community and are not intended as a definitive 
solution to usability. Despite this they still provide value in challenging one’s own 
preconceptions of ways to approach a particular problem or design issue. For this 
reason the methods presented in Table 2.10 are listed and do not include a 
description of the techniques. This falls outside of the scope of this literature review, 
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which is specifically focused on the methods applied by industry and cited within the 
literature. For contextual reasons and potential for manufacturers to consider such 
methods it was considered relevant to present these methods here.   
Table 2.10: Potential Design Methods for Medical Device Development. 
(Adapted from IDEO, 2002) 
Role Playing, Competitive Product Survey, Error Analysis, Cultural Probes, Fly on 
the Wall, Guided Tours, Narration, A Day in the Life, Affinity Diagrams, 
Anthropometric Analysis, Behavioural Archaeology, Rapid Ethnography, Personal 
Inventory, Shadowing, Surveys and Questionnaires, Time Lapse Video, Try it 
Yourself, Camera Journal, Card Sort, Character Profiles, Cognitive Task Analysis, 
Activity Analysis, Empathy Tools, Five Whys, Extreme User Interviews, Unfocus 
Groups, Scenarios. 
 
Understandably there are a wealth of design methods or approaches within the 
literature that a manufacturer could use during the design of a product. Some of these 
methods are established formal techniques whereas others are less well known and 
refer to informal approaches. The purpose of this review is not to identify and 
explain every available design method suitable for improving the usability of a 
product. Rather, the aim of this review is to develop an understanding of the user 
research methods that have been used previously to ascertain current practice 
towards user involvement in home use medical device design. 
The literature review conducted by Martin et al was found to be the most relevant 
study into the methods used for the design of medical devices and therefore forms 
the basis of this section. As previously stated however, this thesis is concerned with 
the actual methods used by designers in practice and therefore must be addressed 
through involvement with industry professionals specifically. As Martin et al 
explain: 
“Published papers do not necessarily reflect methods in practice” (Martin et al, 
2008).  
According to Martin et al the selection of methods for user requirements capture will 
depend on the stage of development, the types of users, the time, cost and necessary 
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expertise available to conduct the research (Martin et al, 2008). Thus the process of 
designing a medical device will have significant implications for the consideration 
and involvement of device users within the design process. In order to determine the 
methods adopted by industry to capture the needs of their end users requires the 
involvement and questioning of currently practicing designers. Answering research 
question one with regards to current practice will establish whether methods cited 
within the literature reflect those that are used in practice.  
To understand the range of user research methods used throughout the design process 
it is necessary to have an understanding of the design process of a home use medical 
device. The following section explores the design process as a whole from initial 
conception to launched product on the market. The section will begin with a brief 
description of recognised design processes for product development before 
addressing specific medical device processes. 
2.6 Design Process 
 
In order to understand the design processes used by the medical device industry it is 
necessary to have a detailed understanding and familiarity with general product 
design processes. 
In the seminal text, Design for Usability, Gould and Lewis advocate three principles 
as a basis for a general methodology to design (Gould, J.D. & Lewis, C, 1987). 
These can be summarised as follows: 
I. Early Focus on Users and Tasks – Critical to the design process of any 
physical and functional product is the identification of who the likely 
users will be. This is recognised as a fundamental principle of a ‘user 
centred’ approach to design described in Section 2.9 and supported by 
IEC BS EN 62366:2007 for medical devices. The designer must 
understand the user’s cognitive, behavioural, anthropometric and 
attitudinal characteristics including the tasks to be performed (Gould, J.D. 
& Lewis, C, 1987).    
II. Empirical Measurement – Gould and Lewis believe that users should 
actually use and interact with prototypes or simulations early in the 
development process. User’s reactions and performance should be 
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recorded and analysed to assist the development process (Gould, J.D. & 
Lewis, C, 1987).  
III. Iterative Design - Gould and Lewis refer to iterative design as a way of 
‘confronting the reality of unpredictable user needs and behaviours that 
can lead to sweeping and fundamental changes in a design.’ (Gould, J.D. 
& Lewis, C, 1987). Through early and regular design iterations significant 
improvements for device users in terms of safety and usability can be 
made.  
New innovations to market are less likely, if at all, to have an established user base 
and therefore understanding the exact users, their characteristics and other potential 
users can be very difficult. However as Gould and Lewis point out, this scenario 
strengthens the argument for empirical measurements and iterative design in 
industry’s approach (Gould, J.D. & Lewis, C, 1987). In contrast, when modifications 
are made to an existing device, users and user groups should be readily identifiable 
and accessible. This is particularly common in the medical device industry where it 
has recently been reported that manufacturers often prefer to make major upgrades to 
devices rather than launching a completely new innovation (Eatock, J, Dixon, D. & 
Young, T, 2009). Following the principles of Gould and Lewis therefore suggests 
that design refers to a process that by necessity can require empirical methods and 
iteration to transfer an idea to a product (Gould, J.D. & Lewis, C, 1987). Papanek 
also supports this notion of applying a methodical approach to design in his quote 
presented at the beginning in Section 2.2 of this review.  
“Design is the conscious and intuitive effort to impose meaningful order” (Papanek, 
1984). 
There is of course a wealth of research that has explored the depiction and 
understanding of the design process featuring linear processes to iterative cycles. 
One could argue however that in many cases, models of the design process largely 
follow similar principles when taking an initial concept to a manufactured product. 
One such representation of the design process that is familiar to many designers is 
the work of Michael French in what is commonly referred to as the ‘French Model’ 
(French, 2010). In his book, Conceptual Design for Engineers, French refers to 
design as all of the process from ‘conception, invention, visualisation, calculation, 
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marshalling, refinement and specifying of details which determines the form of an 
engineering product’ (French, 2010). French describes the ‘anatomy of design’ in the 
form of the process shown in Figure 2.6. The ovals within the model depict the 
stages reached while the rectangles represent work in progress (French, 2010). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The model developed by French signifies the importance of an early identification 
and analysis of the problem that from the outset dictates the process of design. There 
is also a ‘Feedback loop’ within the model that calls for the reflection of concepts 
and embodiment back to the original analysis of the problem about what the design is 
aiming to solve. Thus, the model developed by French supports the notion of the 
three principles defined by Gould and Lewis described previously. 
 
Figure 2.6: French's Model of the Design Process (Adapted from French, 2010). 
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Gilman et al suggest a simplification of a general design process can be depicted as 
Figure 2.7 (Gilman, B.L, Brewer, J.E. & Kroll, M.W, 2009).   
 
 
 
 
 
Both French’s model and Gilman’s simplification of the design process are 
recognised approaches to product development. An appreciation of specific stages 
involved in product development is fundamental to the process of designing a home 
use medical device. With this in mind the review will now explore design processes 
specific to medical devices used in the home environment.  
2.7 Medical Device Design and Development Process 
 
This review has highlighted that if a medical device is to be a success in the 
marketplace it is essential for a manufacturer to follow detailed and thorough design 
process towards delivering a quality, safe and effective device that meets the needs 
and expectations of device users (EC, 2007; IEC BS EN 62366:2007). A process that 
Gilman et al refer to as ‘design controls’ (Gilman, B.L, Brewer, J.E. & Kroll, M.W, 
2009).  
According to Gilman et al, design controls are a set of defined systematic steps to be 
followed when designing medical devices to deliver a resulting product that is ‘safe, 
effective and can be successful in a competitive marketplace’ (Gilman, B.L, Brewer, 
J.E. & Kroll, M.W, 2009). By virtue of the potential risks presented by medical 
devices it is of necessity that manufacturers have a rigorous design process in place. 
As Medina et al state that the regulatory governance of medical devices requires a 
separate and adaptive process for medical device development (Medina, 2012). In 
their study, Gilman et al refer to smaller companies and the approach taken for the 
medical device design process (Gilman, B.L, Brewer, J.E. & Kroll, M.W, 2009). 
They posit that while smaller companies may have fewer product lines and can 
Concept Development Manufacturing Distribution
Figure 2.7: Simplified Depiction of the Design Process (Adapted from Gilman, 
Brewer & Kroll, 2009). 
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potentially coordinate resources more easily, there is often a lack of time and money 
to conduct user requirements research in the first place (Gilman, B.L, Brewer, J.E. & 
Kroll, M.W, 2009). The fact that individuals can interact more closely in smaller 
companies allows for simpler processes to function effectively. That said however, 
irrespective of whether the company is large or small, ‘the process intricate or 
streamlined, there are specific steps that must be taken and documented to ensure 
that the result is a desired product that is safe, effective and profitable’ alongside 
regulatory compliance (Gilman, B.L, Brewer, J.E. & Kroll, M.W, 2009). 
Figure 2.7 presents the Medical Device Design Process according to Gilman et al 
(Gilman, B.L, Brewer, J.E. & Kroll, M.W, 2009). The authors describe this model of 
the design process as a detailed approach that might be typically followed by a large 
company developing a medical device. However in their paper, Gilman et al describe 
the design process of a medical device under four simpler stages namely: Concept, 
Development, Manufacturing and Distribution (Gilman, B.L, Brewer, J.E. & Kroll, 
M.W, 2009). This would suggest that similar approaches are applied to medical 
devices as those described in Section 2.6 whereby an initial need is developed 
through a process of iteration towards a final product.   
The Gilman et al design process suggests that medical device design is largely 
defined by the regulatory requirements described in Section 2.3 of this review. 
Gilman et al describe three critical tasks that are to be defined in the development 
phase of the design process: Clinical Testing Required, The Regulatory or 
Governmental Clearances Required and the Reimbursement Strategy (Gilman, B.L, 
Brewer, J.E. & Kroll, M.W, 2009).  
Gilman et al conclude that by following a systematic approach for the ‘entire 
development life cycle’ results in the optimisation ‘of producing a reliable product 
that meets the needs of the customer and is successful in the market place’ (Gilman, 
B.L, Brewer, J.E. & Kroll, M.W, 2009). 
In another study, Eatock et al conducted a survey of the medical device industry to 
determine the tools and strategies towards medical device development dependent on 
the size of company. A summary of the findings is presented below under the 
headings defined by the authors (Eatock, J, Dixon, D. & Young, T, 2009).  
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 Expected and supported – Large companies use a wide variety of 
tools/strategies in parallel, while small companies lag in applying LEAN, Six 
Sigma, stage gates and TQM. 
 Not-expected and supported – Large companies prefer known technologies, 
while small companies prefer new-to-the-world technologies. 
 Surprising – Large companies prefer to perform major upgrades even though 
their success of major upgrades is lower, while small companies have a high 
success rate for new-to-the-world technologies. 
 
The study by Eatock et al indicated that smaller companies typically develop ‘new to 
world’ technologies and it could therefore be argued that their products are possibly 
more innovative to that of their larger competitors (Eatock, J, Dixon, D. & Young, T, 
2009). This is supported by the typical business model of the MedTech sector 
whereby larger companies often ‘buy-out’ smaller innovative companies. The study 
also suggests that smaller companies operating in the sector adopt less formal or 
well-established methods for development such as LEAN or Stage Gate processes 
and might therefore utilise flexible or adaptive processes based on the background 
and experience of the design team.   
Another example of a medical device design process found within this review is that 
of the FDA’s Waterfall Model (FDA, 1997). The Waterfall Model provides a 
simplified schematic of the device design process from the conversion of user needs 
requirements into a finished device. This process is depicted in Figure 2.8 and 
represents another example of the medical device design process as a design-
controlled or systematic process. The FDA have omitted the inclusion of iterative 
‘feedback paths’ between each phase of the process in this diagram, that they state 
would be required, in order to emphasise the influence of design controls in this 
particular model (FDA, 1997). Once the design input has been reviewed and 
determined to be acceptable, ‘an iterative process of translating those requirements 
into a device design begins (FDA, 1997). The initial step of this process requires the 
conversion of the identified requirements into a higher-level specification. As such 
these specifications are classified as a design output using the FDA model. When the 
specifications have been verified to conform to the design input requirements they 
then become a design input for the next step in the design process and this is repeated 
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through the process (FDA, 1997). The Waterfall Model calls for a design review at 
each stage of the design process whilst also introducing for this research the concepts 
of ‘Design for Verification’ and ‘Design for Validation’, which are discussed later in 
this section. 
 
 
 
 
 
 
 
 
 
In addition to these medical device design processes, one example of a specific 
design process for home use medical devices was found.  
Home Use Medical Device Design Process 
As part of the conclusion to his thesis, Cifter developed the ‘Dual Verification Model 
Design Process’, which he proposes as a suitable approach for home use medical 
devices (Cifter, 2011). The process, which can be found on his, website at: 
http://homeusemedicaldevices.com/design/dualverification.html is adapted and 
presented in Figure 2.9. The process appears to get its name from the verification of 
‘Essential Requirements’ and ‘User Requirements’ when designing a concept. In 
doing so, Cifter makes a distinction in the design process between the regulatory 
requirements and the need to capture user requirements as part of a dual approach to 
design a home use medical device.  
 
 
Figure 2.8: FDA's Waterfall Model. 
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Figure 2.9: Cifter's Dual Verification Process for Home Use Medical Devices 
(Cifter, 2011). 
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According to Cifter, the Dual Verification Model has been developed to specifically 
support designers who do not have any prior experience in designing home use 
medical devices (Cifter, 2011). As Figure 2.9 shows, the process is comprised of five 
main stages: Discovering the Task, Task Clarification, Design, Testing and Final 
Validation, which are briefly summarised below.   
1. Discovering the Task – Cifter defines the beginning of the design process 
for a home use medical device with the definition of the task and the desired 
outcomes of that task. In doing so, he suggests that two questions should be 
answered: ‘Who are the target lay users of the device?’ and ‘What is the 
intended purpose of the device?’ (Cifter, 2011). 
2. Task Clarification – According to Cifter, at this stage the requirements of 
the task should be ‘specified precisely’ and consequently involves two 
simultaneous and parallel tasks (Cifter, 2011). Firstly, the needs identified 
with respect to the intended purpose of the device must be investigated 
against the Essential Requirements of the MDD (Cifter, 2011). Secondly, the 
requirements of target or intended users must be investigated with the users 
themselves. This task according to Cifter, will ensure the final product 
developed is designed inclusively and considers the capabilities of the target 
users (Cifter, 2011). 
3. Design – With the requirements now specified and understood they must be 
initially translated into concepts and subsequently verified against the 
requirements. Hence, this stage refers to Design Verification asking the 
question of the designer ‘Are we building the right thing?’ (Cifter, 2011). 
Consequently the best solution to meet the identified and verified 
requirements is selected.  
4. Testing – With the best design selected, Cifter now calls for device testing to 
commence involving the lay users of the device and strongly recommends 
that this be carried out in the context of use (Cifter, 2011). Should necessary 
changes be required at this stage there is an iterative loop back to the design 
stage to improve the design (Cifter, 2011).  
5. Final Validation – In the final stage of the Dual Verification Process, the 
validation of the device is carried out which is supported by the FDA 
waterfall model previously shown (Cifter, 2011; FDA, 1997). As a result this 
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stage of the process helps the designer answer the question ‘Have we built the 
right thing?’ (Cifter, 2011) 
To conclude this section of the review on medical device design processes, the 
concepts of ‘Verification’ and ‘Validation’ are defined to provide clarity for the 
reader. 
Design for Verification 
Design for Verification in the context of medical device design refers to the 
evaluative activity or process that checks whether a device design meets its 
requirements. “Specifically, verification involves checking that what has been 
designed (design outputs) meets its requirements (design inputs) (Alexander & 
Clarkson, 2000). Alexander and Clarkson describe this process as the posing of the 
following question “Are we building the thing right?” (Alexander &Clarkson, 2000). 
Thus verification consists of the detailed examination of specific aspects of the 
design, throughout the development process, assessing that outputs meet inputs.  
Design for Validation 
According to the FDA’s design control guidance, Validation is the culmination of the 
design process including design verification and the assessment of user needs and 
intended users to determine the correct product has been built (FDA, 1997). In this 
definition there is a clear expectation for manufacturers to assess the needs of the 
user throughout the process to culminate in a resultant device that meets their needs. 
Ultimately, it is the validation process that ensures a device is fit for purpose 
throughout the evolutionary process of design and will therefore form the assessment 
of a medical device for regulatory approval. Alexander and Clarkson describe the 
process of validation with the following question: “Have we built the right thing?” 
(Alexander & Clarkson, 2000). 
The processes identified in this section provide a guide for designers to follow when 
designing medical devices both for professional and home use. Supporting these 
processes are relevant guidance documents to assist designers and developers in 
meeting the regulatory requirements for medical devices. The following section of 
the review will now explore the relevant design guidance available to manufacturers 
to assist them in the design of home use medical devices.   
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2.8 Design Guidance 
 
The depth and complexity of the regulatory process described in Section 2.3 
highlighted some of the conformance procedures necessary to acquire a CE mark. 
The previous section revealed that the process of designing a medical device is 
multifaceted and complex (Lehoux, P. et al, 2011; Martin et al, 2008). This 
complexity has called for the development of detailed and descriptive design 
guidance to support the design and development of medical devices.  
Of particular interest for this research is the recent trend towards usability for 
medical devices. Over the past 15 years there has been a significant increase in focus 
towards ‘user centred design’ and ‘human factors’ issues, principles and practices for 
medical devices (National Research Council, 2011).  
Currently there are a number of available guidance documents and standards that 
have been produced in attempt to support manufacturers and designers in the 
attainment of such practices (ANSI/AAMI HE75:2009; IEC BS EN 62366:2007). 
Such documents endorse and advocate principles of ‘user centred design’, ‘human 
factors’, ‘ergonomics’ and ‘usability’, which depending on the document one refers 
too are all used interchangeably with respect to usable and understandable medical 
devices.  
An over simplistic premise of their focus is that of identifying, capturing and 
addressing the needs of device users to deliver products that satisfy their 
requirements, needs and capabilities. A more detailed review of ‘user centred design’ 
and its application to medical devices will be discussed later in this review.    
A list of some of the currently available guidance documents that specifically refer to 
usability and medical device design are summarised below: 
 ANSI/AAMI HE48:1993 – Human Factors and Engineering Guidelines and 
Preferred Practices for the Design of Medical Devices. 
 ANSI/AAMI HE74:2001 – Human Factors Design Process for Medical 
Devices. 
 ANSI/AAMI HE75:2009 – Human Factors Engineering – Design of Medical 
Devices. 
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 IEC 60601-1-11:2010 – Medical Electrical Equipment parts 1-8 General 
Requirements for Safety. (Replaced by: IEC BS EN 62366:2007) 
 IEC BS EN 62366:2007 – Medical Devices – Application of Usability 
Engineering to Medical Devices.  
 BS EN ISO 14971:2012 – Medical Devices – Application of Risk 
Management to Medical Devices. 
 BS 7000 Series including 7000-6:2005 – Design Management Systems 
Managing Inclusive Design.  
This list provided here is not exhaustive of all the available guidance open to 
designers but rather presents the most relevant and important guidance documents 
and standards at the time of writing this thesis. It is worth noting that the regulations 
and standards for medical devices are ever changing with the technological 
advancements of the field and therefore one should always refer to the latest 
publications sourced through the MHRA, FDA, BSI and ISO.  
Evidently from the list above there is a wealth of available guidance documents for 
designers and manufacturers alike to refer to, follow and/or implement. Largely these 
documents are standards, which by their nature would imply that compliance is 
voluntary and not mandatory.  As previously discussed however in Section 2.4.3, 
IEC BS EN 62366:2007 is harmonised under the MDD meaning manufacturers have 
a moral obligation to demonstrate how they have considered usability issues in the 
design of medical devices. It is therefore of interest to this research to determine 
what designers’ perspectives of such guidance documents are and if indeed the 
principles outlined are followed and valued. 
Many of the studies identified in this literature review have suggested or alluded to 
designers requiring support in the design and development process of both home and 
professional use medical devices (Buckle et al, 2006; Cifter, 2011; Gupta, 2007; 
Martin, 2008; Money et al, 2011; Vincent & Blandford, 2011). This research aims to 
establish how the guidance available to designers is actually received and whether 
the principles are valued and adopted. To explore this topic further, one must first 
consider that there is a wide range of design guidance and information available to 
designers from domains outside of design standards relevant to home use medical 
devices. The outputs of the work conducted by Gupta and Cifter addressed the need 
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to support designers in the design process of home use medical devices (Gupta, 
2007; Cifter, 2011).  
Information Resource for Designers (Cifter, 2011). 
In conclusion to his thesis, Cifter developed an informative website or ‘reference 
point’ for designers to refer too when designing home use medical devices (Cifter, 
2011). The website aimed to provide one point of reference that designers could visit 
to locate the necessary information concerned with the design of home use medical 
devices. The site includes tabs with links to the following: Design Considerations, 
Regulations, Documents and useful links for extra reading. A screenshot of the 
website is provided below in Figure 2.10. 
The site is undoubtedly a valuable resource in that designers or researchers can 
instantly access a large amount of information related to the design of home use 
medical devices. Such information could be particularly useful to a start-up company 
for example where contextual information may be missing due to a lack of 
experience in the field.  
One must consider however that such a resource (i.e. an online site for information) 
is only truly useful to industry if practitioners are aware of them in the first instance 
Figure 2.10: Website Guidance for Designers developed by Cifter (Cifter, 
2011). 
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and secondly whether the information is legible and interpretable by the target 
audience. Furthermore, there is a need to explore with the intended audience whether 
the motivations to engage with such guidance exists. 
On reviewing the website it would be reasonable to assume that designers or 
researchers, for whom the site is intended, would be able to interpret and understand 
the information presented. The information and language is clear and simple and the 
progression through the website follows a logical and systematic format in line with 
the design process of a home use medical device. What cannot be inferred from the 
viewing the site however is whether practitioners have an awareness of this resource 
and if indeed they value the content and information it displays. At the time of this 
review no evidence was found for the validation of the website and how it was 
perceived by the target audience. Cifter did however conduct his own validation of 
the website which covered the content and presentation of information (Cifter, 2011). 
Twelve interviews were conducted with designers, of whom 3 had experience in 
home use medical device design.  
According to Cifter, the general feedback about the website was positive however a 
number of differences were raised in the perceived value of the information 
depending on the experience of the viewer (Cifter, 2011). Designers with experience 
in home use medical device design found that the information was too introductory 
however in contrast those with little to no experience preferred this format (Cifter, 
2011).  
The information was also perceived to be very academically orientated and did not 
include enough content on actual design practice. This can be a drawback and 
perception of much of the academic guidance across a range of fields. There seems to 
be a common perception from industry that academic work is naturally theoretical 
and as such lacks practical value in the real world setting. As such increasing 
research is conducted to address the gap between research and practice (e.g. 
Knowledge Transfer Partnerships or KTPs).  
Cifter did propose to continue future work on the validation of the website with a 
redesign based on the comments provided by the designers at interview. Evidence of 
this work however was not found at the time of this literature review.   
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An earlier but equally significant body of research into home use medical devices is 
that of Gupta (Gupta, 2007).  
As an output to his thesis, Gupta developed a Spidergram tool to support the design 
of home use medical devices (Gupta, 2007). The tool made use of Gough’s design 
tool for packaging and aimed to address the challenges and considerations identified 
throughout his thesis (Gough, 2007). Gupta’s tool included considerations for: The 
Lifecycle of a Home Use Medical Device; Design and Manufacture, Point of 
Provision and First Encounter, First Use and Familiarisation, On-going Use and 
Disposal, Business and Technology. The Spidergram included an assistive wheel to 
enable users to plot the scores for each issue accurately.  
In total 58 key issues were clustered into 5 groups (Gupta, 2007). The tool was 
developed to have a dual purpose for designing home use medical devices. Firstly, 
designers could use the tool as a reference for the considerations and issues that need 
to be addressed when designing a home use medical device. In this respect the tool 
shares similarities with Cifter’s Website for designers, in the sense that both 
supportive resources have been developed to inform or educate the design 
community. Secondly, the tool was developed so that it could be used to assess the 
performance against each of the issues to see how well they have been met.  
On completion, Gupta validated the tool with 15 researchers with experience in 
product and medical product design. The researchers were asked to use the 
Spidergram using a product, preferably medically related, to identify any issues and 
challenges with its use. The tool was reported to be well received by the research 
community with participants finding it useful (Gupta, 2007). However, the tool has 
not been validated with actual real end users or the target population. Gupta 
recommended that this work should be conducted as part of some future work yet 
such work has not been found as part of this review.  
Both the work of Cifter and Gupta represent the two main theses in the field of home 
use medical devices. As an output to both theses, it was concluded that supportive 
tools or resources (Informative Website and Spidergram tool) were necessary to aid 
the design and development of home use medical devices. Therefore, one could 
interpret that both bodies of work imply that designing home use medical devices is 
indeed complex by necessity and that supporting the designer in his or her role is the 
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best or most appropriate method to ensure the design of safer, usable and 
understandable home use medical devices. Without an understanding or exploration 
into the evaluation of these information resources from designers themselves it is 
very difficult to determine their practical value to industry.  
In addition to this research, another theoretical framework specific to medical device 
design and development was found.  
Theoretical Framework for Involving Users in the Medical Device Technology 
Development Process (Shah, Robinson and Alshawi, 2009). 
A study conducted by Shah et al aimed to develop a framework for designers that 
would support the involvement of users within the ‘Medical Device Technology 
Development Process’ (MDTDP) (Shah, Robinson & Alshawi, 2009). The 
framework was developed in attempt to help manufacturers in planning and decision-
making about user involvement at different stages in the design process or lifecycle. 
Similar to the study described in Section 2.5 conducted by Martin et al, the 
framework developed by Shah, Robinson & Alshawi posits a range of ‘User 
Involvement Methods’ that could be applied to what the authors refer to as the 
MDTDP (Shah, Robinson and Alshawi, 2009). By the authors own admission this 
process is theoretical and therefore applying such a process in practice will be 
influenced by external factors such time, cost and resources available for example.  
Users of medical devices, particularly in the home environment, are not 
homogeneous which Shah et al suggest is often implicitly considered to be the case 
(Shah, Robinson & Alshawi, 2009). The users of medical devices are incredible 
diverse in nature including many different types and groups of users such as; 
healthcare professionals, carers, and end users to name but a few (Shah, Robinson 
and Alshawi, 2009). Satisfying the needs of users in the home environment is 
compounded by the fact that the end user can be one or more of a long list of 
potential users with different abilities and expectations. The consideration of these 
users within the design and development process is essential to develop an end 
product that satisfies a genuine need. This should include a consideration of the 
potential secondary and tertiary users for whom the device is not directly intended 
however are likely to come into contact with the device.  
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Shah et al posited that users have an expectation when devices are supplied or 
provided to them that the technology will fulfil their personal needs and requirements 
(Shah, Robinson and Alshawi, 2009). Failing to meet the user’s needs has been 
shown to lead to device abandonment and subsequently poor adherence (Batavia & 
Hammer, 1990). This is particularly true for a lot of assistive technology and devices, 
which are increasingly used by patients in the home environment. Once users have 
become frustrated with a device due to the failure in meeting the patient’s needs and 
requirements they often discard or abandon the technology. This is even the case 
after the user has attempted to make their own personal modifications to the device 
in attempt to satisfy their own needs (Batavia & Hammer, 1990).  
Perhaps one reason for this, as suggested by Batavia and Hammer is that users can 
fail to recognise and acknowledge their own needs (Batavia & Hammer, 1990). The 
authors argue that through methods of trialling equipment users are then able to 
identify the device most suited to them. Similarly, when asking users their opinions 
on products and attempting to gain insight into their needs they can often find it 
difficult to articulate exactly what it is they require (Martin et al, 2008). Despite this, 
manufacturers should not be deterred from including users within the development 
process. Although user involvement may not always provide technological 
knowledge and understanding about complex products, it should be conducted to 
reveal insight into the mind of the user (Shah, Robinson and Alshawi, 2009). User 
research will give designers and engineers an understanding of the user’s 
requirements and the context of use that is necessary and vital to improve device 
design and patient adherence.    
There is a reported lack of work that has looked at patients as the end users and their 
involvement within the design process. The reasons for this are diverse and many, 
based on company size and the devices in question. Shah et al believe the lack of 
user involvement is attributable to the personal characteristics of users and the 
requirement to prepare, support and train users to enable their involvement initially 
(Shah, Robinson and Alshawi, 2009). 
One must consider however that an inherent limitation of all guidance to some extent 
is that they are exactly that. By virtue of their nature they provide a guide that may or 
may not be followed in practice. Enforcing standards can only be achieved by 
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legislative powers through regulations and mandatory requirements. In addition it 
should be stated that many guidelines are subjective and therefore open to 
interpretation and experience would suggest that users of guidelines would typically 
take the process of least resistance. 
Gould and Lewis posited that guidelines for design are merely general constraints 
and cannot deal with the choices that need to be made which are highly dependent on 
context (Gould, J.D. & Lewis, C, 1987).  
Sharples et al described the difficulty in changing a manufacturer’s perspective on 
design due an apparent lack of demonstrable ‘evidence’ of the benefits that can be 
gained through adopting an alternative, more user centred approach:  
“If we wish to persuade a device manufacturer to consider a change or enhancement 
to a design for example, it is useful, but often challenging, to obtain specific evidence 
that demonstrates the value of modifying the design, and predicting the impact of 
that design change on consequences of use.”(Sharples et al, 2012). 
 
Alam and Kristensson et al posit that despite the existing wealth of literature on the 
benefits and descriptions of user involvement in medical device development, there 
remains a lack of research concerning the actual process of user involvement itself 
(Alam, 2002; Kristensson et al, 2003).  
 
In the context of home use medical devices it is very apparent that design and the 
approaches by manufacturers are by necessity very commercially driven. When 
considering an output for this thesis, the research must consider and address the 
challenge of bridging the gap between research and practice. Addressing initially 
designers perspectives of guidance will determine whether developing further 
support for the design community is the most appropriate method to deliver ‘user 
centred’ principles for home use medical devices. Previous research on designers’ 
perspectives towards guidance for home use medical devices was found in this 
review.  
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“Although some of them pointed out that usability guides may be useful, most of them 
claimed that they would use their experience most of the time to design their devices 
to be user-friendly and safe.” (Gupta, 2007).   
 
This quote suggests a potential scepticism or lack of appreciation for the value of the 
available usability guidance, as designers would prefer to ignore such information 
and use previous experience to guide their design process instead. If this is the case 
then it raises the question of the value in developing more guidance in the first 
instance that may simply be ignored. Gupta also found that: 
 
“The majority of designers who were involved in this study opined that they never 
consulted or had to consult a usability guidance to design their products for ease-of-
use.” (Gupta, 2007). 
 
This quote indicates the perceived value of usability guidance to designers. If one 
considers, that designers in Gupta’s study preferred to use their own experience to 
design and develop home use medical devices; and that the majority of those 
designers opined that they never consulted usability guidance at all; the value of 
guidance for industry comes into question. This raises a serious question into the 
value and awareness of the design community for usability guidance for home use 
medical devices. It is the aim of this research to explore these issues further and by 
answering the three research questions of this thesis it is hoped that significant 
contributions to knowledge can be made in this area. 
 
Cifter also found that designers were less likely to use available guidance resources 
such as information found in books, journals and industry magazines (Cifter, 2011). 
Rather, they would prefer to use customised information developed through 
interviews and observation, similar to that described by (Martin et al, 2008). In his 
research, Cifter reports that designers of home use medical devices preferred to 
actively take part in their data collection rather than refer to guidance (Cifter, 2011). 
 
To summarise this section, a range of guidance documents, models and frameworks 
to support the design of home and professional use medical devices have been 
identified. Previous studies have suggested that designers fail to see the value in the 
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current guidance and would prefer to use their own experience and practices when 
developing home use medical devices. As the aim of this research is to identify how 
the adoption of usability principles can be incentivised for industry it is necessary to 
understand the application of ‘user centred’ principles, as outlined within the 
usability guidance, and how they apply to home use medical devices  
2.9 User Centred Design 
 
“When the point of contact between the product and the people becomes a point of 
friction, then the industrial designer has failed. On the other hand if people are 
made safer, more comfortable, more eager to purchase, more efficient – or just 
plain happier – by contact with the product, the designer has succeeded.” 
(Henry Dreyfuss, 1955) 
The impact of Henry Dreyfuss on design in the 1960’s was instrumental in the design 
for mass manufacture period. In his book ‘Designing for People’, Dreyfuss posited 
that the study of anthropometrics and scaling of human body measurements are 
integral to the role of the designer (Dreyfuss, 1955). This work provided a foundation 
in decision making for mass production. In many cases this movement meant 
significant economic and social gains for manufacturers and business holistically. 
The shift towards volume production at affordable prices resulted in considerable 
market growth and sparked the beginning of consumerism (Coleman, 2007). 
However, the change also meant that increasingly people who did not ‘conform’ in 
terms of physical, cognitive or mental capacity were beginning to be excluded by 
design.  
Typically elderly and vulnerable users fell outside of the ‘calculated norms’ of mass 
production and consequently relied upon adaptive and assistive technology to use 
mainstream products (Coleman, 2007). Invariably, assistive technology, although 
well intended, lacked aesthetical value and too often shared similarities in design to 
that of hospital equipment (Papanek, 1984). The result of which, meant early 
abandonment of technology and an associated stigma towards assistive technology 
that in many cases is still evident today (Batavia & Hammer, 1990).     
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The area in which so many of these designs were deficient was the consideration of 
user experience and requirements within the design process. Through failing to 
consider the likely users of innovations and products, their needs and capabilities 
were overlooked. The market called for changes in the approach to design and the 
inclusive design movement was born. The shift in paradigm raised a widespread 
recognition that the user and their requirements ‘should be considered and 
incorporated at every stage of the design process’ (Coleman, 2007). The movement 
was compounded by the rapidly changing demographics of society that called for a 
change in industry’s approach to design.  
The impact of this change is the realisation that there will be a significant rise in 
users that experience age related capability loss. The reduction in capabilities such as 
eyesight, hearing, mobility, dexterity and cognition will come to us all at some stage 
in our lifetimes and it is down to the designer to accommodate for the changes in 
user needs (Coleman, 2007). In essence a ‘user centred’ approach to design is 
recognised as the response to changes in society and demands from the marketplace 
that positions the user at the core of the design process. Victor Papanek called for a 
social responsibility of designers in their approach to design at a time when the 
market place was dominated by consumerism and mass manufacture (Papanek, 
1985). For the medical device industry there has been a delay in the application of 
truly ‘user centred’ designs made available for patients and professionals alike. It is 
the aim of this research to address this research-practice gap. This thesis sets out to 
understand if a ‘user centred’ approach to home use medical device design is 
realistically achievable in this technology driven and highly regulated market. 
2.9.1 Towards User Centred Design for Medical Devices 
 
Recent developments within research are starting to address the possible connection 
of ‘user centred design’ principles for medical device design (Vincent & Blandford, 
2011). Vincent and Blandford explored how ‘user centred’ perspectives are built into 
the development process and the external forces that effect their implementation. In 
their study, Vincent and Blandford identified that manufacturers of medical devices 
were all aware of the need for ‘user centred design’ and ‘human factors’ engineering 
practices however they experienced difficulty in implementing them (Vincent & 
Blandford, 2011).  
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This is supported by existing research found in this review that has alluded to the 
challenges of delivering ‘user centred’ principles for medical device design (Gupta, 
2007; Cifter, 2011; Martin et al, 2008; Money et al, 2011). In light of the increasing 
complexity and recognised challenges there have been significant leaps in the 
guidance made available to designers. Section 2.8 of this review revealed some of the 
specific usability guidance currently available (e.g. ANSI/AAMI HE75:2009; IEC 
62366:2007). The natural progression to this work calls for the exploration of what 
‘user centred design’ of medical devices and more specifically home use medical 
devices actually looks like in practice.  
There have been previous attempts to bridge these difficulties for practitioners 
developing medical devices (MATCH, 2010). The Multidisciplinary Assessment of 
Technology Centre for Healthcare (MATCH) project in the UK has made significant 
steps in attempt to deliver approaches for ‘user centred design’ that provide practical 
value to medical device developers. The MATCH project is a research collaboration 
between four UK Universities: Birmingham, Brunel, Nottingham and Ulster. 
Founded in 2003, the Engineering and Physical Sciences Research Council (EPSRC) 
funded project is focused on the delivery of methods and tools that assess the value 
of medical devices from concept to final product (MATCH, 2003). The aim of 
MATCH is to deliver improved decision making for companies to bring better 
products to market more quickly and less expensively and enable healthcare 
providers to adopt products more rapidly and with confidence (MATCH, 2003).  
 
The process shown in Figure 2.11 was developed as part of a series of design 
publications for the National Patient Safety Agency (NPSA) and is based on a 
MATCH guide to meeting user requirements in medical device development 
(MATCH, 2010). The process itself has been developed as part of a ‘user centred 
design’ process for medical devices and was the only specific example found of such 
a process in the literature.   
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Figure 2.11: User Centred Design Process for Medical Devices (MATCH, 2010). 
The process suggests potential stages and methods for involving users in a typical 
development pathway. The process is divided into two main elements, initially 
‘Identifying Requirements’ followed by ‘Ensuring Device Meets Requirements’ 
(MATCH, 2010). In doing so this process refers to the principles previously 
described in Section 2.7 ‘Design for Verification’ and ‘Design for Validation’.  
 
The MATCH process suggests a range of methods considered suitable for the 
particular stage in the design process. The process evidently places an emphasis on 
the need for early or ‘front end’ user focused research, which is supported by the 
number and range of methods under the ‘Identifying Requirements’ phase. Largely 
the methods suggested for the early phase of the design process are exploratory or 
used to define the situation or problem. In the ‘Ensuring Device Meets Requirements’ 
the methods refer to more evaluative or validating approaches to ensure the output 
meets its intention. According to the NPSA guide, the entry point into this process 
will vary depending on the product being developed and whether the design process 
is an upgrading of an existing model (MATCH, 2010). Consequently this process is 
provided as guide for practitioners to assess their own process. 
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One limitation of this particular process however, is that it is yet to be validated in 
practice to determine whether such an approach actually leads to a better or more 
usable product for device users. It is not understood whether such an approach can be 
realistically followed and adopted by practitioners in the commercial setting.  
To summarise this section it is apparent that previous attempts have been made to 
explore the role and benefits of a ‘user centred’ approach for medical devices. Much 
less work however has addressed the possibility of applying such an approach in 
practice towards home use medical devices. There has been little published research 
on the practicalities of delivering a ‘user centred’ approached to home use medical 
device design and designers perspectives towards such research.  
2.10 Researcher Identity Memo 
 
Due to the nature of research and one’s personal beliefs, interests and experiences it 
is evident that any form of studious inquiry will bring elements of researcher bias. 
Robson posited that researchers have a tendency to ignore what they bring to the 
research process in the form of bias' and previous experiences (Robson, 2011). Thus 
one must challenge their own ‘experiential knowledge’ brought to a situation through 
their assumptions and values (Maxwell, 2005, Robson, 2011). The views of Hilary 
Putnam argue that there cannot be a single objective view and that every view is 
articulated through someone’s perspective and is thus shaped by the eyes of the 
observer. (Putnam, 1990).  
The values and bias that are traditionally brought to research based on the researchers 
own background should be removed from the study as opposed to becoming an 
influential part of it (Maxwell, 2005, Robson, 2011). To compensate for the 
researcher’s bias in this field, a researcher identity memo has been developed as part 
of this thesis. The researcher identity memo forms part of the conceptual framework 
of the researchers mind set prior to embarking on this study. A copy of the identity 
memo can be found in Appendix 2 of this thesis. 
2.11 Summary 
 
There review has indicated a current gap in the literature relating to how the 
developed support for companies operating in the home use medical device market is 
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received and implemented. Currently, the lack of evidence suggests that it is not fully 
understood how industry are designing to meet the needs of their end users. There is 
insufficient evaluative research into the impact of supportive guidance and 
information developed to benefit designers in the design and development of home 
use medical devices. There is a need to understand how industry design and develop 
medical devices for home use and the reasons behind their chosen approach. The 
research questions presented in Chapter One aim to address these gaps in current 
knowledge and call for more research in the field.  
 
The following chapter will now present the research methodology for the thesis. The 
chapter will discuss the approaches used to investigate the research aim, questions 
and objectives.    
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Chapter 3  
Research Methodology 
 
“While the success of evolutionary artefacts and craft traditions suggests that 
many human beings are able to do a competent job of design, design failures are 
nevertheless common. The most common reasons include lack of method and 
absence of systematic and comprehensive understanding.” 
(Friedman, 2003) 
Chapter One introduced the motivations, context and research questions of this 
thesis. The previous chapter presented a review of existing research in the field of 
home use medical device design. In light of this knowledge, the following chapter 
will now present the relevant research methodologies to achieve the research 
objectives and answer the research questions. The chapter covers the reasoning 
behind each chosen research method and the design of the studies within the thesis.  
3.1 Introduction 
 
Research has previously been referred to as the systematic investigation of a topic to 
further knowledge and understanding. By definition the term research can have a 
range of meanings. In Friedman’s paper, the meaning of the noun ‘research’ is 
defined as follows: ‘1: Careful or diligent search, 2: Studious inquiry or examination; 
especially: investigation or experimentation aimed at the discovery and interpretation 
of facts, revision of accepted theories or laws in the light of new facts, or practical 
application of such new or revised theories or laws, 3: The collecting of information 
about a particular subject.’ (Friedman, 2003).  
In light of this we find that research in the present day takes many forms. Research is 
conducted for a wide range of reasons beyond the traditional perceptions of research 
as merely scientific investigation within a laboratory environment.  
One could be argue that all research, to an extent, is exploratory in nature as it 
attempts to answer the questions of the researcher(s). In some scenarios for example 
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research may be undertaken simply to further the understanding or explanations of a 
situation or phenomenon.  
Robson suggests that design within research involves the conversion of research 
questions into projects (Robson, 2011). It is vital to consider the design and pathway 
of research from the outset and this next section of the thesis, as outlined by Hakim, 
deals with the ‘purposes, intentions and plans within the practical constraints’ of the 
researcher’s study requirements (e.g. location, time and money) (Hakim, 2000).  
3.2 Research Design 
 
Principally, the term Research Design refers to the issues and considerations that a 
specific body of research should and will address. Therefore the role of design within 
research is critical if the ultimate goals, research objectives and questions are to be 
successfully met.   
De Vaus states that “the function of a research design is to ensure that the evidence 
obtained enables us to answer the initial question as unambiguously as possible” (De 
Vaus, 2001). Thus, research design takes the form of a logical structure or 
progression towards answering or developing a solution to an inquiry (De Vaus, 
2001).      
According to Friedman, the most common reasons for design failure include a lack 
of method and absence of systematic and comprehensive understanding (Friedman, 
2003). Here, Friedman refers to design failure within the process of design itself, 
however the quote arguably holds equally true for a research project. Without 
method there is no logical pathway towards progression and consequently the body 
of research will lack systematic or methodical rigour.  
In attempt to develop a structure to this body of research a framework was 
considered and is described in the following section.  
3.2.1 Research Design Framework 
 
Robson believes it can be beneficial to construct a framework for research design 
(Robson, 2011). Robson posits a framework of the fundamental components required 
to tackle any research problem and the relationships between each component 
(Robson, 2011). The model shown below in Figure 3.1 provides an adaptation of 
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Robson’s Framework for research design, reflecting the perspectives of this research 
project.  The framework is divided into individual components.  
The reasons for constructing the research design framework are threefold. Firstly, 
defining the components and their relationship to the research questions helps define 
a foundation from which the research can build. Secondly, the framework provides 
an aid to the researcher when selecting appropriate research methodologies and data 
analysis techniques. Finally, the framework was felt to aid the reader in his or her 
comprehension of the research design process undertaken in the context of this 
thesis. Each of the components will now be described individually to demonstrate 
how they apply to the research questions.  
 
 
 
 
 
 
 
 
 
Purpose 
The purpose of this research, as outlined in Chapter One, is to fulfil the research aim. 
To remind the reader of this aim it is presented here for clarity: 
To incentivise the adoption of usability principles and the practice of user 
involvement in home use medical device design in the United Kingdom. 
Through a systematic and methodical approach (See section 3.14 for Final Design) 
the research will lead to the identification of gaps in industry’s approach and 
Figure 3.1: Framework for Research Design (Robson, 2011). 
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potential incentives for designers to aid the development of future home use medical 
devices.  
Conceptual Framework 
A conceptual framework in research design refers to the theory about the current 
‘state of play’ in the field and the interrelations between such aspects (Robson, 
2011). While it may be disputed that this theory may be expressed with the bias and 
background of the researcher (See ‘Researcher Identity Memo’ in Chapter Two) the 
framework allows those experiences to be challenged in the approach.  
It goes without saying that the conceptual understanding of the researcher has direct 
influence on the construction of the research questions, thus the research design 
framework uses directional arrows to demonstrate the processes of thought and 
planning in the research process. Once the purpose (Research Aim) and Conceptual 
Framework (Research Identity Memo) have been identified it is possible to specify 
realistic and quantifiable research questions that will then feed into the chosen 
methods and strategies to be used when sampling.   
It should be noted that the framework for this research is flexible due to the nature of 
the chosen approach. As theory and findings emerge from the studies there will be a 
requirement to reflect on the aspects that make up the research framework. This may 
result in the refining of research questions as a result of issues arising that could not 
be foreseen. There may be reasoning to re-evaluate the original purpose of the 
research in light of new information or leads that would require answers to rather 
different research questions.  
Research Questions 
 
De Vaus states that research questions in social research are comprised of two 
fundamental types of question: Descriptive and Explanatory (De Vaus, 2001). 
However, as Saunders et al point out there is potential for a third type of research 
question, which is ‘Exploratory’ in nature. Saunders et al posit that exploratory 
research questions and studies are particularly useful when clarifying the 
understanding of a problem (Saunders et al, 2009). This clarification can often prove 
or disprove the need to research the original intended topic (Saunders et al, 2009)   
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With this in mind, the types of questions specific to this research can either be 
defined as ‘Exploratory’, ‘Descriptive’, ‘Explanatory’ or a combination of 
‘Descriptive and Explanatory’ (Saunders et al, 2009). Table 3.1 presents the research 
questions for this research alongside the type of question they represent. With 
exploratory questions previously described, the descriptive and explanatory research 
questions will now be introduced and how they relate to one another to achieve the 
research aim. 
Table 3.1: Types of Research Questions. 
Research Question Question Type 
Research Question One: How do 
designers consider and involve users in 
home use medical device development? 
Descriptive 
Research Question Two: What are the 
challenges for industry to involving users 
in the design process of home use 
medical devices? 
Explanatory 
Research Question Three: How can 
usability for home use medical devices 
be incentivised for industry? 
Explanatory and Descriptive 
 
 
Descriptive Research Questions 
Descriptive research deals with the ‘real world’ issues and problems of a topic or 
area. De Vaus interprets descriptive research in the sense of posing the question 
‘What is going on?’ and therefore refers to the exploration of a research area in 
attempt to define the current state of play (De Vaus, 2001).   
Descriptive research has come under some scrutiny, as it is perceived by some as 
mere ‘fact finding’. Critics argue that descriptive research can lack focus and that it 
fails to add new information to a field. Others argue that descriptive research is 
essential in developing a greater understanding and knowledge of any field (De 
Vaus, 2011). With reference to the medical device arena this is fundamental as the 
topic is so vast in its complexity and the networks from which innovations, new 
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research, funding and regulations arise. Providing clarity to this field will provide 
real benefit to industry and an understanding of the relationships between end users 
and designers. It is worth noting that these challenges are not only unique to home 
use and professional use medical device design and subsequently could have 
applications in other fields such as consumer products for example.  
Good descriptive research should provoke the ‘why’ questions that form explanatory 
research (De Vaus, 2001). As such, descriptive research is fundamental and has 
added immeasurably to our knowledge of the shape and nature of our society today 
(De Vaus, 2001).  
Explanatory Research Questions 
The explanatory questions help define the ‘Why’ questions of research (De Vaus, 
2001). These questions help develop explanations for why a particular theory or 
phenomenon is occurring. In the context of this research these questions deal with 
reasons and theories behind industry’s current approach to design.  
Table 3.1 presents the different types of research questions for this research. 
Research question one is descriptive in nature as it aims to identify facts about 
current design practice towards user involvement in home use medical device design. 
Prior to understanding and exploring the explanatory research, it is necessary to 
clarify the current situation in the field. Only then can theories be built from the 
research, which will lead to the development of future studies. 
Research question two is explanatory in nature and thus requires a change in 
approach to come to a solution. Preliminary answers to explanatory research 
questions may be identified through conducting descriptive research. That is, in 
identifying current practice towards home use medical device users, information on 
the challenges towards their involvement may be revealed. Understanding the 
challenges towards adopting usability principles and involving users in the design 
process of a home use medical devices will reveal suitable incentives to change 
current practice. 
Research question three is both explanatory and descriptive in nature. This question 
combines the approaches and knowledge of research questions one and two to 
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develop a deliverable or incentive to designers and developers of home use medical 
devices to adopt the principles and practices of usability. 
Methods 
Deciding upon a method is generally regarded as the critical element to achieve any 
target or goal. From a research perspective, the chosen methodology will define 
whether the project will end in success or failure. Applying method to design 
research however is particularly difficult. Methodology as a concept in design 
research is relatively new to the field when compared with the more established 
fields such as the social sciences and psychology. Furthermore, it is often argued that 
design or designing in its practical sense is by necessity an inherently creative 
process and as such the application of method and rigour is received with some 
scepticism by some researchers and designers. Despite this, there is now a growing 
body of literature addressing the issues of applying research methodologies specific 
to conducting research in the design field (Blessing & Chakrabarti, 2009).  
The following section describes the theoretical perspective of the researcher and the 
approaches taken for this research. Prior to the selection of any methods or strategies 
it was deemed necessary to explore the topics of theory, epistemology, and research 
philosophy to draw upon existing research and identify the most suitable method for 
the context of this research.  
3.3 Research Philosophy and Approach 
 
Saunders et al define research philosophy as the development of knowledge and the 
nature of that knowledge (Saunders et al, 2009). According to Saunders et al, the 
research philosophy that one adopts in researching a subject will contain ‘important 
assumptions’ based on the perspective of the researcher and the way in which one 
views the world (Saunders et al, 2009). Without due consideration these views or 
bias’ may well be overlooked. The researcher identity memo described in Chapter 
Two of this thesis provides one of the attempts to deal with this potential bias.  
 
Perhaps what is most crucial with regards to research philosophy, as argued by 
Johnson and Clark, is not whether the research concerned is ‘philosophically 
informed’, but rather how well the researcher is able to reflect upon the philosophical 
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choices made and the ability to defend them with respect to the numerous 
alternatives that could have been adopted (Johnson & Clark, 2006).  
 
The relationship between research philosophies and approaches is clearly presented 
in ‘The Research Onion’ developed by Saunders et al (2009), shown below in Figure 
3.2. This image was sourced online at http://noormanmasrek.blogspot.co.uk, 
however can be found in Chapter 5, page 138 of (Saunders et al, 2009).  
 
The model is comprised of different ‘layers’ that essentially refer to the different 
choices that the researcher must consider and make to solve the research problem. 
The following chapter addresses much of these topics presented here and therefore 
the model is provided for clarity to show the associated relationship between what 
Saunders et al define as: Philosophies, Approaches, Strategies, Choices, Time 
Horizons, Techniques and Procedures (Saunders et al, 2009).    
 
 
Figure 3.2: The Research 'Onion' (Saunders et al, 2009). 
 
 
Saunders et al state that prior to any consideration for data collection and analysis 
techniques, something that Robson described is often the first consideration in a 
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research project, it is necessary to address the outer layers of the ‘onion’ first 
(Robson, 2011; Saunders et al, 2009). This is primarily because the philosophy of the 
researcher and the associated assumptions will ‘underpin’ the research strategy and 
selected methods (Saunders et al, 2009). 
 
To have an understanding of research philosophy it is necessary to examine the 
topics of Epistemology and Ontology and how they relate to one another. The 
following section addresses these topics and explores in more detail the approaches 
for this research. 
3.4 Epistemology and Ontology 
 
One aim that arguably all forms of research share is the acquisition of new 
knowledge, to further the current level of human understanding in a particular 
domain or field. As previously described the aspect that makes each study unique is 
the philosophical perspective of the researcher. The researcher’s definition of 
knowledge dictates not only the application of the knowledge acquired but also the 
way in which others perceive that knowledge.  
Epistemology refers to the philosophical understanding of knowledge and is 
therefore determined by the researcher. Gray describes epistemology as the 
philosophical background for deciding what kinds of knowledge are legitimate and 
adequate (Gray, 2009). 
As shown in Figure 3.3, Crotty believes there is a relationship between epistemology 
and methods chosen by researchers (Crotty, 1998). 
Figure 3.3: The Relationship between Epistemology, Theoretical Perspectives, 
Methodology and Methods (Adapted from Crotty, 1998). 
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Ontology refers to the study of being, the very nature of existence (Gray, 2009). 
Saunders et al describe ontology as being concerned with the nature of reality 
(Saunders et al, 2009). Therefore, ontological issues raise questions of the 
assumptions made by the researcher about the way in which the world operates and 
the commitments held to particular views (Saunders et al, 2009).  
In contrast, epistemology tries to understand what it means to know (Gray, 2009). 
Epistemology is concerned with the understanding and interpretation of knowledge 
specifically. Using Figure 3.3 as an example would suggest that at the very least 
there are three epistemological stances, however Saunders et al in the research 
‘Onion’ refer to up to 10 different philosophies (Saunders et al, 2009). For the 
context of this research it was not considered necessary to explore every research 
philosophy available. Rather, it was deemed more suitable to address the commonly 
recognised stances and determine the nature of the researchers own viewpoint and 
how it relates to the intended research strategy. 
An objectivist epistemology holds that reality exists independently of consciousness 
thus there is an object reality (Gray, 2009). Therefore, research of this stance is about 
discovering this objective truth and could perhaps more commonly be associated 
with, but not limited to, quantitative research. The theoretical perspective most 
linked or closely related to objectivism is positivism.  
In contrast to this epistemological stance, constructionism rejects this view of human 
knowledge. Rather, truth and meaning do not exist in an external world but are 
created by the subjects interactions with the world (Gray, 2009). Hence in 
constructionism, meaning is not discovered but constructed by the individual even 
where research may be concerned with the same phenomenon. This form of 
epistemology is most closely linked to Interpretivism (Gray, 2009).  
It is believed that the researcher’s theoretical perspective sits somewhere between 
these two concepts of knowledge and theory: Positivism and Interpretivism. The 
following section will now explore the two philosophies more specifically to provide 
more clarity and to ascertain the implications of theoretical perspectives on research 
designs.  
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3.4.1 Positivist Paradigm 
 
Positivism was regarded as the dominant form of epistemology in social science 
between the 1930’s and 60’s. The core argument, as defined by Gray, being that the 
social world exists external to the researcher and that the aspects or properties can be 
measured directly through observation (Gray, 2009). 
Typically, science does not begin from observation, but from theory, to make 
observations intelligible (Gray, 2009). It is inevitably necessary to grasp an 
understanding of the ‘research arena’, which may include underlying theory that 
drives the need for investigation or observation. A concept that Williams and May 
refer to as observations that are ‘theory-laden’ (Williams & May, 1996).  
One argument against the positivist philosophy is the belief that no theory can be 
proved through observations alone. Popper suggests that it only takes one instance or 
case that refutes that theory to demonstrate that the theory is false and as such 
believes theories in this sense can only be proved to be false (Popper, 1968).  
A positivist research strategy is likely to use an existing theory and will therefore be 
hypothesis based. The existing theory will then be tested, as part of that research to 
confirm or refute the hypothesis hence this type of research is commonly known as 
‘Theory Testing’.  
The topic of home use medical device design for research is very much in its early 
stages. The use of medical devices in the home environment has only seen a 
particular rise in the last 15 years (National Research Council, 2011). Therefore, it is 
understandable that there is a lack of existing theories in the literature associated with 
design practice for their development.  
Chapter Two of this thesis described the works of Gupta and Cifter and how both 
research projects concluded, at least in laymen’s terms, that designers need support 
in the development of home use medical device design. It is widely understood that 
the design and development of home use medical devices is a challenging process 
(Gutpa, 2007; Cifter, 2011; Martin et al, 2008). Thus, it could be argued that the 
existing knowledge of the field and current understanding would suggest that 
supporting the designer in this process is the ‘best’ approach to delivering improved 
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home use medical devices for the end user. These ideas and knowledge represent a 
form of theory for developing ‘user centred’ home use medical devices.  
With this is mind, one of the objectives of this research is to test this theory or 
perhaps more accurately research recommendation, in practice. A fundamental 
component of this research is to establish the extent to which supportive guidance 
and information relating to usability is followed and adopted by practicing designers 
and developers of home use medical devices. By applying the methodology 
described throughout this chapter, this research will ascertain whether supporting the 
designer in the process of home use medical device design is the best approach to 
delivering improved devices for end users. 
3.4.2 Interpretivist Paradigm 
 
An Interpretivist approach asserts that the natural reality including the laws of 
science and the social reality are intrinsically different and therefore require different 
kinds of method (Gray, 2009). Gray explains that while the natural sciences look for 
any consistencies in the data to deduce laws (nomothetic), the social sciences often 
deal with the actions and behaviours of individuals (ideographic) hence the 
requirements for alternate methods.  
An interpretivist would argue that a positivist’s view of the world fails to allow for 
the complexity of the social reality itself (Saunders et al, 2009). They add that the 
origins of interpretivism come from two intellectual traditions, namely: 
Phenomenology and Symbolic Interactionism (Saunders et al, 2009). Whereby 
Phenomenology refers to the way in which humans make sense of the world around 
them and; Symbolic Interactionism places humans in a ‘continual process of 
interpreting the social world around us’ (Saunders et al, 2009). These two paradigms 
are compared in Table 3.2. 
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Table 3.2: Positivist Paradigm Vs. Interpretivist Paradigm (Adapted from 
Easterby-Smith et al, 2002). 
 Positivist Paradigm Interpretivist Paradigm 
Basic 
Beliefs: 
The world is external and 
objective. 
The observer is 
independent. 
Science is value-free. 
The world is socially constructed 
and subjective. 
The observer is a party to what is 
being observed. 
Science is driven by human 
interests. 
The 
Researcher 
Should: 
Focus on facts 
Locate causality between 
variables. 
Formulate and test 
hypothesises 
(deductive approach) 
Focus on meanings 
Try to understand what is 
happening 
Construct theories and models 
from the data (inductive 
approach). 
Methods 
Include: 
Operationalising concepts 
so that they can be 
measured. 
Using large samples from 
which to generalise to the 
population. 
Quantitative methods. 
Using multiple methods to 
establish different views of a 
phenomenon 
Using small samples researched in 
depth or over time. 
Qualitative methods. 
 
While the researcher can relate to both sets of arguments for Positivist and 
Interpretivist research, it is believed that the philosophy of the researcher and context 
of this research is placed within Interpretivism.  
This research is specifically focused on the observation and understanding of current 
practice for home use medical device design. In particular interest of this research is 
the involvement of users within the design and development process and the meaning 
or reasoning behind the methods chosen by practicing designers. The combination of 
an interpretivist stance and the nature of the research questions previously described 
calls for a mixed method approach. The following sections of this review will 
continue to address the ‘layers’ defined by Saunders et al in the ‘research onion’ 
(Saunders et al, 2009).  
Conducting this review on research philosophies has revealed that is it necessary to 
establish the nature of the research approach, in particular the type of reasoning that 
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in turn will establish the use of theory throughout the thesis. As such the following 
section will begin with Inductive and Deductive reasoning.  
3.5 Inductive vs. Deductive Reasoning 
 
The use of theory in research raises an important question for research design. The 
key question as described by Saunders et al is that whether the research will take a 
deductive or inductive approach (Saunders et al, 2000). In a deductive approach, the 
researcher develops a theory or hypothesis and consequently designs a research 
strategy to test that hypothesis (Saunders et al, 2006). In contrast an inductive 
approach involves collecting data and developing a theory based on the analysis of 
the results.  
 
Gray states that deduction in research begins with a ‘universal view of a situation’ 
and therefore is based on an initial theory (Gray, 2009). In contrast, Induction moves 
from ‘fragmentary details’ that in turn develop into a connected view of a situation 
through induced theory (Gray, 2009).  
An alternative way of thinking about induction and deduction in research is that of 
theory testing and theory building. These terms largely refer to the same principles as 
previously described, however for clarity are discussed here.  
3.5.1 Theory Testing vs. Theory Building Research 
 
According to De Vaus, research can be classified as either one of two styles: Theory 
Testing or Theory Building (De Vaus, 2001). Theory testing refers to research that 
begins with a theory and then uses that theory to shape the research process. The 
perceived theory is used to direct the observations to be made and through deductive 
reasoning these observations should test the theory. This deduction enables the 
research to derive propositions about the theory to assess whether the theory is true 
against real world issues (De Vaus, 2001).    
The literature review in Chapter Two discussed the lack of research that has been 
previously conducted in this field. Presently there is very little theory available 
regarding current practice for the design of home use medical devices. In the review 
only two existing theses were found to explore this area of medical device 
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development: Gupta (2007) and Cifter (2011). Thus this type of research is not 
hypothesis based.  
The research will therefore begin with observations and exploratory research 
sometimes referred to as descriptive based research to establish theories from the 
field.  
Typically theory-testing research is associated with quantitative or clinical research 
such as Random Controlled Trials (RCTs) where established theories already exist. 
The nature of this research is very much concerned with the exploration and 
explanation behind current design practice to deliver improvements as far as is 
reasonably practicable. Thus, this research can more suitably be considered as 
Theory Building. 
Theory building is a process by which research begins with observations and uses 
inductive reasoning to derive a theory from these observations. Previously this type 
of research has been referred to as ‘Post-Factum’ theory whereby the researcher 
produces a theory out of the research and can therefore be considered as the 
antithesis of theory testing (Robson, 2011).  
Through conducting studies within industry (Chapters 4, 5, 6, 7 and 8), theory will be 
established about current home use medical device design and subsequently lead to 
recommendations that are hoped to provide practical value to the field.  
In light of this, an inductive and theory building approach to the studies presented in 
this thesis is employed. The following section will now discuss the concepts of 
quantitative and qualitative research.  
3.6 Quantitative Research 
 
The overarching aim of experimental research is the production of credible results 
that are objective, valid and replicable either by the lead researcher or by others 
(Gray, 2009). This form of research is often associated with objectivism and is 
historically determined by a positivistic theoretical stance to research. 
Typically, quantitative research is guided by specific research questions. These 
questions are investigated through the relevant literature, which guides the 
development of formulated research hypotheses. The research is then about studying 
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and analysing the dependent and independent variables to determine whether those 
hypotheses can be accepted or rejected (Gray, 2009). Quantitative research is 
therefore considered by many to be more rigorous and scientific in its application 
than qualitative research. 
There are however criticisms of quantitative research and this approach is not always 
the most suited method to all disciplines for undertaking research. Gray posits that 
quantitative research can often be removed or ‘disengaged’ from people and the field 
of study (Gray, 2009). For some disciplines this may be necessary or considered a 
positive aspect of the research methodology due to the objective nature of the work. 
For fields such as design research, interaction with target populations and the social 
and cultural aspects of research are very much a critical part of the methodology. In 
such instances a qualitative or mixed methods (i.e. combination of quantitative and 
qualitative) approach can be more practical and fruitful in ascertaining theories and 
insights to support design improvements.  
3.7 Qualitative Research 
 
Qualitative research is sometimes criticised for an apparent lack of rigour in its 
methods or approach. Some argue that there is little difference between case study-
based research and qualitative research. Hakim argues that there are however 
fundamental differences between these bodies of work, particularly from a research 
design perspective (Hakim, 2000). Qualitative research is concerned with obtaining 
personal accounts of a situation or event while case study research is concerned with 
obtaining the ‘rounded picture of a person’s life, a situation or event’ using a variety 
of methods or information sources (Hakim, 2000). 
 
In contrast to much of quantitative research, qualitative research is not built upon a 
unified theory or methodological approach (Flick, 2006; Gray, 2009). As such 
qualitative research adopts various forms of theoretical stances and applies a range of 
methods to develop theories and increase the knowledge of a particular phenomenon.  
Essentially, qualitative research involves a number of characteristics that are 
presented in Table 3.3 below (Gray, 2009). 
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Table 3.3: Characteristics of Qualitative Research (Gray, 2009). 
It is conducted through intense contact within a ‘field’ or real life setting. 
The researcher’s role is to gain a ‘holistic’ or integrated overview of the study, 
including the perceptions of participants. 
Themes that emerge from the data are often reviewed with informants for 
verification. 
The main focus of research is to understand the ways in which people act and 
account for their actions. 
 
Qualitative research can be particularly useful in fields or circumstances where 
relatively little is known about the phenomenon, or to gain new perspectives on 
issues where there is already existing knowledge (Strauss & Corbin, 1998; Gray, 
2009). 
Quantitative and qualitative research are two established and widely recognised types 
of research. It is unsurprising therefore that the recent (mixed methods), regarded by 
some as the third, ‘paradigm’ for research is met with some scepticism. The 
following section explores mixed methods research before outlining the relevant 
research strategies for this thesis. 
3.8 Mixed Methods Research 
 
Mixed methods research is a combination of the principles and philosophies applied 
in quantitative and qualitative research. As Johnson et al explain the approach adopts 
a ‘pragmatic method and system’, which is based on a view that knowledge is 
socially constructed (e.g. constructionism) (Johnson et al, 2007). As such a mixed 
methods approach to research makes use of induction, deduction and abduction 
(Gray, 2009). Johnson and Onweugbuzie describe these terms for theory as follows 
(Johnson & Onweungbuzie, 2004): 
 Induction – To identify Patterns 
 Deduction – Testing Theories and Hypotheses 
 Abduction – Uncovering and relying on the best explanations for 
understanding one’s results. 
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As Gray explains, these methods can be used interdependently and in a range of 
different sequences to answer the same research question or different questions 
(Gray, 2009). In his book, Doing Research in the Real World, Gray presents four 
different types of mixed method design, which are shown above in Figure 3.4. The 
image above is sourced online from Google Books and can be found in Chapter 8, 
page 206 in Gray (2009).  
Model One, or Design One as Gray describes, presents an approach utilising a 
qualitative strategy followed by a quantitative strategy and finally a qualitative study 
at the end. In his example, the process begins with an exploratory, qualitative 
framework, which informs the classification of themes and concepts under study 
(Gray, 2009). The importance of the exploratory study at the beginning of the 
research process is to support and aid the development of the quantitative 
questionnaire as shown in Figure 3.4.  The findings of the questionnaire and 
quantitative data are then tested and deepened by the next qualitative study (Gray, 
2009).  
Design Two begins in the opposite fashion to that of Design One. Here, an initial 
quantitative survey is conducted to determine the importance of issues under 
research. This is followed by a qualitative study that provides the researcher with a 
deeper understanding of the phenomenon. To conclude this model, an experiment is 
designed to test some of the results, findings or theories established through 
conducting the earlier studies.  
Figure 3.4:  Four Mixed Methods Models (Gray, 2009). 
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Design Three illustrates the integration of both qualitative and quantitative methods 
that may be necessary to generate an understanding of the case. Finally, Design Four 
presents an example of a multi-wave survey approach (Gray, 2009). According to 
Gray, the initial survey, wave one, indicates to the researcher what the qualitative 
study must look for and the findings of this will then inform and modify the next 
wave of quantitative research (Gray, 2009).  
With these designs in mind there are primarily three types of approach for mixed 
methods research, which are discussed below. 
Qualitative then Quantitative 
This approach is perhaps one of the most common in mixed method designs. As 
shown in Design One, the qualitative study informs the quantitative study. This type 
of design is particularly suited to fields of study when relatively little or nothing is 
known about the research setting or problem (Gray, 2009). In this instance it would 
be inappropriate to launch into a quantitative study, such as a large survey for 
example, when the variables to be measured are unknown or the researcher has an 
insufficient understanding of the topic. Therefore the use of a preliminary or early 
qualitative study informs both the researcher and the research about the variables that 
require further investigation.  
Quantitative then Qualitative 
In contrast to qualitative then quantitative, this approach requires an understanding of 
the research topic to inform an initial quantitative study. This approach is reflected in 
Design Two of Figure 3.4 where the quantitative findings are deepened by a 
qualitative study that might be conducted to establish the ‘why’ questions of the 
research.  
Quantitative and Qualitative Concurrently 
Designs Three and Four combine the strategies of both quantitative and qualitative 
research. It is possible to pose quantitative questions within an interview for 
example, which can then be followed by a qualitative question as part of the same 
methodology. Such an approach can reveal depths and complexities within the data 
that might be missed within a mono-approach.  
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Understandably there a wide range of strategies that fall into the categories of 
qualitative, quantitative and mixed methods research. Some methods can be applied 
to all types of research paradigm and therefore categorising methods under a specific 
type of research presents little value in real terms. What is more pertinent in the 
context of research is whether the chosen method(s), or what Saunders et al refer to 
as Strategies, successfully meet the research objectives (Saunders et al, 2009). The 
following section will now address this issue. 
3.9 Research Strategies 
 
Deciding upon an appropriate research strategy for a particular study is no easy task. 
Saunders et al posit that the decision upon which research strategy to use must be 
based on whether the particular strategy will answer the intended research question 
and subsequently meet the objectives of the researcher (Saunders et al, 2009). Along 
with the research questions and objectives they add that the ultimate selection of the 
research strategy must be informed by the extent of existing knowledge, the time 
given to study, resources (e.g. funding etc.) and the philosophical stance of the 
researcher (Saunders et al, 2009).  
Saunders et al describe seven different research strategies within the research onion 
(Saunders et al, 2009). Note, that these strategies for research are not necessarily 
exclusive and can in fact be used in combination (e.g. a survey within a case study). 
Each of the strategies described by Saunders et al can be used to conduct 
‘exploratory, descriptive and explanatory’ research as described in Section 3.2.1 
(Saunders et al, 2006; Yin, 2003). The strategies described by Saunders et al will 
now be introduced before the chosen research strategy is presented.   
Experiment 
An experiment within research is perhaps most commonly associated with the 
stereotypical and traditional understanding of research in a laboratory environment. 
However, as Saunders et al state this strategy for conducting research is used 
throughout social science and psychology too (Saunders et al, 2009). According to 
Hakim, the purpose of experiments are to study ‘causal links’ and whether a change 
in one independent variable leads to a change in another dependent variable (Hakim, 
2000). Assessing the links between variables through controlled experimental groups 
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is ubiquitous throughout the commercial sector in understanding purchasing 
decisions for example.  
This form of research strategy is typically used for exploratory and explanatory 
research or the ‘how’ and ‘why’ questions of a phenomenon. By their nature, 
experiments are typically guided by a theoretical hypothesis and could therefore 
classically be described as a deductive form of research. For the context of this 
research however, experiments are regarded as unsuitable, both in terms of the nature 
of the research and the ability to successfully answer the research questions of this 
thesis.  
Survey 
Surveys are a commonly utilised research strategy in both quantitative and 
qualitative research. Gray describes surveys as a systematic collection of data that 
whether conducted by interview, questionnaire or observation, must be focused on 
the ‘importance of standardisation’ (Gray, 2009). Here, Gray refers to the 
reproducibility of the survey procedure to eliminate errors in the data collection 
method.  
Irrespective of the chosen method to conduct a survey, the researcher(s) must always 
ensure that the approach taken is the same with every participant to reduce the 
influences of bias (See section ‘Dealing with Bias’) and potential for errors in the 
data.  
The popularity of the survey method is attributed to the relative ease with which 
large amounts of data can be collected in an economical manner (Saunders et al, 
2009). Under the correct strategy, a survey can be used to generate findings that are 
representative of the whole population under study without having to invest 
considerable time, effort and money to access the whole population (Saunders et al, 
2009).  
Surveys are commonly administered as questionnaires. This approach allows for both 
quantitative and qualitative data to be collected from a sample population. Saunders 
et al state that selection of a survey questionnaire is determined on how it is to be 
administered, whether it is to be completed by the individuals themselves or with an 
interviewer posing the questions (Saunders et al, 2009).  
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In spite of this however it should be noted that one of the drawbacks in such an 
approach is the relationship between the length of a survey and response rate. Thus, 
the longer a survey takes to complete the less likely the respondent is to actually 
complete it. Furthermore, the survey is unlikely to be completed as intended by the 
researcher.  
The survey strategy including all of questionnaires, interviews and observation 
present considerable scope for the context of this research. There are however many 
issues to consider when selecting this method, specifically in terms of ethics and 
design.  
Case Studies 
In general research terms, case studies tend to be much more focused and specific to 
a particular domain or phenomenon. While surveys, particularly questionnaires, can 
address a range of issues from a wide range of participants, case studies can focus on 
individuals, organisations or a specific contexts (Gray, 2009). Case studies can be 
invaluable when exploring areas of little or no previous experience as they are an 
ideal way of increasing understanding, extending experience and conviction about a 
subject. To refer back to Gray’s Design One, a case study is a good example of a 
strategy that can inform future quantitative research, particularly in a field such as 
home use medical device design where very little theories currently exist.  
Case studies however do benefit from the prior development of a theoretical position 
to help direct the data collection and analysis process (Gray, 2009). In this respect 
case study research can be deductive in nature as it looks to confirm or reject a 
particular theory about the phenomenon under study (Gray, 2009). Although case 
studies are very flexible in nature they do require the researcher to have formulated a 
structure and detailed research questions that they attempt to answer by doing the 
study. Thus, the researcher must be prepared to quickly interpret responses or react to 
information they receive and be informed enough to make necessary responses.   
Morris and Wood posit that a case study strategy is especially useful ‘to gain a rich 
understanding of the context of the research and the processes being enacted (Morris 
& Wood, 1991). This again supports the notion of an early contextual study that 
informs future studies as part of a mixed methods approach.  
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According to Gray there are four main types of case study design, which are 
presented in Figure 3.5. 
 Single Case Designs Multiple Case Designs 
Holistic 
(Single Unit of Analysis) 
 
Type 1 
Single/Holistic 
 
Type 2 
Multiple/Holistic 
Embedded 
(Multiple Units of Analysis) 
 
Type 2 
Single/Embedded 
 
 
Type 4 
Multiple/Embedded 
 
Figure 3.5: Main Types of Case Study Design (Adapted from Gray, 2009). 
Single, Holistic Case Studies 
In this type of case study, one single case is examined at a holistic level (Gray, 
2009). A case study at this level might explore a programme or organisation rather 
than individual elements within it. According to Gray, a single case study should be 
used when there is a requirement to test a hypothesis or theory, or where there might 
a ‘revelatory case’, which presents a unique opportunity to the researcher (Gray, 
2009). Saunders et al state that single, holistic case studies provide the opportunity to 
observe and analyse a phenomenon that few have considered before (Saunders et al, 
2009). Gray adds that this type of case study design can be used as a ‘precursor’ to 
further studies (Gray, 2009). 
Single, Embedded Case Studies  
An embedded single case study shares similarities with a single holistic design, 
however in this type of study there are a range of different units of analysis that need 
consideration. An example of such a case study might include the analysis and 
comparisons of a process from different employee perspectives within an 
organisation to gain a wider context of the case under study.  
Multiple, Holistic Case Studies 
In this type of case study a single, holistic unit of analysis is studied in multiple 
cases. The aim of this design is not to increase the size of a specific sample but rather 
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to replicate the findings of one (holistic) case across a number of cases (Gray, 2009). 
One of the drawbacks in such an approach however is that due to the holistic nature 
of the study it can be possible for the focus to shift without intention or awareness of 
the researcher. Rather than answering the original questions the case study can 
change direction and consequently answer rather different questions. 
Multiple, Embedded Case Studies 
Finally, a multiple embedded case study makes use of multiple cases and multiple 
units of analysis. Gray argues that embedded cases for multiple case studies are 
advantageous over holistic studies as they reduce the likelihood of problems 
occurring between the research questions and direction of the study (Gray, 2009).  
Action Research 
According to Saunders et al the term ‘action research’ was first used in 1946 and has 
since developed into a range of definitions used by practitioners and researchers 
today (Saunders et al, 2009).  One recognised definition of action research is that the 
purpose and focus must be upon ‘research in action rather than research about action’ 
(Coughlan & Brannick, 2005). Here, the research may be concerned with the 
delivery of solutions to an organisational issue including the implications of that 
change on those who are affected (Saunders et al, 2009).  
A second recognised definition of action research refers to the involvement of 
practitioners within the research itself. In particular, as Saunders et al state, its focus 
is upon the collaboration between practitioners and researchers to deliver a resolution 
that is of mutual benefit to both parties (Saunders et al, 2009). Another emphasis of 
action research is that it takes an iterative form, one that adopts a process of 
diagnosing, planning, taking action and evaluating (Saunders et al, 2009).  
The aim of this research is to incentivise a change in practice amongst designers and 
developers of home use medical devices. Thus this research can be regarded as 
action research in that it attempts to facilitate change, both in terms of delivering 
improvements in efficiency and quality for practice (Robson, 2011).  
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Grounded Theory 
Grounded theory refers to one of the most influential qualitative approaches (Gray, 
2009). It is defined by Strauss and Corbin as a theory that is ‘discovered, developed 
and provisionally verified through systematic data collection and analysis of data 
pertaining to that phenomenon (Strauss & Corbin, 1998). Gray describes grounded 
theory as a process whereby the researcher works with the participants to actively 
construct the data from a position of static analysis to multiple layers of meaning 
(Gray, 2009).  
In grounded theory the data collection process begins without an initial theoretical 
framework (Saunders et al, 2009). This is supported by Gray, who states that unlike 
deduction, grounded theory does not start with ‘prior assumptions about hypotheses’ 
or a theoretical underpinning that is guided by literature (Gray, 2009). Although 
Gray adds that this does not mean that practitioners of grounded theory embark on a 
study without a theoretical position (Gray, 2009). Rather there should be a balance of 
literature and theoretical understanding that does not impede on the creative nature of 
grounded theory as a research approach (Strauss & Corbin, 1998).  
A grounded theory approach typically begins with data collection in the form of 
observations or a series of observations (Saunders et al, 2009). This data collection 
leads to the development of predictions which are later tested through further 
observations that may or may not confirm the predictions (Saunders et al, 2009).   
Ethnography 
Ethnography as a practice is rooted firmly in the inductive approach to research 
(Saunders et al, 2009). With origins from anthropology its purpose is to describe and 
provide explanations within social world research. Ethnographic research therefore is 
predominantly associated with observation within the ‘naturalistic’ setting. As 
Saunders et al explain, ethnography is particularly appropriate for research that is 
interested in gaining insights in a specific context to provide a better understanding 
and interpretation from the perspectives of those under study (Saunders et al, 2009). 
Adopting this approach for research requires a level of immersion within the context 
of the study that will inevitably call for a level of trust amongst participants and due 
consideration for ethical issues along the way.  
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Archival Research 
The final strategy described by Saunders et al refers to a type of research that makes 
use of administrative records and documentation as a principle source of data 
(Saunders et al, 2009). This approach allows for research questions with a focus on 
past information and the subsequent changes over time to be answered in an 
exploratory, descriptive or explanatory fashion. Understandably this process is 
largely guided by the availability of data both in terms of what exists and what can 
be legally and ethically accessed. Therefore research adopting this approach must 
carefully explore what data and information is available before the research proposal 
is clarified.  
In summary, this research is considered to be a form of action research that attempts 
to provide recommendations and incentives leading to design improvements for 
home use medical devices. Having explored the strategies described by Saunders et 
al, it was concluded that the early stages of this research process will begin with case 
study research. Specifically two case studies will be conducted to provide a 
contextual background and to form the research clarification. Following these case 
studies will be a quantitative study as guided by Gray (2009) in Design One (See 
Section 3.8). This study will then inform a final qualitative study that it is hoped will 
provide answers to research question three of this thesis. By answering all the 
research questions in a systematic approach it is believe that this research will 
successfully meet its aim, which is to deliver recommendations and incentives for 
improved home use medical devices.  
The following section will now discuss the topic of sampling strategies employed in 
this thesis.   
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3.10 Sampling Strategy and Methods 
 
According to Gray, when conducting research to make generalisations about data, a 
sample must be chosen that is representative of the population as a whole (Gray, 
2009). Thus, the characteristics of the chosen sample must be similar or identical to 
those within the population under study. In such scenarios, it is typically the case that 
making such generalisations to a population requires an understanding of the exact 
number of individuals within the population under study. This is highlighted in 
Gray’s definition of the term population as the ‘total number of possible units or 
elements’ that are included in the study (Gray, 2009).  
One example of such a sampling strategy is Random Probability Sampling. This 
strategy implies that each member of the population has an equal chance of being 
selected to take part in a study (Gray, 2009). This however is not always achievable 
in practical terms as access to the necessary information on the exact size of a 
population may not be available. 
It has previously been described that the nature and scope of this research has called 
for a mixed methods approach. Within this approach there are to be a range of 
studies presented in Chapters Four, Five, Six and Seven that will form the 
explanatory and descriptive components of the thesis. In light of this, the sampling 
strategy for this research must be adaptive and reflective in accordance with the 
nature of this research. This does not mean however that the researcher has not 
defined a specific sampling strategy and this will described in the text that follows.  
Section 3.9 provided a summary on the research strategies employed within this 
thesis. In summary, two initial case studies that are exploratory in nature are to be 
conducted to provide research clarification and context for the research. These 
studies intend to reveal insights into current practice for home use medical device 
design that will inform the first quantitative study of this research. For these case 
studies two different companies with experience in home use medical device will be 
chosen to take part in the research. More information on how these companies were 
chosen can be found in Chapters Four and Five.  
The first quantitative study presented in Chapter Five of this thesis attempts to 
identify the current ‘facts of the system’ within the home use medical device 
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industry. Therefore the sampling strategy to be employed for this study is to access 
as many relevant companies as possible with experience home use medical device 
design.  
The target population is anyone currently working or responsible for the design and 
development of medical devices used within the home environment. This includes 
any stage of the design process, as it was considered that ultimately these 
participants, to some extent, would have an influence on the final design. In light of 
this a range of sampling strategies were considered to determine how best to access 
this target population, including the widest range of potential participants. 
Essentially there are two fundamental forms of sampling; probability and non-
probability sampling. Qualitative research typically utilises purposive non-
probability samples as it seeks to obtain insights into particular practices that exist 
within a specific location, context and time (Gray, 2009).  
In non-probability sampling, participants are identified due to their characteristics or 
known behaviours relevant to the research area (Gray, 2009). Due to the very 
qualitative and mixed methods nature of this research and its intentions to access 
designers’ perspectives towards home use medical devices and their users, it is vital 
that involved participants have experience in this field. Accessing this target 
population therefore becomes much more specific and consequently calls for a 
necessary consideration for appropriate sampling methods.  
This approach contrasts quite markedly from quantitative approaches where samples 
are pre-planned. For qualitative research it is much more likely that samples develop 
or evolve once the research has begun. Table 3.4 presents the range of sampling 
methods that were considered for this research. While the list is not exhaustive (there 
are a wide range of methods available) it does provide an insight into some of the 
considerations made by the researcher for this research methodology. The rightmost 
column in the table briefly describes the relevance or suitability of the method for the 
proposed research pathway.  
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Table 3.4:  Sampling Methods (Adapted from Gray, 2009). 
Sampling Method Description Relevance 
Simple Random 
Sampling 
Takes a completely random 
sample of the population. 
This method is used when it 
is believed that the 
population is homogenous 
with respect to the research 
context and questions. It 
relies on access to a 
complete list of the 
population. 
Identifying the complete list 
of designers for home use 
medical devices is a very 
difficult task. No evidence of 
such figures was found 
therefore accurate and correct 
application of this method is 
not achievable for the context 
of this research. 
Criterion 
Sampling 
A sample is selected based 
on the focus of the study 
therefore all cases would be 
chosen to meet this 
criterion. 
Criterion sampling would be 
relevant for this research as 
participants would be 
specifically home use medical 
device designers. Their roles 
within this process however 
will differ considerably and 
would therefore not necessary 
fit this sampling method. 
Theory Based 
Sampling 
A formal approach to 
Criterion sampling whereby 
participants are identified 
through theoretical 
constructs. 
The literature revealed a lack 
of theory towards home use 
medical device design and 
therefore this method would 
not be suitable. 
Purposive 
Sampling 
Participants are deliberately 
selected by the researcher 
for a particular trait to give 
what is believed to be a 
representative sample. 
Purposive sampling is very 
targeted and specific to the 
researcher and could 
potentially achieve a cross 
section of the population. 
Snowball 
Sampling 
The initial group of 
respondents are used to 
inform or nominate relevant 
parties or individuals for 
study. 
Snowball sampling is a very 
useful method to locate 
additional designers in the 
home use market. Given the 
niche market, snowball 
sampling would be very 
useful for this research. 
Quota Sampling 
Participants are non-
randomly selected from 
identified strata until the 
planned number of subjects 
is reached. 
Accurate use of this method 
again requires an 
understanding of the size of 
the population. One can 
speculate, but exact figures 
are unknown. 
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Based on Table 3.4 it was concluded that the sampling strategy most appropriate for 
this research is to adopt a combination of purposive and snowball sampling to 
achieve the widest sample of home use medical device designers as possible. An 
initial cohort of companies will be contacted to take part in the research and 
subsequently be asked whether they are aware of any further companies operating in 
the field of home use medical device design. 
To achieve this, a range of different strategies will be employed to locate, contact 
and gain access to this population. It must be considered however that when working 
with modest samples it is vitally important to ensure there is a high quality of sample 
achieved. In order for this research to provide a meaningful contribution to 
knowledge it must be explicit in its involvement of participants who only have 
experience in home use medical device design. Further information on the access to 
participants under study is provided in the specific chapters. 
3.11 Ethics for Research 
 
Ethical considerations are fundamental within any research project. The issue of 
ethics presents itself as one begins to plan a research project and the necessary access 
to individuals, a population or organisation to collect, analyse and report data 
(Saunders et al, 2009). As such research must be planned, conducted, handled, 
analysed and written in a moral and responsible manner.  
Saunders et al state that the general issue for ethics in research design is that the 
research design itself should not submit those under research (i.e. the population) to 
‘embarrassment, harm or any other material disadvantage’ (Saunders et al, 2009). In 
particular one must consider the issue of informed consent and the extent to which 
participants are both aware and happy to be part of the research itself.  
Gray provides a checklist that outlines the ethical commitments and responsibilities 
for qualitative research (Gray, 2009). 
 Have I honoured my commitments about confidentiality and privacy? 
 Have I acted in the spirit of informed consent? 
 Have I used my research effectively and morally? 
 Have I generalised appropriately? 
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 Do I have responsibility to anticipate how others might use my research and 
explanations? 
All of these considerations cited by Gray must be taken into account when the 
research enters the beginning and planning of the study phase. This checklist 
however does not address how research should be conducted ethically across an 
entire project. Figure 3.6 covers this in more detail.  
As Figure 3.6 shows there are a range of different ethical considerations and issues 
that the research must address at different stages within the process of conducting 
research. Saunders et al state that one of the key ethical issues for research is that of 
gaining access to participants (Saunders et al, 2009). Robson explains that pressure 
must not be put upon intended participants to grant access (Robson, 2011).  
As this research project forms part of a funded body of work for Loughborough 
University by necessity the researcher has an obligation to act ethically in accordance 
with the university’s code of ethics. Saunders et al describe a code of ethics as a 
statement of principles and procedures that outline the manner in which research 
should be conducted (Saunders et al, 2009).  
In light of these identified ethical considerations, this research will take all necessary 
steps to act ethically with upmost importance placed upon the involvement of 
participants. Each chapter from this point forward will include the ethical principles 
and considerations that were specifically addressed at the time of study. 
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Figure 3.6: Ethical issues at different stages of research (Adapted from 
Saunders et al, 2009). 
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3.12 Data Analysis 
 
There are a multitude of data analysis techniques available to researchers, many of 
which include specific software packages that simplify the process of analysis for 
large quantities of data. For this thesis the data analysis techniques used throughout 
this research are cited within the individual chapters. This decision was made on the 
basis that readers could review the analysis of the results for a particular study 
alongside the write up for that study. Thus, the selection of a technique for data 
analysis was based upon the nature of the study and the type of data collected. Refer 
to the necessary chapters to find further information on the analysis and handling of 
data within this thesis. 
3.12.1 Triangulation 
 
The concept of triangulation within mixed methods research refers to the 
combination of several qualitative or quantitative and qualitative methods to 
compensate for the potential weaknesses in a mono-method approach (Gray, 2009). 
By combining such methods it is believed that triangulation of the findings produces 
results that are more reliable in that they are supported by other bodies of evidence.   
As previously describe in Section 3.8, this research intends to adopt Design One 
described by Gray (2009). Through a combination of case studies, a quantitative 
survey and semi-structured interviews the research design of this thesis will be able 
to triangulate the findings based on multiple bodies of evidence, to determine 
whether the initial predictions were in fact correct about home use medical device 
design.  
 
3.12.2 Validity and Reliability 
 
Within research the terms validity and reliability refer to attempts to apply rigour to 
an approach. In essence these terms could be argued to have the same purpose in that 
the researcher attempts to demonstrate that findings are in fact replicable by others. 
As previously addressed, one of the criticisms often cited of qualitative research is 
that it is ‘unscientific, anecdotal and based upon subjective impressions’ (Gray, 
2009). Therefore applying such terms to qualitative research is met with some 
criticism.  
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While the concept of validity is typically associated with quantitative research, recent 
times have seen the concepts of internal and external validity be adopted in 
qualitative research. Saunders et al describe validity as being concerned with 
whether the findings of a body of research are really about what they appear to be 
about (Saunders et al, 2009).  
 
Internal Validity 
 
According to Flick the issue of internal validity refers to the level with which the 
‘constructions’ of the researcher are based on the constructions of those being 
researched (Flick, 2006). One must consider however the impact and influences of 
researcher bias within this process of reporting validity. Hall and Callery are critical 
of this issue and state that the researcher makes the assumption that the data collected 
is independent of their ‘subjective interpretations’ (Hall & Callery, 2001). Thus, Hall 
and Callery argue the need for what they call a ‘reflexive approach’ to critically 
reflect on the researcher’s influence on the research process (Hall & Callery, 2001). 
This issue is addressed further in the following section on dealing with bias within 
research. Note that attempts to challenge the researcher’s influence on the process 
were explored in the ‘Researcher Identity Memo’.  
 
Of course during any data collection activity it is possible for data to be ‘fabricated, 
discounted or misinterpreted’ (Gray, 2009). Being reflective in one’s own approach 
to data collection is one way in which this can be overcome. Gray states that one 
approach is to involve those being researched in the checking of the data for 
accuracy (Gray, 2009). However this approach may not always be possible as 
repeated access to participants can be difficult.  
 
Throughout this thesis the researcher must take reflective steps when progressing 
from one study to another. Furthermore, for the purpose of internal validity, attempts 
will be made to clarify details with participants, as far as is reasonably practicable, so 
that the data is interpreted and presented as intended by the participants.  
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External Validity 
Validity that is said to be external refers to the extent by which it is possible to 
generalise from the data with respect to other cases or situations (Gray, 2009). As 
Saunders et al explain external validity is a term that is used interchangeably with 
generalisability (Saunders et al, 2009). Therefore external validity refers to the extent 
to which the findings of a study have significant implications that are applicable to 
other research settings.  
 
When conducting research, the researcher must be aware of the claims they are 
making about the data and its application in other settings. As Saunders et al state, as 
long as the research does not claim to show results, conclusions or theory that is 
generalisable, without sufficient evidence then external validity is typically not an 
issue (Saunders et al, 2009).  
 
Reliability 
The reliability of data refers to the extent to which the collection techniques and 
analysis procedures have been considered by the researcher to ensure they will yield 
consistent findings (Saunders et al, 2009). According to Easterby-Smith et al 
reliability of data can be assessed by answering the following three questions 
(Easterby-Smith et al, 2008): 
 
1. Will the measures yield the same results on other occasions? 
2. Will similar observations be reached by other observers? 
3. Is there transparency in how sense was made from the raw data? 
 
For the purpose of this research, each of these questions will be answered before and 
during the commencement of the aforementioned research strategy. Each chapter will 
include a section on the reliability of the data it presents. 
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3.12.3 Dealing with Bias 
 
Bias, it could be argued, is present within all types of research and therefore the 
researcher has an obligation to address the various types of bias that may be present 
within data.  
 
One form of bias within research is that of ‘Researcher Bias’. Saunders et al refer to 
this type of bias in an example where the researcher is also the interviewer for 
participants. Here, the interviewer introduces their bias to participants through the 
comments, tone or non-verbal behaviour (face-to-face interviews), sometimes 
without an awareness of doing so (Saunders et al, 2009). The researcher has an 
obligation to address this within the research design so as to not influence 
participants in their responses. After all it is widely understood that individuals act 
differently when under review or observation (Robson, 2011).  
This research will take all necessary steps to ensure that any potential bias that is 
controllable by the researcher is removed from the data collection process. The 
researcher identity memo presented in Chapter Two has already discussed the 
perspective of the researcher before the presentation of any findings. In doing so, this 
memo allows readers to be aware of the researcher’s position and therefore removes 
any potential bias in the presentation of data and information to its audience.  
Another bias to consider, specifically when conducting a survey or interview based 
research strategy is the issue respondent or response bias. This type of bias occurs 
when the respondent has preconceptions about the interviewer themselves and what 
they are in fact researching. For example this could lead a respondent to answering 
questions in a manner to which they think the interviewer is looking for, rather than 
answering in an honest and truthful manner.  
Another common issue that can lead to the introduction of respondent bias refers to 
leading questions or behaviour when conducting research with respondents. These 
specific issues for bias will be addressed in chapters presenting the studies of this 
thesis accordingly.  
Finally, it should be stated that the use of triangulation within this research has been 
designed to further reduce the potential for bias. As Gray states, the use of 
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triangulation in mixed methods research is often used to ensure the ‘inherent bias of 
one measure is counterbalanced’ by the strengths of another method (Gray, 2009). A 
combination of these approaches will ensure that the results and information in this 
thesis in honest and credible with the least amount of bias possible. 
3.13 Research Methodology for Design Research 
 
Design as a practice is unavoidably humanistic and multidimensional in approach. 
Assigning a methodology therefore can often prove challenging. Particularly where 
medical device design is concerned the process of design is incredibly complex given 
the range of stakeholders and the regulatory requirements of the field. 
Methodologies for studying design therefore have to be flexible and adaptive to be 
able to respond to the multiple components and stages within the design process. 
What is arguably integral to all permutations of design research however is the 
attainment and realisation of an understanding and improvement for a specific design 
situation. As Eckert et al state design research is driven by the twin goal of 
understanding and improving (Eckert, 2003). The methodological approach for this 
research is founded and adapted from the principles of Design Research 
Methodology (DRM) by Blessing and Chakrabarti (Blessing & Chakrabarti, 2009).  
3.13.1 Design Research Methodology (DRM) 
 
DRM was created to combat the challenges relating to the application of 
methodological issues in design research. The main aims of DRM are to help 
researchers in identifying research areas and projects and to aid the selection of 
suitable research methods to address the issues of concern (Blessing & Chakrabarti, 
2009).  
 
Blessing and Chakrabarti define design research as the integration of two main 
strands of research; the development of Understanding and the development of 
Support (Blessing & Chakrabarti, 2009). As one informs the other, an understanding 
of a phenomenon informing the development of support, it is apparent that the two 
strands are closely linked. As such when considered in combination these strands 
achieve the overall aim of design research that according to Blessing and Chakrabarti 
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is ‘to make design more effective and efficient’ and consequently enable design 
practice to develop more successful products (Blessing & Chakrabarti, 2009).  
With this in mind there are two recognised objectives of the DRM approach 
(Blessing & Chakrabarti, 2009): 
1. The formulation and validation of models and theories about the phenomenon 
of design with all its facets. 
2. The development and validation of support founded on these models and 
theories, in order to improve design practice, including education and its 
outcomes. 
 
The ‘facets’ of design as defined by Blessing and Chakrabarti refer to the people, 
products and knowledge/methods/tools and encompass the generation of knowledge 
about design research that in turn through methodical study will lead to improved 
design (Blessing & Chakrabarti, 2009). They posit that the ‘facets’ of design are 
inherent parts in the process of studying design and should at the very least be taken 
into account in design research.  
 
Research question three of this research sets out to define what it will take to increase 
the uptake of usability principles and the involvement of users in the design of home 
use medical devices. In order to answer this question successfully it is necessary to 
answer the earlier research questions first to generate a better understanding of the 
field and current practice towards home use medical device design. Therefore the 
questions and aim of this research are similar to that described by DRM and Blessing 
and Chakrabarti in the sense that they meet the objectives described previously and 
the overall goal to deliver improved medical devices for users in the home 
environment.  
Essentially DRM consists of four main stages, which are clearly depicted, in Figure 
3.7. The diagram depicts the main stages in the centre with the basic means by which 
each stage is explored to the left and the outcomes that are delivered on completion 
of each stage to the right.  
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At the Research Clarification stage, it is typical for a literature review to be 
conducted although there may well be some form of initial or exploratory data 
analysis. This stage of the research process is about identifying evidence that 
supports the research intention and formulates the research goal (Blessing & 
Chakrabarti, 2009).  
Chapter Two of this thesis very much followed this approach in its aim to identify 
existing research in the field of home use medical device design and gaps in current 
knowledge for the field.  
The Descriptive Study 1 stage refers to the detailed description of the situation under 
study and the factors that need to be addressed in order to improve the clarification of 
the research pathway. At this stage of the methodology, the research should have a 
clear goal and focus that gives the researcher a solid ‘understanding’ of the situation.  
Using this understanding and the findings of Descriptive Study 1, the Prescriptive 
Study stage can begin. With a detailed description and understanding of the research 
direction, the prescriptive study represents the ‘vision on how addressing one or 
more factors in the existing situation would lead to the realisation of the desired, 
improved situation’ (Blessing & Chakrabarti, 2009). In Figure 3.7 this is represented 
Figure 3.7: DRM Design Research Methodology (Blessing & 
Chakrabarti, 2009). 
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by the delivery of support to improve the effectiveness and efficiency of the specific 
design situation.  
To achieve the aim of this thesis it is necessary to ascertain the challenges towards 
involving users in the design process of a home use medical device to identify how 
user involvement can be incentivised for industry. Using a combination of 
Descriptive and Prescriptive studies this approach can be tested and in doing so will 
ensure that this research meets its aims and objectives defined in Chapter One. 
The final stage of the DRM methodology is the Descriptive Study 2. This stage of 
the research process refers to an investigation into ‘the impact of the support and its 
ability to realise the desired situation’ (Blessing & Chakrabarti, 2009). This is where 
the value of output can be validated in the context of study to determine whether or 
not the research has in fact met its original goal. This stage of the methodology is 
vital to the research process as a whole and must be implemented as part of this 
research methodology. Only through accurate validation and reflection of one’s own 
approach can improvements in the future be realised. 
Despite the methodological approach defined in DRM, the authors state such an 
approach can only support the design research process. Blessing and Chakrabarti 
posit that a methodology should be carried out in a ‘flexible and opportunistic’ 
manner in order to adapt where necessary to any interesting findings or ‘avenues’ 
that emerge (Blessing & Chakrabarti, 2009). For example, the results of a particular 
empirical study may reveal a need for further, ‘erstwhile unplanned, studies’ that are 
founded on the knowledge gained from earlier findings (Blessing & Chakrabarti, 
2009). At the research clarification stage it might be necessary to carry out some 
exploratory study (i.e. descriptive study) to clarify the research goals and to develop 
a research plan, when little is known about the phenomenon of interest (Blessing & 
Chakrabarti, 2009).  
 
In light of this approach, the final design methodology will now be presented as a 
conclusion to the chapter. 
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3.14 Methodology: Final Design 
 
Figure 3.8 presents the final design methodology for this research. The design is 
based upon the principles of a DRM approach and Gray’s Design One which has 
been specifically adapted to include the research strategies for this research. 
The methodology is presented with three different components that outline the 
research strategies, study chapters and their relationship to the research questions. 
Following the principles of DRM each chapter builds on the findings and knowledge 
of the previous chapter. Thus, the findings of the literature review inform the thesis 
as a whole and the case studies presented in Chapters four and five provide a 
foundation for study chapters six and seven. Chapter eight explores the proposed 
interventions of this thesis in a validation study with stakeholders from the home use 
medical device field. As outlined in the thesis framework in Chapter one these 
findings are then synthesised in an overview chapter presented in Chapter nine.
 140 
Figure 3.8: Final Design Methodology including strategies, studies and outcomes. 
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3.15 Summary 
 
To summarise this chapter a final design methodology based on the DRM approach 
and Gray’s design model one, has been adapted for the context of this research 
(Blessing & Chakrabarti, 2009; Gray, 2009). It has been established that the 
researcher’s personal philosophical stance is closely linked to that of interpretivism 
and constructionism. The research presented in this thesis is theory building, in that 
there is recognised theory for home use medical device design as a practice. Rather 
there are ideas based on existing research, which this research aims to explore 
further.  
The final design methodology includes two case studies that will form the research 
clarification (Chapters Four and Five); a descriptive study into designers and 
manufacturers perspectives of home use medical device users (Chapter Six); an in-
depth explanatory study into current practice and challenges towards user 
involvement in home use medical device design (Chapter Seven) and a prescriptive 
validation study on the interventions and recommendations of the research (Chapter 
Eight). 
The following chapter will now present the first case study of this research.  
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Chapter 4  
Case Study One: 
Towards Idealised 
Practice 
 
“Most things are not designed for the needs of the people but for the needs of the 
manufacturers to sell to people.” 
(Victor Papanek, 1985) 
 
The previous chapter presented the methodology of this research. It was concluded 
that two case studies would be conducted with different companies currently 
operating in the home use medical device market. The first of these case studies, 
presented in the following chapter, attempts to identify a theoretical idealised 
practice towards home use medical device design. The identification of an idealised 
approach to home use medical device design will build on the knowledge acquired in 
the literature review and provide a basis from which future studies could be 
compared. Chapters Four and Five represent the research clarification of this thesis, 
which is recognised as a component of a Design Research Methodology (DRM) 
approach.  
4.1 Introduction 
 
Case study research is recognised to be useful in contexts of little or no previous 
experience (Gray, 2009). It has previously been stated that there is currently very 
little knowledge of design practice for home use medical devices within the literature 
(Cifter, 2011; Gupta, 2007). Previous research has identified that there is a lack of 
research specifically focused on the consideration and capturing of user issues during 
medical device development holistically (Martin et al, 2008).  
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To develop an understanding of the practicalities of home use medical device design, 
a leading design consultancy based in the United Kingdom was contacted to take part 
in this case study. The aim of the study was to attempt to establish a theoretical 
idealised approach towards involving users in the design process of a home use 
medical device.  
The idealised approach would be established through exploration of a unique 
organisation in the field. This unique perspective is built upon a consultancy 
partnership with an academic institution, providing a theoretical core to the 
commercial consultancy. While the company contacted for this study represent a 
commercial business, they simultaneously represent an academic institution and 
therefore have access to the resources available to a university. This specific case is 
considered unique to the field as it provides the collaboration between theory and 
practice in the medical device sector. For the purpose of this study this organisation 
were considered a suitable candidate for a theoretically idealised approach due to 
access to resources that would not be available to a stand-alone company. Note that 
for reasons of confidentiality the company name is not mentioned throughout this 
document.  
No evidence of an existing theoretical idealised approach towards home use medical 
device design was found within the literature review of this thesis. It is believed that 
through identifying an idealised approach towards user involvement in home use 
medical device design would provide a benchmark from which further studies could 
be compared. Furthermore, the researcher will gain a depth of understanding and 
context that cannot be established from the literature alone.  
4.2 Background 
There have been previous attempts to define a design process for home use medical 
devices (Cifter, 2011). The Dual Verification Model, identified in Chapter Two of 
this thesis refers to the dual verification of the regulatory essential requirements and 
specific user requirements, including the identification of lay users’ requirements 
(Cifter, 2011). What cannot be inferred from this process however, are the specific 
details in relation to how users are or should be involved in the design process. There 
is no evidence within the model of the practicalities faced by designers and 
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developers of home use medical devices towards involving users in the design 
process. 
The current literature on involving users in the design process in this field is much 
more typically focused on professional use medical device development (Bridgelal 
Ram, Grocott, & Weir, 2008; Craven & Martin, 2010; Martin et al, 2008; Money et 
al, 2012; Shah & Alshawi, 2010; Shah, Robinson, & AlShawi, 2009). Much less 
evidence is available however on the involvement of users in the design process of a 
home use medical device.  
There is a need for more research into how designers tackle the practical challenges 
of remaining commercial whilst delivering home use medical devices that are usable 
and safe for their users. Buckle et al posit that there is a significant opportunity and 
need to develop a body of ‘best practice’ case studies and exemplars on how ‘user-
centred’ design practice can lead to better and more competitive products for patient 
safety (Buckle et al, 2006). With the recognised use of medical devices in the home 
on the rise there is a need for more research to address and focus upon how designers 
in industry apply ‘user centred design’ principles. 
4.3 Rationale 
 
The reasons for conducting this case study were two-fold. Firstly, to gain a more 
detailed insight into current design practice by industry to inform and direct the 
research studies presented in this thesis. In doing so, this case study will provide 
preliminary answers to the first research question of this research and thus provide 
clarification for future studies. 
Secondly, the case study would attempt to define a ‘theoretical idealised practice’ 
that would provide practical value to the industry. Although theoretical frameworks 
are available within the literature, no ‘idealised practice’ case studies specific to 
home use medical devices were found in the literature review. Literature based 
frameworks, such as that produced by Shah, Robinson and Alshawi provide a 
theoretical core towards the involvement of users in medical device development. 
However, it is not understood how this process is actually conducted by companies 
operating in the marketplace (Shah, Robinson, & AlShawi, 2009). There is a need to 
identify the specific steps designers take to ensure devices are as usable and safe as is 
 
 
146 
 
reasonably practicable for the home environment. Revealing this information will 
provide research clarification to this thesis and identify how designers and 
developers of home use medical devices are best supported in delivery of home use 
medical devices to patients.  
4.4 Methodology 
 
A leading design consultancy based in the United Kingdom with extensive 
experience in home use medical device design was contacted to take part in the case 
study. The company was purposefully chosen for this research for two reasons:  
1. The connection to academia and resources for current research and 
theory in the field – With research ties this consultancy could be 
considered suitable to represent an idealised approach to design as they 
have access to both industry and academic resources as opposed to a 
solely commercial outlook. This unique perspective would provide a 
foundation from which other companies identified in Chapters Six and 
Seven could be compared. 
2. The breadth and experience in medical device design, particularly home 
use medical devices - The consultancy have a wealth of knowledge in the 
home use field therefore providing the necessary insights and context 
required for this case study and thesis. 
A scenario or ‘role-play’ based interview was selected to conduct the case study. 
Case studies designs were described in the previous chapter. The following study is 
an example of a single, holistic case study as it refers to specific practice of an 
organisation. The study presented here presents a unique perspective to home use 
medical device development, described by Gray as a ‘revelatory’ case for the context 
of this research (Gray, 2009).  
The scenario involved two interviewers (Researchers) posing a hypothetical device 
to be launched onto the home use market. In total, three respondents (Industrial 
Designers) were present and all provided significant contributions to the discussion. 
Two interviewers were used as facilitators of the case study to pose the scenario to 
the company. 
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Scenario 
The scenario involved a hypothetical device (haemodialysis equipment) currently 
used by trained healthcare professionals (HCPs) in the hospital environment. The 
interviewers posing as the manufacturer of this device were looking for opportunities 
to diversify into the home use market. The manufacturer was therefore contacting 
this organisation to understand how the device could migrate into the home 
environment to be used by lay users. The manufacturer was specifically concerned 
about the changes in design requirements for the potential end users and use 
environment. 
Aim 
The scenario-based interview aimed to identify and develop a theoretical idealised 
practice towards successfully delivering a device into the home environment, 
including suitable considerations for the needs of end users. 
The entire interview was recorded and later fully transcribed verbatim for analysis. 
The key themes of the discussion were reviewed and, where appropriate, have been 
used in the presentation of this case study.  
The analysis of the transcriptions resulted in the development of the idealised 
approach presented in Figure 4.3. Once an initial design was constructed Figure 4.2, 
based on the interpretations of the two interviewers present, the process was later 
iterated with the design consultancy to ensure the final model presented within the 
case study was accurate and verified.  
The following section presents the topics and themes discussed during the interview 
with the design consultancy. Following the presentation of the discussion, the 
unverified idealised design process is presented Figure 4.2. This following section 
describes how the initial design process was developed. 
4.5 Discussion 
 
The interview began with the introduction of the scenario to the design consultancy 
as per the methodology (Section 4.2.2). After the introduction, a discussion 
commenced on which users should be involved in the design process to ensure the 
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device could be used safely and effectively in the home environment. One 
respondent suggested that potential ‘lead’ or ‘expert’ users could be used as a starting 
point to identifying user requirements.  
Note: ‘ID’ denotes Industrial Designer and ‘RE’ Researcher. Each Industrial 
Designer and Researcher was assigned a number for the purpose of this study and 
these are used in the reporting of transcripts below. 
{RE 1}: “…talking about user involvement and including lead users. How typically 
would that be done? And who would you go and speak to?” (Case Study #1). 
{ID 1}: “That depends on the product. Sometimes we say lead users we don't really 
mean lead users…Sometimes we just mean expert users. There is a slight difference. 
An expert user being somebody who has used already similar machinery [devices]. 
(Case Study #1). 
According to the designers in this study, it was evident that the decisions upon who 
to involve within the design process was project dependent. This was to be expected 
as it is recognised that a consultancy would work on a variety of projects for different 
clients. The issue of expert or lead users however raises the question of lay user 
involvement in the design process more specifically. If expert users are considered as 
someone who has used similar devices previously, they therefore have prior 
knowledge of device interactions. Use errors experienced by lay users without that 
existing knowledge or experience of use therefore might not be considered by such 
an approach. Using expert or lead users alone would suggest that, under specific 
circumstances, representatives of end users might be used in place of the intended 
users of home use medical devices. The interviewers therefore explored this issue 
further with the company. 
{RE 1}: “Is that a heuristics rather than a data collection process? Would you use a 
proxy user who embeds lots of other users, so carers are an in-hospital 
[experienced] user for example? Would that be a shortcut?” (Case Study #1).  
{ID 1}: “That wouldn't be what we’d recommend in the first instance. That might 
end up being a practical thing that happens...Within the budgets of the project if 
somebody doesn't have the scope to get to end-users. Ideally we would get to actual 
end users.” (Case Study #1). 
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This indicates that companies might make use of representative users in 
circumstances when the constraints of the project would be restrictive for real end 
user involvement. The company alluded that this would not be advocated in an 
idealised approach however; certain clients might resist involving real end users on 
the grounds of time and costs. This suggests that both time and financial issues are 
perceived as potential barriers to involving users in the design of home use medical 
devices. This supports previous studies that have identified ‘Time’ and ‘Cost’ to be a 
challenge in the involvement of users in professional and home use medical device 
development (Cifter, 2011; Gupta, 2007; Martin et al, 2008). It could be argued that 
these issues are more pertinent in the current economic climate where costs are even 
more crucial to the commercial success of a company. 
On the other hand, one of the arguments to support the involvement of real end users 
within the design process is the potential financial and reputational damage to a 
company for an expensive device recall (Money et al, 2011). Advocacy for following 
usability principles with respect to involving users early and often however would 
appear to be ignored by some manufacturers and clients in this company’s 
experience. In spite of a leading consultancy advocating the involvement of real end 
users, their clients are still keen to look for shortcuts or cheaper alternatives to 
designing medical devices for the home.  
On this topic the interview turned towards attempting to reach a theoretical 
acceptable level of device usability, should such a level exist. Having identified that 
a manufacturer might make a commercial decision how to involve users and who to 
involve in the design process of a home use medical device, the researcher was 
interested in how such a decision is made.  
{RE 1}: “Do you have a process, on the one end we’ve got the idealised state of 
delivering what the user might like and the other end we’ve got the purely functional 
end of just delivering what the clinical requirement might be and somewhere in 
between we’ll legitimise it…. Is there any specific guidance that we can use in our 
processes or we could use with you in our process to steer us through the right 
course between these two extremes and still meet this obligation?”(Case Study #1). 
{ID 2}: “In terms of usability?” (Case Study #1). 
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{RE 1}: “Yes, because obviously it is a fairly open ended bucket that we could pour 
money into and make it nicer and nicer and nicer but it already does what is says on 
the tin. You know, why should we spend that money?” (Case Study #1) 
{ID 2}: “…There’s a core in the middle that is about safety and efficacy. That's the 
bit you have to satisfy….Outside of that core becomes a commercial decision then as 
to how much or how little or efficiently you apply something which allows this to 
commercialise [the device]”. (Case Study #1) 
The interview indicated that in spite of home use medical device development 
representing a field of strong moral arguments for exemplar design practice, the 
commercial realities of operating as a business are paramount to manufacturers. 
Highlighted in the quote above, many of the clients this consultancy work with 
essentially make a ‘commercial decision’ on how many users to involve, furthermore 
who should be involved, not necessarily based on idealised practice or design 
principles, but on what will make a device safe enough to sell. It suggests that a 
manufacturer will fulfil the essential safety requirements of a medical device 
however the involvement of users in that process and more specifically the 
application of usability principles are based on the commercial nature of the 
company. As a practice of designing devices to be used in the home by a multitude of 
potential users this represents a detrimental finding for end users. It would suggest 
that users of devices in the home are required to ‘make do’ with a device that is 
regarded as good enough; not from an understanding of end user needs but rather a 
commercial decision to draw a profit.  
In light of this, the case study turned towards identifying other potential barriers and 
or challenges to applying usability principles towards home use medical device 
design. In particular, the focus of the discussion addressed whether in practice the 
principles of usability and ‘user centred design’ can realistically be mapped onto the 
model and requirements for home use medical device development. The following 
section presents a list of some of the preliminary challenges identified through 
conducting this case study. 
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4.6 Challenges to Applying Usability Principles to Home Use 
Medical Devices 
 
The literature review identified existing research that has referred to the challenges 
of home use medical device design (Cifter, 2011; Gupta, 2007). The context of this 
case study and thesis is focused primarily on the challenges to applying usability 
principles and involving users in the design process specifically.  
The following section introduces some of the preliminary challenges towards user 
involvement identified in this case study that provide a foundation to research 
question two of this research.  
Table 4.1 presents the challenges identified in collaboration with the consultancy in 
this study. Some of the issues identified support the previous work conducted by 
Abdusaleem Cifter and Suresh Gupta (Cifter, 2011; Gupta, 2007;). The table shows, 
each challenge cited by the company alongside a description as to how it specifically 
implicates or could influence a company to adopt an alternative approach to that of 
one advocated by usability principles in documents such as IEC BS EN 62366:2007.  
It is worth noting here that the challenges identified in Table 4.1 are the perceived 
challenges from the point of view of the designers in this case study. The findings are 
based on the company’s previous experiences with clients and projects. The findings 
are therefore enriched with the knowledge, understanding and expertise of the 
respondents of this study and are not based on the potential bias and subjective 
opinions of the researchers conducting the interview. All of the findings and views 
expressed in this study were verified with the consultancy prior to writing this report.  
In light of this it is not appropriate for generalisations to be made on these findings 
from a single, holistic case study. Rather the preliminary challenges identified in 
Table 4.1 act as a foundation from which future studies can explore in a quantitative 
manner with a wider target audience. In order for this research to progress in 
accordance with its methodology and to answer research question two it is necessary 
to identify whether the wider population experiences such issues.  
Future studies should explore how these challenges relate to one another in terms of 
weighting to see if any particular factor is more challenging to overcome than others 
from a commercial perspective. This could then lead to the identification of potential 
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routes to offer best value in supporting the involvement of users and application of 
‘user centred’ principles for home use medical device design.  
In total seven different challenges to applying usability principles, including the 
involvement of end users, were identified for home use medical devices in the case 
study. Table 4.1 outlines the consequences for design practice by designers and 
developers who avoid the advocated principles for usability.  
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Table 4.1: Identified Challenges to applying a User Centred Approach to Home 
Use Medical Device Design. 
Challenge Description Consequence 
Common Language - 
A disparity of 
language exists 
amongst the design 
community with 
respect to usability for 
medical device design. 
Precious time is lost during 
the development of a 
device due to a lack of 
common language between 
stakeholders in the process. 
User research is often 
interpreted as a marketing 
research activity. In the 
medical setting, healthcare 
professionals avoid 
participation on the basis 
that their perceived 
involvement makes them 
liable. 
Ethics - The task of 
gaining ethical 
approval for user 
research during 
development 
Gaining ethical approval to 
conduct user studies can be 
a lengthy process for 
companies, particularly 
where the National Health 
Service (NHS) is 
concerned. 
Companies avoid 
conducting studies that 
require stringent ethical 
approval and look for 
alternatives to user 
research. 
Finance - The costs 
involved to implement 
a ‘user centred’ 
approach to medical 
device design. 
There is an industry wide 
perception that all user 
research activities are 
hugely expensive. 
Companies look for cheaper 
alternatives to identify the 
needs of end users. 
Recruitment - The 
task of gaining 
participation from end 
users for user studies. 
Considerable time and 
money is spent on locating 
and recruiting real end 
users for user studies. 
To compensate companies 
look for proxies or 
representatives of the end 
user. 
Shared 
Understanding - A 
lack of understanding 
about the methods and 
principles of a ‘user 
centred’ approach to 
medical device design 
due to different 
backgrounds and 
education. 
Considerable time and 
money is spent on 
educating stakeholders in 
the design process to attain 
a level of shared 
understanding. 
Designers and 
Consultancies have to 
educate companies and 
stakeholders on the benefits 
of a ‘user centred’ approach 
and the principles involved 
slowing the development 
process. 
Technical Difficulties 
- The intrinsic 
difficulties of working 
in teams to achieve a 
desirable outcome. 
Time is spent to achieve a 
common ground. Each 
stakeholder in the process 
brings his or her own 
perspective and bias, which 
creates its own challenge. 
Marketing and Finance 
ultimately have the final say 
in many companies, which 
often results in cost driven 
practices taking priority. 
Time - The time 
associated with 
delivering a ‘user 
centred’ approach to 
medical device design. 
Time to conduct user 
research studies is 
perceived to be extremely 
resource intensive. 
Companies often accept the 
quickest route for 
development to keep the 
cost and time to market 
down. 
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Push Factors
Economic Pressures
Liability Issues
Regulations
Technology 
Capabilities
Pull Factors
Commercialisation
Empathy for Home 
Use
User Awareness
User Capabilities
4.7 Step Factors for Improved Usability of Home Use Medical 
Devices 
 
Behind the rise in use of home use medical devices, the case study revealed a range 
of drivers, referred to by the company as step factors, increasing the demand for 
improved usability. Their presence within this case study was an unexpected 
outcome of the interview however the nature of the questioning and discussions 
happened to lead to their influence on design. Note the step factors raised by the 
company do not refer to the rise in demand for home use medical devices, as 
described by Gupta, but more specifically to the rise in perceptions or expectations 
from users of such devices (Gupta, 2007).   
The case study revealed that historically home use medical devices have been a 
technology driven industry. This finding is supported by previous research, which 
has addressed the implications for design in professional and home use medical 
devices (Gupta, 2007; Martin et al, 2008; Money et al, 2011).  
Figure 4.1 presents the existence of push and pull factors upon designers and 
developers of home use medical devices that have raised the demand and 
expectations for improved usability.  
 
  
Figure 4.1: Step Factors for Improved Usability of Home Use Medical Devices. 
 
 
155 
 
A ‘Push’ factor in the context of this study refers to the forces and consequences 
facing devices of poor usability that ultimately may compromise patient safety. The 
consequences of a poorly designed medical device have been identified to 
compromise patient safety and lead to use errors (Ward & Clarkson, 2004; IEC 
62366: 2007; ANSI/AAMI HE75: 2009). In contrast ‘Pull’ factors upon 
manufacturers refer to a rise in expectations by device users specifically and 
represent the demand for improved usability of home use medical devices.  
Push Factors  
Economic Pressures – This factor refers to the financial consequences to a 
manufacturer for placing a faulty device with the potential to cause harm onto the 
market. As was seen with the Exubera device described in Chapter Two the cost to 
medical device manufacturers can be in the £billions. The case study indicated that 
there is an increased emphasis in recent times upon manufacturers to consider and 
deliver devices of improved usability that do not compromise patient safety,  
Liability Issues – This factor refers to liability of a manufacturer should anything go 
wrong with a medical device once it has been launched onto the market. Chapter 
Two identified that the responsibility under medical device regulation is upon the 
manufacturer who places a device onto the market. The manufacturer has a right to 
ensure that all devices placed on the market are safe and usable for the target 
population. This represents a considerable push upon manufacturers for improved 
usability of devices intended for the home environment.  
Regulations – The governance of medical device regulation worldwide provides 
stringent requirements for designers and manufacturers to develop devices that are 
first and foremost safe and effective. With continuous updating of the requirements 
within the regulations in line with the rapidly changing technology capability, the 
push for improved device usability looks set to continue into the future. Chapter Two 
described how the usability engineering standard for medical devices (IEC BS EN 
623366:2007) is harmonised under the current Medical Device Directive (MDD). 
Therefore manufacturers have a moral obligation to consider usability throughout the 
design and development process.  
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Technology Capabilities – Widely regarded as one of the leading factors towards 
medical device development in general. The sophistication, availability and 
capability of technology are ever increasing and consequently medical devices are 
more accessible and affordable today than they have ever been. The case study 
indicated that the capabilities of technology from competitor products, particularly 
for ‘consumer medical devices’, are raising the demand for improved devices and 
usability within the home environment.  
Pull Factors 
Commercialisation – The recognised shift towards commercially available home 
use medical devices (i.e. retail), referred to by the FDA as ‘consumer medical 
devices’, was indicated by the company as pull factor upon manufacturers to deliver 
devices of improved usability (FDA, 2013). The company opined that some 
manufacturers now seek to offer improved usability in home use medical devices to 
gain competitive advantage in the market place. This competition amongst 
manufacturers was identified to raise the standard of usability for home use medical 
devices.  
Empathy for Home Use – The case study revealed that there is now an increasing 
awareness of the ageing population and requirement for home healthcare globally. In 
light of this the company opined that there is an empathic understanding from 
manufacturers to deliver devices that cater for the needs of vulnerable users within 
the home environment.  
User Awareness - According to the design consultancy in this study it was indicated 
that participants for user research were becoming increasingly aware of the 
technologies and devices available to them. The company opined that as users 
become increasingly educated in the use of home use medical devices there is a pull 
upon manufacturers to deliver devices that offer greater flexibility in use. Improving 
the usability of devices to cater for the needs of such users was identified by the 
consultancy as fundamental as user groups become more experienced and diverse. 
User Capabilities – The final pull factor identified by the company referred to the 
capabilities of users specifically. The company posited that, as users are becoming 
increasing aware and educated on the use of home use medical devices their 
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capabilities from interacting and using such devices improves. In light of this there is 
a demand for increasingly sophisticated and usable devices to be used in the home 
environment in the future.  
Both types of factor have a varied degree of influence over the commercial decisions 
made by manufacturers to invest in usability for home use medical devices. While 
the extent to which these factors influence manufacturers cannot be drawn from this 
study, it was highlighted that the pull factors facing manufacturers of home use 
medical devices has seen a rise in recent years.   
The designers interviewed for this study highlighted that user expectations with 
respect to not just device capability and performance but furthermore usability have 
seen a significant rise in demands based upon the capabilities of consumer 
technology devices.  
One designer in the study said: 
{ID 2}: “…people have come to us because of expectations of android phones and 
apple… So there is a little bit of a pull expectation from that you could argue”. (Case 
Study #1) 
This suggests that as users become more experienced with technology and aware of 
the capabilities of technology available to them, their expectations are carried 
through to what other devices should and must be able to do. This is not only limited 
to medical devices. Users of consumer products and other technologies have an 
expectation of technology capability including how such devices operate (e.g. 
affordances). These experiences are then expected in similar or related technology 
and consequently raise the expectations of device users.   
The company opined that the commercialisation of home use medical devices with 
respect to the increasing number of devices that are now bought by users themselves 
raises the issues of desirability and aesthetics for home use medical devices. 
According to the company in this study, manufacturers of home use medical devices 
now target users to purchase their device over brands available on the shelves. A 
shift towards commercial home use medical devices marks significant implications 
for design. The company indicated that this trend looks set to continue into the future 
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as users will have increased choice in the selection of devices they use for treatments 
and diagnosis in the home environment.  
The step factors identified within this case study are specific to the company and 
their experiences with manufacturers and clients of home use medical devices. Only 
through further exploration with a larger sample of practitioners could such findings 
be generalised to a wider population.  
These challenges represent preliminary answers to research question two of this 
thesis. In order to successfully answer this research question the challenges towards 
user involvement in home use medical device design will be explored with design 
practitioners in more detail. For more information on the identified challenges within 
this thesis please refer to Chapter Seven.  
Following the discussion on the challenges and step factors towards applying 
usability principles for home use medical devices, the interview turned towards the 
development of the idealised design process.  
4.8 Theoretical Idealised Design Process 
 
The design process shown in Figure 4.2 presents the initial design process that was 
developed after the interview process. Once all of the data from the interview was 
collected and transcribed the process was based on the transcripts, sketches and 
information recorded during the interview.  
The initial design process was later evaluated with the consultancy to verify the 
model and ensure the interview data had been interpreted correctly A copy of the 
verified idealised design process is presented in Figure 4.3 as a conclusion to this 
first case study. 
Chapter two described the French Model to design whereby the process begins with 
an identified problem or need (French, 2010). The idealised process indicated by the 
company in this case study shared this beginning to the design process. For medical 
devices a need or problem may be identified through a range of sources such as a 
new technology capability, a modification to an existing design or individual needs 
of patients.  
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Once a need has been identified there is an exploratory phase at the beginning of the 
process to understand the context of the problem. This is typically conducted 
concurrently with the next step in the process ‘User Profiling’. According to the 
company these two stages at the beginning of the design process are essential in 
adopting a ‘user centred’ approach to home use medical device design. The process 
shown in Figure 4.2 describes the early phase of the design process as consisting of 
user research, feasibility studies and early stage formative testing. The evidence 
collected from this early feasibility research informs a fundamental step in the 
process of professional and home use medical device design ‘Usability Goals’.  
{ID 3}: “At the very beginning you would set yourself some usability goals and you 
might set that based on benchmarking previous products, existing products or ideals 
of what your marketing research has indicated.” (Case Study #1) 
Usability goals or ‘usability objectives’ as referred to in the American National 
Standard are defined quantitative metrics that are applied during usability testing to 
provide test acceptance criteria (ANSI/AAMI HE75:2009). Typical examples include 
task completion times, success or error rates and user satisfaction goals. These goals 
are often established from early stage feasibility studies that might include task 
analysis or dummy runs conducted by the designer themselves. The process here 
assists the designer in establishing at an early stage the potential for use errors to 
occur. One designed explained: 
{ID 3}: “Try to go through the steps of somebody doing it in their home… To see 
where users are likely to fall over, have difficultly.” (Case Study #1) 
Establishing usability goals early in the design process is critical to ensuring that 
iteration can occur during the summative testing phase of the design process. This 
will assess whether the goals have in fact been met with the final design. 
Unsurprisingly, ANSI/AAMI HE74 and HE75 by the FDA recommend that 
manufacturers set usability objectives as a best practice (ANSI/AAMI HE75:2009). 
These usability goals are then built into the design specification for the final design.  
The early collation of data for user requirements and usability goals all form part of 
the technical file for a medical device. An integral part of this document is the 
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consideration and ultimately regulatory assessment of the Design Inputs and Design 
Outputs.  
{ID 1}: “The whole point is that the technical file is about Design Inputs and Design 
Outputs. Design Inputs are what this product needs to be, what you decide it is and 
the Design Outputs are the all the things that deliver those Inputs if you like and it is 
basically just to check them through. So you’ve got a PDS, you would typically 
conduct a risk analysis.” (Case Study #1) 
During this pre-concept phase and once a product specification has been clarified 
there is then a need to consider the issue of risk. According to the company in this 
study, many companies fulfil this requirement in the form of a Failure Modes and 
Effects Analysis (FMEA).  
{ID 1}: “That FMEA allows you to go from the top down and look at it as a big 
system and also break it down by component, sub-assembly by the journey maps if 
you are a doing a user FMEA but it basically allows you to break down these things, 
identify all the possible risks that you can potentially think of…” (Case Study #1) 
In an idealised approach this would typically be conducted with three different 
FMEA’s.  
{ID 1}: “My recommendation to you is that you should be doing fundamentally three 
different forms that all linked up together. If you come from a design background you 
would intuitively do this. So there is the Design FMEA, as you design the product 
you are looking at the typical technical risks so component failure and what the 
implications of that component failure are. There is a user FMEA where you are 
looking at use error, because they have changed the law now where it has gone from 
user error to use error. The difference being if the user gets it wrong, it is not the 
users fault anymore it is your fault for not forecasting where the user will get it 
wrong in the first place. The final one would be a process FMEA which is just 
ensuring that how you make it comes out the same as your exemplar product that you 
have designed.” (Case Study #1) 
The culmination of these early stages defines the design inputs that ultimately form 
an essential part of the verification and validation stages in medical device 
development. As was described in chapter two of this thesis, verification is about 
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asking the question “Are we building the right thing?” through the comparison of 
design inputs and design outputs (Alexander & Clarkson, 2000).  In comparison, 
validation refers to the wider process of design and user needs, asking the question 
“Have we built the right thing?” (Alexander & Clarkson, 2000). According to the 
findings of this study however, the consideration of the user within this process is 
where many companies fall short. The company in this study advocate the 
involvement of users within the design process to gain insights into actual device 
use.  
{ID 1}: “Verification is that it does what it says it does and validation is that it needs 
to run through the requirements basically. But if you apply that back across to users 
you can start identifying user errors as well and this is where a lot of people get 
missed out. So with user error there could be a real problem with this, if you have 
come from a non-medical background as well. Home use it could be anyone of us. 
How does the user know how to use it? There are a number of ways you can 
approach that. The way I would recommend is that you actually get some users 
involved in this process somewhere.” (Case Study #1) 
At this stage in the process concepts start to be explored based on the early 
requirements capture in the design process. Informing the creation of these concepts 
however requires due consideration for how the insights gained from users are 
translated into design requirements. 
{ID 3}: “So it’s not sitting down with users and saying what would you like us to 
create. It is sitting down with the user to understand; what’s going on, what the user 
environment is like, what their daily routine is like, how do they interact with the 
technology that existed, and trying to use that information to develop enough 
empathy and understanding of the situation to come up with a solution.” (Case Study 
#1) 
Using the information gathered through early studies and FMEA type analysis, 
prototypes or simulations of concepts are then created and tested with real end users. 
This stage will often call for repeated iteration of conceptualisation based on testing 
with the identified user population until a detailed design is selected for the 
evaluation phase. This is typically where the regulatory ramp up for approval is 
conducted and validation in the form of summative testing would occur. This stage in 
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the process is about the company ensuring that the resultant device of the process 
successfully meets its aims. As stated in chapter two, this forms the critical 
component of the regulatory approval process. Ultimately the MHRA in the United 
Kingdom will base the decision on whether a device is suitable to launch on the 
validation of a medical device.   
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Figure 4.2: Theoretical Idealised Design Process for a Home Use Medical 
Device. (Non-verified Model). 
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4.9 Verified Idealised Design Process 
 
Following the development of the initial design process the model was referred back 
to the design consultancy to verify the stages and components. A copy of the verified 
idealised design process for a home use medical device is presented in Figure 4.3. 
Evidently, the process itself changed quite markedly from the initial design process 
shown in Figure 4.2. The following section outlines the amendments proposed by the 
company during verification. 
Features of the Verified Idealised Design Process 
Formative Testing - The first change made on verifying the process concerned the 
timing of formative and summative testing within the design process of a home use 
medical device. In the initial design it was stated that formative testing would begin 
in the early stages of the design process, however the company opined that this is 
typically not the case. Figure 4.3 demonstrates that formative testing would occur 
during the verification process or ‘Verify’ stage. According to the company, this 
process would typically involve 5-8 users from each homogenous user group that the 
device itself would be targeting. The earlier profiling stage outlined in the ‘Identify’ 
phase of the process is where the range of potential users would be established and 
defined for future formative studies. The figure of 5-8 users per homogenous user 
group is based on the guidance of both IEC BS EN 62366:2007 and ANSI/AAMI 
HE75: 2009 that states testing with such numbers will see patterns emerge. For an 
idealised approach however the company within this study suggested a more 
comfortable range of users for a formative study would involve 10-12 users per each 
homogenous user group.  
Summative Testing – According to the company the summative testing phase was 
located in the correct stage of the design process presented in Figure 4.2, however 
verification of the process revealed more detail here too. Summative testing relies 
upon sample size based error rate and specific acceptance criteria that again are set 
early in the design process with usability goals and specifications. According to the 
consultancy, this phase of testing would typically see 16-20 users from each 
homogenous user group. For instances of high risk devices, such as infusion devices 
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for example, the company opined that samples of over 24 users per homogenous user 
group would be involved in summative testing.  
ISO 14971:2007 Medical Devices: Application of Risk Management to Medical 
Devices – On presenting the initial design process to the consultancy it was 
expressed that the key element of risk should be more explicit within the idealised 
design process. The company highlighted that the application of risk management 
throughout the design process of any medical devices is an essential requirement for 
regulatory approval. One respondent explained how the design process itself is 
largely based on the principles and stages involve in the risk assessment process for 
medical devices. Thus, Figure 4.3 demonstrates this mapping of the risk assessment 
procedure onto the idealised practice design process itself. According to the company 
an idealised process has to take into account the requirements of ISO 14971:2007 
and therefore each stage within the design process supports for the risk management 
process of a medical device. The stages in the design process use two-way arrows to 
demonstrate the iterative nature required in this process. The company indicated that 
the identification of one risk may reveal new risks to device users therefore an 
idealised approach must account for design iterations with device users.  
Identify, Specify, Verify, Validate – Finally, using all the information collated in 
the final design it was decided that the process would be broken down into four 
stages, namely: Identify, Specify, Verify and Validate. The decision to classify the 
process into four specific stages was largely to simplify the process itself. Evidently 
there are a number of key decisions that need to be made within the design process of 
a home use medical device. The four stages in the verified model simplify the 
legibility of the key concepts within the design process. The choice of terms is based 
on the importance and significance of end users and their requirements within the 
design process.  
The early stage calls for the identification of the users themselves through profiling 
and feasibility studies. With an understanding of the problem and potential users one 
can then begin to develop usability goals and the necessary Product Requirement 
Specification (PRS) and User Requirements Specification (URS) that form the 
‘Specify’ stage of the process. Conceptualisation can then begin which leads into the 
verification stage of the process. This is where the process calls for formative testing 
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with users to ‘verify’ that the design outputs meet the design inputs. Finally the 
process moves into the validation stage with the final design ready to conduct 
summative testing with real end users and the attainment of regulatory approval. 
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Figure 4.3: Theoretical Idealised Design Process for a Home Use Medical Device 
(Verified Model). 
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4.10 Conclusion 
 
This chapter has revealed a significant amount of information about the design of 
home use medical devices. The study indicated some of the preliminary challenges 
faced by manufacturers towards adopting usability principles in the design of home 
use medical devices. Early answers to research questions one and two have been 
identified and now require further study with a wider population to ascertain whether 
such issues are industry wide.  
The study developed a theoretical idealised design process towards home use 
medical devices in collaboration with a leading UK based design consultancy. The 
verified design process includes information relating to the involvement of users 
within the design process and management of risk throughout. 
To summarise this chapter a number of conclusion are presented below: 
 Seven Preliminary challenges to designing usable home use medical devices 
were identified and discussed. The challenges include: Common Language, 
Ethics, Finance, Recruitment, Shared Understanding, Technical Difficulties, 
and Time. 
 A series of step factors driving the rise for improved usability of home use 
medical devices were identified. These step factors were identified as either: 
Push Factors or Pull Factors. 
 Push Factors included - Economic Pressures, Liability Issues, Regulations 
and Technology Capabilities. 
 Pull Factors included – Commercialisation, Empathy for Home Use, User 
Awareness and User Capabilities.  
 A theoretical idealised design process for home use medical devices was 
developed and verified in collaboration with a leading UK Design 
Consultancy. 
Chapter Five presents the second case study of this research that combined with this 
chapter forms the research clarification of the thesis. Following the research 
clarification, Chapter Six will present the first descriptive study of this research. 
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Chapter 5  
Case Study Two: A 
Stakeholder Network 
 
 
The previous chapter revealed seven preliminary challenges to the adoption of 
usability principles in the design of home use medical devices. The company in the 
case study indicated that the involvement of end users (e.g. patients) in the design 
process is, to some extent, defined by the various stakeholders. Chapter Four 
revealed that a lack of common language and shared understanding amongst 
individuals within the design and development process were a challenge to 
implementing usability principles. The following chapter explores this issue further 
with a home use medical device manufacturer to establish the range of individuals 
involved in the process of delivering a home use medical device to market.  
5.1 Introduction 
 
It is recognised that there are myriad people with different requirements involved in 
the delivery of home use medical devices (Gupta, 2007). In 2002 the head of the 
medical department at PDD, a product innovation consultancy based in London, 
described the importance to understand the needs and requirements of all the 
stakeholders within the process in order to design a successful medical product 
(EMDT, 2002). From an end user perspective the final product will ultimately be 
defined by the requirements of the stakeholders within the design process. Therefore, 
the potential for ‘contradictions’ between stakeholders is recognised to seriously add 
to the complexity of successfully delivering a medical device to market (EMDT, 
2002). Cynically, it could be argued that any product whether medical device or 
otherwise is the result of compromises made throughout the design process. The real 
challenge for development is delivering a device that will ultimately benefit the end 
user whist satisfying the requirements of all necessary stakeholders. 
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The following chapter presents a case study from the perspective of a buyer of 
technologies for the home use medical device market. The company in this case 
study act as a distributor and supplier of home use medical devices to the National 
Health Service (NHS) in the United Kingdom (UK).  
5.2 Rationale 
 
The purpose of this case study is to build upon the researcher’s understanding of the 
home use medical device industry and to ascertain a context for the thesis as a whole. 
The chapter forms the second component of the research clarification as part of a 
design research methodology (DRM) approach.  
The study is focused upon the development of an exemplar stakeholder network for a 
supplier and distributor of home use medical devices in the UK. Understanding the 
potential stakeholders of a home use medical device company will reveal insights 
into the relationships and networks between the different parties involved in 
delivering of a device to the patient. This case study aims to ascertain the 
compromises or challenges that exist between stakeholder relationships in attempting 
to deliver usable and understandable home use medical devices. 
This chapter builds on the findings of the previous chapter by reviewing the design 
and development process more abstractly from the perspective of different 
stakeholders. The stakeholder network developed within this chapter will provide 
further insight into the individuals involved in the delivery of a home use medical 
device to patients.  
In doing so the following case study will provide answers to the following questions: 
 How do different stakeholders interact with one another?  
 What influence, if any, do these stakeholders have on the design process?  
 Where does the patient sit in this process and how are their needs considered? 
5.3 Methodology 
 
A semi-structured interview was conducted with a home use medical device 
distributor and supplier based in the United Kingdom. The purpose of the study was 
to identify an example of a stakeholder network for home use medical devices 
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including the influencing bodies or individuals that affect the selection, design and 
delivery process.  
 
The company in this study was identified and recruited through a medical device 
conference in the United Kingdom. As a distributor and supplier of home use 
medical devices to the diabetes market, the company were considered suitable 
representatives of the target population of this research. The profile of the company 
is presented below. For reasons of confidentiality, the name of this company will 
remain anonymous. 
 
Number of Employees: 35 
Annual Turnover:  £5 Million 
Devices Developed:  Drug Delivery and Monitoring 
Context of Use:  Home and Professional Use 
 
For the purpose of this case study the company were asked to refer to their home use 
medical devices specifically. As the aim of the study was to ascertain the various 
stakeholders that interact with an exemplar home use medical device company, a 
semi-structured interview protocol was developed. The questions were structured to 
identify the various stakeholders involved and the nature of their relationships. The 
interview was approximately one hour in duration and covered a range of issues.  
 
The interview was recorded using an audio-recorder and later fully transcribed 
verbatim. Analysis of the recorded data resulted in the development of the 
stakeholder network in collaboration with the company. Two interviewees were 
present from the company at interview and the researcher acted as the sole 
interviewer. Each interviewee (supplier) was assigned a number and these are used in 
the reportage of the interview transcripts.  
 
During the interview notes, diagrams and sketches were made in discussion with the 
interviews and where appropriate these are used throughout the presentation of this 
case study.  
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5.4 Discussion 
 
It is recognised that stakeholder requirements and relationships add to the complexity 
of delivering medical devices to market (EMDT, 2002). The company in this case 
study indicated that a hierarchy amongst their stakeholders influenced the 
consideration and capturing of patient user needs. A copy of the stakeholder network 
from the perspective of the company in this case study is presented in Figure 5.1.   
 
The network developed applies to devices used for drug delivery and disease 
management for diabetes care in the United Kingdom. The company in this study 
predominantly operate in this market and therefore the process does not relate to 
other devices or stakeholders.  
According to the company, stakeholder relationships can be interpreted from a top-
down or bottom-up approach. The nature of this approach is defined by the specific 
device or innovation and how the concept is conceived. The company described that 
a bottom-up approach refers to a concept or idea that is specifically identified from a 
patient need and subsequently filtered upwards towards a manufacturer. This could 
be through a simple request to a healthcare professional at primary care or practice 
level that then might filter up to a manufacturer.  
Alternatively, and in the experience of the interviewees’ for this case study, this 
process would more typically be technology driven and therefore ‘sold-down’ to the 
patients. The adoption of usability principles including the involvement of users for 
the participants in this case study it was indicated that user engagement would typical 
stop at the nurse level within the stakeholder network. 
{S1}: “The bottom-up approach is effectively where you would go to the nurse 
stakeholders and drive change at the very local level”. (Case Study #2) 
In light of this the interviewees expressed that they would not typically attempt to 
drive change from the patient level upwards. Much more likely would be the 
involvement at the primary care level, which was considered less time intensive. The 
company indicated that involvement of healthcare professionals (HCPs) provided 
access to specialist knowledge about patients and their needs. This was highlighted in 
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the quote above whereby a bottom-up approach to user involvement was considered 
to begin with the nurse stakeholders as opposed to the patient themselves.  
This approach would suggest that there is a hierarchy amongst the stakeholders in 
home use medical device development. This finding supports the work of Money et 
al, who also found that a hierarchy exists amongst the medical device design field 
(Money et al, 2011). Money et al, in their study on manufacturers’ perspectives 
towards involving users in the design process, found that some manufacturers believe 
the needs of patients do not originate from the patient themselves (Money et al, 
2011). They found that manufacturers perceived the needs of patients to be better 
articulated through a ‘hierarchy’ of health professionals including surgeons and 
clinical champions (Money et al, 2011).  
The stakeholder network in Figure 5.1 demonstrates the nature of this hierarchy for a 
drug delivery or diagnostic device used in the home environment. Evidently, the 
patient in this particular network has little influence on the device design and 
ultimately choice in the device they use. This is primarily the result of the hierarchy 
in place for such devices. According to the company in this case study diabetes 
devices (e.g. insulin pens) used by patients in the home are ‘sold down’ to patients. 
The interview protocol explored why involving patients was not considered as 
valuable as the involvement of healthcare professionals in the selection and delivery 
of home use medical devices. According to the company it was felt that working 
from the patient need upwards was deemed a much harder sell to investors and 
subsequently much more difficult to implement change when selling a medical 
device into the NHS in England. 
{S2}: “The problem with that is it becomes hugely time intensive, because you are 
literally, you know, granulation is massive. The number of people you have got to try 
and talk to.” (Case Study #2) 
The company felt it was too time intensive to talk with what was considered large 
numbers of patients to have an impact on the use, uptake and design of a device.  
{S1}: “If we do it on the…patient level we have a limited number of patients that will 
potentially change from product X to product Y and that takes a long time.” (Case 
Study #2)   
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In light of this, the company often preferred to approach the launch of a new device 
through avenues with much wider populations of potential users rather than identify 
specific needs or requirements.  
{S1}: “We like to work in population units of 5 million…Its just literally there are 5 
million people that live in West Yorkshire for example and out of that population 
there are 200,000 diabetics or whatever it may be. So if we can influence on that 
level then we can potentially capture 20-30% of the business. That is the easiest way 
for us [to drive change].” (Case Study #2) 
The company indicated that influencing patient selection and use of their devices 
required a different approach of delivery. According to the company a top-down 
approach involving influential or ‘key stakeholders’ is more powerful in changing 
the devices that patients use. It was expressed that such an approach would provide 
more ‘clout’ to driving change in the NHS and consequently was the approach to 
medical device delivery that was more typically adopted by buyers and suppliers in 
the home use market.  
Interestingly, the involvement of users in the design process for this company 
referred much more specifically to marketing research as opposed to user needs 
research. The case study indicated that the company were driven by financial and 
commercial decisions as opposed to identifying and understanding the needs of 
device users specifically. This consequently influenced the practices and 
stakeholders that were involved throughout the delivery of a device to patients.  
The company explained how more typically their business, including the design and 
selection of devices they provide, was driven by a ‘top-down’ approach. In the 
context of this study, the top-down approach would typically begin with the Clinical 
Commissioning Groups (CCG’s) formerly known as Primary Care Trusts (PCT’s) in 
the UK until April 2012.  
According to the company, the stakeholders represented at this level would typically 
include Chief Financial Officers (CFO’s) and Chief Executive Officers (CEO’s). The 
case study indicated that the company in the delivery process of a medical device 
would occasionally consult these stakeholders. More typically the company would 
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consult the head of medicines management at this level within the stakeholder 
network shown in Figure 5.1.  
{S2}: “If you are talking about stakeholders in there your sort of ‘go to’ person 
would be the head of medicines management…and if you like at the senior level here 
[CCG level] you would have people like chief financial officers, these are obviously 
hierarchically above them…and also occasionally we would engage with chief 
executive officers (CEO’s).”(Case Study #2) 
The company revealed that they would engage with CEO’s if they encountered any 
resistance at the medicines management level and would therefore approach 
individuals higher within the hierarchical process of medical device delivery to 
overcome such resistance (See Figure 5.1).  
{S2}: “And that is normally if we have got a resistance here [medicines management 
level]…We would go and talk to these guys [CEO’s] because they are more 
interested in the money…at the PCT level these are normally the ‘go-to’ 
gatekeepers.” (Case Study #2) 
At the most senior level of the hierarchy, the CEO’s and financial officers were very 
much considered the ‘gatekeepers’ to the marketplace for the company. By 
consulting these stakeholders, manufacturers were much more likely to receive the 
backing by medicines management which would filter down to the acute hospital 
trusts and primary care. 
{S2}: “Some PCT’s will then drive that change…That message will then go out to 
practices and that can be directly from the PCT, which will be a letter. Sometimes it 
can be just a website….” (Case Study #2) 
The company explained that manufacturers have a responsibility to establish 
relationships with the stakeholders shown in the stakeholder network. According to 
the company this is fundamental if a manufacturer wishes to have an impact on the 
uptake of a medical device. This refers not just to the patients themselves but also by 
the sector as a whole, including healthcare professionals for example. In the context 
of this case study, the company explained that prescribers of their devices were the 
gateway to patients.  
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This case study indicates that the delivery of home use medical devices to patients is 
a hierarchical process. The company in this study opined that senior stakeholders 
(e.g. Financial and Executive Officers) are the most influential stakeholders in 
driving changes in devices used by patients in the home. It was not considered part of 
the scope of this research to address the requirements of each of the stakeholders 
identified in this study. The study suggests however that there could be value as part 
of further research to promote advocacy of usability research to senior executives 
and board members. According to the company in this case study these individuals 
represent the key influencers in the device design and delivery process. If ‘user 
centred’ principles are addressed at a senior level, the findings of this study would 
suggest that such practices could be filtered down the hierarchy to offer benefits to 
the end users.  
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Figure 5.1: An Example of a Home Use Medical Device Stakeholder Network. 
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5.5 Conclusion 
 
This chapter has revealed an example of a stakeholder network for a distributor and 
supplier of home use medical devices in the UK. The company’s perspective 
provides a unique insight into the different stakeholders in the delivery process of a 
device for diabetes management in the home. The findings of the study support the 
work of Money et al, in that the study revealed an emphasis towards consulting 
senior healthcare professionals rather than addressing the preferences of patients 
specifically. As with the previous chapter, the case study presented here has revealed 
that the home use medical market is largely commercially driven. The company in 
this study indicated that devices are more often ‘sold down’ to patients as opposed to 
identifying the needs of users and iterating such information with designers and 
developers. 
To conclude the main findings of the case study are summarised below. 
Main Findings:  
1. The case study has highlighted the power of a top-down approach whereby 
the use of a particular device is ‘sold down’ to the patient. Where real patient 
needs are concerned, the ‘bottom-up’ approach was considered much less 
likely to have an impact on the uptake of a device by patients due to their lack 
of influence in the process as a whole.  
2. A bottom-up approach to delivering a home use medical device in this case 
study was seen to stop at the nurse stakeholders. The company in this case 
study indicated that healthcare professional feedback was more valuable and 
influential than that of patients. 
3. Patient involvement in the process of selection and delivery was considered 
to be too time consuming and had little effect on uptake by users. The 
company in this case study opined that they would typically operate in large 
populations where the influence on the market has a greater influence on 
sales. 
Chapters four and five represent the research clarification of this thesis. The 
following chapter will now present the first descriptive study of this research as part 
of a DRM approach.   
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Chapter 6  
Designers’ and 
Manufacturers’ 
Perspectives 
 
 “If the full benefits of involving users are to be realised, more primary research is 
needed to better understand manufacturers’ perspectives and motivations and also 
how the results of user research can be effectively incorporated into the product 
development process.” 
(Martin & Barnett, 2012) 
 
Chapters four and five presented two case studies that provide a context and 
clarification for the research presented in this thesis. The chapters highlighted the 
commerciality of the home use medical device industry. Chapter four of this research 
revealed seven preliminary challenges faced by designers and developers of home 
use medical devices. As part of a Design Research Methodology (DRM) the 
following presents descriptive study one of this research. The chapter presents an 
insight into current designer and manufacturer perspectives towards home use 
medical device users.  
6.1 Introduction 
 
The aim of this study is to answer research question one of this research.  
Research Question One: How do designers consider and involve users in home use 
medical device development? 
According to Martin and Barnett, to increase industry’s uptake of ‘user centred 
design’ practice for medical devices requires a better foundation and understanding 
of manufacturers’ perspectives towards user involvement (Martin & Barnett, 2012). 
The purpose of this study is to ascertain current designer perspectives towards user 
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involvement in home use medical device design through a descriptive with practicing 
designers.  
6.2 Rationale 
 
Previous research has conducted surveys amongst the design community in an 
attempt to ascertain perspectives on medical device design. Abdusaleem Cifter 
conducted a survey with designers to explore their perspectives, requirements and 
expectations for a suitable method to support them in the designing of home use 
medical devices (Cifter, 2011). The study formed the major component of his thesis 
‘An inclusive approach towards designing medical devices for use in the home 
environment’. The survey was completed by 43 designers.  
The primary focus of Cifter’s study was to identify a method to support designers in 
the development of home use medical devices. The main findings of Cifter’s study 
with industry can be condensed into the following points: 
 Cifter found that 76% of respondents believed there is a difference between 
designing home use medical devices and everyday consumer products (Cifter, 
2011). This finding contrasted the work of Gupta as previously described in 
Chapter 2 (Gupta, 2007). 
 The most reported reasons for differences in the approach were cited as the 
‘Safety and Risks of the Device’, ‘User Related Issues’, ‘Regulations and 
Legislation’ and ‘Function and Usability’ (Cifter, 2011).  
 Cifter found that the majority of designers in his study consulted a specialist 
when collecting user information to support the design of home use medical 
devices. This was closely followed by observation techniques or simply using 
the Internet to find information on their users. Interestingly, only 3.8% of 
respondents stated that they would refer to a toolkit to collect information 
(Cifter, 2011).  
 Cifter found three main areas where designers may require assistance when 
designing home use medical devices: ‘Regulatory Information’, ‘Specific 
Information regarding the design process of home use medical devices’ 
and ‘Other sources where designers may find information relevant to the 
design process’ (Cifter, 2011). 
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In light of this knowledge the following study aims to build on this understanding of 
design practice towards home use medical devices. The study will therefore address 
the following two questions, which have been developed on the basis of existing 
research: 
1. If designers consider the involvement of users in the design process to be a 
unique challenge to the design of home use medical devices then how are 
users incorporated into the design process?  
2. What types of process are designers of home use medical devices following 
and at what stages are users involved? 
The following study will address these questions to ascertain designers’ perspectives 
of users in home use medical device design. Aside from the work of Cifter and 
Gupta, previous research has addressed the design approaches taken by the medical 
device industry. 
Eatock et al conducted an exploratory survey with the medical device industry to 
identify the tools and strategies used by varying company sizes (Eatock et al, 2009). 
The survey addressed the manufacturing practices and techniques adopted by 38 
companies across 68 products. Table 6.1 below presents some interesting 
conclusions from the study. 
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Table 6.1: Conclusions from Eatock et al (Eatock et al, 2009). 
Expected and Supported: 
 Large companies use a wider range of methods. 
 Small companies have a very low uptake of Lean, Six Sigma, Stage Gates 
and Total Quality Management (TQM). 
Not Unexpected and Supported: 
 Large companies like to stick with known technologies. 
 The survey findings proved consistent with the innovation model where 
large companies buy up the new technology they need. 
 Large companies use a number of different methods possibly in parallel. 
 Small companies prefer new-to-the-world technologies. 
Surprising Findings: 
 Major upgrades versus minor upgrades are favoured by the large companies 
even though the success rate of major upgrades is lower than that of minor 
upgrades. 
 High success rates reported by those with new-to-the world technologies. 
 
Using these findings by Eatock et al, it was deemed necessary for this study to 
consider the impact of company size on the findings for this research. Martin et al 
posit that the size of a company will have a direct influence on the resources 
available to conduct user research (Martin et al, 2008).  
The principle aim of the research conducted by Gupta and Cifter was to develop 
support for designers and developers of home use medical devices. However, as 
previously stated, it is not currently known the extent to which practicing designers 
make use of such support. There is a need to explore how designers perceive user 
involvement in the design process of a home use medical device. Cifter identified 
that only 3.8% of respondents in his survey would refer to a toolkit for information 
therefore raising the question for this research on the value that current design 
guidance has in practice (Cifter, 2011).  
In exploring these issues, this descriptive study will answer the first research 
question and reveal current industrial perceptions towards the involvement of users 
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in the design process of a home use medical device. It is believed that this knowledge 
will identify avenues for further research that will provide the most value to industry.  
6.3 Methodology 
 
Designing a survey must address a range of core issues in the planning stage to 
ensure that resulting data is reliable, concise and unbiased.  
The previous section described previous research conducted by Cifter, Gupta and 
Eatock et al, which indicated that conducting surveys in the medical device sector 
can be met with difficulty (Cifter, 2011; Eatock et al, 2009; Gupta, 2007).  
Accessing currently practicing designers for research that is focused on their methods 
and processes will always be met with some difficulty given the priorities, workload 
and confidentiality of individuals and organisations. In Cifter’s study with designers, 
400 different individuals were contacted to take part in his study, however a response 
rate of 13.25% was received (Cifter, 2011). This clearly highlights the issue of non-
response and the difficulty to access participants for research. Despite this, the 
findings are no less powerful or potent for their audience if the correct sampling 
frame has been chosen. Cifter adopted a purposive sample of a target population 
which was successfully reached thus the responses are regarded as indicative of 
current practice, even though wide assertions of the findings cannot be explicitly 
expressed.  
The design of this survey must therefore take into consideration the lack of time 
designers can spare to take part in this research. The survey must be designed in such 
a way that respondents are willing and focused to complete the survey honestly and 
truthfully in its entirety.  
Chapter three of this research introduced that a survey-based approach to descriptive 
study one would be adopted. This strategy was selected as part of a Design Research 
Methodology (DRM) approach to develop greater insights into current designers’ 
perspectives towards user involvement in home use medical device design.  
Surveys are recognised as one of the most common methods to collect significant 
amounts of information from large populations (Gray, 2009).  
 
 
184 
 
The initial draft of the survey aimed to provide answers to the first research question. 
With this in mind, a series of key themes were identified that the survey should probe 
from respondents. These themes would collectively provide answers to the first 
research question and in doing so reveal current designer perspectives towards user 
involvement in home use medical device design.  
The initial themes of the study that the survey would attempt to address were as 
follows: 
 The types of medical devices designed. 
 The drivers for selecting a project. 
 The challenges to involving users in the design process. 
 Who industry considers to be their users. 
 How designers prioritise the needs of users. 
 The processes designers follow for home use medical device development. 
 How success is measured. 
 The stages of user involvement in the design process. 
Identifying and answering the questions of the researcher often requires a separate 
and different question to be posed to the respondent. This makes the process of 
designing questionnaires particularly difficult. Gray described a series of steps that 
are important considerations when drafting questions for questionnaires (Gray, 
2009). 
 The researcher has to be clear about the information required. 
 The respondent must interpret the question in a way that the researcher 
intended. 
 The respondent must construct an answer that contains information that the 
researcher has requested. 
 The researcher must interpret the answer as the respondent had intended it to 
be interpreted.  
It is therefore critical to ensure that the presentation of the questionnaire and 
accompanying information facilitates an ease of understanding for the participant. 
This can be achieved through clearly worded, unambiguous questions that are 
concise on the issues they address.  
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Following these principles, a series of questions were developed that attempted to 
address these issues. At this stage, consideration for the presentation and delivery of 
the questionnaire were considered. In order to ensure the methods employed in the 
study were suitable for the target population a range of methods were considered 
prior to selection.  
6.3.1 Paper-based Questionnaires  
 
Sometimes referred to as Postal questionnaires, paper-based methods for collecting 
information from participants are suited to populations that are distributed widely 
geographically and where the target population have a high level of interest in the 
subject matter (Gray, 2009). The design of such questionnaires must be short and 
straightforward to complete as to not have a negative impact on the response rate 
from participants. Paper-based questionnaires are also particularly suited to situations 
where the content may be personal to provide an anonymous medium for participants 
to respond.  
One of the drawbacks to this method of data collection however is the relatively low 
return rate. According to Gray, response rates of 40-50% are common therefore 
strong generalisations about the data to a wider population can be difficult (Gray, 
2009). There is also the opportunity for response bias within the data as respondents 
with low levels of literacy may not understand or be able to complete the 
questionnaires.  
This method of data collection does offer advantages for the target population of this 
study however. As the study targets designers of home use medical devices, the 
population will conceivably have a high level of interest and knowledge in the 
context of this research. The drawback however being that the time and effort to 
complete and return the questionnaire may result in a low response rate. Therefore a 
more rapid method of distribution and completion needs to be considered to ensure 
the best response rate possible.   
6.3.2 Internet and Web-based Questionnaires 
 
Online questionnaires can be administered in two forms, either by email or via the 
World Wide Web (WWW). One of the advantages to using email questionnaires is 
the relative ease to access a respondent’s email address and consequently distribution 
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of the questionnaire amongst a target population. It is possible to create mail merge 
templates that enable large numbers of participants to be contacted at one time. This 
form of distribution however could potentially be received by some participants as a 
form of ‘spamming’ or ‘cold-calling’ and it is widely understood that people do not 
appreciate receiving unsolicited messages (Gray, 2009).  
Despite this, distributing questionnaires via email can be very effective at increasing 
response rates and allows questions to be either included within the message itself or 
in a separate attachment. Difficulties can be experienced in evoking visual 
stimulation or interactivity however (Gray, 2009).  This can be achieved much more 
effectively with web-based questionnaires that provide a formal platform from which 
the questionnaire can be presented. Some argue that many of the limitations of paper-
based questionnaires also apply for email questionnaires, as participants are unable to 
make use of the available skip patterns and drop down menus for example (Gray, 
2009).  
The advantage of web-based methods over paper-based questionnaires however is 
the rapid return of data from participants. Once the questionnaire has been completed 
online the data is instantly available to download in a format ready for analysis. For 
this study such an approach would be particularly suited to the busy schedules of 
designers operating in the field.  
6.3.3 Chosen Method 
 
On reflection of the methods presented above the questionnaire for this study was 
conducted online through a survey-based website. This method of questionnaire 
distribution was chosen for a number of reasons: 
 The ease for respondents to answer the questionnaire without requirement to 
send any paper based forms via post saving both time and money on behalf 
of both the researcher and the respondent. 
 The interactive nature provided by the web-based platform with drop down 
boxes and scales. 
 The simplicity and readiness to access the results online. 
 No requirement to enter the answers to the questionnaire into a software 
package ready to be analysed. 
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 The ease of accessing data in a format suitable to data analysis. (E.g. SPSS 
or Microsoft Excel). 
Once the selected method for administering the survey was identified, the issues of 
design were considered. Using a preliminary design for the questionnaire based on 
the themes described earlier in this chapter, pre-testing was necessary. The following 
section describes the pre-testing process used to assess the ambiguity of the questions 
and whether they were perceived in the manner the researcher intended.  
6.4 Pre-testing  
 
Pre-testing a questionnaire is fundamental to assess the form, structure and wording 
of questions prior to any piloting. Questionnaires are recognised as a one shot 
opportunity for data capture and therefore any ambiguity or misleading questions 
cannot be modified or re-worded as would be the case in an interview scenario for 
example. It is therefore of paramount importance that the respondent understands 
what the survey is asking of them in order to provide a response that is both relevant 
and meaningful.  
Robson suggests pre-testing can be carried out informally among colleagues, friends 
and family to provide constructive comments to ensure the questions are clear, 
simple and unambiguous (Robson, 2011). Gillham advises trialling the initial 
questions with two or more people from outside the target population to answer the 
questionnaire and point out any questions that are unclear (Gillham, 2000).   
For the purpose of pre-testing in this research the initial survey was presented to 
academics with experience in questionnaire design and conducting design research. 
As a follow up to pre-testing, a formal pilot would then be conducted with 
representatives of the target population to finalise any modifications to the 
questionnaire. If the results from the piloting were as intended then the questionnaire 
could be sent out formally as part of the first descriptive study. 
The pre-testing process raised a number of issues and identified problems with both 
the wording and structuring of questions in the initial survey.  
One of the issues raised by respondents to pre-testing concerned the appearance and 
usability of the survey system. While some of the issues raised were restricted by the 
 
 
188 
 
limitations of the software used to develop the online questionnaire (Survey 
Monkey), some respondents opined that a survey website with the questionnaire 
embedded within it may improve the aesthetics of the survey and allow for more 
information about the research as a whole. 
One respondent to pre-testing questioned the use of rating scales within the survey 
design. The respondent argued that the options of ‘Not Applicable’ and ‘Don’t know’ 
were unnecessary responses questions within the survey, as they perceived people for 
whom the questionnaire was intended would only answer the questionnaire.  
 
Whilst the survey was intended for designers and developers with experience in 
home use medical device design, it was considered unsuitable to remove these 
options from the question design. Distributing a survey online via email does not 
guarantee that only the target population will only answer the questionnaire, despite 
every effort being made to ensure they are the respondents. It is possible that a 
company may be very busy and thus feel they have no time to fill in the 
questionnaire, even though it has been designed to take the shortest amount of time 
possible to complete. In such cases the questionnaire may be handed to someone else 
within the company that does not fall into the target population.  
 
Furthermore, it was reasonably foreseeable that certain questions within the 
questionnaire may not be relevant or applicable to every company or individual 
completing the questionnaire. For this reason the option to include the responses 
‘Don’t know’ and ‘Not applicable’ were kept in the questionnaire to give 
respondents the choice. It was felt that providing these options to respondents would 
possibly result in higher user satisfaction when completing the survey and thus lead 
to a better response rate and more meaningful results.  
The pre-testing of the questionnaire proved to be extremely valuable prior to any 
formal piloting amongst the target population. A number of iterations were made to 
the question lengths and number of questions. The feedback from respondents to 
develop a website and embed the survey within it was chosen as the preferred 
method to submit the questionnaire to the pilot audience. The following section 
describes the design of the survey website 
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6.5 Design 
 
The survey was designed and developed using the online survey and questionnaire 
tool Survey Monkey. The service allows users to create questions, distribute surveys 
and analyse results online. Survey Monkey was selected as the most appropriate 
method to develop the survey due to the ability to edit, preview and analyse the 
survey and results online. Furthermore the data collected from participants remains 
safe and secure under recognised online trust seals including Norton, TRUSTe and 
McAfee (Survey Monkey, 2013).  
The design of the survey included a progress bar to provide a reference for 
respondents of much of the survey they had left to complete. The length of the 
survey was identified as a critical issue for response rate as it is widely understood 
that long questionnaires result in respondents losing interest or simply not 
completing the survey (Robson, 2011). 
Once the survey has been completed by participants the results are instantly available 
to download in a format ready for analysis in software packages such as SPSS. SPSS 
is an advanced Statistical Package for the Social Sciences (SPSS) that provides 
modelling techniques for accurate analysis and handling of statistical data.  A copy 
of the survey final design is presented in Appendix 3 of this thesis. 
 
The survey website was developed through the use of the online website developer, 
Wix. The service enables users to develop their own website with interactive content 
that is viewable to anybody with access to the Internet. The screenshots shown in 
Appendix 4 present the look and design of the survey website. The design makes use 
of bold colours with black font on either yellow or white background to ensure the 
best possible legibility for the reader. All of the important information in relation to 
the research and study was presented on the website. A contact page was provided on 
the website to allow users with questions or difficulties to quickly send an email or 
provide feedback to the lead researcher. 
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6.6 Piloting 
 
Following the completion of pre-testing, the website design was distributed in a pilot 
to three contacts representative of the target population. The email briefly introduced 
the research to give context to the message and then included the following link: 
www.wix.com/tgrantmail/medicaldevicedesign to allow respondents to access the 
website and questionnaire in their own time. The survey was open between 
November 2011 and February 2012.  
The first participant to complete the pilot represented a home use medical diagnostic 
device company. The company was identified and selected at a medical device 
networking event within the United Kingdom. The company were considered 
suitable respondents to the survey based on their experience of designing and 
developing home use medical devices for patient use.   
The second of the pilot contacts was a global pharmaceutical company. As part of 
their research and development, the company specialise in diabetes management 
devices for use in the home. Diabetes represents a rapidly increasing problem in this 
country and worldwide and an area of disease management that is commonly treated 
in the home environment. This company was the largest of the companies contacted 
and as part of the pilot survey the questionnaire was submitted to the UK head of 
Diabetes and the Diabetes head of Japan, Australia, Canada, and Europe (JACE).  
The final of the three pilot questionnaires was sent to a diabetes specialist company 
that develop a wide range of injection devices available on the market today.  
Each of the pilot contacts was selected on their representation of the target 
population for the research. While only three contacts were chosen for the original 
pilot, the questionnaire was forwarded onto the head of diabetes for the UK and 
JACE and subsequently submitted worldwide. The spread of contacts based on the 
markets in which they operate and size of the company in terms of turnover/number 
of employees allowed the results of the pilot to identify any possible early themes 
that could be explored further in the real study.  
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6.7 Distribution and Sampling 
 
A purposive strategy towards distributing the survey amongst the target population 
was developed. The plan was supported by previous studies from the literature that 
attempted to evaluate design practice by medical device companies. In his thesis, 
Gupta used www.designdirectory.co.uk, a database of design companies and 
consultancies to identify medical device manufacturers (Gupta, 2007). Using this 
service enables bespoke searches to be conducted for companies specialising in 
‘Industrial Design – Medical and Equipment Design’. Conducting this search at the 
time of this study (November 2011-February 2012) provided an initial list of 54 
companies registered in the UK.  
This cohort of contacts provided a foundation from which other companies would 
then be identified. Purposively contacting design consultancies operating in the field 
of home use medical devices would hope to reveal other companies that were 
suitable for this study. In light of this, as described in Chapter three of this research, a 
combination of purposive and snowball sampling methods were adopted to gain 
participants for the first descriptive study.  
Purposive sampling is a recognised method used by researchers to define a 
population for study. A sample is built using the researcher’s judgement to satisfy 
their specific needs in the area of study (Robson, 2011). As the research 
methodology chapter described, the nature of the first study uses a flexible design or 
mixed method approach which Robson describes as appropriate for purposive 
sampling (Robson, 2011). Once the initial sampling has been carried out, results of 
the study may be analysed and further explored using alternate methods of sampling. 
Follow up sampling methods might include methods guided by emerging theories 
developed within the data such as theoretical sampling, as described in Chapter three 
(Robson, 2011).  
Due to the nature of the target population for the survey, locating a wide range of 
home use medical device companies is a particularly difficult task. This meant that 
once a company was identified they would be asked if they were aware of any further 
companies operating in the field. In this respect a snowball sampling approach to 
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participant recruitment was appropriate to establish as many practicing designers, 
with the relevant experience, as possible.  
According to Robson, snowball sampling is particularly useful when there is 
difficultly to identify members of a population (Robson, 2011). Once a participant 
has been identified from the target population they are used as informants to identify 
other members of the population who again will be used as informants to identify 
other participants and so on (Robson, 2011) Hence the analogy of a snowball, 
participant recruitment should continue to grow significantly. Using a snowball 
method enables the researcher to identify networks for a particular area of study. 
Through acquiring participation, the study will also determine the connections that 
occur between companies, consultancies and organisations such as Medilink UK. 
Medilink UK is a not-for-profit organisation that aims to bring together the NHS, 
academia and industry to ‘stimulate innovation and support the of the healthcare 
technologies sector’ (Medilink Website, Date viewed: July 2012). 
To access further participants for this research, the regional Medilink bodies were 
contacted to identify industry partners involved in home use medical device design. 
Medilink is comprised of eight bodies that make up the UK network and are spread 
across different regions.  
Initial contact with Medilink was made to the East Midlands (EM) organisation as 
they were identified at a medical device conference in 2011. Medilink EM suggested 
that the research was particularly relevant to many of the members registered under 
the West Midlands (WM) region. In light of this both regions were contacted 
regarding the nature of the research and study. While Medilink EM and WM were 
contacted for this study it was believed that should any alternative Medilink body, or 
external company, be recommended by these organisations as suitable to provide 
further assistance with the research they too would be contacted. Each Medilink body 
consists of a wide range of members that operate in the healthcare sector. Members 
of the Medilink network include organisations such as; medical device companies, 
suppliers, pharmaceutical companies, contractors and many more.  
On contacting the Medilink bodies it was indicated that contacting the home use 
medical device companies directly was not possible or appropriate due to the 
agreements held with their members. Alternatively, using the Medilink webpages 
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each member was reviewed and then the relevant companies were explored further 
using their official websites to determine who was relevant and suitable to contact. 
As the intended respondents were designers and developers with experience in the 
home use medical devices, the websites were reviewed for any content relating to 
this nature. If a company was deemed suitable as a potential respondent, they were 
initially contacted via email to introduce the research and the online survey.  
Further contacts were established through exhibitions and conferences attended 
throughout the first year and second year of this thesis (2011/2012). Attendance to 
events such as the Medilink Innovation Day, Design 4 Health Conference in 
Sheffield and the Medtech UK exhibition in Birmingham were all used as 
opportunities to identify participants.  
This approach to recruiting participants was considered appropriate due to the limited 
existing knowledge of home use medical device companies based within the United 
Kingdom. The following section covers the recruitment of participants in more 
detail. 
6.8 Recruitment 
 
All of the participants identified through the distribution strategy described in the 
previous section were collated into a spreadsheet. Initial contact with participants for 
the study was made via email. The developed spreadsheet included contact details 
and specialisms of each company in Microsoft Excel software for clarity and project 
management purposes.  
Using this spreadsheet as a foundation of potential participants, a mail merge 
template was developed to assist in the distribution of a large number of emails to 
participants. The advantages of using such an approach to contact participants are 
summarised below:   
 Rapid Email Distribution - Once the template and contact information is in 
place, large numbers of participants can be contacted with a single button. 
Due to the number of participants contacted in this study, speed of contact 
was vital to the strategy selection.  
 Consistency – Using a template will ensure that each participant receives the 
same structured and formatted information.  
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 Time Saving – Mail merging enables the researcher to type the necessary 
message only once thus saving a considerable amount of time when 
contacting each participant individually and consequently allowing numbers 
of participants to be contacted within a finite time frame. 
 Record keeping – Having every contacted participant in a spreadsheet 
improves project management by keeping a record of when initial messages 
were sent thus providing a reference for when follow up contact is necessary. 
The recruiting email introduced the researcher and the nature of the research in the 
opening paragraph. A copy of the initial contact email can be found in Appendix 5 of 
this thesis. To support the recruitment email participants were provided with an 
information sheet that outlined further information about the study (Appendix 6).  
The website was designed to provide participants with much more detailed 
information about the research and study so the email could be kept suitably brief 
(www.wix.com/tgrantmail/medicaldevicedesign). Providing further information this 
way meant that participants could conduct the survey and have access to further 
information at their leisure. Participants would also be able to refer back to the 
website at any time to read further information or to get in contact with the 
researcher through the ‘contact’ page.  
It has been reported that there are approximately 11,000 Medical Device companies 
in Europe, 80% of which are small and Medium Enterprises (EC, 2013; Quotec, 
2010). Over 2000 of these companies are registered in the UK (Quotec, 2010). Of 
those 2000 small and medium companies operating in the United Kingdom, no 
evidence for the breakdown of the companies into Micro, Small, and Medium 
enterprises was found.  
In light of this, a population of specialist home use medical device companies cannot 
be established for the purpose of this research. With that in mind, the study aimed to 
contact as many home use medical device companies as practicable within the UK. 
To establish a wider audience of home use medical device companies, the 
professional network ‘Linked In’ was explored. Linked In is an online networking 
platform for professionals in all fields and sectors to contact and share content with 
one another. 
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For the context of this study the head of the largest online Medical Devices Group 
was contacted with reference to the possibility of contacting participants through the 
group and online forum. The request was successful and an advert for participation 
for the research was submitted online and can be seen in Appendix 7 of this thesis. 
The recruiting advert included; a brief introduction to the research and researcher, the 
intended respondent profile and a link to the online survey.  
This advert was purposively targeted at the Medical Devices Group on Linked In and 
was specifically focused upon home use medical device designers. According to the 
group leader the members were indicative of Small and Medium Enterprises in the 
medical device industry, which as previously described represent approximately 80% 
of the marketplace (EC, 2013).  
With the recruitment of participants and survey design presented the following 
section introduces the results of the survey from current designer perspectives 
towards user involvement in home use medical device design. The section includes 
the presentation of qualitative and quantitative data, statistical analysis where 
appropriate and a discussion of the main findings to the survey.  
6.9 Results 
 
The following section presents the results to the survey in the order in which the 
questions were presented to respondents. Each question is provided with the number 
of respondents that answered each specific question. A total of 42 respondents 
completed the survey. The section begins with the presentation of all of the data from 
the study before the analysis performed on the results. Following the presentation of 
the data and analysis the interpretation and discussion of the results is presented.  
Questions One, Two and Three: 
The survey opened with simple profiling questions designed to ease respondents into 
the survey and to ascertain the profile of respondents. The questions included: 
Company Details, Approximate Number of Employees and Approximate 
Turnover/Annum (£). A copy of the respondent profiles is presented in Appendix 8 
of this thesis.  
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The company size for each participant was calculated using the reported company 
headcount and turnover in conformance with the definition provided by the European 
Commission (EC, 2003). According to the recommendation by the European 
Commission 2003/361/EC enterprises qualify as micro, small and medium-sized 
enterprises (SMEs) if they fulfil the criteria summarised in Table 6.2. 
Table 6.2: Defining Small and Medium Enterprises (Adapted from EC 
2003/361/EC). 
 
A total of 35 respondents answered question three with seven respondents not 
providing an answer. Twelve participants expressed that certain information 
pertaining to company turnover was confidential and therefore no figures were 
disclosed. Table 6.3 provides a summary of company size for the different 
respondents in the study. 
Table 6.3: Company Sizes Represented in the Study. 
Company Size Number of Respondents 
Micro 19 
Small 10 
Medium 4 
Large 2 
 
Micro companies represent companies with fewer than ten employees and 
consequently have less-resources available to conduct user research with end users. 
These companies represent a unique perspective for this study in reference to how 
they overcome the preliminary challenges to user involvement highlighted in the 
idealised practice case study (See Chapter Four). In contrast Small companies 
Enterprise category Headcount Turnover or Balance sheet total 
Medium-sized < 250 ≤ € 50 million ≤ € 43 million 
Small < 50 ≤ € 10 million ≤ € 10 million 
Micro < 10 ≤ € 2 million ≤ € 2 million 
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represent a workforce of less than 50 employees and Medium and Large 
organisations represent companies with upwards of 250 employees. 
One participant in the study represented a company that conflicted with the values 
provided by the EC towards defining the size of the company. While this company 
had fewer than ten employees (Micro company), the turnover of the company was 
greater than £2M, which would technically define them as a small company. For the 
purpose of this study it was decided that employee headcount would take priority in 
this scenario as respondents were found to be more likely to answer question two in 
relation to headcount as opposed to question three which referred to annual turnover. 
This could be attributable to some respondents perceiving such information to be 
confidential.  
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Figure 6.1: Types of Devices Designed by Respondents. 
Question Four: Which of the following best describes the area(s) of medical 
devices you have worked on?  
A total of 29 respondents answered this question with 13 respondents skipping the 
question. The results to this question are presented in Figure 6.1, which presents the 
different types of medical devices developed by respondents. Note the results to this 
question are not exclusive. It was highly foreseeable that respondents would have 
experience in more than one domain of medical device development and as such 
could potentially be involved in all domains shown in Figure 6.1. 
 
Question Five: If you were designing a medical for the home environment, what 
would be the prime drivers for development? 
 
A total of 36 respondents answered this question with six respondents skipping the 
question. The results to question five are presented in Figure 6.2 concerning how 
designers and developers of home use medical devices identify and select a project to 
take forward for development. The maximum value of importance that could be 
assigned to any one driver was seven. The mean ranks expressed in Figure 6.2 
present the mean scores from all respondents to question five. To compare the 
differences between the identified drivers for development the Freidman Test and 
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Figure 6.2: Perceived Importance of Selected Drivers for Home Use Medical 
Device development. 
Pairwise Comparisons were performed on the results. Please refer to the analysis 
section for information on the statistical tests performed in this study.   
Question Six: What do you consider to be the barriers and or challenges to user 
involvement in your design process? 
A total of 36 respondents answered question six of the survey with six respondents 
skipping the question. The results to question six are presented in Figure 6.3 
concerning the challenges towards involving users in the design process of a home 
use medical device. The results to this question are not exclusive.  
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Figure 6.3: Perceived Challenges Towards Involving Users in the Design Process 
of a Home Use Medical Device. 
Question Seven: When designing a medical device for your core business, who 
from the following list do you consider to be your users? 
A total of 35 respondents answered question seven with seven respondents skipping 
the question. The results to question seven are presented in Figure 6.4. A range of 
potential home use medical device users was developed based upon the case studies 
(Chapters 4 and 5) and existing research (Cifter, 2011; Shah & Robinson, 2008). 
Respondents were also given the option to provide additional users to the list through 
the use of the ‘Other’ category. The results to question seven are not exclusive, as it 
is foreseeable that any one device could potentially have a multitude of users (Martin 
et al, 2008). The option of ‘All of the above’ was provided to participants if they 
considered every user mentioned on the list to be a potential user for a home use 
medical device.  
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Figure 6.4: Designers’ Perspectives of Perceived Users for Home Use Medical 
Devices. 
Figure 6.5: Designers’ Perspectives on Priority Users of Home Use Medical 
Devices. 
Question Eight: Of the user groups mentioned in the previous question, who 
needs do you consider to be the most important? 
 
A total of 38 respondents answered this question with four respondents skipping the 
question. The responses to question eight are presented in Figure 6.5. The responses 
to this question are exclusive as respondents were asked to provide a single answer. 
 
 
202 
 
Question Nine: What are your reasons for choosing this user group? (Open-
ended question). 
A total of 42 respondents answered this question. Question nine required participants 
to provide an answer in order to continue with the survey. Eighteen respondents 
provided random alpha-numerical responses that were not considered coherent 
answers to the question. The 24 genuine responses provided for question nine are 
presented in Table 6.4:  
Table 6.4: Descriptive responses provided for Question Nine. 
User Group 
Selected 
Participant Response 
ALL OF THE 
ABOVE 
All are involved in product use and have important roles.  
Chain of involvement means if one member of the chain 
fails the product will be ineffective. 
PATIENTS 
They are the end user and therefore the most important. 
Everyone else is just helping them use [the device]. 
PATIENTS [We] design devices for intended users 
CONSULTANTS 
For theatre lighting: Tend to be the front line user and have 
significant influence on purchase decision.  For kitchen 
design would choose consumers/buyers. 
PATIENTS 
They are ultimately the user (recipient) of the medical effect 
or treatment. 
NOT ANSWERED 
Because we design and develop a broad range of devices all 
for different segments and markets each will have a different 
set of user group priorities, for example a home health care 
advisory product for detecting breast abnormalities is 
completely different to a clinical device for measuring 
retinal function. 
PATIENTS 
They are the least ""expert"", but again it depends... if it is a 
piece of specialist equipment used by the clinicians or nurses 
only and safety is critical then the focus would be on making 
is easy (and error free) for the professionals to use. 
PATIENTS 
I am a design researcher and my job is mainly to examine 
the design of the product from a user's perspective, through 
research and evaluation.  The product user will ultimately 
use the product and it is extremely important that the device 
is free from misuse, but also accepted by the user (patient 
compliance is a really important issue often ignored by 
designers). 
PATIENTS Assisting them is the whole point of the exercise! 
ALL OF THE 
ABOVE 
Not a straightforward question.  As we design many 
products, there are many answers. 
PATIENTS 
The end user will determine whether the product meets the 
specific need in an adequate way - i.e., cost effective, easy to 
use, accurate and reliable, etc., 
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User Group 
Selected 
Participant Response 
GENERAL 
PRACTITIONERS 
GPs are the gateway 
CONSULTANTS They're our end-user 
PATIENTS They use the product 
NURSES 
The nurse has to meet her user needs (i.e. the patient has to 
be confident in the nurse’s choice of dressing). But the 
Nurse also has to satisfy the clinical need as well. Gets both 
bits and generally has to apply the dressing to the patient and 
will receive the complaints if performance is unsatisfactory 
CARERS It’s the group we address 
PATIENTS 
Products largely used in the home care setting by the end 
user. 
PATIENTS 
Depends on the product type, but the patients' needs tends to 
be considered most important, particularly in home use 
medical devices. With this type of device, it is often the case 
that the patient will also be the main end user and the one 
directly interacting with the product. Therefore it is 
important that their experience of that product and its 
usability is well considered, especially during the design and 
development stages. 
GENERAL 
PRACTITIONERS 
I'm answering as though I were still at Cardiac Science 
where most of our products were sold through distribution to 
general practitioners. 
PATIENTS 
Technology needs to support patients first. Reducing the cost 
of health care  -  and enabling better patient support is 
something long overdue 
PATIENTS 
Scope of survey is home care and therefore end user is the 
patient and design considerations would be focused on the 
end user in this case, the patient. 
NOT ANSWERED That definition seems to be the most logical. 
CARERS Closest to the end user 
PATIENTS None is happy if the patient is not happy. 
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Figure 6.6: Different Design Processes Followed by Respondents. 
Question Ten: What best describes the process you follow when designing or 
developing a new device for the market? 
A total of 31 respondents answered question ten with eleven respondents skipping 
the question. For the purpose of question ten a range of commonly recognised design 
processes were presented to participants. Respondents were provided with an ‘Other’ 
category should they have followed an alternate process to the examples presented in 
the list.  The results to question ten are presented in Figure 6.6.  
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Question Eleven: Do you actively collect design feedback from your end users 
once a product has been launched onto the market? 
A total of 35 respondents answered question eleven with seven respondents skipping 
the question. The results to question eleven are presented in Figure 6.7.  
 
Figure 6.7: Is Design Feedback from End Users Actively Collected by Designers. 
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Question Twelve: How do you measure the success of a new device once it has 
been launched onto the market? 
 A total of 34 respondents answered question twelve with eight respondents skipping 
the question. The results to question twelve are presented in Figure 6.8. For the 
purpose of question twelve respondents were provided with different criteria relating 
to the launch of a medical device onto the market.  As with question five, the 
maximum value of importance that could be assigned to any one measure of success 
was seven. The mean ranks expressed in Figure 6.8 present the mean scores from all 
respondents to question twelve. 
 
 
 
  
Figure 6.8: Designers’ Measures of Success for Home Use Medical Devices. 
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Question Thirteen: At what stage(s) and to what extent during your design 
process do users become involved? 
 
A total of 34 respondents answered question thirteen with eight respondents skipping 
the question. Using a Likert Scale, question thirteen asked respondents to rate the 
level of user involvement for six different stages of a typical or generic design 
process: Initial Concept, Design Stage, Product Design Specification, Product 
Development, Product Testing and Post Launch. The rating scale ranged from 1 = 
‘Not Involved’, 2 = ‘Rarely Involved’, 3 = ‘Sometimes Involved’, 4 = ‘Often 
Involved’ and 5 = ‘Highly Involved’. Figure 6.9 presents the results to question 
thirteen. 
 
 
 
 
The following section will now present the descriptive results of the study. 
 
  
Figure 6.9: The Level of User Involvement at Different Stages within the Design 
Process of a Home Use Medical Device. 
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Dealing with Descriptive Data 
 
A number of responses from respondents in the study fell under the ‘Other’ category. 
On exploring the responses provided by respondents it became apparent that only 
five participants used the ‘Other’ category in question five. The descriptive insights 
provided by respondents were considered more appropriate to reflect on qualitatively 
and to support future work with designers in the field.  
The qualitative nature of the open-ended questions in the study was considered for 
grouping into themes that could subsequently be added to the original data set. This 
was however considered unacceptable for the reliability of the study and the 
opportunity to introduce potential researcher bias.  
While respondents were openly allowed to provide their own responses for ‘Drivers 
for Development’ it was deemed inappropriate for these responses to be regrouped 
based on the researcher’s subjective interpretation of the responses. The responses 
are limited in context due to the data being collected from an online survey. If the 
survey was conducted as part of an interview there could have been more detailed 
insight and discussions into the interpretation and understanding of respondents. 
Using this methodology would have the added benefit to the researcher of exactly 
what the respondent meant by their answer.  
The data however did provide interesting insights for future probing as part of some 
further research to explore what respondents understood by each term and whether 
recurring themes emerged.  
Table 6.5 presents examples of the ‘Other’ responses provided by participants for 
question five.  
Table 6.5: 'Other' Responses for Question Five. 
Responses Potential Theme 
Profitability Cost 
Ease of use Performance/User Needs 
Business case Cost 
Profit Cost 
Safety Performance/User Needs 
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Three of the responses (‘Profitability’, ‘Business Case’ and ‘Profit’) it could be 
argued refer to the commercial drivers behind home use medical device 
development, which are closely related to the implications of ‘Cost’. The ‘Safety’ 
and ‘Ease of Use’ of a device potentially fall into two categories, namely 
‘Performance’ and ‘User Needs’ dependent on the interpretation of the respondent. 
The results shown in Table 6.5 therefore can be considered indicative of the whole 
population of respondents as no new themes for possible ‘Drivers for Development’ 
were identified. It would be reasonable to assume that the respondents to this study 
deemed the options presented in question five covered their desired responses to the 
question of project selection. 
With all of the results recorded in the study now presented the following section will 
describe the analysis performed on the results to explore the data and its implications 
further. 
6.10 Analysis 
 
To understand the differences and significance of the results in this study it was 
necessary to perform statistical comparisons of the data. The following section 
describes the analysis conducted on specific questions within the survey. 
Question Five (5) of the survey addressed designers’ perspective of the drivers 
behind the development of home use medical devices. To ascertain whether any 
significant differences exist between the drivers cited by respondents a Freidman 
Test followed by a Pairwise Comparison was performed on the data for question 
five.  
The Freidman test is the non-parametric equivalent of the one-way within-subjects 
analysis of variance (Brace, Kemp & Snelgar, 2012). The test is sometimes referred 
to as the Freidman two-way ANOVA because in a within-subject analysis of 
variance participants are considered to be a factor (Brace, Kemp & Snelgar, 2012). A 
copy of the Freidman Test results is presented in Equation 6.1.  
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The test revealed that respondent’s perception of drivers for the development of 
home use medical devices varied significantly:  
Equation 6.1: Freidman Test 
X2 (5, N=31) = 56.838, p < 0.05 
Where;  
 X2 is the calculated value for the Freidman test, which is assessed for 
significance using X2  distribution. 
 The degrees of freedom = k – 1, where k is the number of levels of the factor. 
Hence, the value of 5 for this question (Six Drivers).  
 P is the p value. 
The results of the Freidman test alone however do not determine where the 
significant differences exist. This non-parametric test demonstrates that a significant 
difference is present in the data set as a whole. To determine which drivers are 
significantly different from one another requires a Pairwise Comparison to be 
performed on the mean ranks for the perceived drivers. 
A pairwise comparison of a data set determines the relationship between the 
variables and reveals which results are significantly different from one another. The 
simple null hypothesis test summary shown in Figure 6.10 demonstrates that one or 
more of the drivers when compared with each other produced a result that was 
statistically significant. A full breakdown of the Pairwise Comparison results can be 
found in Appendix 9 of this thesis.   
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The Pairwise Comparison shown in Figure 6.10 compared each variable with one 
another to determine any significant differences in the data. The significance level 
for the test was 0.05. Any p value less than 0.05 was recognised as statistically 
significantly. A Bonferroni correction was conducted on the data set. 
Figure 6.10 revealed seven significant differences in the results received for question 
five. The differences in order of significance are shown below: 
1. ‘Performance’ (Rank = 4.18) significantly differed from ‘Sustainability’ 
(Rank = 1.92). 
2. ‘User Needs’ (Rank = 4.77) significantly differed from ‘Sustainability’ 
(Rank = 1.92). 
3. ‘Function’ (Rank = 4.08) significantly differed from ‘Sustainability’ (Rank 
= 1.92). 
4. ‘User Needs’ (Rank = 4.77) significantly differed from ‘Intellectual 
Property’ (Rank = 2.50). 
5. ‘Performance’ (Rank = 4.18) significantly differed from ‘Intellectual 
Property’ (Rank = 2.50) 
Figure 6.10: Pairwise Comparison Test Results for Question Five. 
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6. ‘Cost’ (Rank = 3.55) significantly differed from ‘Sustainability’ (Rank = 
1.92). 
7. ‘Function’ (Rank = 4.08) significantly differed from ‘Intellectual 
Property’ (Rank = 2.50). 
Analysis of Results to Question Twelve: 
In order to understand the significance of the differences in the results for question 
twelve, the Freidman Test followed by a Pairwise Comparisons was performed. As 
before, the significance level for the test was 0.05. Any p value less than 0.05 was 
recognised as statistically significantly. A Bonferroni correction was conducted on 
the data set. A full breakdown of the results can be found in Appendix 10 to this 
thesis.  
The tests revealed eight significant differences between the measures of success for 
home use medical devices: 
1. ‘Number of Sales’ (Rank = 5.83) significantly differed from ‘Industrial 
Awards’ (Rank = 1.85). 
2. ‘End User Feedback’ (Rank = 4.87) significantly differed from ‘Industrial 
Awards’ (Rank = 1.85). 
3. ‘Number of Sales’ (Rank = 5.83) significantly differed from ‘Purchaser 
Feedback’ (Rank = 3.32). 
4. ‘Healthcare Professional Feedback’ (Rank = 4.42) significantly differed 
from ‘Industrial Awards’ (Rank = 1.85). 
5. ‘No Product Recalls’ (Rank = 3.93) significantly differed from ‘Industrial 
Awards’ (Rank = 1.85).  
6. ‘Number of Sales’ (Rank = 5.83) significantly differed from ‘No Product 
Complaints’ (Rank = 3.78) 
7. ‘No Product Complaints’ (Rank = 3.78) significantly differed from 
‘Industrial Awards’ (Rank = 1.85) 
8. ‘Number of Sales’ (Rank = 5.83) significantly differed from ‘No Product 
Recalls’ (Rank = 3.93). 
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Analysis of Results to Question Thirteen: 
As before, a pairwise comparison of the results collected for question thirteen was 
performed to ascertain any significant differences between the highest stages of user 
involvement in the design process of a home use medical device. A copy of the 
results can be found in Appendix 11 of this report. 
The test revealed two significant differences in the data received for question thirteen 
in the survey.  
1. ‘Product Testing’ (Rank = 4.54) significantly differed from ‘Product 
Development’ (Rank = 2.88). 
2. ‘Product Testing’ (Rank = 4.54) significantly differed from ‘Product 
Design Specification’ (Rank = 2.94). 
The implications of the analysis presented in this section are discussed in the 
following section. Section 6.11 describes the interpretations of the study results and 
its relation to existing research in the field.  
6.11 Discussion 
 
The aim of this study was to answer research question one of this research: 
Research Question One: How do designers consider and involve users in home use 
medical device development? 
In exploring designers’ perspectives of home use medical device users and their 
involvement within the design process, the study has revealed information about 
current design practice in industry towards home use medical device design.  
Respondents to this study typically represented ‘Monitoring’ ‘Drug Delivery’ and 
‘Assistive Technology’ devices for use in the home. Figure 6.1 revealed that 
approximately 52% of respondents in this study had experience in designing 
‘Monitoring’ devices for use in the home, while 45% of respondents were 
experienced in ‘Drug Delivery’ and ‘Assistive Technology’ devices. One could argue 
that this is perhaps to be expected from developers of home use medical devices as 
these types of devices are currently representative of the most commonly used 
medical devices in the home. According to the National Research Council, the 
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coming years will see a shift towards more sophisticated and complex medical 
devices migrating in to the home environment (National Research Council, 2011). 
Consequently, increased numbers of emergency and post-acute care devices may find 
their way into the home thus placing higher demand on designers to cater for these 
needs. 
In light of the recognised trend towards consumer home use medical devices it was 
hypothesised that the companies participating in this study would be specifically 
focused on the costs associated with development (FDA, 2011). This would support 
the findings of Chapter Four whereby participants in the case study indicated that 
design decisions are often based on commercial reasoning rather than the needs of 
end users specifically. Question Five of the survey addressed this issue to ascertain 
where user needs sit alongside the commerciality of the sector. For the purpose of 
this study participants were provided with potential drivers identified through 
conducting the case studies of this research. These drivers included: Cost, Function, 
Intellectual Property, Performance, Sustainability, User Needs, and Other. 
Figure 6.2 revealed that ‘User Needs’ were perceived as the most important driver 
behind the development of home use medical devices for designers in this study. The 
results suggest that the needs of users are considered more important to designers 
than the performance and function of the device itself at the outset of the design and 
development process. To ascertain whether there was any significant differences in 
the drivers cited by respondents in the study the data was analysed using the 
Freidman Test and a Pairwise Comparison. 
Figure 6.10 indicated that ‘Sustainability’ and ‘Intellectual Property’ were of lesser 
priority to designers in the study at the outset of a project. Perhaps these issues 
become more important later in the development process when the device is closer to 
launch, however this was not explored in the survey. No evidence of a significant 
difference was found between ‘Cost’, ‘Function’, ‘Performance’ and ‘User Needs’ 
thus assertions to a wider population are not possible. This means that if this test was 
repeated with different participants from the home use market ‘Performance’, 
‘Function’ or ‘Cost’ may well be perceived as the most important driving factor for 
the development process. To ascertain a statistically significant result for this 
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question would require a wider range of respondents to complete the survey. Due to 
time and project constraints this was not possible within the scope of this research. 
It must be considered that respondents could have answered the survey in the way 
they would like to be perceived externally. Previous research has shown respondents 
can answer questionnaires and surveys in ways that are not always truthful to real life 
(Robson, 2012). Respondents can feel a pressure when answering questions to 
provide a response they think the researcher is looking for. When answering the 
questionnaire, which forms part of a body of research for Loughborough University, 
there is an inherent awareness of likely publications and the presentation of the data. 
As such respondents may feel obliged to answer the questionnaire in a manner that 
depicts their methods, processes and perspective towards design in the best light. 
One approach to overcome this is to conduct a secondary stage interview whereby 
answers to the previous questions are probed. At interview themes and previous 
responses can be explored in more detail with respondents to challenge the thoughts 
and opinions expressed in the initial questionnaire. This is explored further in 
following chapter, which presents an understanding of current design practice for 
home use medical devices.  
 
Despite this, it may well be that user needs, including those of patients are of primary 
concern to designers for home use medical devices. This is of course a requirement 
of the harmonised standard IEC BS EN 62366 (IEC 62366, 2007). According to IEC 
BS EN 62366, manufacturers are required to identify and describe the intended user 
population, the intended user profile and the conditions of use (IEC BS EN 62366: 
2007). This highlights an incentive for the design community to consider and involve 
the end users within the design process and thus could have driven a rise in the 
importance of ‘User Needs’ for the development process since its introduction in 
2007. The fact that the standard is internationally recognised and harmonised under 
the Medical Device Directive provides a moral obligation for manufacturers to 
consider usability. The implications of IEC BS EN 62366: 2007 were discussed in 
detail in Chapter Two. 
With the drivers for development in mind, the challenges towards involving users 
specifically were addressed in question six of the survey. For the purpose of this 
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question, respondents were provided with six potential challenges to involving users 
in the design process of a home use medical device as well an ‘Other’ option. For 
clarity purposes to designers in the study an example of each potential challenges 
was provided with the question. The challenges included: Access to Specialist 
Knowledge (e.g. In-house or Externally), Cost (e.g. The cost involved to conduct 
user research), Education or Training (e.g. The training of research methods), Ethics 
(e.g. Gaining ethical approval to conduct user research), Regulations (e.g. 
Compliance with the Medical Device Directive) and Time (e.g. The time involved to 
conduct user research). All of the challenges cited in this question were based on 
existing research found within the literature review. Participants were also provided 
with ‘Don’t Know’ and ‘Not Applicable’ options.  
Figure 6.3 revealed that ‘Cost’ in the context of involving users in the design process 
of a home use medical device was identified as the leading challenge cited by 
respondents (64%). This supports previous research that has indicated the cost of 
involving users as a challenge to medical device development. In a study by Money 
et al it was found that product developers perceived user needs research to be 
disproportionality costly in relation to the benefits gained from conducting such work 
(Money et al, 2011). 
Perhaps designers find it difficult to see an immediate benefit from including users in 
the design process for home use medical devices. This is compounded by an upfront 
cost to involve users with no immediate monetary feedback from doing so. One must 
consider however that the cost of not involving users in the design process could be 
significantly higher in terms of implications for due diligence, legislation and also 
the potential for a device recall. As was described with the Exubera Inhaled Insulin 
device in Chapter Two of this thesis, the consequences of launching a device that 
fails to meet the needs of end users can be extremely costly.  
Figure 6.3 supports that the challenges of ‘Cost’ and ‘Time’ are fairly fixed 
constraints on medical device design for manufacturers. Product development cannot 
continue endlessly. Similarly, the amount of money spent on developing a product 
must remain within a realistic budget that will potentially bring profit to a company. 
These factors were therefore hypothesised by the researcher to be cited as significant 
challenges to involving users in the design process of a home use medical device.  
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A reported 58% of designers in the study cited ‘Time’ as challenge towards 
involving users in their design process. The context in which ‘Time’ is used here 
refers to the actual or perceived time from the perspective of the designer to conduct 
user needs research. Thus, it can be said that the hypothesis of the researcher is 
supported by the results of this question. Consequently, the implications of ‘Cost’ 
and ‘Time’ are significant for the involvement of users in the design of home use 
medical devices.  
Aside from the costs and time involved in conducting user needs research, the results 
revealed that ‘Regulations’ in the United Kingdom were perceived as a challenge by 
50% of the designers in the study. This finding contrasts with the findings of Chapter 
Four whereby the current regulations were identified as a push factor towards the 
improved usability of home use medical devices.  
 
The regulatory requirements for medical device development have been previously 
cited as a barrier to involving users in the design process of a medical device (Martin 
et al, 2008; Money et al, 2011). By necessity manufacturers are required to meet the 
relevant regulations prior to a device being tested with real end users and 
subsequently launched onto the market. Medical device developers therefore can be 
resistant to changing a device once the relevant regulation has been met (Martin et al, 
2008). This is due to the potential requirement for re-submission once the tests have 
been conducted. If necessary changes to the device design are identified at a late 
stage in the process it can have significant implications for the cost of development. 
Developers should therefore have a strong incentive to involve users early and 
throughout the design process to ensure such an incident does not occur.  
 
A third of designers (33%) in this study cited ethics as a challenge towards involving 
users in the design of home use medical devices. In the context of this study the term 
ethics refers to designers and developers gaining ethical approval to conduct research 
with potential users of home use medical devices. Thus one could infer that some of 
the designers in this study perceive the process of gaining ethical approval to be 
challenging. Perhaps the designers in the study believe the process of gaining ethical 
approval to be difficult or time consuming. Consequently the process of gaining 
approval could lead to the delays in the design and development process. Without 
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further insight into the reasoning behind the responses of designers it is not possible 
to draw a conclusion upon why ethics is perceived as a challenge. Further research 
must ascertain why 33% of designers in this study perceived ‘Ethics’ to be a 
challenge to involving users in the design process. 
Interestingly, question six indicated that only 8% of respondents considered 
‘Education’ as a challenge or barrier to user involvement in home use medical device 
design. ‘Education’ in the context of this survey refers to the relevant training and 
experience to conduct user research appropriately. This result suggests that designers 
consider themselves equipped to conduct user research for home use medical devices 
without the need of design support or training on appropriate methods for user 
requirements capture. 
It is understood that a wide range of medical devices are currently designed with 
poor considerations for device users. This is supported by the recognised increase in 
use errors globally (IEC BS EN 62366:2007). The findings of this study therefore 
suggest that a range of possible scenarios exist within the field of home use medical 
device design in relation to understanding and capturing the needs of users.  
Scenario One: Designers are aware of the principles and methods for user needs 
research but do not apply them. 
 
Scenario one implies that designers of home use medical devices are aware of the 
principles and practices outlined in documents such as IEC BS EN 62366:2007 and 
ANSI/AAMI HE75:2009 yet fail to apply them in practice. In this scenario designers 
know what they should be doing in practice but either chose to ignore such guidance 
or are unable to apply or conduct user needs research in practice due to specific 
constraints on the project.  
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Scenario Two: Designers are not aware of the relevant methods and so cannot 
apply them at all. 
 
Scenario Two implies that designers are not aware of the relevant principles and 
methods to conduct user needs research and consequently cannot adopt the 
approaches outlined in IEC BS EN 62366: 2007 and ANSI/AAMI HE75: 2009. In 
this scenario designers cannot conduct the approaches advocated by the current 
medical device guidance because they are either not aware of the guidance in the first 
instance or the available methods to conduct user research with patients.  
 
Scenario Three: Designers are aware of the principles and methods for user needs 
research but apply them sub-optimally.  
The final scenario implied by this study considers that designers are aware of the 
principles and methods to conduct user needs research however are unable to apply 
them optimally in practice. Similar to scenario one in that designers are aware of the 
approaches they should be taking towards identifying the needs of their users 
however in this instance they are unable or unwilling to adopt ‘idealised’ practice 
based on the constraints of projects.  
Through questionnaire studies such as this it is not possible or appropriate to draw 
conclusions on which scenario is occurring and why. It is necessary to conduct 
further research that explores current practice in more depth to ascertain which 
scenario is occurring and why. Future studies in this research will reflect on these 
scenarios presented here to understand why home use medical devices are designed 
in the manner in which they are.  
Previous studies have explored user requirements capture during the design process 
of medical devices. Martin et al indicated that user requirements research in medical 
device design appears to be considered and captured during the design and 
evaluation stage of the product life cycle (Martin et al, 2008). Martin et al described 
the process of involving users as often being an ‘after-thought’ in the design process 
(Martin et al, 2008). This would imply that medical devices are sometimes designed 
for the end users’ needs or requirements retrospectively and towards the end of the 
design process. 
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In contrast, the results of this study indicate that ‘User Needs’, specifically the needs 
of ‘Patients’ (see Figure 6.5) are the priority consideration for designers of home use 
medical devices. Figure 6.4 revealed that 74% of designers in this study believed 
patients to be the majority users of home use medical devices, with a reported 58% 
of designers citing ‘Patients’ as the priority user group (see Figure 6.5).  
The literature review of this research addressed the need to define the term ‘user’ in 
the context of home use medical device design. According to the harmonised 
standard, IEC BS EN 62366, a user is defined as the “person using i.e. operating or 
handling, the medical device.” Understandably, for home use medical devices this 
can cover a broad range of individuals with diverse capabilities from servicing and 
installers to patients and healthcare professionals (Shah & Robinson, 2008).  
While Patients were identified as the leading users of home use medical devices, 
many respondents to survey perceived healthcare professionals to be users of home 
use medical devices. Figure 6.4 revealed that; nurses, clinicians and general 
practitioners (GPs) accounted for 60%, 46% and 43% of responses from participants 
respectively. This finding shares similarities with existing research on the users of 
medical devices. 
 
Shah and Robinson explored the concept of the term ‘user’ in a structured review of 
existing literature (Shah and Robinson, 2008). The authors combined existing 
perspectives on the term ‘user’ resulting in a classification for users based on two 
classes, seven types and several types and sub-types (Shah & Robinson, 2008). 
Initially the users were divided into Primary and Secondary users before being 
classified into seven different types of user. These types included: Healthcare 
Professionals, Patients, Carers, People with Special Needs, Trainees & Students, 
Researchers and Others (Shah & Robinson, 2008).    
 
Shah and Robinson posited that for the purpose of design, medical users are often 
assumed to fit in one of two generic categories ‘Clinicians’ and ‘Patients’ (Shah and 
Robinson, 2008). Figure 6.4 indicated that the majority of designers identified 
‘Patients’ and healthcare professionals including ‘Nurses’, ‘Clinicians’ and ‘General 
Practitioners’ as users for home use medical devices. It could be argued that the 
results of this study support the work of Shah and Robinson in that the designers in 
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this study predominantly designed for these two ‘generic’ user groups. Shah and 
Robinson posited that assumptions ‘by default, if not by design’ of medical device 
users are that they typically fall into ‘one of two ill-defined generic categories 
clinicians and patients’ (Shah & Robinson, 2008). Consequently they add that such 
assumptions have ‘led to a narrow two-dimensional approach to users’ which has 
‘belied the richness and complexity’ of the manner in which medical devices are 
adopted in everyday use (Shah & Robinson, 2008).  
 
Aside from these two recognised user groups, Figure 6.4 indicated that Buyers 
(23%), All of the Above (9%) and Standards Agencies (6%) were the least likely of 
user groups to be considered by designers for their core business. This supports the 
findings of Figure 6.2 in the sense that the process of designing a home use medical 
device is perceived, as a user needs driven process by respondents to this study. This 
finding however contrasts with the earlier work conducted in this thesis, which 
indicated that, the process of designing a home use medical device is commercially 
driven (See Chapter Four).  
 
In spite of this it would be inaccurate and inappropriate to assume or conclude from 
this study alone that such a finding implies that designers consider buyers or 
standards agencies of little importance or priority in the design process. It may well 
be that designers do in fact prioritise for such groups but do not consider them to fit 
under the heading of the term ‘User’. Perhaps if a separate question asked for the 
‘Stakeholders’ within the process of designing a home use medical device there may 
have been different results to this question.  
 
Approximately 58% of respondents perceived ‘Patients’ to be the priority users of 
home use medical devices. This finding contrasted with the hypothesis of the 
researcher. Based on existing research it was believed that designers of home use 
medical devices would place an emphasis upon satisfying the requirements of 
healthcare professionals above the needs of patients. Chapter Five of this thesis 
indicated that a home use medical device company based in the United Kingdom 
typically based decisions and their delivery process on the requirements and needs of 
senior level healthcare professionals with influences on procurement.  
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In a study conducted by Money et al, it was also found that designers typically 
valued the views, requirements and needs of healthcare professionals above that of 
the patients (Money et al, 2011). One manufacturer in their study considered 
surgeons to have sufficient knowledge to act as representatives of the end users for 
the home environment (Money et al, 2011). In their study, Money et al found that a 
manufacturer justified the decision to use surgeons for user needs research due to 
their influence upon the promotion and sales of the device to their patients. A similar 
finding was also found in the idealised practice case study of this research whereby 
the use of representative users was discussed in light of the practical constraints 
facing designers in the home use medical device industry. 
Question nine of the survey set out to ascertain designers’ perspectives and reasoning 
for selecting their priority user group. Table 6.5 revealed a diverse set of responses 
from participants that given the multiplicity of respondent backgrounds was perhaps 
to be expected. For clarity the list of potential users presented to respondents in the 
survey included: Buyers, Carers, Clinicians, Consultants, General Practitioners, 
Nurses, Patients, Standards Agencies and All of the Above. Respondents were also 
provided with the option to include any extra users they considered in the design 
process. 
 
A summary of respondents reasoning behind their chosen priority user group is 
presented below: 
 
All of the Above – 2 out of 24 responses were for All of the above (8%). One of the 
designers in the study opined that everyone on the list in Figure 6.5 is a potential user 
therefore all of the needs must be considered. 
Carers – 2 out of 24 responses were for Carers (8%). One designer felt that carers 
were the closest to the end user therefore the needs of carers should take a priority 
when designing a home use medical device.  
Consultants – 2 out of 24 responses were for Consultants (8%). One designer 
referred to the influence consultants have on the procurement process therefore 
designing for their needs was the priority for their company. 
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General Practitioners – 2 out of 24 responses were for General Practitioners (8%). 
Both responses for General Practitioners referred to them as a means of distribution 
for medical devices whereby meeting their requirements improved the chances of 
uptake in the marketplace.  
Nurses – 1 of 24 responses was for Nurses (4%). One designer felt that the nurses 
have to meet the needs of their patients therefore the needs of the nurse were a 
priority consideration for design which would then be delivered to the patient.  
Patients – 13 out of 24 responses were for Patients (54%).  Every designer who 
selected patients as the priority user group alluded to the fact that for home use 
medical devices they are the ultimate end user in the process thus their needs are the 
most important for design. 
To ascertain how the designers in this study considered and designed for the different 
user groups in this study the survey addressed the design process itself. Figure 6.6 
indicated that 45% of designers in this study reportedly followed a ‘user centred 
design’ process towards home use medical devices. This result suggests that many of 
the respondents in this study are in fact aware of user centred design as a practice and 
furthermore reportedly implement such a process in the design of home use medical 
devices. The issue of how designers implement a ‘user centred design’ process 
however cannot be explored through a survey strategy alone. As part of further 
research for this thesis it is necessary to explore in greater depth the stages and 
methods involved in such an approach towards home use medical device design. 
 
A reported 35% of respondents in the study indicated that they followed a Detailed 
Design Process towards home use medical device development. Again, further 
research is necessary to understand respondent’s different interpretations of such a 
process including the involvement of users towards home use medical device 
development. This will be addressed later in the discussion when the results of 
question thirteen in the study are discussed.  
 
Figure 6.7 revealed that 86% of respondents in the survey actively collected design 
feedback from their end users post launch. According to the National Research 
Council, there is opportunity after a product or system is marketed to ‘solicit and 
 
 
224 
 
analyse’ feedback from users to inform updates or new designs (National Research 
Council, 2011). Therefore by collecting feedback from end users it is possible to 
identify early stage problems with device use whilst also providing design insights to 
be iterated into future designs or upgrades. This approach is advocated by user 
centred principles where an iterative approach to design with involvement from end 
users throughout the development process reportedly leads to safer and more usable 
devices (IEC BS EN 62366: 2007).  
One of the limitations of question eleven in the survey however is the potential for 
respondents to misinterpret user feedback with post market surveillance, which is a 
legal requirement from a regulatory perspective. One participant during piloting 
highlighted that they considered this question to refer to post-market surveillance and 
the monitoring of a device after launch. Subsequently the wording of question eleven 
was adapted for the final survey design. This is a recognised limitation of 
questionnaires as the researcher is unable to rephrase or reword a question to the 
respondents to draw meaningful answers as intended.  
If, however, the designers in this study have interpreted this question to refer to post 
market surveillance it would be present a very concerning finding for the medical 
device field, whereby 14% of respondents (n=5) do not actively collect post market 
complaints.  
Despite this however the findings suggest that there is proportion of the design 
community that do not actively collect design feedback from their users after 
launching a device onto the market. As previously described this is a fundamental 
component of a user centred approach and part of the Usability Engineering Process 
as outlined in the IEC BS EN 62366: 2007. It will be interesting as part of further 
research to explore exactly what feedback is actively collected from users post 
launch and how this information is used in future upgrades or new development 
projects.  
 
Figure 6.8 of the results revealed that designers in the study considered the ‘Number 
of Sales’ to be the leading measure of success for home use medical device 
development. For clarity the measures of provided to participants included: End User 
Feedback, Healthcare Professional Feedback, Industrial Awards, No Product 
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Complaints, No Product Recalls and Number of Sales. Respondents were also 
provided with an ‘Other’ category to add any of their own success measures. The 
emphasis upon the number of sales highlights the significance of remaining 
commercial in this competitive field. Sales will ultimately make a company 
profitable and ensure they remain in business therefore it is understandable and 
perhaps expected that a company would regard this as a critical factor for success.   
 
End user feedback was found to be the second highest measure of success for new 
developments onto the home use medical device market. This result suggests that the 
users of home use medical devices are highly valued from the perspective of 
designers in this study. This is despite 14% of respondents (n=5) indicating that they 
did not actively collect end user feedback post launch. 
According to Dixon et al in a paper entitled, Experiences of New Product 
Development in the Medical Device Industry, product quality relative to competitors 
and as defined by the customer was revealed to be the most important factor in how a 
product performed in the market (Dixon et al, 2006). The authors posit that due to 
the highly competitive nature of the medical device industry ‘product quality and 
increased value compared with competitors have the greatest effects on the likely 
success of a new product.’ (Dixon et al, 2006). Thus the findings of this study 
support the findings of Dixon et al in that the designers in this study perceived end 
user feedback to be an important measure of success for a home use medical device 
(Dixon et al, 2006). 
Figure 6.8 indicated that end user feedback was reportedly valued above that of the 
healthcare professionals. This finding contrasts with that of Money et al and the 
earlier case studies of this research whereby the views of senior healthcare 
professionals were held in higher esteem than that of patients (Money et al, 2012). It 
might be that although designers value the initial insight from healthcare 
professionals their influence is less pertinent once a device has been launched onto 
the market. This would require further research with designers in person to ascertain 
whether this is the case. 
The results to question twelve also revealed a relatively low priority placed upon 
purchaser feedback. Chapter Five of this research identified purchasers as one of the 
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driving influences in decisions selected and used by patients. In contrast the results 
of this study suggest that purchaser feedback is of lesser significance to designers in 
measuring the success of a home use medical device.  
Interestingly industrial awards and accolades were identified to be the lowest priority 
for measuring the success of a new product onto the market. The analysis of question 
twelve revealed that ‘Number of Sales’, ‘End User Feedback’, ‘Healthcare 
Professional Feedback’, ‘No Product Recalls’ and ‘No Product Complaints’ 
significantly differed from the attainment of ‘Industrial Awards’.  
The Freidman Test and Pairwise Comparison for question twelve revealed that the 
‘Number of Sales’ was significantly more important than ‘Purchaser feedback’ in 
measuring the success of a home use medical device. This is despite previous 
research recognising the need for designers address purchaser’s views in the design 
process (Money et al, 2011). It could therefore be inferred that designers might 
ignore a purchasers insights if they perceive an alternate approach to increase the 
sales of a medical device.  
To understand the specific stages of user involvement within the design process of a 
home use medical device, participants were asked to indicate the level of user 
involvement throughout a generic design process. Figure 6.9 revealed that the design 
stage with the reported highest level of user involvement was ‘Product Testing’ with 
a mean rank of 4.54. The second highest recorded mean rank was ‘Post Launch’ at 
3.96. This finding suggests that designers in this study typically involved users 
towards the end of the design process when either a prototype for testing or a final 
product has been realised.   
In spite of the study indicating that ‘User Needs’ were the leading driver behind 
home use medical device development, Figure 6.9 suggests that actual involvement 
does not occur in a large capacity until after the design stage of a home use medical 
device.  
Previous studies have also found that user involvement for medical device 
development typically doesn't occur until after a design brief has been produced 
(Martin et al, 2008). Martin et al posited that this may be attributable to medical 
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devices typically being technology driven rather than the result of identifying an 
existing un-met need (Martin et al, 2008).  
Figure 6.9 suggests that users would be involved highly for the testing of a device or 
for post launch analysis. Involving users at this stage within the design process 
however provides limited scope for their involvement to have influence on the design 
of a device. As the National Research Council explain the ‘best way to ensure a good 
fit with user needs, expectations and capabilities’ is through ‘repeated prototyping, 
testing and revisiting of the design’ (National Research Council, 2011). Thus, 
advocating an iterative approach to design with users throughout the process as a 
whole. The National Research Council refer to iteration as follows:  
 
“The term “iterative” applied to the design process refers to the fact that the process 
should not be a one-way linear progression from concept to product.” (National 
Research Council, 2011). 
 
As previously described, a user centred approach in the form of a usability 
engineering process as described by IEC BS EN 62366: 2007 requires an early focus 
upon users and throughout the design process iteratively (IEC 62366, 2007).  
Question thirteen of this study suggests that the manner in which designers 
implement such an approach differs greatly. This again is perhaps to be expected as 
the practice of ‘usability engineering’ for medical devices is recognised to vary 
widely. According to IEC BS EN 62366: 2007, the variation in practice is attributed 
to the diversity of the practitioners themselves (IEC BS EN 62366, 2007).  
Due to the diverse range of devices that fall under the ‘umbrella’ term of a medical 
device, and particularly home use medical devices (See Chapter Two for a taxonomy 
of home use medical devices), it is perhaps understandable that many practitioners 
have different backgrounds from fields such as engineering, psychology and design 
(IEC 62366, 2007). Consequently the practice of design for medical devices is 
recognised to vary quite markedly from company to company and designer to 
designer. The complexity of devices, users and use environments will of necessity 
call for slightly bespoke approaches to the design and development of home use 
medical devices. This was supported by the idealised practice case study presented in 
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Chapter Four in which the interviewees described a ‘tool kit’ they would bring to the 
process of medical device development that is typically influenced by the 
commercial challenges of delivering a device to market.  
A pairwise comparison of the results for question thirteen indicated that there was a 
significant difference between the levels of user involvement during product testing 
and the Product Development and Product Design Specification (PDS) stages of the 
design process. This suggests that participants in this study were significantly more 
likely to involve users during the late Product Testing stage of a home use medical 
device rather than in the development of the PDS or during development.  
6.12 Summary  
 
In summary the results of this study suggest that designers of home use medical 
devices typically involved users towards the end of the design process of a home use 
medical device. In light of this, the study supports the work of Martin et al who 
reported that users were rarely involved or considered until after the design brief for 
a device had been developed (Martin et al, 2008). Failing to incorporate the users 
early and throughout the design and development stages of a device results in a 
design that is so advanced along the design process that any involvement after that 
stage will not be included in the final design. Despite 45% of designers in the study 
indicating that they follow a ‘User Centred Design Process’ and ‘User Needs’ being 
identified as the leading driver for development, the involvement of users within the 
design process was typically retrospective.  
 
The designers’ perspectives of users within this study support the findings of existing 
research. Money et al discussed the commonly held view by some designers that 
‘superficial’ design features may be added on at the end of the development process 
(Money et al, 2011). Gulliksen et al refer this to as a ‘cake-frosting’ exercise 
(Gulliksen et al, 2006). This approach to design contradicts the principles of a user 
centred approach or a user needs driven development process. Further research must 
explore the process of design in more detail to ascertain how users are involved 
specifically. In order to answer research question two of this research designers of 
home use medical device must be consulted to understand the specific challenges 
towards user involvement in home use medical device design. Only then can research 
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question three of this research be addressed to incentivise a change in current 
practice towards home use medical device development.  
 
The following sections will now discuss the reliability and validity of the data 
followed by the limitations of the study. The chapter will conclude with a summary 
of the findings and proposed future work. 
6.13 Ethical Considerations 
 
The ethical issues in the context of this study were considered before, during and 
after the collection and presentation of any data or information. The ethical principles 
described in Chapter Three as outlined by Saunders et al were employed for this 
study (Saunders et al, 2009). Every participant was made clear of his or her rights to 
privacy, anonymity and to withdraw at any stage in the research process. This 
included once participants had completed the online survey should they wish to do 
so. Subsequently their results would be removed from the data set without any 
questioning into the reasoning to withdraw. Participation in the study was voluntary 
and no incentives were used to force participation upon individuals or organisations. 
 
Finally, in accordance with Loughborough University’s Code of Ethics, an ethical 
clearance checklist was completed by the researcher in early 2011 and co-signed by 
the supervisors of this research.  
6.14 Reliability and Validity 
 
When collecting information through questionnaires there are a number of issues 
relating to reliability and validity that need to be considered. As with the ethical 
considerations of this research the issues of reliability and validity of data were 
explored in chapter three of this research. To address the reliability of the data in this 
study, the three questions identified in chapter three posed Easterby-Smith et al will 
now be addressed (Easterby-Smith et al, 2008). 
1. Will the measures yield the same results on other occasions? 
All reasonable steps have been taken to conduct this study in a manner that is 
open and replicable. No results have been manipulated, modified or deleted in 
the presentation of this study. All results are indicative of the raw data 
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collected from participants currently operating in the home use medical 
device field. The presentation of the methodology, recruitment, questions and 
results enables any interested researcher to repeat the study if they so wish. 
2. Will similar observations be reached by other observers? 
Due to the nature of this descriptive study it would be unrealistic for the study 
to be repeated by others and to draw the exact same conclusions. This is due 
to the nature of open-ended questions and qualitative research in general. As 
before all steps have been taken to make this study as reliable and valid. The 
study was both pre-tested and piloted with target participants before the final 
design was distributed.  
3. Is there transparency in how sense was made from the raw data? 
The methods of analysis used in this study are made explicit throughout the 
chapter. All of the data collected for this study is presented in this chapter. 
Exact figures and numbers are used throughout the chapter that make all 
results in the study explicit. 
Further to these questions, additional steps were taken to ensure the results of this 
study were reliable and valid. The wording and structure of questions play a key role 
in ensuring the information received is reliable. Ambiguity in a question’s wording 
will lead to misinterpretation by the respondent and ultimately unreliable results. To 
combat this, the questionnaire was both pre-tested with a lay audience and then 
formally piloted with the target audience to determine any potential flaws in the 
questionnaires design.  
Gray describes that there are two main threats to validity of questionnaires: the extent 
to which respondents complete the questionnaires accurately and the problem of non-
response (Gray, 2009). If the response rate is particularly low then generalisations of 
the findings becomes limited thus affecting the validity of the data. It is therefore 
critical to ensure that questions are structured in such a way to cover the intended 
research areas and concise in its length as to ensure the best possible response rate to 
the survey. As far as was practicable this study was designed to have a minimal time 
requirement to complete the questionnaire as this has been shown to adversely affect 
response rate (Gray, 2009; Robson, 2011).   
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Finally no generalisations of the data were made. The findings of the study were 
compared and contrasted with the work of others in the field however for explicit 
generalisations to be made would require a larger sample of respondents. As part of 
further research posed towards the end of this chapter, the following study will 
explore the issues of this study with respondents in greater depth to triangulate the 
findings for this research. On completion of the next study the researcher will be able 
to reflect upon the reliability and validity of the findings and conclusions in this 
chapter.  
6.15 Limitations 
 
To evaluate any course of work requires the consideration of potential limitations in 
the chosen methodology and data analysis. For the purpose of this study perhaps the 
main limitation can be attributed to the use of a questionnaire as the study method. 
Prior to selecting a study method the advantages and disadvantages of potential 
approaches were considered. The design of the questionnaire was constructed in such 
a manner to attempt to combat some of the associated limitations of questionnaires. 
However, on reflection of the data analysis for this study, the research has 
established that generalisations from the data are restricted by the limitations of the 
methodology.  
The most apparent limitation of the study is the lack of depth and insight behind the 
responses of participants. The survey provides a ‘snapshot’ of current practice for 
home use medical device design based on standalone responses from designers in the 
field. While the findings are indicative of current practice and are compared with 
existing research in the field it is necessary to conduct further, more in depth research 
with the participants of this study to gain an understanding behind their responses. 
Further insight into the ‘why’ questions of current practice could not be explored 
through the manner in which the survey was delivered to respondents. To explore 
these issues further would require an interview-based method with participants that 
could facilitate discussion in a two-way conversation between researcher and 
participant.  
Another limitation to consider for the study refers to distribution of the online survey 
amongst participants. One must consider the fact that only individuals and 
organisations with access to the Internet would have been able to complete the online 
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survey. To accommodate for this participants were offered the option of paper-based 
questionnaires. However the decision to distribute the survey online was deemed 
suitable due to the nature of the global market in which many medical device 
companies operate. It was therefore considered reasonable to assume that such 
companies would have access to the Internet and therefore the survey. Note that no 
participants completed paper-based questionnaires.  
Finally, it should be added that although much of the contact and access to 
participants was made online, the nature of the sampling strategy (i.e. purposive and 
snowball) for the study meant that potential participants were accessed in a number 
of ways and not just through a company’s website online. Despite this, one must 
consider that this approach to sampling presents a limitation for research in that the 
respondents in the study are self-selecting. The context of self-selection here refers to 
respondents having a personal interest in the research therefore expressing a 
willingness to participate. Consequently one must consider that the respondents in 
this study come with a potential bias, background and experience in the home use 
medical device industry.  
6.16 Future Work 
 
Following the completion of the first descriptive study, a number of themes have 
been identified for further research within this thesis. 
 
The limitations section highlighted that a number of the questions from the survey 
lacked the level of depth and insight to draw more meaningful conclusions from 
respondents. Therefore further research must probe on previous responses to explore 
the context of the findings for the descriptive study in greater detail. An interview-
based approach to follow on from the descriptive study presented here has been 
selected as the most suitable method to generate this information from participants. 
The first descriptive study revealed that a number of participants have expressed a 
willingness to continue with the research which is particularly advantageous from a 
recruitment perspective.  
One issue that future studies within this thesis must address is the perceived 
significance of the challenges towards involving users in the design of home use 
medical devices. It is believed that by identifying and describing the challenges 
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towards adopting the principles of a usability engineering process, this research will 
reveal potential opportunities to incentivise a change in industry’s current approach 
towards home use medical device design.  
The following chapter will address in greater detail the methods adopted by the 
design community to identify the needs of their end users and to overcome the issues 
of regulations and ethics identified as challenges within this study. This information 
will only be revealed through interaction between the researcher and the designers 
themselves to understand the ‘why’ questions of this research.  
6.17 Conclusion 
 
In summary, this chapter has presented a descriptive study on designers’ perspectives 
towards users and their involvement in the design of home use medical devices. The 
discussion of this chapter has provided answers to research question one: 
Research Question One: How do designers consider and involve users in home use 
medical device development? 
The chapter alludes to a decision process for designers based upon the balance of 
meeting the needs of end users against the commerciality of the medical device 
industry. The study suggests that the design of home use medical devices is 
influenced by the incentives to involving users in the design process, as advocated by 
IEC BS EN 26366: 2007, against the challenges of applying such principles in 
practice.  
 
This study highlights a reported user needs driven process that is ultimately dictated 
and measured by the commercial success of the device on the market. The study 
revealed that Cost, Time, Regulations and Ethics present challenges to designers in 
involving users in the design process of home use medical devices.  
 
The study offers three potential scenarios to explain the reasons behind industry’s 
current approach towards user needs research.  
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Scenario One: Designers are aware of the principles and methods for user needs 
research but do not apply them. 
OR 
 
Scenario Two: Designers are not aware of the relevant methods and so cannot 
apply them at all. 
OR 
 
Scenario Three: Designers are aware of the principles and methods for user needs 
research but apply them sub-optimally.  
 
Designers in the study reported user needs as a leading driver behind the 
development of home use medical devices, with 45% of respondents following ‘user 
centred design’ process to home use medical device design. The results of this study 
imply that designers are aware of the principles of user centred design, however the 
approach towards user involvement in the design process of a home use medical 
device is ‘retrospective’. Further studies as part of this research must address these 
three scenarios to understand current practice in industry towards user involvement 
in home use medical device design. 
 
Using the findings of this study the following chapter presents the explanatory study 
of this research. The chapter presents the semi-structured interviews conducted with 
designers of this study to offer new knowledge to the field of home use medical 
device design. 
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Chapter 7  
Understanding Current 
Practice 
 
“To meet the challenges of the design process requires understanding the 
actions that lead from existing situations to preferred ones.” 
(Friedman, 2003) 
 
Descriptive study one presented in the previous chapter identified some of the 
current perceptions of designers towards the involvement of users within the design 
process of home use medical devices. The study indicated that designers of home use 
medical devices perceived Cost, Time, Ethics and Regulations to be challenging 
towards the involvement of users in the design process. As an output to the previous 
chapter the need to explore these issues further with the same target population was 
discussed. The following chapter presents the explanatory study of this research 
which aims to answer and develop a clearer understanding of the ‘Why’ questions of 
this research. This study is focused on unveiling the manner in which practicing 
designers overcome the previously identified challenges in the design of home use 
medical devices.  
 
7.1 Introduction 
 
Through this explanatory study as part of the Design Research Methodology (DRM) 
approach the following chapter aims to answer research question two: 
Research Question Two: What are the challenges for industry to involving users in 
the design process of home use medical devices?  
In the opening paragraph of the chapter, Professor Ken Friedman posits that in order 
to meet the challenges of the design process requires an understanding of the actions 
that take us from existing situations to preferred ones (Friedman, 2003). 
Understanding the individual steps taken within a design process with respect to user 
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involvement will lead to the unveiling of specific challenges to the designer. With 
this understanding, it is believed that the challenges and constraints of the designer 
can be met with solutions that lead to the delivery of design improvements towards 
end user involvement.  
The following study attempts to build a detailed understanding and explanation of 
current design practice towards user involvement in home use medical device design. 
By applying the findings of this research, this chapter will build upon existing 
knowledge to develop and offer recommendations as a conclusion.  
7.2 Rationale 
 
The previous chapter revealed that the involvement of users within the design 
process of home use medical devices is influenced by certain challenges within the 
design process.  The results of the online survey presented in Chapter Six of this 
thesis suggested that a designers understanding of ‘user centred design’ principles 
contributed to the level of user involvement in the design process. To expand on this 
knowledge it is necessary to explore these challenges in more depth through 
consultations with practicing designers themselves. Gray argues that while the 
descriptions of a phenomenon can provide the basis for analysis, it is necessary to go 
beyond description to interpret, understand and explain the data (Gray, 2009).  
To ascertain the challenges for home use medical device designers requires an 
understanding of the terms used (i.e. interpretations and definitions) by the design 
community within the context of this research. The previous study made reference to 
the use of the term ‘user’ which was identified to potentially be defined as a range 
different ‘stakeholders’ in the design of a home use medical device. Thus, the 
following study will utilise the advantages of an interview-based approach to reveal 
the understanding of designers themselves.  
The reader will be aware that the term designer is used throughout this thesis, 
however as previous research has shown for home use medical devices this can be a 
variety of people within a broad team (Shah & Robinson, 2008). The background of 
a designer in this field therefore could potentially be one of Bioengineering, Physics 
or Design itself to name but a few. Clarifying the definition of ‘designer’ in terms of 
the backgrounds and experiences of individuals within this study will provide a 
 
 
237 
 
further insight into the practice of home use medical device design. Note that many 
of the key terms used throughout this thesis are defined in the Glossary section.  
The previous chapter concluded that an interview based approach to data collection 
would be necessary for this study to gain the level of detail required from 
respondents. While the previous study introduced the perspectives of practicing 
designers towards home use medical device design there was an identified limit to 
the information revealed by the survey. With this in mind, this study will build on 
these findings using the methodology described in the following section.  
7.3 Methodology 
 
For the purpose of this study a data collection strategy was required to elicit 
practicing designers’ experience, knowledge and understanding of user involvement 
in home use medical device design. Due to the depth and detailed responses required 
for the study, an interview-based method was identified as the most appropriate data 
collection strategy to build upon the findings of the previous chapter.  
 
Interviews can play a central role in data collection and as such have a significant 
influence on the quality of the data collected from participants (Fowler, 2002). 
According to Fowler there are three primary roles of an interviewer: 
1. To locate and enlist the cooperation of selected respondents. 
2. To train and motivate respondents to do a good job of being a respondent. 
3. To ask questions, record answers and probe incomplete answers to ensure 
that answers meet the question objectives. 
Gaining cooperation 
Enlisting participants for an interview can be difficult. Fowler describes how the 
interviewer often has to be flexible in their availability for when interviewees want to 
be interviewed (Fowler, 2002). Furthermore, where respondents are ‘hard-to-reach’ 
be it through geographical location or poor telecommunication links, the interviewer 
must be able or willing to go where the respondents are in order to collect data.  
There are however many options available to interviewers to collect data from 
participants and the following section will address this.  
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Training and motivating respondents 
The performance of respondents including the accuracy of reporting in interviews 
has been linked directly to the orientation and delivery of the interview itself 
(Fowler, 2002). A slower delivery of questions indicates to respondents to take their 
time in providing an answer to the question and consequently provides a more 
accurate and rich response (Fowler, 2002). Encouragement by the interviewer has 
also shown to affect the respondent’s perceptions and expectations of what is 
required and consequently how well they report (Fowler, 2002). The interviewer, 
whether consciously aware or not, teaches the respondent how to behave, something 
Fowler describes is ‘often unappreciated but critical’ part of the interviewer’s role.   
Being a standardized Interviewer 
It is hoped that when conducting interviews the differences in responses between 
participants are attributable to differences in experiences and opinion and are not the 
result of differences in the manner in which the interview has been delivered. This 
includes the differences in stimulus and probes that are affected by question wording 
and the context and way in which questions were asked. Essentially a standardised 
approach by interviewers ensures that the interviewer does not affect the answers 
they obtain. According to Fowler, when training interviewers there are five aspects 
of interviewer behaviour that researchers attempt to standardise. These include: the 
manner in which the study and task are presented, the way in which questions are 
asked, the way inadequate answers (i.e. answers that do not meet the question 
objectives) are probed, the way in which answers are recorded, and the way that 
interpersonal aspects of the interview are handled (Fowler, 2002).  
1. Presenting the study: Respondents should have a common understanding of 
the purposes of the study because the sense of purpose may have a bearing on 
the way questions are answered. It is important to clarify ethical issues at the 
beginning. This includes confidentiality, the voluntary nature of the 
interview, right to withdraw and who will use the data. These issues will all 
have an impact on how a respondent will answer questions at interview. 
Fowler recommends keeping the context of the interview constant to improve 
the quality and consistency of responses from participants (Fowler, 2002). 
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2. Asking the questions: Survey based interviews should be conducted in the 
manner they are written and intended, with no variation in wording. The 
smallest of changes has been shown to have significant effects on the way 
questions are answered by participants (Fowler, 2002). To ensure the data is 
consistent from designers within this study the questions must be asked in the 
same manner to all participants.  
3. Probing: Asking respondents to build or add to a response that does not fulfil 
a question’s requirement may be necessary when conducting an interview. 
The interviewer must therefore be ready to adapt to the responses of 
participants. As Fowler explains however, interviewers are supposed to probe 
‘incomplete answers’ in non-direct ways (Fowler, 2002). Thus, in probing a 
response the interviewer must not influence one particular response over 
another, which would introduce bias into the results. Typical examples of 
simple non-bias probes can include “Anything else?”, “Tell me more?”, 
“How do you mean?” (Fowler, 2002). These nondirective questions ask 
respondents to add more detail to their previous answer without influencing 
the content of the next response.  
4. Recording the answers: A standardised approach to recording must be 
conducted throughout all data collection so that no variation occurs. In open 
discussions with respondents, conversations must be recorded verbatim, word 
for word, without any paraphrasing or summarising at a later stage based on 
any subjective judgement of the interviewer.  
5. Interpersonal relations: The personal issues of an interview can be 
minimised through an emphasis on the professional aspects of interactions 
between the interviewer and interviewee. While Fowler admits that the 
interviewer inevitably brings their own demographic characteristics to an 
interview (e.g. gender, age, education etc.) it is possible to control the 
interpersonal relations through due consideration (Fowler, 2002). This 
includes no expression of views or opinions before or during an interview. 
Such behaviour can again influence a respondent’s answer to a particular 
question. As Fowler states, ‘to behave as a professional, not a friend, helps to 
standardise the relationship across the interviewers and respondents’ (Fowler, 
2002).   
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The previous chapter described that one of the limitations in using questionnaires, as 
a research strategy is the inability to explore, in depth, the meaning or explanations 
behind the answers provided by a respondent.  Gillham explains that “only limited 
inferences can be made because you cannot explore what lies behind the answers to 
the questions” (Gillham, 2005). The inferences and findings presented in the 
previous chapter called for the rationale to conduct interviews as the follow up study 
in this research.  
Research of a qualitative nature that employs a survey-based strategy often reveals 
questions that were not anticipated by the research in the beginning. The questions 
however will always be more focused in scope and subsequently provide a direction 
to the research pathway. Thus, the knowledge acquired from Chapter Six was 
fundamental to the purpose of this explanatory study. 
Before the selection of the interview method it is necessary to answer three specific 
questions, each of which has implications for the interview design. These questions 
are as follows: 
1. What do I expect to find? 
The interviews expect to; identify the methods employed by industry for 
involving users in the design process of a home use medical device, reveal 
whether the available guidance and support materials for the designer are 
used and furthermore valued, unveil greater depth to the findings of chapter 
six including the challenges to applying ‘user centred’ design principles to 
home use medical device design.  
2. What would I prefer to find? 
The study would prefer to find answers to the research questions of this thesis 
including the user research methods, perceptions of guidance and an 
indication of current design processes followed by practicing designers in 
industry. 
3. What would I hope not to find? 
The study would hope to not find that the target population of the study are 
unwilling to participate in the interview. The study wishes not to identify 
reluctance from participants to answer specific questions within the interview 
protocol that relate to the research questions.  
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Addressing these questions before embarking on the selection and design of an 
interview method will ensure that the issues of standardisation are fully considered. 
The following section will now describe the different interview methods considered 
for this study before presenting the final design.  
7.3.1 Structured Interviews 
 
A structured approach to conducting interviews in many ways follows the principles 
of a self-completion questionnaire (Robson, 2011). Robson posits that there are a 
fixed set of questions, which are typically specified during pre-testing and piloting to 
achieve standardised wording (Robson, 2011).  Thus, structured interviews typically 
only feature a small number of open-ended questions where respondents can provide 
a more detailed response to a question. This does not in itself mean that survey based 
questionnaires are the same as structured interviews.  
The fundamental difference between the two strategies is the direct influence of the 
interviewer on the questioning process. Robson argues that characteristics such as the 
skills, experience, personality and degree of involvement within the research itself 
can have complex ramifications for this data collection method (Robson, 2011). To 
overcome these factors and remain ‘standardised’, Robson outlines six general 
advisory points presented in Table 7.1. 
Table 7.1: General advice for interviewers conducting interviews (Adapted from 
Robson, 2011). 
 
  
1. Appearance: Dress in a similar way to those you will be interviewing. If 
in doubt err on the side of neatness and neutrality. 
2. Approach: Be pleasant. Try to make the respondent comfortable. 
3. Familiarity with questionnaire/interview schedule: View yourself as an 
actor, with the interview schedule as your script. Know it thoroughly. 
4. Question wording: Use the exact wording of questions and keep to their 
sequence. 
5. Fixed-alternative response questions: Only allow the standard 
alternatives. 
6. Open-ended response questions: Either code immediately or record the 
answers exactly for later coding. Don't make cosmetic adjustments, correct 
or fabricate.  
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7.3.2 Semi-structured Interviews 
 
In contrast to a structured approach, a semi-structured interview is much more 
flexible in nature. Robson describes semi-structured interviewers as having a 
‘shopping list of topics’ for discussion and consequently this approach exercises 
freedom in the responses from participants in the sequencing of questions and 
probing (Robson, 2011).  
Robson argues that semi-structured interviews are “most appropriate when the 
interviewer is closely involved with the research process (e.g. in a small-scale project 
when the researcher is also the interviewer)”. In this study the primary researcher is 
also the interviewer and as such a semi-structured approach to interviewing was 
considered more suitable than a structured approach. The semi-structured nature of 
the interview however must have a structure in place to ensure a consistent narrative 
as previously described (Fowler, 2002). 
Robson outlines a simplified schedule for semi-structured interviews, which is 
presented below (Robson, 2011).   
 Introductory comments 
 List of topic headings and possible key questions to ask under these headings 
 Set of associated prompts 
 Closing comments. 
The following section considers this schedule in more depth and presents how the 
interviews for this study will be conducted.  
7.3.3 Face-to-Face Interviews 
 
Interviews may be conducted in groups or individually depending on the type of 
information to be elicited from participants. For the aim of this study, it was 
necessary for the interviews to occur in real time to understand the priorities and 
foremost perceptions of designers in this research. Therefore the possibility of email 
interviews, described by Robson, were considered inappropriate for this context as 
they would allow participants to reflect on their answers before providing a response 
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to the interviewer (Robson, 2011). In light of this, Face-to-Face and Telephone 
strategies were considered more appropriate for this study. 
Face-to-face interviews involve the interviewer travelling to the interviewees to 
conduct the interview. One benefit of this strategy includes the contextual 
information gained from observing participants as they answer questions, which is 
not possible in a telephone approach (Robson, 2011). Visual cues within an interview 
can be useful to the interviewer to identify when a topic requires further exploration 
or requires a change of subject to keep the interview progressing. Robson claims that 
face-to-face interviews can be typically longer in duration when compared with 
telephone interviews. According to Robson, telephone interviews are usually less 
than 30 minutes whereas face-to-face interviews can be up to an hour in many cases 
(Robson, 2011). 
7.3.4 Telephone Interviews 
 
In contrast, telephone interviews are typically a quicker, shorter and cheaper 
approach to interviewing. Robson argues that conducting an interview over the 
telephone reduces the potential for interviewer bias (Robson, 2011). The 
characteristics of the interviewer, described previously by Fowler, have less of an 
influence during an interview over the telephone. Robson believes that such an 
approach to conducting interviews are worth considering in situations where a ‘lack 
of resources precludes carrying out an adequate sample of personal interviews’ 
(Robson, 2011). 
7.3.5 Interview Strategy 
 
For the aim of this study, it was considered necessary to conduct face-to-face 
interviews with participants, where possible and practical. This strategy was chosen 
based on the potential to conduct longer interviews with participants and the 
potential to elicit valuable contextual data. Due to the level of detail required in the 
responses by participants approximately one hour would be required for the 
interview protocol. Robson described that telephone interviews were typically less 
than 30 minutes, which would be unsuitable for this study. Where possible, 
participants in the study would be visited at a preferred location to remove any 
inconvenience of travel for participants.  
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It was considered that should participants decline or be unable to commit to a face-
to-face interview the opportunity of a telephone interview would be suggested. This 
was considered necessary due to the difficulty to access participants in the previous 
chapter and the disadvantages of a telephone strategy would have to be considered in 
the reporting of the data.  
7.4 Design 
 
With the interview strategy chosen, the design of the interview protocol itself could 
commence. Designing a semi-structured interview involves the consideration of core 
questions; potential probes and prompts to elicit information that meets the aims of 
the interviewer.  
Table 7.2 adapted from Robson (2011) and Gillham (2005), presents two different 
structures to the process of conducting an interview. Both of the designs presented in 
the table consist of five fundamental steps to the interview process.  
The strategies of Robson and Gillham both describe an interview structure than 
builds in depth and level of detail required from respondents as the interview 
progresses (Gillham, 2005; Robson, 2011). According to the works of Robson and 
Gillham, it is necessary to have introductory or ‘warm up’ questions prior to the core 
questions of the interview (Gillham, 2005; Robson, 2011). Robson posits that ‘risky’ 
questions that could potentially be interpreted as fractious by respondents are best 
left towards the end of the interview once a comfortable atmosphere has been 
established.  
The proposed formats of Gillham and Robson both conclude with a ‘closure’ period 
where respondents are thanked for participation and given a summary of the topics 
covered. According to Gillham and Robson, closure at an interview helps to identify 
any topics potentially missed during the discussion (Gillham, 2005; Robson, 2011). 
The closure stage of the process also enables the interviewer to explain what happens 
next with the data.   
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Table 7.2: Interview sequences (Adapted from Robson, 2011 and Gillham, 
2005). 
The sequence of questions 
(Robson, 2011) 
The conduct of the interview 
(Gillham, 2005) 
Introduction – Introduce oneself, the 
purpose of the interview, confidentiality 
and permission to record. 
Preparation – Prior to the interview. 
Recruitment, informed consent, 
purpose, location and expectations 
Warm up – Begin with easier questions 
to settle any nerves of the 
interviewer/interviewee. 
Initial Contact – Primarily social and 
informal, Introductions and 
‘housekeeping’ 
Main Body of Interview – The main 
purpose of the study. Follow a logical 
progression of questioning. Capitalise on 
responses from participants and save 
‘risky’ questions till the end.  
Orientation – Explaining the 
interview, reciting information 
participants will have already received. 
‘Steer’ the person into the interview 
covering topics such as analysis of 
results, confidentiality, anonymity and 
the interview schedule.  
‘Cool off’ – Winding down the 
interview with straight forward questions 
to remove any potential tensions built up 
throughout the interview. 
Substantive – The core of the 
interview and purpose of the research.  
Closure – ‘Thank you and goodbye’ 
Collate or record any responses once the 
interview is over and be consistent with 
all respondents.  
Closure – Show appreciation for what 
has been covered and address any 
details that were missed. Summarise 
the interview and outline what happens 
next with the data collected. 
 
Using the principles described by Gillham and Robson, an initial design of the 
interview protocol was developed. The principle of questions building in the level of 
detail required from respondents as the interview progressed was employed in the 
initial design.  
An introductory phase given by the interviewer would initially describe the context 
of the research, ethical issues and purpose of the study. Informed consent, right to 
withdraw or refusal to answer a question would be described to the interviewees. At 
this time an informed consent form would be handed to the participant to authorise 
the use of the data collected at interview. A copy of the participant information 
sheets and informed consent forms are provided in the Appendix 12 and 13 
respectively.  
After this introductory phase, outlined by Gillham and Robson, the first stage of the 
interview questioning would begin (Gillham, 2005; Robson, 2011). Stage one of the 
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interview comprised of simple profiling questions to establish the background of the 
participants and to ease them into the interview.  
Using the findings of the previous chapter, a range of themes was identified for 
exploration at interview. The seven themes included: 
 Drivers for the selection and development of a home use medical device. 
 Perceptions and understandings of users. 
 The design process of a home use medical device. 
 The importance of users within the design process. 
 The challenges to involving users in the design process. 
 The active collection of user feedback. 
 The methods employed by designers to incorporate users in the design process. 
 
In light of these themes a range of non-direct prompts were considered before the 
interview to assist the interviewer in anticipation of potential responses from 
participants. Table 7.3 presents examples of the probes considered suitable for each 
theme.  
Table 7.3: Themes and Probes for interview. 
Key Themes Potential Probes and Prompts 
Drivers for the selection and 
development of a home use medical 
device. 
 
 Why? 
 How do you prioritise? 
 Who is responsible for this decision? 
 Can you provide more detail here? 
Perceptions and understandings of 
users. 
 
 Who? 
 Why? 
 How do you identify or create a 
profile for your users? 
 How do you translate needs into 
design requirements? 
The design process of a home use 
medical device. 
 Why? 
 How do you overcome them? 
 What would make them easier? 
 Improvements? 
The importance of users within the 
design process. 
 
 Why? 
 Elaborate further? 
 Can you give me more detail on how 
you design for them? 
 Do you define users, user groups? 
 Can you demonstrate this for me? 
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Key Themes Potential Probes and Prompts 
 Can you give me a product example 
where you have gone through this 
process? 
The challenges to involving users in 
the design process. 
 
 Why? 
 How do you decide on which 
approach to take? 
 Who is responsible for design 
decisions? 
 What do you think of this approach? 
 Can you draw the process for me, in 
diagram form? 
 Are there any challenges to using this 
approach?  
 How could this process be improved 
or made easier for you? 
Active collection of user feedback. 
 
 Why? 
 Assessment? 
 What happens next? 
 Future work? 
The methods employed by designers 
to incorporate user needs. 
 
 How are they involved? 
 Why are they involved? 
 Example? 
 Recent project? 
 Methods? 
 Challenges? 
 
7.5 Pre-piloting 
 
According to Gillham, the process of piloting an interview can be divided into two 
phases, namely the earlier pre-piloting followed by piloting itself (Gillham, 2005). 
Gillham describes pre-piloting as the process of gaining ‘critical feedback’ from the 
respondents, whereas piloting refers to the actual trial run of the real interview 
(Gillham, 2005).  
Pre-piloting the interview structure is necessary to determine what information is 
required to successfully conduct the interview whilst also highlighting potential 
responses from participants. Pre-piloting allows for final changes to be made to 
question wording, focus, order and replacement (Gillham, 2005). This stage should 
be conducted with respondents of similar background to the intended respondents.  
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Final piloting to address the interview schedule as a whole should then follow pre-
piloting. This stage is the final step prior to going out and conducting the interviews 
with real participants.  
For the purpose of this study, three pre-pilot run through sessions were conducted 
with participants knowledgeable and experienced in the field of design research and 
interviewing. Gillham states that three such interviews of the substantive elements 
will allow the interviewer to ascertain whether the questions are giving the responses 
with the ‘required focus’ expected at interview (Gillham, 2005). Each participant was 
asked the series of questions and for their interpretation and understanding of what 
the question was asking, before collecting their feedback on potential improvements 
to be made to the interview protocol.  
7.6 Piloting 
 
With the pre-piloting stage complete the real pilot of the interview protocol was 
conducted. The final pilot of an interview allows the schedule of the protocol to be 
tested in practice with the target population. The timings and sequence of questions 
allow the interviewer to get a feel for how the interview will be conducted in 
practice.  
 
For the purpose of this study two pilot interviews were conducted with participants 
from of the target population. The first pilot was conducted with an industrial 
designer with over six years of experience in home use medical device design. The 
second pilot was conducted with a Managing Director of a design consultancy with 
over 16 years’ experience in medical device design including home use devices.  
 
The pilot interviews were approximately 80 minutes and 65 minutes in duration. It 
was identified that with repeated execution the interview length would be reduced. 
This was attributable to the researcher becoming acquainted with the interview 
protocol. Minor changes to the protocol wording and sequence of questions were 
made for the final design. 
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7.7 Final Design 
 
Following the pre-testing and piloting of the interview protocol a final design was 
developed. The final design consisted of four stages to the interview; Stage 1 - 
Interviewee Profile, Stage 2 - Survey Analysis/Questioning, Stage 3 – A discussion 
on the approach to design, Stage 4 - Wrap up.  A copy of the interview protocol can 
be found in the Appendix 14 of this thesis.  
7.8 Recruitment 
 
Prior to participation in the study it was necessary for all participants to have 
completed the online survey study presented in the previous chapter. This was due to 
the design of the interview protocol, which expanded on the responses and themes 
identified in the previous chapter. At the end of the online survey all participants 
were asked whether they would be willing to participate in further research. Those 
that were interested to take part in further studies were asked to leave their contact 
details at the end of the online survey to allow the researcher to make contact 
regarding future research.  
Initially, 18 participants from the initial survey expressed an interest in further 
research. All of these participants were contacted in the six-eight weeks that followed 
the completion of the online survey. Each participant was contacted via email or 
telephone, dependent on the details provided at the end of the survey. On contacting 
participants about the interview study nine expressed they would no longer wish to 
take part in the study. Due to the ethical considerations of the study, participants 
were not asked for their reasons to withdraw, as this was part of their right when 
consenting to the research. Despite this 50% of the participants gave reasons of time 
and would no longer be available for the study. One participant explained that they 
could not see the relevance of the research to them and would therefore like to be 
removed from the study. This was in spite of the participant completing the online 
survey and being a representative company of the target population for the research. 
Another participant explained that their practices for design were confidential to the 
company and would therefore not be willing to share such information at interview.  
In light of this, it was necessary to recruit further participants for this study to 
achieve a significant number of participants. According to Guest et al in, An 
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Experiment with Data Saturation and Variability, ‘saturation occurs within the first 
twelve interviews’ (Guest et al, 2006). The study by Guest et al also found that 
‘basic elements for metathemes were present as early as six interviews’ (Guest et al, 
2006). With this in mind the study targeted the recruitment of a minimum twelve 
different companies for interview.  
To recruit further participants for the study other companies were contacted through 
the methodology described in chapter six. In total four extra participants were 
recruited for the study. All additional participants were asked to complete the online 
survey prior to being interviewed, as this was an essential requirement of the study 
and interview protocol. 
A total of thirteen interviews were conducted with designers of home use medical 
devices. All of the participants in the study were indicative of companies that make 
up 80% of the current marketplace for medical devices (i.e. Small and Medium 
Enterprises) (EC, 2013). All participants had experience in home use medical device 
design, which ranged from 2-30 years.  
7.9 Analysis 
 
Each interview was digitally recorded to allow for later transcription. The recordings 
were transcribed, verbatim, word for word, into Microsoft Word Processing 
software. The transcripts were then transferred into Nvivo 10 ready for content 
analysis. This approach to analysis was necessary to gain the depth of insights and 
any potential themes within the responses of participants in accordance with the 
objectives of this study. The responses from participants were initially grouped based 
on the core questions, as per the interview protocol (see Appendix 14). The questions 
were then further analysed and coded based on the responses of participants and the 
knowledge of existing research. A summary of the content analysis conducted on the 
transcripts is described below.  
Content Analysis  
Content analysis is a recognised approach to analysing qualitative data that involves 
making inferences about data (typically text) by ‘systematically and objectively 
identifying special characteristics (classes or categories) within them’ (Gray, 2009). 
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Achieving a level of objectivity in this process is essential. Gray posits that 
objectivity can be achieved through the creation of specific rules prior to the data 
being analysed, commonly known as ‘criteria of selection’ (Gray, 2009).  
According to Gray there are three procedures for identifying the classes and 
categories before conducting content analysis. These include: Common Classes, 
Special Classes and Theoretical Classes. (Gray, 2009).  
 Common Classes: These categories are comprised of ‘everyday thinking’ or 
common analysis criteria such as Age, Gender, Title etc. These classes are 
useful in identifying associations between specific characteristics or 
demographics in the data.  
 Special Classes: This categorisation is comprised of the labels that specific 
communities or groups used to distinguish amongst things, persons or events 
(Gray, 2009). This might include professional terms given to a specific type 
of practice for example.  
 Theoretical Classes: These categories arise from the process of analysing the 
data itself where ‘key linkages and patterns’ are identified. According to 
Flick these categories are often derived from theoretical models and not 
necessarily from the data itself (Flick, 2006).  
Using the interview protocol and research questions, a series of classes were 
identified in preparation for content analysis. These primary classes are presented in 
Table 7.4 below.  
Table 7.4: Primary Classes for Content Analysis. 
Common Classes Special Classes Theoretical Classes 
Age 
Gender 
Title 
Experience 
Background 
Education 
Ergonomics Background 
User Centred Process 
Design Guidance Followed 
Design Guidance Not 
Followed 
Challenges to involving 
Users 
Definitions of Terms 
Method for Involving Users 
Perceptions of Users 
Design Feedback 
 
According to Gray, the key to content analysis is the reduction in volume of textual 
material (Gray, 2009). Due to range and depth of responses collected at interview 
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this process of categorisation was necessary to make sense of the rich data elicited at 
interview.  
Flick distinguishes three types of analysis process, which are summarised below 
(Flick, 2006). 
I. Summarising Content Analysis 
Here the material (data) is paraphrased which refers to the skipping of less relevant 
passages with the same meaning, a process Flick describes as the first reduction 
(Flick, 2006). A second reduction involves the grouping of similar paraphrases, 
which are ‘bundled and summarised’. Summarising in content analysis therefore 
refers to a process of reducing the transcript data through skipping statements and 
‘summarising the material on a higher level of abstraction’ (Flick, 2006).  
II. Explicating Content Analysis 
This form of content analysis works in the opposite manner to the summarising 
method. Explication in content analysis refers to the clarification of ambiguity and 
contradictory passages by involving ‘context material’ in the analysis (Flick, 2006). 
This can include recognised definitions for terms used from dictionaries to build a 
context to the data. According to Flick, this can be both narrow and broad in context 
(Flick, 2006). Narrow context analysis refers to the selection of additional statements 
from the text to explicate passages to be analysed, whereas broad context analysis 
seeks information outside of the text thus broadening the context of the data (Flick, 
2006).  
III. Structuring Content Analysis 
In a structured content analysis, the text is searched for formal structures within the 
material (Flick, 2006). These structures may be based on formal, typified, scaling or 
as regards to content. In formal content analysis it is possible to filter out an internal 
structure from the text alone. Typifying structuring refers to the seeking of singular 
salient features in the text material and then attempts to describe them more exactly. 
Scaling in structuring is the process of rating material in accordance with predefined 
dimensions (e.g. Low, Medium or High Significance or Not inferable). Finally, 
 
 
253 
 
structuring as regards content refers to the extraction and condensing of data to 
certain domains of content. 
For the content analysis of the data collected at interview the text was initially 
condensed into the classes described by Gray (2009). Using a combination of 
explication and structuring content analysis the data was further explored in a wider 
context to expand on the current state of knowledge in the field. This includes the 
definitions for specific terms used by designers. In the section that follows 
explication and structuring of the data is described where applicable.  
7.10 Results 
 
In total 13 participants were interviewed for the study. Due to practical constraints on 
the availability of participants at the time of this study, it was necessary to conduct 
four interviews over the telephone. A total of nine interviews were conducted face-
to-face. The differences in the approaches and data received through conducting the 
two interview strategies are described later in the chapter. 
All participants who took part in the interview had previously completed the online 
survey study presented in chapter six. This was a fundamental requirement of the 
study to expand on the previous responses of the study.  
Appendix 15 presents the profiling information of the interviewed participants in the 
study. For reasons of confidentiality each participant is assigned a number and no 
names or locations are presented in this report. All participants in the study were 
male. This was not an intentional sample of the study, however all responses on 
contacting companies were from male participants. 
In accordance with the predefined classes described in the analysis section Table 7.5 
presents a summary of the participants profiling information. This information refers 
to the common classes in content analysis described by Gray (Gray, 2009). Grouping 
the participants in this respect enables comparisons to be made in relation to the 
common classes of the study. In the discussion section of this chapter these classes 
will be used to compare and describe the relationships between responses from 
participants. 
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Table 7.5: Common Class Profiles. 
Common Class Information 
Age 
Range: 30-59 
30-39 x 2 
40-49 x 4 
50-59 x 7 
Gender 13 Males 
Title 
Include: Director x 5, Managing 
Director x 2, Industrial Designers x 2, 
Group Leader x 1, Big Leader x 1, 
President x 1, Freelance x 1 
Experience: Numbers of years’ 
experience in medical device design 
Range: 2-30 Years 
0-5 Years x 2 
6-10 Years x 6 
11-15 Years x 1 
16-20 Years x 2 
20+ Years x 2 
Background: Educational and 
experience domain 
Industrial Design x 3 
Product Design x 2 
Ergonomics x 2 
Mechanical Engineering x 2 
Engineering x 1 
Biochemistry x 1 
Sports Science x 1 
Cognitive Psychology x 1 
Education: Highest qualification 
achieved 
BSc or BA x 8 
Msc or Above (e.g. PhD) x 5 
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7.10.1 Drivers for the Selection and Development of Home Use 
Medical Devices 
 
In Chapter six participants were asked to prioritise specific drivers in terms of 
importance for the design of home use medical devices. At interview participants 
were asked to expand on their previous responses to these driving factors (priorities) 
for selecting a project to take forward into the design process. Participants at 
interview were reminded of their response to the question in the online survey. Table 
7.6 presents the leading driving factors and number of responses from participants at 
interview. The leading factor here in the table represents the single priority factor, 
driving the selection and development of a home use medical device.   
Table 7.6: Responses to Drivers for Development. 
Drivers for Development Number of Participants 
User Needs 7 
Performance 3 
Cost 2 
Other: Business Case 1 
Function 0 
Intellectual Property 0 
Sustainability 0 
 
User needs were considered to be the most important driving factor for the design 
and development of home use medical devices. One participant said: 
“User needs are paramount… involving the users and designing for the user is 
absolutely key to the process.” Participant #8 
When probed about why the needs of users were considered crucial to the design of 
home use medical devices this same participant added: 
 “Usability is so key because you have got the widest possible group of users” 
Participant #8 
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One designer felt that the focus on user needs has come to fruition in the last two 
years in particular and added that historically the needs of users were considered a 
lesser priority.  
“Well it [User needs] has historically been, I would say, relatively low level of 
focus…I think in the last 2 years we have seen that changing and certainly from a 
design perspective we have been pushing for a greater focus on user needs.” 
Participant #6 
This designer added: 
“I think there is now a recognition that the drug performance, the device 
performance and everything else it has also got to work for the user and certainly in 
the last 2 years there is a major refocusing of big brands in that area.” Participant 
#6  
Performance was identified as the second most cited driving factor for participants in 
this study. One designer explained: 
“My remit is to generally come up with a delivery device that matches a brand and 
has to be as exactly the same as a brand in terms of performance. So they can be 
marginally worse or equivalent too, but they can’t be better than if that makes sense.” 
Participant #12 
This designer worked freelance assisting manufacturers in the design and 
development phase of medical devices for use in both the home and professional 
environment. This often involved working alongside or around existing patents to 
achieve devices at a cheaper rate to the manufacturer. He explained: 
“So there is brand device that they [the manufacturer] want to copy because they 
want to muscle in on the market and so they give me a patent to see if I can work 
around it. So in that sense I am given freedom to invent if you like.” Participant #12 
He added that: 
“So my expertise is how cheap one can make it and still do the job.” Participant #12 
Another designer in the study viewed performance as the leading driver in the design 
of home use medical devices. This designer did however feel that other factors were 
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close on consideration. He explained: 
“I indicated performance as a main driver but I think some were quite close to each 
other…We have to put a lot of effort in to make sure that our devices, that the output 
is consistent and that insulin must be delivered daily, so it must always be delivered. 
So it is a really important aspect I think.” Participant #13 
Another designer concurred that certain factors were close, if not equal, when 
assessing the driving factors of a home use medical device. He explained: 
“I think if you were to break down, number 1, then obviously efficacy and the 
frequency of the performance must be paramount but we [the company] would 
consider usability of the device as equal priority. Performance is a must, priority one, 
but usability is what we would measure throughout the development.” Participant #2 
Others felt that cost consideration were a significant factor in driving the design and 
development process of a home use medical device. One designer said: 
“The real world out there is highly commercially driven.” Participant #6 
He added: 
“I have seen medical devices at a high level of development fail to reach the market 
because the cost of goods is too high.” Participant #6 
The results of this study support the findings of Chapter six in that the needs of users 
were identified as the leading driver (factor) in the design of home use medical 
devices. Section 7.10.3 in this chapter explores who designers in this study 
considered to be the users of home use medical devices in more detail. The second 
question topic in the survey analysis phase of the interviews explored the barriers to 
involving users in the design process of a home use medical device. 
7.10.2 The Challenges to Involving Users in the Design Process 
of a Home Use Medical Device 
 
The previous chapter reported that Finance, Time and Regulations were the most 
significant barriers to involving users in the design process. At interview all 
participants were asked to expand on why they cited specific factors as a challenge to 
involving users in the design process. Participants were also asked whether there 
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were any other challenges, aside from those in chapter six, towards the involvement 
of users in the design process of a home use medical device.  
 
To assist participants in this study they were reminded of their responses in the 
online survey. At interview a range of new challenges to the involvement of users in 
the design process of a home use medical device were revealed. Due to the range of 
responses from participants at interview it was necessary to analyse the data in depth. 
This was initially conducted through the use of word or tag clouds to identify the 
most frequently used terms within the transcripts.  
 
Using Nvivo 10 software a word frequency query was performed on the data. A copy 
of an early stage word cloud from the analysis is shown in Figure 7.1. The size of the 
text in the cloud provides an indication for the number of times a specific word 
features in the data. The larger the text appears, the more frequently referenced the 
word.  
 
 
 
 
 
 
 
 
 
 
 
The use of tag clouds in the early stage of analysis enables any possible early themes 
in the data to be identified. The software allows the user to click on any word in the 
cloud to explore the excerpts of text where the word appears. This simple process of 
Figure 7.1: Early Tag Cloud during Content Analysis. 
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analysis however does not replace the systematic approach applied to the data in this 
study, which was outlined in Section 7.9. 
 
All of the responses to questioning about challenges to the involvement of users were 
collated and analysed. In the early stages of analysis any mentioned difficulties or 
challenges that related to the involvement of users in the design process were coded 
under the heading of ‘Challenges to User Involvement’ in Nvivo 10. Using the 
principles of structured content analysis the responses were then coded again under 
provisional headings that summarised the nature of that challenge to designers. The 
headings were chosen based on the salient features of the text for each specific 
challenges to involving users as described by Flick (Flick, 2006). Note: Each 
challenge is defined explicitly in the discussion section of this chapter. 
 
The table below presents the new range of challenges cited by respondents at 
interview. The in-depth responses and questioning revealed a different range of 
challenges that were not identified through the survey study presented in Chapter six. 
Each challenge in Table 7.7 is presented with the number of coded references (times 
cited) and range of sources (number of participants). 
Table 7.7: Responses to Challenges for Involving Users. 
Perceived Challenges Sources Coded References 
Commerciality 12 58 
Client Relationships 11 76 
Financial Constraints 8 29 
Access to Participants 7 24 
Knowledge of Usability 6 44 
Incentives for Adoption 6 21 
Ethical issues 4 13 
Regulations 4 8 
Hierarchy of Users 3 7 
Diversity of Users 3 7 
Intellectual Property Considerations 2 6 
Other Issues 2 6 
 
 
 
260 
 
The data collected at interview revealed ‘Commerciality’, with respect to being 
competitive in business and the ability to make profit, as the leading challenge to 
involving users in the design process of a home use medical device. In summarising 
the commercial reality of operating in the field of medical device design, one 
designer said: 
“I think in the perfect world we would all [involve users more] the client would like 
it, we would like it, everyone would like to do it but all too often the commercial 
pressures are such that it just doesn't take place.” Participant #3 
This designer acknowledged the need for involving users in the design process 
however described a lack of incentive to really conduct studies with users correctly. 
Under the commercial constraints experienced by his company he added that current 
practice restricted access to patient users of home use medical devices: 
“We never get to the end user. We will get to the clinician, we will get to the installer 
or we’ll get to the carer possibly but we very rarely get to speak in detail with 
patient.” 
To analyse these challenges further it is possible to make comparisons on the 
common classes and their influence on the perceived barriers to involving users. 
Using the common classes described in section 7.9 the perceived barriers will now be 
considered from the following positions: experience in years, education and whether 
design guidance is followed. 
Perceived challenges to involving users based on a designer’s experience 
Participants in the study had a wide range of years’ experience in the field of home 
use medical device design from two years to more than 20 years’ experience. To find 
out whether experience had an influence on the perceived challenges to involving 
users in the design process, participants were grouped into the following 
classifications: 0-5 years, 6-10 years, 11-15 years, 16-20 years and 20+ years. Using 
this information a matrix query was performed on the data. Table 7.8 and Table 7.9 
present the number of participants represented by each experience classification and 
the results to the matrix query.  
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The colour coding in Table 7.9 provides an indication of the number of references for 
each specific challenge (i.e. the darker the shade of blue, the more references 
received).  
Table 7.8: Experience of Participants in Years. 
Experience in Years Number of Participants 
0-5 2 
6-10 6 
11-15 1 
16-20 2 
20+ 2 
Table 7.9: Matrix Query Results to show the Effect of Experience on the 
Perceived Challenges towards the Involvement of Users in the Design Process of 
Home Use Medical Devices. 
Challenges to User 
Involvement 
Experience 
0-5  
Years 
6-10  
Years 
11-15  
Years 
16-20  
Years 
20 + 
Years 
Commerciality 
1 Ref, 1 
Source 
24 Refs, 6 
Sources 
10 Refs, 1 
Source 
8 Refs, 2 
Sources 
15 Refs, 2 
Sources 
Client Relationships 
0 Refs, 0 
Sources 
33 Refs, 6 
Sources 
16 Refs, 1 
Source 
9 Refs, 2 
Sources 
18 Refs, 2 
Sources 
Financial 
Constraints 
0 Refs, 0 
Sources 
10 Refs, 4 
Sources 
1 Ref, 1 
Source 
9 Refs, 2 
Sources 
9 Refs, 1 
Source 
Access to 
Participants 
1 Ref, 1 
Source 
9 Refs, 2 
Sources 
5 Refs, 1 
Source 
5 Refs, 2 
Sources 
4 Refs, 1 
Source 
Knowledge of 
Usability 
0 Refs, 0 
Sources 
37 Refs, 3 
Sources 
0 Refs, 0 
Sources 
5 Refs, 1 
Source 
2 Refs, 2 
Sources 
Incentives for 
Adoption 
0 Refs, 0 
Sources 
5 Refs, 3 
Sources 
2 Refs, 1 
Source 
1 Ref, 1 
Source 
13 Refs, 1 
Source 
Ethical Issues 
0 Refs, 0 
Sources 
7 Refs, 2 
Sources 
0 Refs, 0 
Sources 
4 Refs, 1 
Source 
2 Refs, 1 
Source 
Regulations 
0 Refs, 0 
Sources 
3 Refs, 2 
Sources 
0 Refs, 0 
Sources 
3 Refs, 1 
Source 
2 Refs, 1 
Source 
Hierarchy of Users 
0 Refs, 0 
Sources 
4 Refs, 1 
Source 
1 Ref, 1 
Source 
2 Refs, 1 
Source 
0 Refs, 0 
Sources 
Diversity of Users 
0 Refs, 0 
Sources 
1 Ref, 1 
Source 
0 Refs, 0 
Sources 
4 Refs, 1 
Source 
2 Refs, 1 
Source 
Intellectual Property 
Considerations 
0 Refs, 0 
Sources 
5 Refs, 1 
Source 
0 Refs, 0 
Sources 
1 Ref, 1 
Source 
0 Refs, 0 
Sources 
Other Issues 
0 Refs, 0 
Sources 
6 Refs, 1 
Source 
0 Refs, 0 
Sources 
0 Refs, 0 
Sources 
0 Refs, 0 
Sources 
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Perceived challenges to user involvement based on education 
At interview participants were asked to state the highest level of qualification 
achieved relevant to the field of home use medical device design. All of the 
participants in this study were qualified to undergraduate degree level or above, 
including Master Degrees (MSc) or Doctor of Philosophy (PhD). In total eight 
participants were qualified to the level of BSc or BA and five participants had 
qualifications of MSc or Above (e.g. PhD). To explore the differences in perceived 
challenges based on educational qualifications, a matrix query was performed. Table 
7.10 presents the results to the matrix query.  
Table 7.10: Matrix Query Results to show the Effect of Qualification Level on 
the Perceived Challenges towards the Involvement of Users in the Design 
Process of Home Use Medical Devices. 
Challenges to User Involvement 
Qualification 
BSc/BA Level MSc or Above 
Commerciality 40 Refs, 7 Sources 18 Refs, 5 Sources 
Client Relationships 35 Refs, 7 Sources 41 Refs, 4 Sources 
Financial Constraints 23 Refs, 5 Sources 6 Refs, 3 Sources 
Access to Participants 9 Refs, 3 Sources 15 Refs, 4 Sources 
Knowledge of Usability 7 Refs, 3 Sources 37 Refs, 3 Sources 
Incentives for Adoption 16 Refs, 3 Sources 5 Refs, 3 Sources 
Ethical Issues 8 Refs, 3 Sources 5 Refs, 1 Source 
Regulations 7 Refs, 3 Sources 1 Ref, 1 Source 
Hierarchy of Users 2 Refs, 1 Source 5 Refs, 2 Sources 
Diversity of Users 7 Refs, 3 Sources 0 Refs, 0 Sources 
Intellectual Property Considerations 6 Refs, 2 Sources 0 Refs, 0 Sources 
Other Issues 6 Refs, 1 Source 0 Refs, 0 Sources 
 
Perceived challenges to involving users based on whether design guidance is 
followed 
Seven out of the 13 participants at interview expressed they followed the design 
guidance available to assist with usability issues for home use medical devices (e.g.  
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ANSI/AAMI HE75:2007). Six participants reported that they do not to follow 
specific usability guidance. On design guidance one designer said: 
“There are two or three pieces of guidance, draft guidance and proposed guidance 
that we use all the time…draft guidance by the FDA from June 2011 and that is 
freely available on the FDA website and that would basically give some guidance as 
to how to set up and report human factors studies. Some guidance from the American 
standards institute called HE75 from 2007 which again provides lots of guidance on 
how to set up and run usability testing and also provides quite a lot of best practice 
in terms of implementing human factors in to the design of your product. Then there 
is an ISO standard which is 62366 which is a more European focused thing but 
again that has got a lot of good guidance in there about how to document, how to 
gather the evidence that you have understood who your users are and how they are 
going to use the device and what they want.” Participant #7 
Evidently this designer has an awareness of the available guidance on an 
international level that has been developed to support the design of medical devices 
for the needs of users. Further information on designers’ perceptions of the available 
guidance is described later in the chapter. 
The following section of the results refers to the influence of design guidance on the 
perceived challenges to involving users in the design process. A matrix coding query 
was performed on the data to understand the differences between the two groups. 
Table 7.11 presents the results:   
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Table 7.11: Matrix Query Results to show the Effect of whether Design 
Guidance is followed on the Perceived Challenges towards User Involvement for 
Home Use Medical Devices. 
Challenges to Involving Users 
Design Guidance 
Not Followed Followed 
Commerciality 13 Refs, 5 Sources 45 Refs, 7 Sources 
Client Relationships 12 Refs, 4 Sources 64 Refs, 7 Sources 
Financial Constraints 4 Refs, 2 Sources 25 Refs, 6 Sources 
Access to Participants 6 Refs, 3 Sources 18 Refs, 4 Sources 
Knowledge of Usability 1 Ref, 1 Source 43 Refs, 5 Sources 
Incentives for Adoption 0 Refs, 0 Sources 21 Refs, 6 Sources 
Ethical Issues 4 Refs, 2 Sources 9 Refs, 2 Sources 
Regulations 4 Refs, 2 Sources 4 Refs, 2 Sources 
Hierarchy of Users 0 Refs, 0 Sources 7 Refs, 3 Sources 
Diversity of Users 1 Ref, 1 Source 6 Refs, 2 Sources 
Intellectual Property Considerations 0 Refs, 0 Sources 6 Refs, 2 Sources 
Other Issues 6 Refs, 1 Source 0 refs, 0 Sources 
7.10.3 The Design Process of a Home Use Medical Device 
 
Chapter six revealed that approximately 45% of respondents to the online survey 
reportedly followed a ‘user centred design’ process for home use medical devices. At 
interview the design process itself was explored further with participants as they 
were asked to sketch and describe the key stages involved in the design process of a 
home use medical device. Due to the nature of the mixed method approach to 
interviewing (i.e. face-to-face and over the telephone), different strategies had to be 
employed for this phase of the interview.  
During the face-to-face interviews participants were provided with an A3 sheet of 
paper and a black marker pen. They were then asked to draw out the key stages of 
their typical design process for a home use medical device. The process itself could 
be presented however the respondent felt suitable but it had to cover the key stages in 
the design process they perceived to be necessary to deliver a home use medical 
device to market. Once the design process was complete, participants were then 
 
 
265 
 
provided with a red marker pen to highlight on the process where users are currently 
involved within the process. Participants were asked to describe some of the methods 
used at these specific stages to identify user requirements. After these tasks 
participants were asked, hypothetically, to highlight on the process where and how 
they would involve users in the design process if there were none of the challenges 
previously described in section 7.10.2.  
Over the telephone this approach to analysing the design process was more 
challenging, solely for the practical reasons of not being present with the 
interviewee. Therefore during the telephone interviews a different approach was 
employed. Participants were asked to complete the same task however the 
interviewer would annotate and draw out the design process as it was described. If at 
any stage the interviewer were unclear of a stage, process or method described, he 
would ask the interviewee to repeat it. Again, participants were asked to describe 
where users were currently involved in the design process and how they would like 
to involve users if there were no barriers or challenges to their involvement, 
For the purpose of clarity in this report all of the design processes are presented in a 
linear format. This was due to legibility and the ease of making comparisons between 
the design processes. Note that many of the design process were originally depicted 
as cycles and all of the processes include iterative design stages.  
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Table 7.12: Participant Design Processes. 
Participant 
Reported Process 
Followed 
Design Process 
#1 User Centred Process 
Understanding the Context > 
Specification > Concepts > Concept 
Testing > Detailed Design > 
Evaluation 
#2 
User Centred Design 
Process 
Ideation > Concept Selection > 
Proof of Concept > 
Industrialisation > Manufacture 
#3 Contingent Design Process 
User Research > Concepts > 
Technical Development > Prototype 
Development > Evaluation 
#4 
User Centred Design 
Process 
Proof of Concept > Concepts > 
Feasibility > Detailed Design > 
Manufacture 
#5 Detailed Design Process 
Market Research > Concepts > 
Development > Prototypes > 
Evaluation 
#6 Detailed Design Process 
Ideation > Development > Research 
> Refine > Implement 
#7 
User Centred Design 
Process 
User Research > Concepts > 
Specification > Detailed Design > 
Evaluation 
#8 
User Centred Design 
Process 
User Research > Concept Design > 
Detailed Design > Prototyping > 
Adapt > Implement 
#9 
User Centred Design 
Process 
Identify > Design > Build > 
Validate > Production 
#10 
User Centred Design 
Process 
Requirements Capture > 
Interaction Design > Visual Design 
> Specification > Construction > 
Evaluation 
#11 
User Centred Design 
Process 
Research > Concepts > Proof of 
Concept > Prototype > Detailed 
Design > Evaluation 
#12 Prescribed Procedure 
Market Research > Concepts > 
Proof of Concept > Prototypes > 
Evaluation 
#13 Detailed Design Process 
Market Research > Concept Design 
> Prototypes > Producability > 
Manufacture 
 
Table 7.12 presents the design processes for all 13 participants in the study in a 
descriptive format. The table includes the reported design process followed alongside 
the specific stages taken to deliver a home use medical device to market. The stages 
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highlighted with Green text indicate the stages in the design process where users 
were involved.  
Table 7.13 indicates and compares the characteristics of reported ‘user centred’ 
design processes against the alternative processes followed by participants (e.g. 
Contingent, Detailed Design or Prescribed process). In total eight participants in this 
study followed a ‘user centred’ approach to home use medical device design. The 
figures in Table 7.13 reveal that the design processes featured in the study have 
approximately the same number of design stages for ‘user centred’ processes as they 
do for alternative processes. On average the percentage of user involvement was 
typically higher in a ‘user centred’ design process. The proportion of designers that 
followed design guidance was higher for companies following a ‘user centred’ 
design process as opposed to an alternative process. 
Table 7.13: Comparisons of Participant Design Processes. 
 
 
For clarity and to gain a clearer understanding of where typically users were involved 
in the design process a comparison based on whether design guidance was followed 
is presented in Figure 7.2 and Figure 7.3. The darker shade of purple indicates a 
design stage where users were involved. In contrast the lighter shade of purple 
indicates no user involvement.  
 
 
Criteria 
User Centred Design 
Process 
Alternative 
Processes 
Number of Companies 8 5 
Design Process Stages 
44 (Average 5.5 per 
process) 
25 (Average 5 
per process) 
Stages Involving Users 29 14 
Average Percentage User 
Involvement 
66% 56% 
Follow Guidance 63% 40% 
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Understanding the 
Context
Specification Concepts
Concept 
Testing
Detailed 
Design
Evaluation
User Research Concepts
Technical 
Development
Prototype 
Development
Evaluation
Ideation Development Research Refine Implement
User Research Concepts Specification Detailed Design Evaluation
User Research
Concept 
Design
Detailed 
Design
Prototyping Adapt Implement
Identify Design Build Validate Production
Requirements 
Capture
Interaction 
Design
Visual Design Specification Construction Evaluation
Ideation Concept Selection Proof of Concept Industrialisation Manufacture
Proof of Concept Concepts Feasability Detailed Design Manufacture
Market Research Concepts Development Prototypes Evaluation
Research Concepts
Proof of 
Concept
Prototype
Detailed 
Design
Evaluation
Market Research Concepts Proof of Concept Prototypes Evaluation
Market Research Concepts Proof of Concept Prototypes Manufacture
Figure 7.2: Participant Design Processes (Guidance Followed). 
Figure 7.3: Participant Design Processes (Guidance Not Followed). 
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7.10.4 The Methods for Involving Users.  
 
At interview participants were asked to describe the methods used to identify the 
needs of their end users. The methods cited by participants ranged from informal 
discussions with users themselves through to formal interviews in controlled 
environments. Table 7.14 presents all the methods cited by participants in the study 
alongside the number of participants that expressed they used that particular method 
when designing home use medical devices.   
Table 7.14: Responses to User Needs Identification Methods. 
User Needs Identification 
Methods 
Number of 
Participants 
Observation 19 Refs, 7 Sources 
Interviews 17 Refs, 7 Sources 
Prototypes 6 Refs, 5 Sources 
Video Analysis 5 Refs, 5 Sources 
Test Rigs 4 Refs, 4 Sources 
Task Analysis 7 Refs, 3 Sources 
Focus Groups 5 Refs, 3 Sources 
User Studies 11 Refs, 3 Source 
Surveys 4 Refs, 2 Sources 
Usability Tests 2 Refs, 2 Sources 
Role Play 2 Refs, 2 Sources 
Informal Meetings 4 Refs, 2 Sources 
Anthropometry 2 Refs, 2 Sources 
Desk Research 2 Refs, 2 Sources 
Simulations 2 Refs, 2 Sources 
Benchmarking 4 Refs, 2 Sources 
Other Methods 15 Refs, 1 Source 
 
In total, 26 different methods to capture the needs of users were referred to by 
participants in the study. All methods that were mentioned by one source only were 
grouped into the other methods category in the table. Observation and interviews 
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were identified as the most commonly adopted method for user needs capture. 
Observation methods here refer to a range of different techniques used to explore 
user interactions with a device. One participant said: 
“So usually it is a 1-to-1 interview as a design team, we usually sit behind 2-way 
mirrors or video it. It is really important for the designers to understand the difficulty 
patients are having because you wouldn't believe how difficult some patients find it 
to use devices.” Interview Participant #2. 
Observation was considered important for the translation of user needs as opposed to 
asking users questions. When asked about the ability to translate user insights into 
specific user needs, one participant said: 
“I mean the best way to get round that is to observe what people do when they are 
handling devices.” Interview Participant #7.  
This participant opined that observing users interact with devices revealed actual use 
scenarios as opposed to participants citing how they use a device based on what they 
believe the interviewer might be looking for. Further discussion on the methods for 
involving users in the design process is provided in the following section.  
With the results of the interviews reported a discussion of the findings will now be 
presented. The following section describes the implications of the results that have 
been presented in this section.  
7.11 Discussion 
 
The aim of this study was to answer research question two of this research: 
Research Question Two: What are the challenges for industry to involving users in 
the design process of home use medical devices?  
The purpose of the study was to understand current design practice towards 
involving users in the design process of home use medical devices in the United 
Kingdom. The interview protocol was designed to build on the findings of Chapter 
six and the perspectives of practicing designers towards current usability guidance 
for home use medical devices. In the literature review of this thesis it was found that 
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previous research had alluded to industry’s lack of uptake for usability guidance. In 
his thesis, Gupta explained: 
“The majority of designers who were involved in this study opined that they never 
consulted or had to consult a usability guidance to design their products for ease-of-
use.” (Gupta, 2007). 
 
Gupta’s study found that the majority of designers would use their experience most 
of time to make their device ‘user friendly and safe’. This raised the question for this 
research of the value of usability guidance to practicing designers, who would prefer 
to use their own experience. Chapter six concluded with three potential scenarios that 
could explain the current approaches by practicing designers towards home use 
medical devices. This study set out to address these scenarios specifically, in attempt 
to identify recommendations to incentivise the application of ‘good design’ 
principles for home use medical device design in the future.  
7.11.1 The Challenges to Involving Users in the Design Process 
of a Home Use Medical Device 
 
The idealised practice case study presented in Chapter Four identified a series of 
preliminary challenges to adopting user centred principles in the design of home use 
medical devices. These findings were explored further in Chapter six in an online 
survey of designers’ perspectives. Content analysis of the interview data from this 
study revealed eleven specific challenges towards involving users in the design 
process of home use medical devices. These challenges will now be discussed in 
order of precedence based on the number of sources (participants) found in the study. 
Each challenge is presented with a summary of the core issues at the end of each 
section.  
Challenge One: Commerciality 
Commerciality in the context of this study is defined in accordance with the Oxford 
dictionary definition (Oxford Dictionaries, 2013). As a derivative of the adjective 
‘commercial’, the term commerciality is used here to refer to the following: 
I. Concerned with or engaged in commerce: a commercial agreement. 
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II. Making or intended to make a profit: commercial products. 
The commerciality of the companies in this study was identified as the most cited 
challenge towards involving users in the design process of a home use medical 
device. One designer explained how the commercial pressures take priority over the 
practicing of usability principles and the studies they would like to conduct with 
users:  
“So, you know the whole idea that we’d go off and set up a focus group with a bunch 
of patients in this zone and have detailed conversations with them…long enough and 
with enough of them to get something that was statistically relevant is just not going 
to happen.” Participant #3. 
In this instance this particular designer worked for a design consultancy supporting 
manufacturers in professional and home use medical device design. This designer 
described how the pressure of meeting deadlines successfully took priority over 
delivering a device design that was successful in their opinion and experience. This 
participant described a process that was based on a decision of whether to refuse 
work or deliver what is possible within the commercial constraints of the project. On 
the topic of involving users this designer said: 
“It is a major problem and maybe we [designers] are just not pushing hard enough. 
Maybe we should be stamping our little designer feet and making more of a fuss 
about it but in reality, the commercial reality is, if a client says we haven’t got time, 
we haven’t got the budget, you know, we haven’t got six weeks to do studies…you've 
got two choices. You either refuse to do the job or you do it to the best of your ability 
with what you've got.” Participant #3. 
This quote mirrors the findings of the idealised practice case study where the 
participating company opined that outside of the safety and efficacy of the device, it 
becomes a ‘commercial decision’ on the approach to usability principles and user 
involvement. Currently, IEC BS EN 62366: 2007 advocates the application of 
usability engineering principles however there is no legal obligation to satisfy these 
requirements in the United Kingdom. Consequently, the companies in this study 
opined that they or their clients, in the case of a design consultancy, would not invest 
heavily in usability research, as there is currently no legal obligation to do so. 
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Other participants in the study referred to the commercial constraints upon the 
industry that are influencing design practice. One participant believed that the 
commercial focus of the sector has been gaining momentum in recent times. This 
participant posited that: 
“…as well as being technically adept and maybe offering pharmaceutical 
performance enhancement it has got to be commercially sound otherwise it gets 
canned…I think there has been a commercial focus in the last 5 years, partly driven 
by the global market…it is a really fine line between making sure that this [the 
device] has the greatest success of making it through to the production.” Participant 
#6. 
Evidently once a device has entered the development phase there is a focus upon 
delivering the device to market, which is driven by the investors. According to this 
participant, who expressed ‘User needs’ as a priority (i.e. driving factor), there is a 
point within the design process where ‘commerciality’ takes precedence and thus the 
usability of the device becomes of lesser priority.  
Another designer in the study shared this opinion:   
“Once it [the device] has gone past the design team who has handed it over there is 
an operations team, that we can educate, but they will just ignore us because they 
are driven by cost and money…the trouble is that you are often faced by managing 
accountants or engineers and they all have great numeric answers.” Participant #8. 
While there is evidence in the literature of potential benefits to both patients and 
manufacturers in applying usability principles, it remains difficult to demonstrate the 
benefits of such an approach in terms of finance and consequences of use. Sharples et 
al posited that:  
“If we wish to persuade a device manufacturer to consider a change or enhancement 
to a design for example, it is useful, but often challenging, to obtain specific evidence 
that demonstrates the value of modifying the design, and predicting the impact of 
that design change on consequences of use.” (Sharples et al, 2012). 
 
In an industry where the commercial consequences of device failure are so great, as 
was identified with the Exubera device (See Section 2.2), investors are often 
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searching for demonstrable evidence of device success in the design process. In this 
respect one of the drawbacks for usability principles is that there is an upfront cost 
for undertaking the research that predicts potential benefits in the future. As one 
participant explains:  
 
“Your launch date is the time you start making the money and this is an expensive 
programme.” Participant #9. 
Thus, the commerciality of home use medical device development presents a 
considerable challenge to the endorsement and advocacy of usability principles 
outlined in such documents as IEC BS EN 62366: 2007 and ANSI/AAMI HE75: 
2009. This finding is supported by the work Bridgelal Ram et al who posited that the 
commercial pressures of getting a device to market as a challenge for manufacturers 
(Bridgelal Ram et al, 2008).  
Core Issues 
 Commerciality takes priority over Usability Principles. 
 Tensions between insights and understanding of what is required by the 
Regulations and what is required from a Commercial Perspective. 
 Lack of time places pressure upon design iterations and referring back to the 
same users in previous studies. 
 Design consultancies that are paid to conduct user research on behalf of 
clients, typically accept projects despite an awareness that design practice is 
not as good as it could be. 
 Internal Procurement pressures take precedent over User Research during 
development. 
 Designers and Developers search for where the best value of end user 
research will come from, influencing chosen methods. 
Challenge Two: Client Relationships 
The term ‘Client’ as defined by Oxford Dictionaries refers to the following: 
“A person or organisation using the services of a lawyer or other professional 
person or company.” (Oxford Dictionaries, 2013). 
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Thus in the context of this study and research, a client refers to a ‘professional person 
or company’ in collaboration with the design and development of a home use 
medical device. This covers the range of persons cited at interview by participants in 
the study. This, for example, includes manufacturers as a client of a design 
consultancy who might be recruited to conduct user research on behalf of an 
organisation. It can also refer to General Practitioners themselves who can approach 
a manufacturer or consultancy with an innovative concept for development. The 
challenge, with respect to user involvement and the application of usability 
principles, is therefore established between the relationships of two or more parties 
attempting to deliver a home use medical device to market.  
‘Client Relationships’ were the second most cited challenge to applying usability 
principles in the design of home use medical devices by designers in the study. The 
relationships between clients revealed differences in the understanding and 
expectations of projects. One participant said: 
“…internally in the company they are presenting it to, perhaps the other design team 
get it, but the finance team don't and the marketing department don't. They don't see 
why they just handed over £60,000 and they got some great ideas from it, but 
couldn't they have got some great ideas without flying off to California and looking 
at somebody digging a hole or following some people in India on a motor bike for 3 
months. It is that type of thing…so there is still a conflict in the merging of this.” 
Participant #1. 
This company explained how their approach to design and specifically user testing 
was rejected by a past client on the grounds of having a preferred internal procedure 
in place. While, the manufacturer in this instance had recruited a consultancy to 
conduct user research the process for which they had paid for was ignored for 
internal reasons to the company. This participant explained:  
“It was difficult for us to apply the process that we wanted to apply...but we couldn't 
really get into the mapping of the use of the [device]…We got a map of the use but 
we couldn't get involved with the usability testing of [the device]. No, they wouldn't 
do the testing, they had their own testing procedure that they wanted to follow.” 
Participant #1. 
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The interviews revealed that client relationships not only inhibited the uptake of 
usability principles, but also affected the speed with which such an approach could 
be adopted. As was identified in the idealised practice case study, there is a 
recognised disparity of language between practitioners in the field of home use 
medical device design. At interview another participant opined that education on the 
principles and benefits of a user centred approach presented a big challenge to his 
company: 
“On the client side, we spend an enormous amount of time explaining the process…I 
am assuming nothing on that side and I really try to get them [the client] not only to 
buy in, of course they have to buy your services that's what I’d like to them to do 
obviously. But they really have to feel that this is going to be value added for them 
and again I think in a lot of cases it is the blindness that everybody has in their own 
field. We jump so quickly to just doing the thing and assuming a lot on the other side 
and saying ‘Well you must know what I am doing and why I am doing it’ ‘You must 
know that this technique is really helping me’ ‘You must understand when I do an 
interview or when I do an observation, I am trying to do a task analysis here, instead 
of trying to get to high level product value goals, which is really what you do in 
market research.”  Participant #10. 
This participant then added: 
“But a task analysis is a jargon word in itself even though it is recognised by two 
words which are very easy to understand.” Participant #10. 
For this participant it was perceived that the use of ‘jargon’ terms such as ‘task 
analysis’ or ‘user centred design’ presented a challenge when attempting to sell and 
deliver services (e.g. user research, user testing) to clients. Despite a manufacturer 
willingly investing in the guidance, service and support of a design consultancy’s 
expertise the challenging relationships between two or more parties restricted the 
adoption of usability principles.  
Core Issues 
 A disparity of language and use of jargon terms amongst different 
communities and stakeholders restricts the uptake of usability principles. 
 A shared understanding and expectation of the client’s role inhibits user 
involvement for home use medical devices.  
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 Financiers and Marketing Professionals are perceived to struggle to relate to 
the value of a ‘user centred’ approach and therefore can be resistant to 
adoption.  
 Internal testing procedures and practices for larger organisations were 
revealed to take precedent over guidance on usability from a design 
consultancy.  
 Client relationships are motivated by financial gains 
 Clients look for figurative gains or a tick box exercise - Expectations of 
perceived risks. 
 Clients are primarily driven by technology led companies 
 Time spent explaining or educating clients on justification of processes and 
methods  
 Perceived questioning of authority 
 Clients regularly look for shorter and cheaper workarounds 
 Clients like to code early, sometimes prior to exploration of users and 
designing 
 Clients often like to conduct the studies and work themselves with their own 
practices.  
 Access to users (patients) only available through the client. In respecting the 
clients wishes and confidentiality one designer expressed the limited access 
to the actual end users.  
 Hierarchical structure of clients  
 Contrasting requirements between marketing and engineering 
 Different clients attending each meeting making continuity and consistency 
difficult. 
 Perceive user involvement can be conducted at the end 
Challenge Three: Financial Constraints 
The noun Financial in the context of this study and its use in the phrase ‘Financial 
Constraints’ is defined as follows: 
“The finances or financial situation of an organization or individual” (Oxford 
Dictionaries, 2013).  
Thus the implication of the word ‘Constraints’ emphasises the associated challenges 
to designers and developers of home use medical devices in terms of user 
involvement. This challenge refers to the implications that costs and perceived costs 
have on a company’s ability to involve the end user in and throughout the design 
process.  
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Chapter six identified that the cost of user involvement is one of the most significant 
challenges to adopting usability principles including user involvement in home use 
medical device design. It could be argued that ‘Financial Constraints’ are closely 
linked with the challenge of ‘Commerciality’. However there is a distinct difference 
between the two challenges towards applying usability principles. Financial 
Constraints refer to the purely cost aspect of applying formal and informal methods 
for user research. Whereas, Commerciality is concerned with the ability to create a 
profit, which includes the lead times of a device to remain competitive and the 
success of the device in the marketplace post launch for example.  
Referring explicitly to financial issues and adopting a user centred process, one 
participant said: 
“If you are going to do it properly there is a huge cost and time.” Participant #2. 
This cost, as explained by another participant in the study, was inhibitive to the 
uptake of what participants would consider as idealised practice.  
“I mean the most difficult thing is coping with restricted budgets and time 
scales…you have then got the complication of trying to do it all on a shoe string 
budget so maybe you don't have the luxury of getting as wide a group of subjects to 
interface with as you would like.” Participant #4. 
In one participant’s experience they found that the perceived costs for conducting 
‘human factors’ was far greater than the actual costs to conduct such work: 
“We find that there is a perception by manufacturers that doing human factors data 
is an expensive and time consuming thing to do.” Participant #7. 
As a consequence of the financial implications for conducting user research, the very 
importance of its role in the design process can be called into question according to 
one designer in the study: 
“…Cost is absolutely an issue because this is expensive and most of our clients don't 
like to pay the money and they will argue with us about whether it is important.” 
Participant #9. 
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Core Issues 
 Proxies or representatives of device users are used in place of real end users 
due to the financial constraints to access real end users. 
 Conducting user research early and iteratively will require additional cost 
upfront, which many of the smaller companies cannot afford.  
 Typically smaller samples of users are involved than companies would like 
based on the financial constraints of the company. 
 The number of medical devices that actually make it to production is actually 
very small; therefore companies are very risk averse when it comes to 
spending money. 
 Very often the perceived costs put companies off before considering the 
implications of what the user research might open up for them 
 Due to the costs of involving users in assessments and trials many companies 
look for cheaper or quicker alternatives that provide a ‘good enough’ option 
to meet regulatory approval.  
Challenge Four: Access to Participants 
Access in the context of this study is defined as follows: 
“The right or opportunity to approach or see someone.” (Oxford Dictionaries, 2013).  
Thus the ability for companies (i.e. designers and developers) to access participants 
for user research can be a considerable challenge to industry. Gaining the active 
participation of the target or end users within the design process was revealed to be 
particularly challenging for designers in the study. In a case study on user 
involvement for patients with Epidermolysis Bullosa (EB) Brigdelal Ram et al found 
that access to vulnerable users and commercial pressures were challenging for user 
engagement. They state that ‘pursuing the ideal of an iterative process of user 
engagement and product refinement is challenging in terms of both accessing 
vulnerable users and resourcing the process in the face of commercial pressures to 
get products into the market place.’ (Bridgelal Ram et al, 2008). 
If ‘user centred’ principles are to be adopted successfully for home use medical 
devices the process itself must involve and iterate with actual end users from 
conception through to production taking into consideration the real needs of end 
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users (IEC BS EN 62366, 2007). Accessing patients for devices to be used in the 
home environment, at the right time, in the right amounts and in the right profile for 
the specific device can therefore be very difficult for industry. On access issues one 
participant explained that: 
“It is not simply that people want to use input from users but rather that they can’t 
get access to these people. So it is not so much the tools and the process and the 
reasons why you are doing it, it is just the pragmatics of well we don't know how to 
get to these people. We don't know how to effectively take time and use their input 
and get enough of it in the process to make it really work well.” Participant #10. 
Another designer in the study referred to the difficulty to access patients in a 
voluntary manner. Once a profile for a specific user group or groups has been 
identified, this particular participant experienced difficulty in accessing the diversity 
of users at the same time as well as being willing to participate.  
“Yes it is quite difficult to get different patients around the table because they have to 
be voluntary.” Participant #13. 
The challenge of approaching users for the purpose of research was also highlighted 
by another participant in the study. Participant three, a managing director with 11-15 
years’ experience in the field explained:  
“It is very difficult for, you know as a product designer if you are working for a 
medical device company you can’t then really go straight to a user group or a focus 
group of potential users or consultations.” Participant #3. 
He then added that: 
“Building up a profile of exactly what’s required is again limited by this access to 
the right people…we never get to the end user. We will get to the clinician, we will 
get to the installer or we’ll get to the carer possibly but we very rarely get to speak in 
detail with patient.” Participant #3. 
This quote would suggest that access to real end users for home use medical devices 
(i.e. patients) is restricted to some designers. In the aforementioned study by 
Bridgelal Ram et al, it was identified that access to patients for researchers is less of 
an issue and challenge than it is for manufacturers. The authors state that ‘as clinical 
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researchers’ access to the user groups and research process ensures that the message 
of user needs is not ‘lost or misinterpreted by the manufacturers.’ (Bridgelal Ram et 
al, 2008).  
Many of the designers in this study alluded to the difficulty of conducting user 
research with patients specifically. While it is evident that some designers in the 
study are able to access clinicians and carers for the purpose of user research, access 
to patients was considered much more of a challenge to designers in this study.   
Core Issues 
 Accessing the user profiles of a home use medical device can be very 
challenging for designers and developers of home use medical devices. 
 Repeated access to the same participants for the purpose of iteration can be 
difficult.  
 Accessing patient users who voluntarily participate in user research studies 
was identified as challenge to designers in the study.  
 Locating and accessing patients that match a specific profile (e.g. Symptoms 
or Conditions) was perceived to be a challenge. 
 Healthy patients were found to be much easier to access and more willing to 
participate in user research. 
 Accessing patients across different countries (Member States) can be 
difficult, if a company plans to sell a product globally.  
 Companies often use a third party to access patient users to overcome the 
challenge of gaining participation. 
 Representative users are used in place of real end users when access is an 
issue.  
Challenge Five: Knowledge of Usability  
The term ‘Knowledge’ in the context of this study refers to issues related to an 
industry wide (i.e. different stakeholders) understanding of usability principles and 
conducting user research with patients in the home environment. Knowledge as 
defined by Oxford Dictionaries is as follows (Oxford Dictionaries, 2013): 
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“Facts, information, and skills acquired through experience or education; the 
theoretical or practical understanding of a subject”. 
And 
“Awareness or familiarity gained by experience of a fact or situation”. 
The designers in this study opined that considerable time is spent educating clients, 
colleagues and participants (e.g. patient users) with no prior knowledge of the 
principles and justification of user research. One participant in the study said: 
“It is both our clients and product managers that we work with and it is also the end 
users themselves when we go out and actually interview people. I find that there is a 
serious lack of understanding of what this process is about and more so even than an 
unwillingness to participate.” Participant #10. 
In the case of this company, this participant experienced the challenge of educating 
persons to understand the process more significant than access issues previously 
described. He added that: 
“We spend at least, I would say, a quarter of the time explaining the process and 
explaining why this is relevant.” Participant #10. 
The difficulty in educating ‘clients, product managers and end users’ themselves was 
perceived challenging to his company due to the lack of common terms used in the 
practice of applying usability or ‘user centred’ principles. The participant explained 
previous examples from his own experience where adoption of the process he was 
advocating was met with difficulty:  
“This guy talks to you about stuff that you have never heard of before, he uses words 
that you have never heard of before and describes a process that you have never 
heard of before and you instantly have to accept it and see it has a value and play 
your role in it. A lot of people are just not comfortable with that.” Participant #10. 
Other participants in the study described how a lack of knowledge of usability 
principles presented challenges for user involvement. One designer explained that a 
company’s interpretation of usability for a medical device he had worked on 
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previously was considered as purely interface design and aesthetics. He explained 
that: 
“They [the client] wanted somebody to design the screen and that is their usability 
done…However, the interpretation of that is we will make the screen pretty. So there 
is not a necessarily thorough understanding yet of the whole user experience.” 
Participant #1. 
According to some participants this issue was not limited to smaller companies. One 
participant, representing a design consultancy, had experience of working with larger 
organisations that has also demonstrated a lack of understanding and appreciation of 
the role of usability in professional and home use medical device design. This 
participant posited that: 
“Often at times we are working with Big Pharma [the pharmaceutical industry] and 
clients who themselves don't have the expertise to do this. Or don't know what they 
should be doing…so we spend a lot of time educating them.” Participant #9. 
In consistencies with industry’s understanding and interpretation of usability 
principles suggests that successful adoption is difficult for designers and developers 
in practice.  
Perhaps the issue that current regulation in the United Kingdom does not mandate the 
principles of usability engineering is one of the reasons behind the lack of uptake by 
practicing designers. As previously stated IEC BS EN 62366: 2007 outlines specific 
design guidance for medical devices with respect to usability. However, without 
mandated requirements specifically stated within the regulations, the adoption of 
usability principles is expressed as a ‘moral obligation’ that denotes non-compliance 
as ‘permissible’ (Blumenthal, 2013). In an article on the use of auxiliary verbs, ‘Shall 
vs. Should’ and their presence in quality management system (QMS) documentation, 
Blumenthal explains that the differences between the two terms are often overlooked 
(Blumnethal, 2013).  
According to Merriam-Webster the auxiliary verb ‘Shall’ is ‘used in laws, 
regulations, or directives to express what is mandatory.’ (Merriam-Webster, 2013). 
In contrast, ‘Should’ is ‘used in auxiliary function to express obligation, propriety, or 
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expediency.’ (Merriam-Webster, 2013). Thus, as Blumenthal states, the term ‘Should’ 
allows ‘document users to make their own judgment calls’ (Blumenthal, 2013).  
When asked about ‘user centred design’ principles one designer in the study with 
over 26 years’ experience in medical device development explained that he was not 
familiar with the term: 
“User Centred Design {Pause} I am not familiar with it being put like that. No I 
have never really, you get the occasional customer appraisal, small marketing 
exercises done.” Participant #12.  
The results of the interviews imply that there is a lack of universal understanding and 
appreciation on the principles and value of ‘user centred’ practices for home use 
medical devices. One participant in the study summarised this in the following 
statement: 
“It would be nice if people stopped looking at it as a checkbox exercise and looked 
as this will lead to a better product that we will sell more of.” Participant #1. 
Core Issues 
 User research is perceived by many to be a marketing exercise or market 
research.  
 A recognised disparity of language between the design community for 
professional and home use medical devices.  
 Some companies perceive the activity of user research to be a ‘checkbox’ 
activity as opposed to a process that will lead to a better product and benefit 
them financially. 
 Uptake of usability principles is inhibited by the use of a process and ‘jargon’ 
terminology that stakeholders in the design process are not familiar with. 
 Considerable time is spent educating individual on the concepts and value of 
a ‘user centred’ process that delays the time to market.  
 The established medical model for conducting research obstructs the uptake 
of user research by Healthcare Professionals (HCPs). 
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Challenge Six: Incentives for Adoption 
The term ‘Incentives’ in the context of this study refers to the factors that influence a 
company’s decision to invest and adopt ‘user centred’ practices. Oxford Dictionaries 
define an incentive as ‘a thing that motivates or encourages someone to do something’ 
(Oxford Dictionaries, 2013). Six of the designers in the study referred to a lack of 
incentive or motivation that justified investing more money and time into conducting 
user research throughout product development.  
One participant opined that, in his experience, some companies do not consider it 
valuable to invest in user research studies, as patients will use the devices that they 
are given: 
“A lot of companies don't consider it actually that important to talk to the customer, 
to talk to the end user, to talk to the person who is going to use the syringe driver 
because they’ll use whatever they’re given”. Participant #3. 
Evidently the companies that this designer was referring to failed to see an incentive 
to invest in usability research. All six respondents who cited a lack of incentives to 
adopt usability in practice referred to the difficulty to apply cost-benefit analysis. 
Typically, companies are financially motivated; this was seen with the commerciality 
challenge for user involvement, so very often the decisions for conducting user 
research are dictated by a return on investment (ROI). One participant opined that: 
“It is very difficult to have an impact from a design point of view, on marketing and 
development within large organisations.” Participant #6. 
Another participant explained that: 
“As an industry ergonomics suffers by not having lots and lots of good cost-benefit 
analysis.” Participant #8. 
There is a need for usability research to develop improved evidence on the cost-
benefits for conducting user research. Sharples et al state ‘there is a clear need for the 
analysis and demonstration of the relationship between the goals of the device, its 
design and the consequences of its use.’ (Sharples et al, 2012). Such evidence could 
provide further incentive and motivation for the uptake of usability principles in 
home use medical device design.  
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Core Issues  
 It is difficult to assign a monetary value to usability and user satisfaction with 
respect to the financial gains for a company. 
 Some manufacturers do not consider it important to involve the end user at all 
in the design process, as they believe they will make do with what is given to 
them.  
 It is difficult for design as a discipline to have an impact on marketing and 
finance departments within a company.  
 Currently the requirement to save money outweighs the perceived benefits of 
investing in early and iterative user research.  
 Cost-benefit analysis is very difficult for companies to conduct within the 
realms of usability research and user satisfaction.  
Challenge Seven: Ethical Issues 
The use of the term ethics in the context of ‘Ethical Issues’ and its relevance to this 
study are defined as ‘moral principles that govern a person’s behaviour or the 
conducting of an activity’ (Oxford Dictionaries, 2013). Thus, these issues in the 
design of home use medical devices refer to the necessary approvals and practices 
that must be in place by law within the United Kingdom (UK) for user research to be 
ethically conducted. It is regarded that any research involving patients or healthcare 
professionals can often be a lengthy and complicated process (Martin et al, 2008). In 
the UK and the NHS, permission to conduct research is made via an application to 
the National Research Ethics Service (NRES). NRES Research Ethics Committees 
(RECs) are responsible for the ‘safeguard of rights, safety, dignity and wellbeing of 
people participating in research in the NHS (NRES, 2013). Wald has previously cited 
this issue as a barrier to research in the NHS, as all research involving NHS staff or 
patients requires an ethical review regardless of whether the research is 
interventional or not (Wald, 2004).  
The consequence of ‘lengthy’ ethical reviews and the perceived bureaucracy in 
gaining ethical approval is that companies tend to look for alternative approaches to 
conducting user research with actual target populations. On ethical issues one 
participant said: 
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“It is difficult and it depends on who you are involving and where you are involving 
them. If it is NHS staff, you can gain access to NHS staff without having to gain 
ethical approvals provided it is in their own time and they are willing to take part 
and happy to be involved.“ Participant #1. 
Provided the target healthcare professionals are available and willing to participate at 
the time of conducting user research, this alternative to gain ethical approval is an 
option adopted by some companies. However, for home use medical devices in the 
United Kingdom the real end users of such devices are typically patients and their 
families. In such cases, one designer in the study described how ethical approval 
could be avoided through the use of proxy or representative users: 
 “So they end up using proxies…going to surgeons, going to experts and talking to 
them rather than talking to the user because getting to the user just takes too damn 
long. And not too long because they don't know where the user is [Access Issues] but 
too long because they can’t get the agreement to go through.” Participant #1. 
Other designers in the study described how the bureaucracy of ethical approval in the 
United Kingdom and the use of NHS patients influenced their design practice. When 
asked about gaining ethical approval for user research, one participant explained how 
he would typically avoid the process: 
“No it is underneath the radar for ethics. It is really in the experimental phase with 
enthusiastic colleagues if you like. So it is rather like Dr Jekyll experimenting on 
himself really.” Participant #12. 
For this designer, conducting user research with actual end users of the device was 
typically replaced with internal studies with his own colleagues, including testing 
and using devices themselves as opposed to with actual end users.  
Core Issues 
 Gaining ethical approval for conducting user studies and testing in the United 
Kingdom was perceived as lengthy and restrictive. 
 The study revealed that designers would typically search for alternative 
methods to conduct user research to avoid bureaucracy.  
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 Companies seek involvement from HCPs from the NHS in their own time 
and they are so willing to avoid ethical issues. 
 The time taken or perceived time to attain ethical approval in the United 
Kingdom and NHS prevents the adoption of usability principles with device 
users. 
 Proxies or representatives are often used in place of real end users, as it is 
quicker and less bureaucratic.  
 Some designers conduct their own research on themselves rather than with 
end users. 
 Personal situations make conducting research for some diagnostics 
challenging ethically.  
 The hospital setting has a perception of clinical trials that makes gaining 
participation from HCPs challenging for user research. 
 The default position of some HCPs is an unwillingness to participate in user 
research for fear of liability.  
Challenge Eight: Regulations 
Regulations are widely recognised as rules or directives that are ‘made and 
maintained by an authority’ (Oxford Dictionaries, 2013). Section 2.3 of this thesis 
described the current regulations in force in the UK under the recognised Competent 
Authority, the MHRA. Under the current regulations in the UK, usability engineering 
as outlined in the recognised harmonised standard IEC 62366:2007 outlines 
guidelines that are open to the interpretation of its users. Presently there are no 
mandatory usability requirements with respect to user research in medical device 
design. There are also no recognised specific regulations in the United Kingdom for 
home use medical devices with respect to usability.  
As described in section 2.3, the current regulations mandate specific ‘essential 
requirements’ that refer to the safety and efficacy of medical devices. Satisfying 
these requirements is essential for a medical device to be launched onto the market in 
the UK and Europe.  
Designers in this study opined that manufacturers of professional and home use 
medical devices focus on the satisfaction of safety and efficacy requirements as a 
priority. Usability considerations are typically considered towards the end of the 
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design and development process, as they are currently not a mandated requirement 
under the Medical Device Directive (MDD). 
On the topic of regulation one consultancy in the study explained how typically the 
companies they worked with felt controlled by the regulatory requirements. 
“A very large majority of companies which we work with live in fear of, whether they 
have got regulatory compliance or not.” Participant #1. 
In this designer’s experience, clients were fearful of not meeting the regulatory 
requirements to get a device onto the market that usability was not considered a 
priority. Others argued that some of the regulations were open to interpretation that 
meant satisfying the requirements was challenging. 
“There is some interpretation, the regulations are open to some interpretation on 
numbers and the way, what a homogenous group is and all sorts of stuff.” 
Participant #9.  
The interviews also revealed that some designers in the study considered the process 
of applying to the regulatory authority, the MHRA, as expensive. 
“It is just the process of applying to the MHRA is not cheap.” Participant #12. 
Thus, designers were fearful of not satisfying the legal requirements regarding home 
use medical devices, which would require a costly re-submission to the competent 
authority for approval.  
Not all designers in the study considered the current regulations to be a challenge for 
involving users in the design of home use medical devices however. One designer in 
the study opined that the current regulations were specific with regards to the 
regulatory requirements and thus meant compliance was achievable if one followed 
the documents. 
“I mean regulations aren’t really a problem because they are quite specific so you 
always know what you are working with.” Participant #4. 
However, one participant explained that the regulatory requirements were less clear 
when designing for the European Union (EU) market. Under the current MDD, 
different member states transpose the directive into specific regulations that can 
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mean compliance for devices sold throughout the EU is less consistent than meeting 
the regulatory requirements for the UK. After citing that the current regulations are 
open to interpretation, this designer added that: 
 “Especially when you get into Europe where you can generally apply the same logic 
as the FDA but not quite the same.” Participant #9. 
The study suggest that some designers perceived the guidance on usability for both 
professional and home use medical devices is open to interpretation and at times 
confusing for medical device developers. Designers in the study opined that priority 
is placed upon satisfying the regulatory requirements, the ‘shall’ statements in the 
regulation, with ‘should’ requirements allowing for permissible non-compliance, 
provided that justification is given.  
Core Issues 
 Designers and developers focus upon the mandatory regulatory requirements, 
often overlooking the obligatory requirements for usability considerations. 
 Non-compliance with usability guidance is regarded as ‘permissible’ under 
the current regulatory requirements in the United Kingdom. 
 Applications for regulatory approval through the MHRA are perceived to be 
expensive for device developers, enforcing the focus upon meeting the 
regulatory requirements in development. 
 Following usability principles including the involvement of end users in the 
design process is considered a ‘moral obligation’ rather than necessity for 
regulatory requirement in the United Kingdom. 
Challenge Nine: Hierarchy of Users 
The term ‘Hierarchy’ in the context of this study refers to the hierarchical nature of 
stakeholders within the design and development process of a home use medical 
device. A hierarchy, as defined by Oxford Dictionaries, is ‘a system in which 
members of an organization or society are ranked according to relative status or 
authority.’ (Oxford Dictionaries, 2013). Previous research found in the literature 
review has described a potential hierarchy amongst the field of medical devices 
(Money et al, 2011). Money et al posited that the needs of users from the perspective 
of some manufacturers do not originate from patients themselves. Rather, patient 
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needs are often articulated through a hierarchy of healthcare professionals such as 
surgeons or clinical champions (Money et al, 2011). This was also found in case 
study two of this thesis which identified that individuals with purchasing powers 
were typically consulted during the design and development process rather than 
patient users themselves.  
During the interviews for this study it was found that other designers referred to a 
hierarchy when capturing the needs of users in the field of home use medical devices. 
One designer in the study opined that the hierarchical nature of the medical device 
field affected his practice of user research, because senior HCPs were often resistant 
to the process he was advocating: 
“In a medical environment, it is fairly hierarchical. I find that people are a little 
more abrasive and they’re just…they don't see the point of you asking them 
questions.” Participant #10. 
He added that this ‘characteristic’ was not unique to the field of professional and 
home use medical devices, but posited that participation from some individuals 
within the hierarchy of HCPs was inhibitive to applying usability principles for 
design.  
“It is not the only field that has this characteristic but I find in medical, people are 
less interested in what you are doing and less open to being involved.” Participant 
#10. 
Another designer in the study opined that individuals with purchasing power and 
access to budgets for medical devices were typically consulted over patients for the 
purpose of identifying or capturing user needs. 
“So you go down that hierarchy and then buyers do become more of an issue 
because they make big purchase decisions.” Participant #9. 
This designer added that in some situations, as it is permissible to do so, HCPs were 
consulted in focus groups to identify the needs of their patients rather consulting or 
involving the patients themselves.  
“We might focus group nurses where we get 3 or 4 of them in just to cover the 
ground faster.” Participant #9. 
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The designer in this instance explained that this was a quicker method to understand 
the needs of end users rather than interact with the individuals directly. Similarly, as 
was described in the ‘Access to Participants’ section, one designer described how the 
clients he worked with preferred to consult and involve individuals from positions 
higher within the hierarchy consequently restricting the access to patient users. 
 
“We never get to the end user. We will get to the clinician, we will get to the installer 
or we’ll get to the carer possibly but we very rarely get to speak in detail with 
patient.” Participant #3. 
 
Some of the designers in this study opined that a hierarchy, based upon expertise and 
financial power, exists amongst the medical device industry. As a consequence for 
design, the involvement of end users was perceived by some designers to be of lesser 
value and necessity in the design of home use medical devices. Many of the 
designers in the study opined that they consult senior HCPs or buyers of devices to 
address their specific needs, for reasons of commerciality rather than involving the 
patient directly.  
Core Issues 
 Designers consult senior healthcare professionals (HCPs) to identify the 
needs of patient users for reasons of commerciality. 
 Some designers in the study perceived HCPs to be unwilling and uninterested 
to participate in user research studies, as it was not considered important to 
them.  
 In certain circumstances some consultancies were restricted to only 
consulting with senior HCPs to address the needs of end users. 
 Some designers opined that individuals with purchasing power were often 
involved in the design process to meet their specific needs rather than the 
needs of end users. 
Challenge Ten: Diversity of Users 
The term ‘User’ as previously described throughout this thesis is defined in 
accordance with IEC BS EN 62366: 2007. Under the harmonised standard a user is 
defined as the person using (i.e. operating or handling) the medical device, which 
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includes and is not limited to, cleaners, maintainers and installers (IEC BS EN 
62366: 2007). The standard’s definition recognises that users can also be patients or 
laypersons (IEC BS EN 62366: 2007). Therefore it is understandable that users of 
home use medical devices can be any one of a multitude of people with a complex 
range of needs. One participant in this study explained: 
“So as you start to list all of these users as stakeholders you get a feel for the mine 
field that it all is to launch a product.” Participant #4. 
In this respect designing with the needs of users in mind was identified as 
challenging for designers in the study. One participant described how devices could 
be used by patients with co-morbidities, multiple conditions that effect the 
interactions with devices, consequently presenting a challenge to accessing the 
diversity of device users for research:  
“If you get into cystic fibrosis or multiple sclerosis or something like that where you 
have co-morbidities as well. You have people who are able to use say an injection 
device for a while and then become incapable of using it. You have got to make sure 
that you are talking to people from that whole spectrum.” Participant #9. 
This participant added that when designing for the European market in accordance 
with the current requirements there is a lack of diversity achieved which is typically 
regarded as acceptable to launch a product: 
“…Basically you are using 10 people in Germany and 10 people in Spain as a stand 
in for the entire European market…Whereas if you think of it in those terms, half of 
them are male, half of them female. So you have got 5 men and 5 women standing in 
for the whole of Europe.” Participant #9. 
Core Issues 
 Identifying and accessing the diversity of device users for home use medical 
device design was perceived as challenge for the sector. 
 Engaging with patients with comorbidities was identified as both challenging 
but essential to understanding the diverse range of patient capabilities.  
 Satisfying the current requirements from a regulatory perspective does not 
ensure that the diversity of device users is considered.  
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Challenge Eleven: Intellectual Property Considerations 
The final challenge identified at interview referred to Intellectual Property (IP). The 
Intellectual Property Office (IPO) describes IP as ‘any form of original creation that 
can be bought or sold’ (IP, 2013). According to the IPO there are four main types of 
IP rights; Patents, Trade Marks, Designs and Copyright. Two designers within this 
study described how IP presented a challenge to their company in relation to having 
‘freedom to operate’. One participant explained: 
“One thing that I would actually like to add to the complexity is the intellectual 
property world. It is highly complicated… I would say it is one area of my experience 
that still throws up surprises.” Participant #6. 
He added that: 
“It [Intellectual Property] can be a massive barrier in terms of worldwide capability, 
freedom to operate and also freedom to supply to the market.” Participant #6. 
Another participant in the study explained that ‘Freedom to Operate’ was a challenge 
in the sector shared this perception of IP: 
“The biggest problem with an inhaler is not, you know, I need to have IP on this. It’s 
I need to be able to have freedom to operate. Freedom to operate is a massive 
problem.” Participant #9. 
Consequently settlements between organisations sometimes have to rely on 
negotiations between lawyers: 
“In effect it can come down to negotiations between organisations as to who does 
what and I have worked on many projects which have been dormant for a very long 
time and with very good tools and research behind them and it is pretty much, 
unfortunately in my opinion down to lawyers at the end whether it actually makes it 
or not.” Participant #6. 
Core Issues 
 Designers in the study opined that ‘freedom to operate’ around existing IP 
was a challenge for the home use medical device sector. 
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 Negotiations between lawyers can ultimately dictate whether projects will go 
ahead on the grounds of intellectual property agreements. 
7.11.2 The Perceptions of Design Guidance 
 
The context in which the term ‘Design Guidance’ is used here refers to literature that 
has been specifically developed to assist the designer or developers in conducting 
user needs research, including the identification of needs or improving the usability 
of devices.  
 
While many of the designers in this study (62%) opined that they adopted a ‘user 
centred design’ process, the understanding and interpretation of this process was 
diverse, as has been previously presented. On this topic one participant in the study 
described that despite designers often having a level of knowledge on ergonomic 
principles, the concept of ‘designing for ourselves’ is still extant: 
“One of the biggest problems with what we do is that we are designing for people 
and we are people. We design for ourselves. It's a classic mistake but it still goes on, 
even though everyone has possibly read an ‘ergo’ [ergonomics] book, it still goes on 
today.” Participant #8. 
Stephen Pheasant and Christine Haslegrave described this concept in what is known 
as the Five Fundamental Fallacies in their book titled ‘Bodyspace: Anthropometry, 
Ergonomics and the Design of Work’ (Pheasant & Haslegrave, 2006). On designing 
for one self, Pheasant and Haslegrave said: 
“The designer considers the matter tries out the prototype and concludes that it 
‘feels alright to me’, with the clear implication that if it is satisfactory ‘for me’ it will 
be for other people too”. (Pheasant & Haslegrave, 2006). 
Designing in such a way fails to account for the recognised diversity of home use 
medical device users (e.g. size, weight, strength, visual acuity, dexterity, cognitive 
capability etc.). That is before considering the environment for which the device is to 
be used and tasks that must be performed.  
The five fallacies described by Pheasant and Haslegrave include ‘two principle 
themes’. The first of these themes describes the ‘contrast between the investigative 
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methods of the empirical sciences and the creative problem solving methods of the 
designer’ (Pheasant & Haslegrave, 2006). The second theme within the five fallacies 
is one of ‘human diversity’, which Pheasant and Haslegrave describe as ‘the single 
most important characteristic of people’ in the world of design and practical affairs 
(Pheasant & Haslegrave, 2006). The Five Fallacies are presented in Table 7.15.  
Table 7.15: The Five Fundamental Fallacies (Pheasant & Haslegrave, 2006). 
1. This design is satisfactory for me – it will, therefore, be satisfactory for 
everybody else. 
2. This design is satisfactory for the average person – it will, therefore, be 
satisfactory for everybody else. 
3. The variability of human beings is so great that it cannot possibly be 
catered for in any design – but since people are wonderfully adaptable it 
doesn't matter.  
4. Ergonomics is expensive and since products are actually purchased on 
appearance and styling, ergonomic considerations may conveniently be 
ignored. 
5. Ergonomics is an excellent idea. I always design things with ergonomics in 
mind – but I do it intuitively and rely on my common sense so I don't need 
tables of data.  
 
In the context of this study it is arguable that some of the responses made by 
participants mirror the themes of the fifth fallacy in Table 7.15 (Pheasant & 
Haslegrave, 2006).  
It is often commonplace for manufacturers and design consultancies to market their 
services, products and methods as ‘user centred’ or user friendly. In total eight 
designers in this study reportedly followed a ‘user centred design’ process towards 
home use medical device development. Despite this, 46% of designers in the study 
opined that they did not follow the available usability guidance, as they believed it to 
either be ‘common sense’ or lacking in practical value.  
One designer in this study felt that much of the guidance and literature they had seen 
on the topic of user research was simply ‘common sense’. This participant felt that 
sufficient user research could be carried out with ‘a quick 10 minutes on Google’. 
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This company for whom this participant was Managing Director held a sceptical 
view of the value of such guidance in practice. He described design guidance as: 
 
“Common sense branded in another way” Participant #2. 
 
Another designer in the study felt that the available guidance is perhaps more 
suitable for academics as opposed to designers in industry. 
  
“I guess they are possibly more of an academic interest than perhaps of use on a 
practical project.” Participant #11.  
 
On this theme some participants cogitated that the available guidance suffered from a 
lack of practical value and would therefore choose not to make use of such material 
or in some cases not look for such guidance at all. 
 
“I don't look for dedicated designer information…No I don't get the quality of 
information I want is the blunt answer really” Participant #12 
 
Evidently some designers in the study held a negative perception of the value that 
design guidance could provide for them or their company. One theme that was 
common to 83% of the designers that did not follow design guidance was the issue of 
experience in the field. These participants felt that experience from working in the 
field was more valuable in terms of understanding the needs of users than any form 
of approach or method that could be provided within design guidance. When asked 
whether one designer in the study used any particular design guidance he said: 
 
“I can’t recall anything we have used recently. I mean we have got quite an 
experienced team that have been doing this for years so we generally use our own 
internal resources to get together and figure out an approach that might be useful.” 
Participant #4 
 
This designer then added: 
 
“We rely on our experience of what has worked in the past.” Participant #4 
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Due to the inherent complexity and diversity of home use medical devices the 
designers in this study implied that designing a successful device can only be 
achieved through greater experience and an understanding developed over years of 
working in the industry.  
 
“It is more experienced based because we can be dealing with quite a range of 
requirements. The requirements have to be developed by the experienced team and 
include a lot of variable inputs into that and that is predominantly through 
experience.” Participant #6                      
 
This finding supports claims within existing literature. In his thesis, Gupta found that 
designers of home use medical devices regarded experience to be more valuable than 
any form of usability guidance (Gupta, 2007). One designer in Gupta’s study felt that 
75% of designing for home use medical devices was attributable to experience 
(Gupta, 2007).                            
 
The results from this study suggest scepticism of the practical value that the currently 
available guidance provides to designers and developers of home use medical 
devices. This scepticism was particularly evident from designers with over 15 years’ 
experience in the field. This could perhaps be due to the development of one’s own 
skills and interpretations of what is required within projects and preferred practices.  
 
Relying on one’s own intuition and experiences however can create harm to the end 
user, as assumptions can find their way into design practice, which can have negative 
consequences. When an activity becomes unconscious by means of repeated 
execution, unforeseen or unrecognised errors can occur. This is particularly evident 
when people learn to drive for the first time. As individuals gain more skill at driving 
they become less aware of the task they are performing to the point where a whole 
journey can be completed without the driver being aware of how they made that 
journey.  
 
Designing a product, whatever it may be, cannot take place unconsciously to the 
designer. Good design practice should as closely as possible follow a formal process 
that challenges preconceived ideas. One participant in this study said: 
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“It is very easy to be misguided by what people have done before on the proposition 
that they knew exactly what they were doing.” Participant #12 
This very quote makes a strong argument for having an early exploratory phase with 
device users and iteration throughout design. Understanding the problem and the 
needs of the users at the very beginning will then dictate the design process and 
ultimately the final solution. 
It is understood that the medical device market is very much a technology driven 
domain thus the capabilities of devices are ever changing and improving for home 
users (Cifter, 2011; Gupta, 2007; Martin et al, 2008; Money et al, 2012).  
Donald Norman posited in, The Design of Everyday Things, that technology offers 
the potential to make life easier and more enjoyable with each new technology 
providing increased benefits (Norman, 1998). Paradoxically, added complexities also 
arise increasing the difficulties and frustrations to device users (Norman, 1998).  
For new and sophisticated medical devices migrating into the home there is always 
an inherent complexity brought about through miniaturisation and the capabilities of 
technologies that were not possible in previous years. Designers should consider that 
whenever the number of functions and required operations exceeds the number of 
controls, the device will be complicated for the user (Norman, 1998). This defines 
the so called ‘Paradox of Technology’ whereby, on the one hand, we have a 
technology that simplifies a task through providing greater function, but on the other, 
complicates life for the user by making the device harder to learn and harder to use 
(Norman, 1998). Only by applying sound principles to design can this balance be 
managed to achieve a device that meets the needs of the end user.    
On ‘common sense’ in design, Pheasant and Haslegrave posited that: 
“I would only add that common sense sometimes seems remarkably rare” (Pheasant 
& Haslegrave, 2006).  
The role of the designer in the delivery of a medical device cannot stop at the point 
of just ‘good enough’.  Referring to usability testing of a medical device by one 
trained healthcare professional, one designer in this study said: 
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“You wouldn't believe the mistakes that are made”. Participant #9. 
He added: 
“Most people I would have thought would have figured out the way to use this but 
this person held it like that [demonstrated an incorrect action]. So the mouthpiece 
was clearly the wrong shape, like that and she used it. I was gob-smacked. What 
made it more shocking was that wasn't a patient that was a nurse who had 20 years’ 
experience. We were so surprised we actually got her, at the end of the interview, we 
got her to train one of us the way she would train a user to see how she trained it in 
case we just missed something and that was the way she used it. That is someone who 
is out there right now teaching people to use it the wrong way and those people are 
not getting a dose. No medication. You wouldn't believe it.” Interview Participant #9 
Evidently this designer has experienced first-hand the errors that users of home use 
medical devices can make, however this designer still considered the issue of 
designing for the end user as ‘common sense’.  
It is without question that experience of the designer and an appreciation of these use 
scenarios has a role to play in design. This research has not been conducted to 
question the expertise, competence or knowledge of the designers in this study. 
However, recognising the likelihood of use error occurring in well-established 
products by trained professionals presents a case for adoption of idealised design 
practice.   
Pheasant and Haslegrave do concede that there is an element of truth in the five 
fundamental fallacies. They stated that “human beings are indeed very adaptable” 
and that “they will put up with a great deal and might not necessarily complain” 
(Pheasant & Haslgrave, 2006).  
While humans are adaptable and develop workarounds, sometimes without a 
conscious awareness of doing so (Holtzblatt & Beyer, 1993), for home use medical 
device design this can compromise the safety of patients when devices are 
misunderstood and used incorrectly. Designing devices that are intuitive to use 
requires manufacturers to conduct research with real end users, which this study has 
identified is a challenging process for industry.  
 
 
301 
 
According to Pheasant and Haslegrave design reflects society in the sense that the 
objects of the designer are influenced by the world in which they are created 
(Pheasant & Haslegrave, 2006). Thus the practice of design and adoption of idealised 
practice (i.e. making products and devices as good as they can be) is recognised as a 
compromise on the basis of commerciality and the ability to draw a profit. This is 
arguably ubiquitous throughout the design of all products and services that operate as 
a business.  
This research has revealed that many of the challenges for the adoption of usability 
principles and the involvement of users in the design process are inhibited by the 
lack of incentives for companies to invest in user research. The eleven challenges 
identified in this study largely refer to organisational challenges and the relationships 
between stakeholders within the design and development process of a home use 
medical device. Participant six in the study described the commercial reality of the 
industry in the following quote:  
“The fundamental thing is that the statistics on the number of design developments 
and pharmaceutical developments that actually make it to production are very slim. 
So I would say that the commercial pressures on the pharmaceutical world, partly 
driven by governments, haven’t actually been very good for R&D.” Interview 
Participant #6.  
With a decline in the number of developments successfully reaching the market there 
is increased pressure upon companies to keep costs under control. Now more than 
ever, every development decision comes under fine scrutiny from marketing and 
financial departments. In many companies these departments have the budgetary 
control and as such have great influence over design decisions. The participants in 
this study expressed that due to a lack of ability to express the benefits of involving 
users in the process in monetary terms it was very difficult to get the marketing and 
financial teams on board. 
In light of this, investments in home use medical devices are perceived as a risk to 
manufacturers. This was of course identified in the idealised practice case study 
presented in Chapter four where one consultant said: 
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“I suppose with anything it’s about commercial viability. The thing is it should be 
about risk reduction and competitive advantage. What I mean is not risk reduction to 
the people using it but risk reduction to the company in investing in this and gaining 
a product that is likely to gain more market acceptance and likely to give better 
advantages over other products that currently exist.” Case Study 1. 
Consequently, a company might launch a product knowing that it is not as good as it 
could be and potentially look to make improvements in an updated model. For 
usability issues however it may well be that the perceived costs of improvement are 
much higher than actual costs. Pheasant and Haslegrave argued that beyond all the 
considerations for design the simple fact remains “that making something the right 
size is often no more expensive than making it the wrong size” (Pheasant & 
Haslegrave, 2006). On this theme one participant in the study opined that the clients 
he had worked with typically perceived the costs of conducting user research to be 
much higher than the actual costs involved.  
“We find that there is a perception by manufacturers that doing human factors data 
is an expensive and time-consuming thing to do. We find that with pharmaceutical 
companies because they have got a very strong mental model that clinical studies are 
huge and expensive and take a long time.” Participant #7. 
In this designer’s experience, there is a misperception about user research for the 
purpose of usability studies and clinical research involving patients. To compensate 
for this the participant explained how he would educate clients on process of user 
research and the associated benefits. 
“We try to educate them [clients] that human factors studies are much smaller, much 
quicker and don't need to be lots of people. You can test them in 5 or 6 or 7 or 8 
people and that would be perfectly adequate. So that is one thing we try to sell that 
the benefits outweigh the costs. The costs aren’t anywhere near as great as our 
potential client’s think they are.” Participant #7.  
This participant did concede however that selling the benefits of adopting a usability 
engineering process was part of ‘twin track’ approach. He explained that the 
generation of data for future submissions to the regulatory authorities was the ‘easier 
sell’ to clients to conduct user research. This would suggest that the advocacy of the 
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benefits for user research do not in itself provide sufficient incentive for 
manufactures to adopt such practice. Rather the enforcement of regulatory 
requirements that are mandated by law has greater influence on changing design 
practice. 
7.11.3 The Design Process 
 
Each participant in the study described the key design stages involved in the design 
process of a home use medical device (See Section 7.10.3). Figure 7.2 and Figure 7.3 
present a schematic comparison of the design processes adopted by participants in 
this study.  
The results revealed that participants who reportedly followed design guidance were 
more consistent with their involvement of users in the design process. It is not 
possible from this study to state whether this trend is statistically significant. Instead 
this study presents the findings that are indicative of current practicing designers in 
the field of home use medical devices. The comparison of Figure 7.2 and Figure 7.3 
indicate that those who did not follow the available design guidance were less likely 
to involving users during the early phase of the design process and evaluation phase.  
The design processes cited by participants suggest that user involvement at what is 
commonly referred to as the concept stage or ‘conceptualisation’ is low. This part of 
the process is typically located towards the middle of a design process once a 
specification has been established. Perhaps the reason for the low levels of user 
involvement during design conception is attributable to companies developing ideas 
internally before approaching users for feedback for future developments. This stage 
of the process is where the designer or developer of a home use medical device is 
translating the user needs or insights into practical design solutions and therefore it 
could be argued that there is little need for user involvement at this phase.  
7.11.4 The Understanding of Users and their Needs 
 
The designers understanding and definition of the term user has been identified as 
critical to this research. Previous studies have recognised that the term user can relate 
to a wide variety of people (Shah & Robinson, 2008; Shah et al, 2009). One designer 
in this study said: 
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“I think philosophically we would look at the very wide range of the list. So we 
would probably include in that the people that are going to service the machines, the 
ones who clean it…Possibly I think also the families of patients as well. So that is 
something that comes up, we are doing a device at the moment and the patients are 
unconscious when they are on the machine [haemodialysis] so it is actually the 
families are the ones who experience it.” Participant #11. 
In this quote the designer recognises that the users of home use medical devices 
expands beyond the traditional groups of healthcare professionals and patients (Shah 
& Robinson, 2008). The appreciation of servicing, maintenance and family 
member’s supports that the users of such devices are a diverse population and 
considerations of this cross section of users is important for design (Privitera et al, 
2009b). In the context of this study one designer felt that there is often confusion 
between customers and users.  
“We really make the distinction between customers and users, which is the next 
phase [of the process], so user requirements versus customer requirements, we try to 
explain to people that it’s important to realise that users are not customers. I think a 
lot of companies and a lot of people who do design confuse the two way too much 
and I think the customers are not users.” Participant #10. 
This designer makes a distinction between the two groups, customers and users, 
however for ‘consumer medical devices’ as defined by the FDA, the customer can 
also simultaneously represent the user (FDA, 2009).  
Translating User Insights into Design Solutions 
 
During the interview process participants were asked to discuss how the insights 
gained from their own user research informed the final design solution. The aim of 
these questions was to explore the manner in which these insights translated to 
formal user requirements. Analysis of the data revealed six different themes of 
translating user insights into design requirements, which are discussed below: 
 
Inherent Designer Quality – Designers in the study opined that the very nature of 
user requirements translation from user research is partly attributable to an inherent 
quality that designers as practitioners possess. One participant said: 
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“I think to some degree that is kind of part of what the designers role is.” Participant 
#1 
This designer suggested that through their own educational background one develops 
experience and a set of skills that equips them to identify actual needs of end users. 
This goes beyond simply asking what the user wants from a product. It is the process 
of understanding the wider context of device use that will influence the final design 
solution. However, the insights of this context can only be accurately identified 
through the involvement of representative users in the design process.  
“It is sitting down with the user to understand; what’s going on, what the user 
environment is like, what their daily routine is like, how do they interact with the 
technology that existed, and trying to use that information to develop enough 
empathy and understanding of the situation to come up with a solution.” Participant 
#1 
This quote above highlights the importance to explore the wider context of device 
use and its implications for design. In doing so it leads coherently into the second 
identified theme for user needs translation, which refers to gaining a detailed 
understanding of the fundamental principles of ergonomics and human factors.  
Detailed Understanding of the User, the Task and the Environment – Designers in 
the study explained that in order to successfully translate insights into needs, there 
has to be a consideration for the fundamental principles of ergonomics: User, Task, 
Environment.  
 “…Understand who the users are, understand the task and understand the 
environment.” Participant #8. 
Another participant in the study felt that it is important to understand the needs of 
users in general as opposed to asking questions about a specific design or 
development opportunity. 
“So it is really more often a case of really understanding where they are more 
generally. Whether their needs are, as I say, at a basic level rather than specifically 
ask them questions about a new technique or opportunity.” Participant #1 
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Gaining Expert Opinion – Some participants in the study opined that they relied on 
expert opinions to translate the needs of their device users. One participant described 
how they would use clinicians to understand user needs based on their experience 
and familiarity of the market.  
“Yes that is where clinicians come in handy because clinicians by and large are 
familiar with a broad range of products on the market.” Participant #12 
Employing an Agency or External Company – Other participants explained how 
they would recruit a consultancy to conduct in depth interviews with device users 
externally. Thus, some companies rely on other specialists to translate the insights 
into actual device needs. 
“Generally we would recruit specialist interviewers to do that, so usability studies.” 
Participant #2. 
Educating Users – Many participants described the process of translating user 
insights as one that required an education of users.  
 “It is an education process.” Participant #8. 
For some this meant ‘facilitating’ dialect with users to assist them in arriving upon a 
solution.  
“…“If you could do that, and it lead onto that, what would you think about that?” So 
part of it is education as well as questioning.” Participant #4.   
“I certainly wouldn’t try and dictate but we do try and facilitate conversation and 
discussion so they arrive at the right decision with our help.” Participant #8. 
Participants in the study suggested that educating users throughout the process of 
user research was particularly important in domains where the technology or 
techniques were novel to them. 
Observation Techniques – The final theme identified referred to observation of 
device use. Many of the designers in the study opined that in order to understand the 
differences between what users’ say they do versus what they really do it was 
necessary to observe users in practice. Section 7.10.4 of the results revealed 
observational methods to be the most frequently cited method for user research by 
 
 
307 
 
participants. Participants in the study believed that in order to understand genuine 
user needs observation methods were an essential part of the design process. 
“I mean the best way to get round that is to observe what people do when they are 
handling devices.” Participant #7. 
The participant who described that his company would recruit a specialist 
consultancy to conduct user research explained that he would refrain from involving 
designers directly in the research process. 
“It is important that designers don't do the research because they will lead the 
witness. So it is important that they observe.” Participant #2. 
Despite this, he added that in order to ensure that the needs of users were translated 
to the design team they would use two-way mirrors or record interviews with 
participants so that footage could be viewed later.  
“So usually it is a one-to-one interview as a design team, we usually sit behind two-
way mirrors or video it. It is really important for the designers to understand the 
difficulty patients are having because you wouldn't believe how difficult some 
patients find it to use devices.” Participant #2. 
A total of six different themes were cited by participants in this study for translating 
user insights into actual needs and design solutions. While many of the participants 
provided responses to these questions at interview there was a consensus that 
translating needs from insights is not an exact science per se. Many of the designers 
in the study expressed a difficulty to explain, explicitly how they translate user 
insights and needs into design requirements. This is perhaps summed up in the 
following quote made by one participant in the study.  
‘It is one of those where you have no definitive answer’ Participant #1. 
 
7.11.5 The Use of Design Feedback 
 
The active collection of design feedback from users was explored with participants. 
On design feedback one participant explained that they use nurses who are 
experienced in training patients as a medium to gain user feedback: 
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“Besides complaints we have quite good contact with our distributors so if they have 
people in the field. So for instance in the Netherlands there are diabetic nurses with 
experience with our device. They actually go to the patients and they explain how it 
is used, how the device is used. From them it is quite a valuable, quite a good 
resource for possible improvements.” Participant #13. 
Another participant representing a design consultancy explained that they would 
typically be impartial to the collection of design feedback from users, as their clients 
would perform this activity. When asked whether this participant actively collected 
feedback he said: 
“No not formally. {Pause} There is obviously the feedback we get from the user 
studies but it is not actually us [the consultancy] collecting it. Our customers [clients] 
do that [feedback collection] we don't actually get involved in it. Quiet often and a 
lot of the time, the work we do is under non-disclosure so we wouldn't be allowed to 
do that.” Participant #2. 
Evidently this designer was restricted from engaging in the collection of design 
feedback from users due to the confidentiality agreements made with clients. Others 
regarded the active collection of feedback from users as the regulatory requirement 
to collect and analyse complaints.  
“In terms of, is there a process by which this is done for design reasons? Then I 
would say the answer is generally no. Is there feedback? Yes, there is feedback 
because there is the complaints procedure.” Participant #9. 
He added: 
“Any drug delivery company has to have that in place. There must be a complaints 
procedure and that must be collected and that must be fed back. If there are device 
failures it very quickly becomes apparent. If they are more subjective then no. If 
people find something difficult but can still use it that doesn't really get collected 
until someone is to design an improvement.” Participant #9. 
Evidently there is priority placed upon the safety and efficacy of a device when 
compared with usability issues for device users. This designer states that the 
consideration of use issues once a product has been launched is typically not 
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considered unless an improved design is to be made in the future.  
This research suggests that there is potential for improved information sharing 
between designers, developers and users in relation to usability issues for home use 
medical devices. This study has indicated that currently design feedback, in relation 
to the usability of a device, is not widely collected by designers and developers of 
home use medical devices from device users.  
7.12 Proposed Interventions 
 
In light of the findings of this study, and research of as a whole, a series of 
interventions have been identified to address the challenges towards adopting 
usability principles in practice for home use medical devices. This research suggests 
that current design perspectives and practice towards home use medical device 
design lacks enforceable incentives for manufacturers to adopt usability principles in 
development and to iterate with their device users. The studies of this thesis has 
revealed that an advocacy of the benefits for adopting usability principles and 
guidance is not sufficient to change the way in which home use medical devices are 
designed for their end users.  
To refer back to the previous chapter it was suggested that one of three possible 
scenarios could explain the reasons behind the current approaches taken by 
designers. This included the following:  
 Designers are aware of the principles and methods of user needs research but 
do not apply them. 
 Designers are not aware of the relevant methods and so cannot apply them. 
 Designers are aware of the principles and methods for user needs research but 
apply them sub-optimally. 
The findings of this study suggest that scenario three would explain current practice 
to home use medical device design. Many of the designers in this study opined that 
there were aware of the principles and practices for user needs research however 
were unable to apply them in practice because of the revealed challenges towards 
involving users and a lack of incentives to adopt idealised practice. 
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In light of this, three interventions specific to the home use medical device industry 
and its stakeholders have been identified. The following section introduces the 
proposed interventions of this research, which will be addressed further in the next 
chapter.  
Intervention One – A Regulatory Update 
Under current regulation in the United Kingdom there is no recognised regulation 
specific to the design of home use medical devices and their potential users. 
Furthermore, there are no recognised mandated requirements for manufacturers to 
consider usability in the design of professional or home use medical devices. This 
research has indicated that current practice towards home use medical device design 
and the involvement of users within the design process is dictated by the 
commerciality of the industry. In light of this, intervention one of this research 
proposes a change in the current regulation of home use medical devices within the 
United Kingdom. The introduction of mandated requirements for home use medical 
device design would improve the quality and consistency of the devices designed and 
also clarify the requirements of manufacturers in the design and development 
process. This study has indicated that some manufacturers perceive the current 
regulations and standards to be open to interpretation and thus this research calls for 
clarification on what is required by manufacturers.  
Intervention Two – Endorsing Usability 
Currently there is no recognised endorsement or certification for devices of improved 
usability. This research has highlighted that the perceived and published benefits of 
following usability principles in the design of home use medical devices fails to 
incentivise manufacturers to adopt such practices. The second intervention of this 
research therefore calls for an increased recognition of usability within the 
certification of home use medical devices. It is believed that by endorsing devices 
that meet a specific standard in terms of usability and suitability for target 
populations, devices will be more usable and understandable for their users. 
Similarly, manufacturers of devices will receive recognition for improving the 
usability of their devices that in turn could raise the standard and quality of devices 
industry wide. This could take the form of an amendment to the Medical 
Technologies Evaluation (MTE) programme currently performed by the National 
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Institute for Health and Care Excellence (NICE).  Under the MTE programme NICE 
select and evaluate new and innovative devices for adoption into the NHS (NHS, 
2013). The current evaluation process by NICE does not account for usability within 
the assessment criteria which presents an opportunity for further development. This 
will be explored further in Chapter eight.  
Intervention Three – Patient User Review Forum 
This study suggests that design feedback from end users (e.g. patients) of home use 
medical devices is currently underutilised in the United Kingdom. The designers in 
this study opined that design feedback, including usability issues, from users would 
only be collected post launch if an updated device were to be developed. This study 
revealed that designers would rarely actively collect design feedback from end users 
after launching a device onto the market. In light of this, this research proposes the 
development of a ‘patient user review forum’ that enables device users to provide 
feedback on device related, usability issue. This resource would enable patient users 
of home use medical devices to interact with one another, sharing information on 
different devices used for specific conditions. This resource could then be of 
significant value to manufacturers who would have direct access to their device 
users. The review forum would enable manufacturers to understand how device users 
are coping with their devices leading to potential development opportunities.  
The three interventions presented here are the culmination of the research to this 
point of study. Each of the interventions describes a different approach to addressing 
the challenges identified in this chapter that aim to incentivise a change in current 
design practice towards home use medical devices. To ascertain the value and 
potency of these interventions for industry the following chapter will address the 
views of different stakeholders in the home use medical device industry.  
7.13 Ethical Considerations 
 
The fundamental issue concerning ethics when conducting interviews is that the 
participants involved should not be harmed in any way by the research or questioning 
(Gray, 2009). Respondent have the right to terminate an interview at any stage 
should they so wish and this must be made explicit before the commencement of the 
interview. The most efficient procedure of dealing with the ethical considerations 
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and rights of participants is to provide a Participant Information Sheet (see Appendix 
12) that explains explicitly the research, the necessary information and expectations 
for participation in the study. Once participants were aware of the requirements of 
the interview and the nature of the questions they were provided with a copy of the 
informed consent document (see Appendix 13).  
7.14 Reliability and Validity 
 
To address the reliability of the data presented in this chapter, the three questions 
identified in Chapter three and also addressed in Chapter six will now be discussed in 
relation to the context of this study (Easterby-Smith et al, 2008). 
1. Will the measures yield the same results on other occasions? 
All reasonable steps have been taken to conduct this study in a manner that is 
open and replicable. No results have been manipulated, modified or deleted in 
the presentation of this study. All of the information conveyed in this chapter 
is indicative to how it was collected at interview from participants currently 
operating in the home use medical device industry. The presentation of the 
methodology, recruitment, interview protocol and results enables any 
interested researcher to repeat the study if they so wish. 
2. Will similar observations be reached by other observers? 
The interview methodology described within this chapter makes exact 
replication of the study unlikely. Despite this, if one were to repeat this study 
with participants from the home use medical device industry using the 
content analysis process outlined in the methodology it is believed that many 
of the challenges reported in this chapter would be revealed again. As 
previously described all reasonable steps have been taken to make this study 
as reliable and valid. The study was both pre-tested and piloted before the 
interview protocol was presented to participants within this study. 
3. Is there transparency in how sense was made from the raw data? 
The use of content analysis to identify the salient themes within this study 
was identified and described before conducting this study. The methodology 
used to interview the participants in this study (e.g. interview protocol) is 
presented within the Appendix 14 of this report. All of the figures relating to 
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the sources and citations for each of the results collected at interview are 
presented within this chapter.   
7.15 Limitations 
 
As with the previous chapters the limitations of this study were considered and are 
discussed here as a conclusion to this chapter.  
One limitation to consider with the findings of this study is the issue of self-selection 
by participants who were willing to take part in the research. Chapter six of this 
research discussed the implications of self-selection on the results of the online 
survey. Due to the methodology of this study, participants were recruited using 
similar approaches to that of Chapter six. In light of this the results of this study are 
the views of participants that volunteered to participate in this study. With this in 
mind, there is a need to consider the potential for bias in the reporting of the results 
based on prior experience and perspectives of home use medical device design.  
Another limitation to consider is the use of content analysis as a method of analysing 
the transcripts. Flick argues that a ‘categorisation of text based on theories may 
obscure the view of the contents rather than facilitate analysing the text in its depth 
and underlying meanings’ (Flick, 2006). Furthermore, the use of paraphrasing can 
remove the initial meanings behind the text in cases where it is used to not only 
explain basic text but also replaces it (Flick, 2006).  
For the purposes of this study however the use of paraphrasing, in the sense of 
replacing wording to explain meaning, was not adopted. All text within the results 
and discussion of this chapter is presented as it was explained to the interviewer. The 
process of categorisation was planned and described before the interviews were 
conducted and the coding process has been presented to demonstrate how the 
categories were developed.  
7.16 Future Work 
 
As an output to this chapter necessary further work has been identified. The 
discussion section of this chapter introduced three interventions to address the 
challenges towards the adoption of usability principles and involvement of users in 
home use medical device design. The following chapter within this thesis must 
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address these interventions further and validate the practical value of the 
interventions with different stakeholders of home use medical devices. In order to 
ascertain how the interventions of this research could be implemented in practice it is 
necessary to explore the benefits and constraints of each intervention with the 
difference individuals affected by the propositions of this research. Conducting this 
work will identify a leading strategy to change current design perspective and 
practice towards home use medical devices and will reveal opportunities for future 
development.  
7.17 Conclusions 
 
A total of thirteen semi-structured interviews were conducted with designers of home 
use medical devices. All interviews were recorded verbatim and fully transcribed for 
analysis. Content analysis of the interview transcripts was performed using Nvivo 10 
to identify themes within the responses made by participants. The analysis allowed 
the qualitative data to be analysed quantitatively and comparisons between salient 
themes to be made. 
The aim of this study was to answer the second research question of this research, 
which was as follows: 
Research Question Two: What are the challenges for industry to involving users in 
the design process of home use medical devices?  
This study revealed eleven specific challenges towards the involvement of users in 
the design process of home use medical devices.  
The challenges revealed in this study, in order of citation, were as follows: 
Commerciality, Client Relationships, Financial Constraints, Access to Participants, 
Knowledge of Usability, Incentives, Ethical Issues, Regulations, Hierarchy of Users, 
Diversity of Users, Intellectual Property Considerations.  
The study discussed the nature of each challenge and how it inhibits the involvement 
of users in the design process of a home use medical device. This study suggests that 
home use medical devices are currently designed based on the commerciality of 
industry, which prevents the involvement and iteration with real end users in the 
design process. The study suggests that home use medical device design in the 
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United Kingdom lacks an enforceable incentive for designers, developers and 
manufacturers to adopt the principles of usability and involve users within their 
design process.  
As a summary to the results of this study, three interventions are proposed to 
incentivise a change in current practice towards home use medical device design. 
The proposed interventions are as follows: 
Intervention One – A Regulatory Update Towards Home Use Medical Device 
Design in the United Kingdom.   
Intervention Two – An Endorsement or Certification for Usability for Home Use 
Medical Devices. 
Intervention Three – A Patient User Review Forum for Home Use Medical 
Devices.  
Further research must now explore the practicalities of these interventions with the 
various stakeholders involved in home use medical device development.  
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Chapter 8  
Proposed Interventions: 
Stakeholder Workshop 
 
The explanatory study in the previous chapter presented the challenges faced by 
designers and developers of home use medical devices to involve users in the design 
process. The chapter described the practical constraints faced by designers in 
industry to adopting the principles advocated and outlined in current design guidance 
(IEC BS EN 62366: 2007; ANSI/AAMI HE75: 2009). The previous chapter 
identified a lack of uptake by industry of usability principles for home use medical 
devices, which is supported by existing literature. As a conclusion to the chapter, 
three possible interventions were identified to overcome the challenges faced by 
designers by enforcing the approaches outlined in the guidance documents and 
harmonised standards. The following chapter describes the development of those 
interventions and presents a study with industry professionals from the field of home 
use medical devices. The study answers the final research question of the thesis and 
proposes incentives for a change in current design practice for home use medical 
devices. 
8.1 Introduction 
 
The following chapter aims to answer the final research question of this thesis, which 
is as follows: 
Research Question Three: How can usability for home use medical devices be 
incentivised for industry?  
Using the understanding and knowledge of the thesis to this point the following 
validation study explores the proposed interventions of the research with industry 
professionals (i.e. stakeholders). The previous chapter described how in order to 
change current design practice and perspectives with respect to usability and user 
involvement, a change in the incentives for adopting such an approach is required. 
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Three interventions were identified as possible solutions towards changing current 
practice: a Regulatory Update, An Endorsement for Usability and a Social Media 
Platform for Patient Users (User Voice).  
Each intervention has a shared focus, which is to offer an incentive to change the 
way in which home use medical devices are currently designed for the needs of their 
end users. The aim of the study is to propose the incentives of this research to 
stakeholders within the field. The stakeholders must be relevant to the field of home 
use medical device design and selection must be based on the relevance of the 
interventions. This validation study proposes that involving and discussing the 
recommendations of this research with practicing stakeholders will identify the 
intervention with the most value to the field to be developed further.  
8.2 Rationale 
 
This thesis has identified that current design practice for home use medical devices 
fails to offer a significant incentive for designers and manufacturers to adopt the 
design principles outlined in guidance documents such as IEC BS EN 62366: 2007 
and ANSI/AAMI HE75: 2009 in the United Kingdom. In the United States of 
America (USA) the Food and Drug Administration (FDA) addressed the issue of 
designing home use medical devices by publishing a guidance document, Design 
Considerations for Devices Intended for Home Use (FDA, 2012). In the UK there is 
currently no such guidance published by the MHRA outlining design requirements 
for home use medical devices. As a consequence medical devices for use by patients 
in the home environment remain regulated under the same requirements for devices 
intended for use by professionals. This is despite extensive research acknowledging 
that these populations are markedly different (Gupta, 2007; Cifter, 2011; Martin et 
al, 2008; Money et al, 2011).  
Adoption of the current usability standard for medical devices, IEC BS EN 62366: 
2007 Application of Usability Engineering to Medical Devices, is a harmonised 
standard of the Medical Device Directive (MDD) and perceived by designers as a 
‘moral obligation’ (See previous chapter). Furthermore, non-compliance with the 
harmonised standard is permissible provided that the manufacturer duly justifies the 
decision.  
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In a field that is widely recognised as being technology and commercially driven, the 
adoption of usability guidance lacks emphasis and priority in the design process.  
The findings of this thesis therefore posit that in order to change current design 
practice, with respect to usability considerations, in the United Kingdom greater 
emphasis must be directed upon the enactment of usability principles by designers 
and manufacturers. The following study presents the proposals of this research and 
addresses the need for new incentives for the design of usable and understandable 
home use medical devices.  
8.3 Proposed Interventions 
 
The following section presents the three interventions that are proposed in the study 
in more detail.  
8.3.1 Intervention One: Regulatory Update 
 
The first proposed intervention of this research calls for a regulatory update with 
respect to usability requirements. As previously described, the current regulatory 
system in the United Kingdom specifies the application of usability engineering as a 
‘Should’ requirement for manufacturers and developers of medical devices, both for 
professional and home use. Thus, the first intervention proposes to incentivise a 
change in current design practice by enforcing a legal requirement for usability 
requirements. For example, IEC BS EN 62366: 2007 states: ‘usability engineering 
professionals should become involved at a projects inception’ of which such 
individuals can be ‘employees of the organisation or outside consultants’. This is a 
voluntary requirement and one that is not mandated by law. Thus, the proposal to 
change the regulation on usability considerations could call for a ‘qualified person’ 
to be involved from inception and throughout the design and development process of 
home use medical devices.  
The proposed amendment to the regulations is aligned with the current proposals for 
a major overhaul in medical device regulation in the UK. At present there are on-
going discussions into new proposals for medical device regulation that aspire to 
make the regulatory process more transparent and consistent across the different 
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member states. In the proposals for change by the European Commission it states 
that: ‘In an internal market with 32 participating countries and subject to constant 
technological and scientific progress, substantial divergences in the interpretation 
and application of the rules have emerged, thus undermining the main objective of 
the Directives’ (EC, 2013). The main objective of the regulations being the safety of 
medical devices and their free movement within the internal market (EC, 2013). 
One of the recognised amendments under the new proposed medical device 
regulations is the introduction of a ‘Qualified Person’ (QP).  The QP must be within 
the manufacturer’s organisation and is responsible for regulatory compliance. The 
EC state that ‘similar requirements exist in EU legislation on medicinal products’, 
thus the introduction of a QP makes the regulatory compliance process more 
consistent across the multitude of devices and drugs on the market today.  A QP as 
recognised by the EC is defined as follows: 
Definition of a Qualified Person under the new Proposals (EC, 2013).  
Manufacturers shall have available within their organisation at least one qualified 
person who possesses expert knowledge in the field of medical devices. The expert 
knowledge shall be demonstrated by either of the following qualifications:  
(a) A diploma, certificate or other evidence of formal qualification awarded 
on completion of a university degree or of an equivalent course of study, in 
natural sciences, medicine, pharmacy, engineering or another relevant 
discipline, and at least two years of professional experience in regulatory 
affairs or in quality management systems relating to medical devices;  
(b) Five years of professional experience in regulatory affairs or in quality 
management systems relating to medical devices.  
The current intention is for the new regulations to come into force in May 2014, 
although the transition period might see the new regulations not coming in to 
enactment until 2018-2020.  
Intervention one is the first recommendation of this research that calls for the 
introduction of a ‘qualified person’ in the field of usability, ergonomics or human 
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factors to inform the design process. The introduction of mandated requirements for 
usability and a possible QP at each manufacturer, or alternatively available on a 
consultancy basis, will ensure that necessary user considerations are satisfied and 
potential for use errors are not overlooked.  
8.3.2 Intervention Two: Endorsing Usability 
 
The second proposed intervention calls for an endorsement for usability by 
recognised professionals that acknowledges devices that meet a specific standard. 
The previous chapter introduced the idea of an amendment to the current Medical 
Technologies Evaluation (MTE) Programme conducted by the National Institute for 
Health and Care Excellence (NICE). The MTE programme ‘selects and evaluates 
new or innovative medical technologies’ assisting the NHS to adopt ‘efficient and 
effective medical devices and diagnostics more rapidly and consistently’ (NICE, 
2013). Thus, satisfying the requirements of the MTE programme can aid 
manufacturers in having their product or device adopted by the NHS in the UK. 
The aims of the MTE programme are as follows (NICE, 2013): 
 To promote faster uptake of new medical technologies in the NHS. 
 To encourage collaborative research, in both industry and the NHS, to 
generate evidence on the clinical utility and/or healthcare system benefits of 
selected technologies.  
At present the MTE programme does not account for usability in the assessment 
criteria for new technologies and innovations. Prioritisation for the referral of 
technology appraisals falls into the following four categories: Population, Disease 
Severity, Resource Impact and Claimed Therapeutic Benefit (NICE, 2010).  
In contrast to intervention one where it is proposed that usability requirements are 
mandated, intervention two proposes to endorse usable and understandable devices 
for patient benefit. The inclusion of ‘usability engineering professionals’ on the 
selection and appraisal committee for new devices and innovations to be adopted into 
the NHS, could incentivise a more ‘user centred’ approach for manufacturers of 
home use medical devices. In addition to identifying potentially costly and harmful 
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use errors during development, the introduction of usability to the appraisal 
programme would aid entry in to the NHS market space.  
8.3.3 Intervention Three: Patient User Review Forum 
 
The third proposed intervention of this research offers the concept of a social media 
platform for patient users of home use medical devices to review and post feedback 
on device usability. While interventions one and two share an emphasis upon 
enforcing a change in current design practice, intervention three proposes to 
influence a change through the user’s voice.  
In the past decade there has been a significant rise in the use of social media by 
consumers and businesses. Social Media platforms are now is regarded as a 
ubiquitous tool in the marketing of brands and organisations and current trends have 
seen the technology become more sophisticated and strategic (Pick, 2013). 
According to Pick, 97% of all consumers search for local businesses online. 
Wirthman adds however that while the majority of companies use social media for 
marketing and sales purposes ‘it can be an even more effective tool for customer 
service’ (Wirthman, 2013). Wirthman posits that: 
‘When companies are listening, they can also quickly respond to customer requests 
and complaints. As many companies have learned the hard way, unanswered 
complaints can go viral, causing real damage to a company’s brand.’ 
If companies are proactive in responding to their customers through social media it is 
believed to be beneficial for future business. The NM Incite report 2012 entitled 
‘State of Social Customer Service’ found that 71% percent of consumers receiving a 
quick response from a brand on social media would likely recommend that brand to 
others (NM, 2012). The report also states that approximately one in three users of 
social media ‘prefer to reach out to a brand for customer service’ than through more 
conventional means such as over the telephone (NM, 2012). Consequently the power 
of social media in terms of audience and benefits for understanding the marketplace 
and users of products and devices is highly valuable for business.  
The power of user voice for medical devices has previously been adopted through an 
online resource known as Which Medical Device (www.whichmedicaldevice.com). 
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The Which Medical Device website features specific information about medical 
devices developed by clinicians for clinicians. The aim of the site is to share 
information ‘about medical devices to help make better decisions and use devices 
well’ (Which Medical Device, 2013). This resource however is currently limited to 
clinicians and professional use medical devices.  
Examples of other social media platforms for patients also currently exist. Patients 
Like Me is a website resource that allows patients to share experiences, compare 
treatments and track healthcare over time (Patients Like Me, 2013). Through shared 
experiences and data contributions, Patients Like Me, is a valuable resource for 
patients and others to research specific conditions and treatments. The proposed 
intervention of this research aims to build on this concept of sharing information 
between patients to deliver a valuable resource to both patients and industry.   
Intervention three proposes a social media platform for patient users of home use 
medical devices to provide feedback and comments on experiences with devices they 
have used. The platform would therefore allow other patients with the same 
condition or receiving similar treatments to find out about other patients who have 
used the same or similar devices. Patients would be allowed to rank their device in 
terms of specific characteristics, including aesthetics and usability, thus enabling 
comparisons of different devices available on the market and informing decisions on 
which device most suits the users’ needs. Sharing patient feedback through social 
media could then allow manufacturers to respond to patient concerns or issues whilst 
also identifying potential opportunities for future development.  
The following section of the study now presents the methodology and describes how 
the interventions of this research were introduced to industry professionals from the 
field of home use medical devices.   
8.4 Methodology 
 
With the three proposals identified it was necessary to validate the recommendations 
of the research with individuals practicing in the field of home use medical devices. 
Gray defines evaluations as the ‘systematic collection of data about the 
characteristics of a programme, product, policy or service’ (Gray, 2009). The process 
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of evaluation itself, as described by Warr et al, often involves the exploration of 
‘what needs to be changed, the procedures that are most likely to bring about this 
change, and whether there is evidence that change has occurred.” (Warr et al, 1970). 
While the purpose of basic research can be to discover new knowledge, evaluative 
studies are concerned with the application of existing knowledge to ‘inform and 
guide practical action’ (Gray, 2009).  
Easterby-Smith describes four different schools of thought with respect to 
evaluations: Experimental, Systems, Illuminative and Goal-Free (Easterby-Smith, 
1994). To which Gray adds: Decision Making, Goal-Based, Professional Review and 
Interventionist (Gray, 2009). A schematic of these evaluations is presented in Figure 
8.1. 
 
 
 
 
 
 
 
 
 
 
 
Experimental Evaluation 
An experimental approach to evaluation aims to demonstrate that any changes 
observed in behaviours or outcomes are attributable to the intervention (Gray, 2009). 
This approach to evaluation is focused, typically, on quantitative measurement and 
Experimental 
Illuminative
Goal-Free
Systems
Decision Making
Goal-Based
Professional 
Review
Interventionist
Figure 8.1: Types of Evaluation (Adapted from Easterby-Smith, 1994) 
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thus can involve control groups that are often associated with experimental research. 
Easterby-Smith warns against such an approach if sample sizes are not sufficiently 
large however (Easterby-Smith, 1994). Due to the interpretivist nature of this 
research an experimental approach to evaluation was considered inappropriate in this 
case. Such an approach would require an experimental methodology adopted 
throughout the research, which as described in Chapter three of this thesis is not 
appropriate for the epistemology and ontology of the researcher.  
Systems Evaluation 
In contrast, in a systems evaluation there is an emphasis for specifying the objectives 
of the evaluation including outcomes and then providing feedback on the outcomes 
to those providing training (Gray, 2009). Gray adds however that one of the 
drawbacks for such evaluations is their ‘mechanistic view of the world’ and that 
objectives tend to be selected by one particular group of individuals with a vested 
interest. Thus, a systems approach can fail to recognise the ‘subtleties and 
complexities’ of a system.  
To evaluate the impact of the interventions for this research requires a specific range 
of individuals from the home use medical device field. While certain individuals in 
the study will have a vested interested in the proposals (e.g. Designers and 
Developers), other participants would experience a change in behaviour and working 
practices (e.g. Healthcare Professionals). Understanding the influence of the 
proposals from both of these perspectives is necessary to evaluate the impact of the 
interventions. With this in mind a systems approach is not suitable as an evaluation 
method for this research.  
Illuminative Evaluation 
An illuminative approach to evaluation adopts a much more flexible approach than 
those previously described. In contrast to a focus upon measurement, an illuminative 
evaluation seeks to gain the views of participants as it recognises that there are 
multiple perspectives that relate to any one matter under scrutiny (Gray, 2009). 
Rather than aiming to achieve pre-specified outcomes this form of evaluation seeks 
to ‘promote communal awareness’ about a body of research. It is the flexible nature 
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of an illuminative evaluation that is often associated with qualitative research 
including methods such as in-depth interviews and direct observations.  
One of the recognised drawbacks in such an approach, as described by Gray, is that 
clients or sponsors of a project may want more than ‘illumination’ (Gray, 2009). 
While Gray posits that illuminative evaluations do not always lead to action, it is 
possible for research of this kind to address action in its proposals and 
recommendations. Another argument against illumination as an evaluation method is 
that, as with case study research, the views can be open to subjectivity based on the 
views of the evaluator. To compensate for this possibility, experts in the field of 
study can be involved in the evaluation process to provide feedback on the relevance 
and suitability of the recommendations.  
Interventionist Evaluation  
An interventionist approach incorporates a range of different approaches to 
evaluation. Gray refers to two specific types of interventionist evaluation: 
Responsive and Utilisation (Gray, 2009). A responsive evaluation ‘concentrates on a 
programme’s activities rather than its planned intentions’ through exploring the 
different stakeholder perspectives involved (Gray, 2009). A utilisation approach is 
focused on the ‘importance of identifying the motives of key decision makers’ and 
the types of information to be collected (Gray, 2009). Thus, in a utilisation focused 
evaluation the evaluator must involve stakeholders before, during and after the 
research to understand what they need to know and the means by which the emerged 
knowledge and data may be put to use.  
Both responsive and utilisation focused evaluations share the commitment to 
achieving change and impact on a specific domain and the individuals within it. One 
criticism of this form of evaluation is the belief that the approach may become too 
adaptive as evaluators become too involved with clients or stakeholders within the 
process to remain objective. Thus, the evaluator and researcher must remain 
objective throughout the research programme as to not be influenced by potential 
bias or leading opinions.  
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Chosen Evaluation Method 
Gray describes that the philosophy underlying the ‘schools of thought’ described by 
Easterby-Smith, including ontology and epistemology, are implicit in the approaches 
chosen for evaluation (Gray, 2009). Thus one must consider their philosophical 
position and nature of the research before decided upon a suitable evaluative 
approach.  
Chapter three of this research described the epistemology and ontology of this 
research. It was concluded that the philosophy of this research is most closely related 
to interpretivism and constructionism. That is, the natural reality including the laws 
of science and the social reality are intrinsically different. This philosophical 
perspective called for the mixed methods approach described throughout this thesis.  
According to Gray, in constructivist or more naturalistic approaches evaluators might 
work closely with practitioners in a collaborative manner to act not only as an 
evaluator but also as a facilitator of change (Gray, 2009). With this in mind a 
constructivist approach to evaluation has been selected for the nature of this research. 
Illuminative and interventionist as previously described are the most appropriate 
methods for this research in that both approaches seek to gain the perspectives of 
individuals (stakeholders) within the programme (i.e. Home Use Medical Device 
Design).  
The following section will now explore different data collection tools for evaluations 
that are recognised under more constructivist approaches to evaluations.  
8.4.1 Opinionnaire 
 
Evaluation tools or strategies as described in Chapter three include a wide range of 
techniques include common examples such as questionnaires and interviews. One 
such example of a tool for evaluation, which is recognised as a variant of a 
questionnaires, is known as an ‘opinionnaire’ (Campbell, 1997). Campbell posits that 
an opinionnaire differs from a questionnaire in that it elicits participant opinion about 
a specific context or programme. In an opinionnaire type evaluation participants are 
asked to indicate their level of disagreement or agreement with different statements 
about a programme followed by providing written comments to support their 
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opinion. Campbell does warn however that reliance must not be placed upon the 
numerical ratings collected by such an evaluation as the data of ‘feelings and 
opinions collected remain subjective’ (Campbell, 1997).  
One drawback of such evaluations however, from a constructivist perspective, is the 
lack of direct involvement and collaboration between evaluator and participant. 
Distributing a questionnaire or ‘opinionnaire’ to stakeholders fails to address 
important discussions about the adoption of proposals in practice between the 
different stakeholders. A strategy that allows for collaboration not only between 
evaluator and participants but also between participant and participant is fundamental 
to understanding how the interventions of this research impact upon the multitude of 
stakeholder relationships in the field.  
8.4.2 Group Interview 
 
Group interviews refer to a type of interview strategy that are typically non-
standardised and involve two or more people (Saunders et al, 2007). Saunders states 
that group interviews typically involve between four and eight participants, but can 
extend to upwards of twelve, depending on the nature of the topic under study and 
participants required (Saunders et al, 2009).  
When conducting such interviews it is vital that each participant has the opportunity 
to state their opinion and answer the questions of the interviewer. Saunders states 
that where ‘one or two people dominate the discussion’ the interviewer should seek 
to reduce these contributions and invite other participants to share their thoughts 
(Saunders et al, 2009).  
In order to ascertain different stakeholder perspectives on the interventions of this 
research a group interview strategy was identified as the most appropriate strategy 
for this validatory study. Given the diverse nature of participants in this study it is 
recommended that each participant is aware of each other’s contributions and 
relevance to the research. Saunders et al state that a shared understanding of the 
purpose of the research and the individual’s contributions will ensure that there is an 
accurate understanding of the discussions at hand (Saunders et al, 2009). With this in 
mind the design of the group interview must include a presentation on the 
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background, context and implications of the research with respect to the different 
stakeholders present.  
Due to the nature of this study the group interview strategy will be described as a 
stakeholder workshop to clarify to participants the nature of their involvement in the 
research.  
8.5 Design 
 
An interview structure was devised for a stakeholder workshop to be conducted at 
Loughborough University’s Design School. This location was selected on the basis 
that the environment was neutral to the participants attending. Saunders et al advise 
against selecting an environment where participants may not feel relaxed and there is 
a likelihood of interruption or being overheard (Saunders et al, 2009).  
Due to the availability of intended participants, from the range of backgrounds 
required for this evaluation, a limit of 1 hour 30 minutes was selected for the study. It 
was felt that should the stakeholder workshop be any longer in duration participant 
recruitment would be difficult.  
To ensure that all participants present understood the context and purpose of the 
evaluation, a summary presentation on the findings of Chapters 4, 5, 6 and 7 would 
be provided at the beginning of the workshop. Specific questions concerning the 
interventions would then be required to ensure the discussions following the 
presentation were focused on the purpose of the evaluation.  Finally a group 
discussion would be necessary to ascertain whether there was a consensus between 
all participants and, if not, where differences in opinion lay. With these outcomes 
and requirements of the evaluation in mind a design for the group interview was 
developed and is provided below in Figure 8.2.  
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Summary and Wrap Up (10 Minutes)
Provide a summary of the topics discussed and answer any questions participants 
may have.
Group Discussion on Leading Intervention (20 Minutes)
Identify whether a consensus amongst participants exists on a leading 
intervention to change current design practice. Hold a group discussion on the 
practicalities and drawbacks of implementation to identify improvements.
Introduce Intervention Three (10 Minutes)
Discuss whether the intervention has potential to change current design practice, 
the drawbacks and possible improvements.
Introduce Intervention Two (10 Minutes)
Discuss whether the intervention has potential to change current design practice, 
the drawbacks and possible improvements.
Introduce Intervention One (10 Minutes)
Discuss whether the intervention has potential to change current design practice, 
the drawbacks and possible improvements.
Presentation (30 Minutes)
Summary of research findings to provide a context for the interventions
Figure 8.2: Stakeholder Workshop Design 
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8.6 Piloting 
 
The stakeholder workshop was piloted twice with academics at Loughborough 
University to gain feedback on the content, timings and possible improvements. 
Minor changes to the question wording were made specifically in relation to the 
interventions of the study. The duration of the presentation was highlighted as a 
critical component to keeping the audience interested and engaged for the group 
discussion at the end. To ensure that the interest of participants was maintained 
throughout the group interview it was proposed that the number of slides in the 
presentation was reduced. Following the pilot the recommendations were 
implemented into the final design before conducting the workshop with the 
stakeholders of the study.  
8.8 Recruitment 
 
In order to evaluate the efficacy and value of the proposed interventions of the 
research a diverse array of individuals from the field of home use medical devices 
was required. The impact of each intervention extends beyond the role of the 
designer or developer alone. For this reason it was necessary to recruit 
representatives of Healthcare Professionals, Patients and Regulatory Experts to 
evaluate the value of the proposed interventions.  
Healthcare Professional Recruitment – The Leicester Royal Infirmary (LRI) was 
contacted regarding the study in October 2013. Due to the focus of this research on 
home use medical device design it was considered most appropriate to contact the 
Diabetes Clinic at the LRI as Diabetes represents a condition that is regularly treated 
in the home environment by patients themselves. HCPs responsible for training and 
prescribing patients in the use of devices such as insulin pumps and insulin pens 
were recruited for the workshop. Each participant from the clinic had extensive 
experience in patient care including first-hand experience of use errors and design 
problems with existing devices. In total three HCPs from the local diabetes clinic 
attended the workshop.  
Patient Recruitment – Patient recruitment for the study was very difficult as 
participation of patients from the NHS would require an time intensive ethical 
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approval by the National Research Ethics Service (NRES), as previously described in 
Chapter Seven. Due to time constraints this approval was not achievable at this point 
of study. Despite this patient representation was achieved at the stakeholder 
workshop. During the introductions of each participant at the workshop it was 
highlighted that three of the participants present were diabetic and take insulin to 
control their blood glucose levels. In this respect these three participants 
simultaneously represented experts in their domain whilst having empathy for the 
patient perspective based on their own experiences as users of home use medical 
devices.   
Regulatory Experts – A range of medical device regulatory professionals were 
contacted about the stakeholder workshop. These individuals were identified through 
networks created throughout the period of study and through the online professional 
network, Linked In. Gaining participation of regulatory professionals is particularly 
difficult as their availability is limited. One participant from a regulatory background 
was present at the workshop.  
Designer and Manufacturer Recruitment –Participants from the online survey and 
interview study were contacted regarding the stakeholder workshop. Due to the time 
constraints and requirement to complete the thesis, the date proposed for the 
workshop inhibited a number of designers and manufacturers attending on the day. In 
total two participants, representing different companies represented the designer and 
manufacturer perspective.  
A total of six participants attended the workshop held in November 2013. The 
participants included: Three HCPs (including two patient representations), one 
industrial designer, one manufacturer (also acting as a patient representative) and one 
regulatory expert. 
8.9 Analysis 
 
All discussions at the workshop were recorded. The audio recording was later 
transcribed verbatim to eliminate any paraphrasing or potential for bias based on the 
subjective interpretation of the researcher. All of the responses to the questions for 
each intervention were grouped into three specific categories; Benefits, Drawbacks 
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and Improvements. Following the group discussion of each intervention, the 
responses to the leading intervention were then grouped and organised.   
8.10 Results 
 
Each intervention was introduced separately to participants to allow specific 
comments and discussions to pursue without being presented with too much 
information initially. The following section reports the results of the discussions for 
each intervention in the order that they were presented to participants. Each 
intervention is presented with the grouped suggestions and concerns in the results 
section. The discussion section of the chapter builds on these themes and describes 
the benefits, drawbacks and suggested improvements.  
Each participant present at the workshop including the interviewer was assigned a 
reference code: Healthcare Professionals (HCP 1, 2 and 3), Regulatory Expert (RE), 
Industrial Designer (ID), Manufacturer (M). In circumstances where the participant 
simultaneously represented the patient perspective they were assigned *P*. The 
number of participants that made comments, suggestions or concerns for each 
intervention is provided at the end of each sentence in the following section.  
Intervention One – A Regulatory Update 
Suggestions 
Mandated Usability Engineering (UE) File Submission – To enforce the 
requirement to consistently deliver UE principles for home use medical devices it 
was suggested that a UE file become a mandated requirement in the UK (ID) (RE). 
“In the EU, particularly at the moment there is no expectation that you submit a 
usability engineering file which is very different from the US where it is an integral 
part of your submission. I know from our experience with many clients they won’t do 
usability work because they don't need to submit it in Europe and cross their fingers 
and just hope they are never asked for it.” (RE). 
Pre-Approval Inspections for Usability – It was suggested that the current 
regulatory system in the UK should be aligned with the rigour required by the 
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pharmaceutical industry and Food and Drug Administration in the US (ID) (M) *P* 
(RE). 
“I must admit I favour something much more akin to the pharmaceutical regulatory 
environment. Where you do have pre-approval inspections, you have unannounced 
inspections by regulatory authorities like the MHRA, FDA and so on.” (RE). 
Improved Requirements for Manufacturers to Achieve Regulatory Approval – 
It was identified that to coincide with a change in regulatory requirements for 
usability there should equally be improved information available to manufacturers on 
what is required and how to gain approval (ID) (RE).  
“I think one concern I would have would be if it was enforced it needs to be clearer 
to manufacturers what they need to do to get approval. Because all of the regulations 
at the moment, or sorry, all of the processes which have been returning in the user 
guidelines assume that you are designing a user interface or usability for a digital 
product.” (ID).  
Concerns 
Applying the Regulation in Practice – A concern about the application of the 
regulation in practice was raised. Two participants believed that some manufacturers 
would set out to meet the regulatory requirements as a ‘tick box’ exercise (ID)(RE): 
“I can see a drawback in that if you make it a legal requirement that is fine, but it is 
how you apply that legal requirement. So you could take a tick box approach and 
they will say yes we have done the bits that are in the legal requirements and we still 
have a device that is not good [in terms of usability] shall we say but you still have 
all the boxes ticked. Then you would have a scenario where the pieces of paper are 
not worth their weight.” (RE). 
“If you enforce it legally people will do whatever they have to in order to get that 
tick box and they will perceive it as a tick box exercise, your proposal of it just being 
good design it will be a case of what do we need to do to just get this through. It will 
just be the same as putting a label on it.” (ID).  
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Repeated use of ‘Professional Patients’ Failing to account for Patient Diversity – 
One HCP in the study suggested that increasing the requirement for user involvement 
will result in the same users being involved in the design process time again (HCP 
3). 
“It is tremendously difficulty though isn’t it because it is like a clinical drug trial. In 
a drug trial you will do a number of studies with X number of patients and you will 
decide on the criteria of those, what sort of group of patients in terms of their age, 
whether they have comorbidities or what stage they are with their diabetes, whether 
they are newly diagnosed or whatever. So my worry would be that you would enforce 
this regulation and then there would be like a group of professional patients almost 
that would come and how would they get the diversity of and again it is actually 
when you get it out there to the wider market that you realise well actually it is no 
good for this group of patients, it doesn’t work well with that group of patients so 
even if you had that regulation how would you diversity of overview of users?” (HCP 
3). 
Increased Regulatory Pressure could ‘Stifle’ Innovation – The manufacturer 
present felt that increasing the regulatory requirements for industry could result in 
companies not entering the development process (M) *P*.  
“I think now the oft quoted figure for bringing a new molecule to market in pharma 
is about a billion, give or take a bit, so the risk because of the increasing regulatory 
requirement gets bigger and bigger and that is why pharma won’t invest in orphan 
or rare orphan diseases now because the risk is too high. So to me, to a degree that 
stifles innovation and I think there is a danger that as this progress’ then the 
innovation goes out of it because the risk rewards becomes disproportionate. And I 
think that is perhaps a little left field from what we are talking about but that would 
concern me. Downstream people are looking at it and thinking actually it is too 
regulated it is not worth enter the development.” (M) *P*. 
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Intervention Two – Certified Endorsement for Usability 
Suggestions 
The Endorsement Should Extend to Manufacturing Processes – One participant 
felt that rather endorsing products alone a certification for usability should consider 
the manufacturers processes too (ID).  
“I wonder if NICE were to look at the Human Factors Engineering process of the 
manufacturer as opposed to the product itself because I wonder what would happen 
if you had got a top star rating for the usability of a product and then it went on to 
kill someone, how would they then justify that? Whereas if you have said that the 
manufacturer has actually gone through a diligent process here and they have 
submitted evidence and we think that they have done everything that they possibly 
can then that might be a safer way of doing it. That might carry more weight as well 
when you are looking at buying devices because it is less subjective.” (ID). 
Opinion Leaders to Advocate Usability – One participant suggested that in order 
endorse usability principles and user involvement requires an advocacy of the 
principles by opinion leaders in the field that can influence policy makers: 
“I think it is one of those where you almost have to build advocacy. You have to get 
people who are respected opinion leaders, the same as you do in Pharma, who 
actually say that the usability factor is important in that and you almost need to 
lobby and push upwards” (M) *P*. 
Concerns 
Budgetary Constraints for Healthcare Professionals – 50% of participants at the 
workshop perceived that devices endorsed for usability would be more expensive and 
as a result HCPs would not prescribe them. Participants opined that the cheaper 
device would be selected as HCPs are concerned with budgets (ID) (M) (RE).  
“I guess the question is will the prescribing GP then prescribe a slightly more 
expensive inhaler being conscious of their budget.” (RE). 
“I think when I heard this article, the guy that was speaking said that 60% of all 
aerosol inhalers are not used properly and it is probably about 20% effective. So if 
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you then think that particular drug is not effective 80% of the time the cost for the 
actual healthcare, realistically if you can offset the cost of a better-designed product 
that people can use against the efficacy and the adherence of use then it would be 
there.” (ID). 
“Yes it is a very difficult argument for the NHS, well to get through the NHS because 
I have seen it in different guises previously and if you say well it is going to cost you 
5-10% more, people are going to be using it 30-40% more often they won’t take it 
because doesn’t come off their budget. They cannot see it on the budget line and they 
are very short sighted. It is almost like you need a cultural change within the NHS, 
because the most expensive drug is the one that stays in the drawer. We have banded 
that around for years. But the NHS still go with well it is only £5 a month and the 
one you want to sell me is £10.” (M) *P*.  
Inconsistent Approvals between the MHRA and NICE could cause tension – 
Three participants opined concerns about device receiving regulatory approval by the 
MHRA but not being endorsed by the proposed NICE amendment. The requirement 
for two different processes of approval could therefore result in tensions between 
manufacturers (ID) (M) *P* (RE).  
“If you have a situation where you have a device that is approved by the MHRA but 
NICE say no and understandably get quite confused and irate. You have a 
manufacturer that says well we have got approval for this device but NICE don’t 
approve it for the NHS.” (RE). 
“It is an interesting point. In pharma speak, the equivalent of this I think is a TAG, 
which is Technology Appraisal Guidance from NICE and theoretically once that has 
been approved by NICE, CCG’s or commissioners have 90 days to implement it and 
they don’t. They absolutely don’t because they will say, and I am working with a 
product at the moment where the list price is £26,000 a year and that has just got a 
TAG from NICE back in July and it is commissioned, it is specialised commissioned 
so it is the NHS England who have commissioned it but they still won’t get it used 
even though NICE have said, and it is a legal requirement that within 90 days you 
have got to have this product available to patients and again they don’t do it. So I 
think the fact that NICE have gone from rubber stamp, they will still say I have got a 
finite budget. My budget in this area is X million pounds per year, this is going to 
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cost me X + Y and that means that something else has got to go to balance the books 
and I think that is a fundamental issue on stuff like this because theoretically it 
should make all the difference but I have seen it twice in the last two years were 
NICE have put a TAG through and people have gone we can’t afford it, what are you 
going to do.” (M) *P*. 
“I have seen a similar thing as well where a product, which I have worked on has 
not been NICE approved and the predecessor has. So everyone is supposed to be 
using where possible but when you speak to users and you are carrying out research 
for the next product they don’t like using it because it is more difficult to use than the 
competitor one which hasn’t been NICE approved but they have to use this one 
because they have got it and they have been told too. So if it is going to be an 
endorsement then for that product usability has to be a big selling point for it. It has 
to actually follow through it cannot just be a case of well some people think it is 
better. It cannot be just clinically more advantageous to use it; it has to be all round 
more beneficial to people. Otherwise I think it just gets tarnished with a rubber 
stamp when it doesn’t necessarily mean it is in the best interests for everyone.” (ID). 
Intervention Three – Patient User Device Forum 
Suggestions 
Collaboration with a Professional Body – It was suggested that the review forum 
for patient users should be attached to a professional body to make the content more 
powerful impactful and to give the forum status (HCP 3).  
“I just wondered if you could have the review forum as part of the charitable 
organisation. So patients that were registered with the organisation were invited, 
because obviously we have got a huge amount of devices within diabetes, we have 
also got it in respiratory disease and what have you. If you use the professional 
bodies and you have an arm of that I think it would be a really good way to access 
these individuals but also people are less likely to just put rubbish on there. And you 
could actually get the charitable organisation itself to have a sort of bio of every 
device, so if we talk about insulin pen devices, GOP devices and can describe the 
device and people were invited to comment on the usability in a form of template.” 
(HCP 3). 
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“It makes it more impactful I think. People are also more likely to already be 
registered. I think with Diabetes UK there are already thousands, I don’t know, but 
there are a lot of members with the charity. There are also healthcare professionals 
as well. So there could be a section for them that might include reasons why they 
don’t use a particular device anymore because I find it is difficult to teach, there are 
too many steps. I found this difficult. I don’t know the right dose.” (HCP 3).  
Concerns 
Limited Diversity of Users Posting Content and Feedback – Some participants in 
the workshop opined that such a resource would not access the diversity of home use 
medical device users. It was believed that while some device users would share 
content online there would be a cohort of patients experiencing difficulties or using 
devices incorrectly that do not want to share information (ID) (HCP 3).  
“The problem you get with it is that it is only the interested users that will actually 
post content. People who are really frustrated or have got poor compliance and poor 
management of diabetes are not going to put a video up of it. They are going to be 
the ones where the device is still sat in their bag and they are out doing whatever 
they want to do. You only get one side of the story; you don’t get the whole thing. I 
think it goes a long way but it is not a complete solution.” (ID).  
Quality and Relevance of the Content – One HCP opined that the content posted 
by patients would have to be controlled to restrict abusive or derogatory messages 
being shared (HCP 3).    
“I mean there is lots of rubbish on the internet isn’t there. A lot of derogatory and 
abuse, all sorts. I am just wondering how you would try and formalise it into 
something that was structured, perhaps people would have to be registered in some 
way to post content so that it wasn’t just anonymous rubbish going on there.” (HCP 
3).  
  
 
 
340 
 
Leading Intervention – Group Discussion 
All participants were asked two questions to identify the leading intervention of the 
research. Participants were initially asked which intervention would change current 
design practice for home use medical devices with respect to usability. The results to 
this question are presented in Table 8.1: 
Table 8.1: Leading Intervention (Short Term). 
Participant 
Intervention 
One: Regulatory 
Update 
Intervention Two: 
Endorsement for 
Usability 
Intervention Three: 
Patient User 
Review Forum 
Healthcare 
Professional 1 
*P* 
Yes No No 
Healthcare 
Professional 2 
Yes No No 
Healthcare 
Professional 3 
Yes No No 
Industrial 
Designer 
Yes No No 
Manufacturer 
*P* 
Yes No No 
Regulatory 
Expert 
Yes No No 
 
Participants were then asked which intervention in their opinion had the most 
potential to change design practice in the future. The results to this question are 
presented in Table 8.2 below: 
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Table 8.2: Leading Intervention (Long Term). 
Participant 
Intervention 
One: Regulatory 
Update 
Intervention Two: 
Endorsement for 
Usability 
Intervention Three: 
Patient User 
Review Forum 
Healthcare 
Professional 1 
*P* 
No No Yes 
Healthcare 
Professional 2 
No No Yes 
Healthcare 
Professional 3 
No No Yes 
Industrial 
Designer 
No No Yes 
Manufacturer 
*P* 
No No Yes 
Regulatory 
Expert 
No No Yes 
 
A consensus amongst the stakeholders present was reached. The workshop indicated 
that the most impactful intervention, in the short term, to change current design 
practice with respect to usability for home use medical devices would be a change in 
the current regulatory requirements in the United Kingdom (Intervention One).  
However, as a longer term strategy the intervention with the most potential to change 
design practice with respect to usability considerations for the future, the workshop 
revealed Intervention Three: A Patient User Review Forum by consensus to be the 
most valuable approach.  
The following section of the chapter provides the discussion of these results, 
including the implications of these results for the wider research arena and the 
practicalities of implementing the interventions of this research.  
8.11 Discussion 
 
A group consensus identified that Intervention One, a regulatory update for usability, 
would change current design practice for home use medical devices. A mandated 
requirement to satisfy usability-engineering principles in the United Kingdom was 
revealed as the leading short-term intervention to change the way in which home use 
medical devices are designed for the needs of their end users. However, the 
workshop also revealed that a long-term strategy in the form of Intervention Three, a 
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patient user review forum, represented the most potential for changing design 
practice in the future.  
Concerns for Intervention One included the application of the regulation in practice, 
which some believed, may ‘stifle’ innovation in the sector. Due to a perceived risk of 
failing to meet the regulatory requirement, one manufacturer at the workshop opined 
that companies may choose not to enter the market. In response to this concern 
participants were asked if a call for tighter regulation, in line with the current 
proposals for the Medical Device Directive, would raise the standard of usability 
significantly enough to warrant increased scrutiny and requirements (EC, 2013). On 
this topic one participant said: 
“I personally think that it is better. If there is an expectation that you are not going 
to get a device through without doing some form of usability, essentially following 
the American model of ramping it up over time. I think having the requirements 
embodied in the legislation and the guidance documents and talking with people in 
the human factors group in CDRH they have started to help people really understand 
what they need and keeping things back when they are not there.” (RE). 
It was suggested that the regulations for usability and human factors should be more 
closely aligned with the Food and Drug Administrations (FDA) model in the US. If 
such changes were imposed it would mean that regulations globally were more 
aligned improving the distribution between markets, which is one of the recognised 
limitations under the current medical device regulations in Europe (EC, 2013).  
Others perceived that changing the regulations on usability and user involvement 
specifically would result in a group of ‘professional patients’ being recruited for 
projects based on interested parties and self-selection. One solution to this issue 
could be to mandate the definition of the target population for a device at the 
beginning of the design process. The regulatory expert present at the workshop 
suggested that by defining the user population at the beginning of the process the 
regulatory approval could then only be applicable to that population of users.  
“Say your users are pre-teens/teens with diabetes then your marketing authorisation 
should not be for everyone else in the diabetes community.” (RE). 
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It was suggested that should this intervention be imposed then there is a requirement 
for clearer information for manufacturers on how to satisfy the requirements for 
usability. Stakeholders in the workshop perceived the current guidance for usability 
to be targeted specifically at user interface design or graphical user interfaces 
(GUI’s). One participant opined that while such guidance is useful for some home 
use medical devices, there are many instances where medical devices, both 
professional and home use, do not include an interface. Thus, it is difficult for 
manufacturers to interpret the information within usability guidance documents and 
apply it in different scenarios for the multitude of medical devices on the market. 
“So it could be a diagnostic or heart-beat meter that in itself doesn’t translate very 
well to things like a breast implant which is still a medical device but you haven’t got 
a screen on it so how do you ensure that is safe to use and that people have got a 
usability engineering process which applies to a completely different type of device.” 
(ID).  
Chapter Seven of this thesis identified scepticism from some practicing designers 
towards the practical value of current design guidance, which in turn resulted in poor 
compliance with such documents. The workshop supports this and highlighted a lack 
of device specific guidance documents, with two participants describing a focus for 
usability requirements upon GUI’s and computer interaction. With the range of 
medical devices on the market today, approximately 500,000 globally, it is 
unrealistic to expect design guidance to be available for every type of medical 
device. However, there is a need for clearer information on the processes and 
strategies for adopting usability engineering principles for home use medical devices. 
As this field represents a rapidly growing market globally, the UK must develop 
valuable, supportive guidance and regulations for home use medical device 
development.  
Some participants opined that the interventions of the study do not have to be applied 
exclusively. It was suggested that the interventions could be combined to enforce the 
requirements upon manufacturers and users of home use medical devices to raise the 
standard of usability in design. The group proposed that intervention one and three 
should be applied simultaneously to have more emphasis and impact upon usability 
in the medical device industry as a whole. Adopting the two interventions 
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simultaneously would invoke the short and long term changes to the industry as 
previously described.  
While this study does not address the explicit changes to the regulations in the 
United Kingdom with respect to home use medical device design it calls for an 
increased recognition for mandated requirements for usability. The current system 
for adopting the principles within harmonised standards (e.g. IEC BS EN 
62366:2007) is not a sufficient incentive to manufacturers to adopt a usability 
engineering process. The challenges identified in Chapter Seven of this thesis are too 
restrictive upon companies to adopt the principles advocated by an idealised practice. 
This study suggests that the alignment of regulatory requirements alongside the FDA 
in the US would be beneficial for home use medical devices designed in the United 
Kingdom.  
Aside from a regulatory change to home use medical device usability, the 
stakeholder workshop indicated the perceived value of an increased recognition for 
the user voice in medical device development. The workshop revealed that changing 
perceptions and advocacy of usability in the future would benefit from patient 
reviews, feedback and experiences of home use medical devices.  
One participant at the workshop indicated that patient collaboration with a 
professional body would add to the quality and relevance of the information shared 
by users. The example given by this participant referred to Diabetes UK, a leading 
charity organisation that ‘cares, connects with and campaigns on behalf of every 
person affected by or at risk of diabetes’ (Diabetes UK, 2013). One benefit of such 
an organisation for the design of home use medical devices is the established 
network of device users registered with the organisation.  
Registered members of charity organisations are not just limited to patients 
themselves. By implementing a patient review forum for device users to provide 
feedback on the design and usability of home use medical devices through a 
recognised charity organisation would allow for users, healthcare professionals and 
manufacturers to all connect with one another.  
One of the challenges to involving users identified in Chapter seven of this thesis 
referred to the ability of industry to locate and access patients directly. An advantage 
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of developing a patient user review forum for device users would provide a network 
of potential patients for industry to contact for the purpose of user research. This was 
however also identified as a concern to participants at the workshop. While there 
may be a recognised increase in the recognition and adoption of patient involvement 
in the design process, the stakeholders opined that there might be an issue with 
repeated or ‘professional’ users. Consequently, companies might use the same device 
users for the purpose of user research to overcome the difficulties of accessing 
suitable and representative users. As a result the quality of user research conducted 
by industry could be compromised due to a lack of diversity amongst device users.  
This issue however could be addressed through the medical device regulations as 
previously described. In light of the proposal to align the requirements in the UK 
with that of the FDA in the US, the marketing authorisation and testing with device 
users could then dictate who the intended user population is for a particular device. 
Thus, a company would not be able to repeatedly use the same device users for the 
purpose of user research for devices of a different intended purpose, user population 
or environment.  
In order to implement the combined strategy (i.e. Intervention One and Three) 
proposed by this study, future research must address the commercial implications of 
enactment. For the purpose of this study it was not possible to explore the costs 
involved in changing the regulatory requirements for home use medical devices. 
Chapter nine of this research will explore this issue in more detail as it presents the 
overview and synthesis of this research. The chapter discusses the meaning behind 
the findings of this research from a regional, national and international perspective.  
8.12 Ethical Considerations 
 
Each participant was made aware of the nature of the workshop and context of the 
research on first contact for recruitment purposes. Prior to the beginning of the 
stakeholder workshop each participant was provided with a participant information 
sheet to read (see Appendix 12). On reading the information sheets participants were 
then provided with an informed consent form to complete before participation in the 
study (see Appendix 13). All participants were made aware of their rights to 
withdraw from the study at any time.  
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8.13 Risk Assessments 
 
Due to the nature of the workshop being held in a neutral environment 
(Loughborough Design School) the participants were made aware on the participant 
information sheet that they would only be exposed to the minimum associated risks 
of working in an office environment. On the day of the workshop all participants 
were informed of the evacuation procedures in light of an emergency. The fire exits 
and assembly points were indicated to participants from the outset of their arrival.  
8.14 Limitations 
 
The stakeholder workshop was held with different representatives of the home use 
medical device field. While every effort to recruit as many stakeholders as possible 
was made, the availability of the required individuals for the purpose of the study 
resulted in six participants attending on the day. Due to the time constraints upon the 
researcher it was not possible to postpone the event further to access more 
participants. While patient representation at the workshop was achieved more patient 
representation, including vulnerable patients, would have been desired. The views of 
these individuals could have been valuable with respect to intervention three and 
social media resources.  
Having HCPs present at the workshop was very important to the discussions with 
practicing designers and manufacturers. All HCPs were recruited through the local 
diabetes clinic in Leicester. As previously described Diabetes represents a domain of 
healthcare that requires frequent treatment and management by patients in the home 
environment. With this in mind the HCPs present were indicative of the stakeholders 
required by the study. Despite this, it is important to recognise that these participants 
all represent the same field and therefore participation of HCPs from other fields 
would be useful for this workshop study.  
Another recognised limitation of the workshop study is the use of self-selection 
sampling whereby individuals express their desire to take part in the research. For the 
purpose of this study it was necessary to recruit individuals from the field of home 
use medical devices that both considered the design of such devices to be important 
and were willing to devote their own time to take part in the workshop (Saunders et 
 
 
347 
 
al, 2009). For these reasons the use of self-selection was considered appropriate. 
Despite this, the research recognises that those individuals who are willing to take 
part do not necessarily represent the entire population of practitioners in the field.  
8.15 Conclusions 
 
A stakeholder workshop was designed and conducted with industry professionals 
from across the field of home use medical devices. A total of six participants 
attended the stakeholder workshop in November 2013. Participants included: Three 
Healthcare Professionals, a Regulatory Expert, an Industrial Designer and a 
Manufacturer. The three interventions of this research thesis were presented to 
practicing stakeholders to gain practical feedback on the value of the proposals for 
industry and patient users of home use medical devices. The interventions included: 
A Regulatory Update for Home Use Medical Devices (e.g. Mandated Requirements 
for Usability), An Endorsement for Usability (e.g. Certification of Usable Devices) 
and a Patient User Review Forum (e.g. User Voice).  
There was a consensus agreement amongst participants that the most effective 
intervention to change current design practice for home use medical devices would 
be a change to the regulatory requirements. This research suggests that in order to 
change current design perspectives and practice towards usability of home use 
medical devices requires mandated requirements for designers and developers.  
This workshop also indicated that intervention three, a social media platform for 
patient users of home use medical devices, has potential to change design 
perspectives practice in the future. All participants were in agreement that a dual 
strategy, implementing a regulatory update (Intervention one) and a patient user 
review forum (Intervention three) would be the most effective strategy, based on the 
findings of this research, to change current perspectives and the manner in which 
home use medical devices are currently designed.  
The recommendation from this work is to conduct further study into the practicalities 
of updating the regulations with respect to usability in the United Kingdom. This 
work suggests an alignment with current regulatory requirements in the United States 
by the Food and Drug Administration would raise the standard of usability in home 
use medical devices in the United Kingdom.  
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The following chapter will now present the overview and synthesis of the findings in 
this thesis. The chapter will explore and discuss the implications of this research on a 
broader context and the meaning behind the results presented throughout this 
research.  
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Chapter 9  
Overview and Synthesis 
 
9.1 Introduction  
 
The purpose of this research has been to ascertain current design perspectives on the 
involvement of users in the design process of home use medical devices in order to 
understand the incentives for adopting user centred practices. Chapters 4, 5, 6, 7 and 
8 have all provided information and knowledge that was essential to answering the 
research questions of this thesis.  
The previous chapter concluded that a dual strategy, including a change in current 
medical device regulation and an increased advocacy of the users’ voice, could 
change current design perspectives and practice towards home use medical device 
design. In light of this knowledge, the following chapter presents an overview and 
synthesis of this research exploring some of the practical implications and barriers on 
a regional, national and international level. 
The chapter includes a discussion on the barriers towards introducing the proposed 
interventions of this research in practice and includes possible areas for future 
research to be conducted by others in this field.  
9.2 Regional Considerations 
 
The scope of this research has addressed current design perspectives and practice of 
home use medical device companies based within the United Kingdom. The 
implications of this research including the recommendations outlined in the previous 
chapter however inevitably experience differences and difficulties on a regional and 
local level will.  
Clinical Commissioning Groups (CCGs) 
Prior to the establishment of Clinical Commissioning Groups (CCGs), Primary Care 
Trusts (PCTs) used to commission most NHS services and controlled 80% of the 
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NHS budget (NHS, 2013a). On April 1st 2013, PCTs were abolished and replaced by 
CCGs.  
CCGs now commission most of the hospital and community NHS services in the 
areas for which they are responsible (NHS, 2013b). NHS England oversees all CCGs 
and is responsible for commissioning primary care services such as GP and dental 
services as well as some specialist hospital services (NHS, 2013b).  
It is understood that home use medical devices are currently accessed, purchased or 
loaned by their users in many different ways (National Research Council, 2011).  In 
light of this, it is conceivable that the provision and accessibility of specific home use 
medical devices may not be consistent to all device users based on their geographical 
location and demographics for example.  
In the stakeholder workshop of this research, one manufacturer opined that while 
there might be demonstrable evidence of improvements in device usability, the cost 
to the individuals responsible for procurement would dictate whether that device 
finds its way to the patient. Chapter eight suggested that while a device might be 
easier to understand or use, if the cost is too high then procurement teams will not be 
interested because the benefit it not seen within their own budgets. Thus, the 
workshop indicated that in order to change current design practice would require a 
change in the current regulations towards usability in the United Kingdom (UK) to 
overcome the commerciality of the sector. This would mean that designers and 
developers had a duty by law to fulfil usability requirements as opposed to having a 
moral obligation to do so, which is the current situation in the UK.  
It is believed that such a change could make the design and delivery of home use 
medical devices more consistent, safe and usable for their users across the UK. One 
must consider however that if devices of improved usability are more expensive to 
develop and subsequently to purchase, then selection and adoption by CCGs and 
users themselves may be inhibited. This applies not only to CCGs and individuals 
responsible for procurement decisions but also to device users themselves who 
purchase ‘consumer medical devices’. If devices are made too expensive for their 
users then the benefits of improving usability will not be experienced by the end 
users themselves. Consequently, patient users of home use medical devices may look 
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for cheaper alternative devices that could compromise patient safety within the home 
environment. 
It is hoped that the current restructuring of CCGs will bring ‘greater consistency and 
fairness in access and provision for patients’ (NHS England, 2013). Thus, the 
differences in provision of devices to patients are intended to be more consistent on a 
regional and local level than they were previously. However, if CCGs are to adopt 
devices that are more expensive to develop, then there is a requirement for the 
procurement process to be reviewed specifically.  
Currently CCGs identify and select preferred devices (e.g. Blood Glucose Meters) 
based on specific criteria for a region. At present there is no standardised approach 
towards the procurement of devices for patients. As a result each CCG will select 
different preferred devices based on the needs of the region for which they are 
responsible. This will include the characteristics and demographics of the population 
within a specific region, including cultural and generational differences.  Preferred 
devices are then prescribed to patients within that region based on the selection and 
decisions made by the CCG.  
With this in mind there is a need for increased evidence, support and advocacy of 
usability within the CCG procurement process in order to ensure that patients are 
prescribed with devices designed for their needs. In order for usability to be featured 
within the procurement process, manufacturers must clearly be able to demonstrate 
the associated patient benefits of a usable device over its competition. This raises two 
very important issues for the adoption of this research, which refer to validity and 
accessibility.  
The validity of usability evidence within both design and procurement processes of 
home use medical devices would be fundamental to changing industry wide 
perspectives and practice. As was identified in Chapter seven of this research, the 
industry’s knowledge of usability was revealed to be one of the challenges towards 
involving users in the design process of a home use medical device. This suggests 
that accessibility, including the use of terms such as ‘usability’ and ‘user centred 
design’ will present challenges on a local level where there is less support and 
understanding of such work. In light of this there is a need to develop a means of 
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dissemination at the regional and local level to both educate and support those 
individuals within the stakeholder network presented in Chapter five.  
One recognised organisation that operates on a national and regional level to support 
the design and development of high quality research proposals is the Research 
Design Service (RDS), which will now be discussed. 
The National Institute for Health Research (NIHR) Research Design Service 
(RDS) 
Chapters four and seven of this research revealed that there is a lack of consistency in 
the use and understanding of specific terms relating to usability amongst the design 
community. With this in mind, mandated requirements for usability within the 
current medical device regulations will expose similar difficulties to individuals on a 
regional level outside of design disciplines too. For example, phrases such as 
usability, accessibility and user research are open to very different interpretations 
between designers, healthcare professionals and patients. Consequently, phraseology 
will affect the implementation of the interventions for this research. It would be 
necessary to support this transition at the local level through CCGs and services such 
as the Research Design Service (RDS).  
The Research Design Service in the East Midlands provides free advice on research 
design to researchers who are developing proposals for open, national, peer-reviewed 
funding competitions for applied health or social care research.  
The stakeholder workshop presented in Chapter eight of this research indicated that 
usability and human factors issues for both professional and home use medical 
devices could benefit from clearer guidance, information and requirements for 
manufacturers. This is supported by previous research that has attempted to address 
these gaps (Cifter, 2001; Gupta, 2007).  
The RDS support researchers in involving patients and carers throughout all stages of 
the research process and could therefore support information dissemination amongst 
local organisations to assist them with user engagement in research.  Similarly, on a 
local level the services of Healthwatch England could be a valuable resource in the 
transition towards usability considerations for home use medical devices on a local 
level.  
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Healthwatch England 
Healthwatch England is an independent consumer champion that gathers and 
represents the public’s views on health and social care services (Healthwatch, 2013). 
Healthwatch operates on both national and local levels to ensure that the views of the 
service users including the public are taken into account. Chapter eight of this 
research suggested that the role of the user’s voice in the design and development of 
home use medical devices could be valuable as a long-term strategy towards 
changing industry wide perspective and practice towards usability.  
In order to implement the proposals of intervention three of this research it would be 
necessary to establish a network of patient users of home use medical devices to 
provide feedback and share experiences with manufacturers and users of such 
devices. Under the current remit of Healthwatch England, this process of feedback 
dissemination could be supported by their engagement with patients and the public. It 
is reported that Healthwatch England possess ‘significant statutory powers’ to ensure 
that the voice of consumers are ‘strengthened and heard’ by commissioners and 
regulators of healthcare services (Healthwatch, 2013). Consequently there is 
potential for an affiliation of a patient user feedback forum for home use medical 
devices with Healthwatch England that could increase the emphasis and advocacy of 
usability considerations for manufacturers.  
Medilink also possess significant potential for information dissemination and support 
opportunities for companies on a regional level if the interventions of this research 
were to be invoked.  
Medilink Regional Organisations 
Chapter Six of this research suggested that education on the principles and practice 
of user research in home use medical device design was not considered a challenge 
to designers in the study. Despite this finding, it is conceivable that smaller or less 
experienced companies would require support in adoption of usability engineering. 
As previously described, Medilink UK is comprised of eight different regional 
organisations that support designers and manufacturers in the delivery of viable 
technologies for the healthcare sector from concept to commercialisation. Medilink 
UK host a wide range of event across the UK to support companies in the 
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commercialisation of medical devices and therefore present a significant opportunity 
to support advocacy and a change in current medical device regulation. To overcome 
the challenges of accessing and supporting small start-up companies with little 
experience in designing and developing home use medical devices, Medilink UK 
could be endorsed to advocate, train and support companies on the role and 
principles of usability. While usability professionals would be necessary to provide 
the relevant training, nationwide Medilink events could present the ideal opportunity 
to market and hold such events for an established network of industry members.   
Key Regional Issues 
 Accessibility of terms such as; Usability, User Centred Design and Human 
Factors to unfamiliar audiences will require support in the transition towards 
implementing the proposals of this research.  
 Information dissemination on usability considerations will require the support 
of regional organisations to assist in the implementation of a new regulation 
for home use medical devices on a local level. 
 Improved evidence and explicit requirements for manufacturers will be 
necessary to support industry in the adoption of proposed mandated 
requirements for usability.  
9.3 National Considerations 
 
The previous section discussed the issues relating to the accessibility of 
implementing a change in practice towards usability on a local level. The following 
section now explores the implementation of the interventions for this research on a 
national level including the organisations affected by a change in regulation towards 
home use medical devices.  
Care Quality Commission (CQC) 
The CQC are responsible for making sure ‘hospitals, care homes, dental and GP 
surgeries, and all other care services in England provide people with safe, effective, 
compassionate and high-quality care’. The CQC then encourage improvements in 
care, including the services within patient’s homes to ensure they meet national 
standards (CQC, 2013). The CQC achieve this through ‘inspecting services and 
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publishing the results’ to inform service users and help them make better decisions 
about their care (CQC, 2013).   
Intervention Three of this research calls for the development of a patient user review 
forum to inform patients about the devices they use and to assist manufacturers in 
understanding the requirements and needs of their end users. In this respect 
intervention three of this research shares similarities with that of the CQC in 
attempting to offer improved care for patients through the sharing of information 
online.  
It is believed that by making information relating to usability and design accessible 
for patient users in the home environment, it will improve the quality of devices 
delivered to those patients. The CQC could facilitate the collection and dissemination 
of public views towards home use medical devices as part of their remit towards 
building better relationships with the public and regulators. Part of the CQCs 
proposals for the next three years is a focus upon improving the relationships and 
awareness of their work on a public level. In their document entitled, Raising 
Standards, Putting People First – Our Strategy for 2013 to 2016, the CQC state that 
they intend to ‘promote greater public understanding and awareness’ of their work 
through improving public information, how they listen and act upon views and 
experiences of care (CQC, 2013b). Engaging with patient users and regulators of 
home use medical devices will increase public awareness of usability issues in 
design. Thus interventions one and three complement one another in a dual strategy 
approach towards changing current design practice for home use medical devices.  
Ultimately, however, if there is to be a change in the regulation of home use medical 
devices in the UK then the Medicines and Healthcare Regulatory Agency (MHRA) 
are crucial to implementation. 
The Medicines and Healthcare Regulatory Agency (MHRA) 
The MHRA is the recognised Competent Authority (CA) from the UK. The remit of 
the MHRA therefore is to ensure that all medicines and medical devices in the UK 
work are ‘acceptably safe’ (MHRA, 2013). Under the current legislation in the UK, 
the MHRA govern the legislative obligations on ‘manufacturers to ensure that their 
devices are safe and fit for their intended purpose before they are CE marked and 
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placed on the market in any EU member state’ (MHRA, 2013). Thus, if the proposals 
of this research were to be imposed the MHRA would need to be trained, supported 
and efficient in the governance of the new mandated requirements for usability. This 
would include the ‘enforcement and surveillance’ of devices placed on the market 
and the development of guidance to assist manufacturers in criteria necessary to meet 
the requirements of the new regulation.  
The designers in Chapters seven and eight of this research opined that current 
guidance towards designing home use medical devices lacked practical value for 
industry. This research has indicated that some designers were unclear about the 
necessary requirements for usability in the design of home use medical devices. 
Furthermore, some designers opined that the current design guidance for usability is 
predominately focused on interface design. In light of this, the findings of this 
research calls for clearer, mandated requirements that manufacturers, designers and 
developers alike have to consider in the design process of a home use medical 
device. It is believed that explicit requirements will improve the quality of home use 
medical devices by making the considerations for usability more consistent.   
Monitor 
Monitor is recognised as the sector regulator for health services in England. The role 
of Monitor is to ‘protect and promote the interests of patients by ensuring that the 
whole sector works for their benefit’ (NHS, 2013d). On a national scale, Monitor 
therefore has huge potential to highlight, monitor and disseminate information about 
the role of usability for medical device design. Chapter eight of this research 
indicated that in order for usability to be enforced within the UK then there would 
need to be an increased advocacy from a professional organisation. Consequently, 
the importance of usability in the design of home use medical devices could be 
driven upwards by influential practitioners in the field to overcome the current lack 
of incentives to adopt such an approach.  
National Institute of Health and Care Excellence (NICE) 
Intervention two of this research described the role of the Medical Technologies 
Evaluation (MTE) programme performed by the National Institute of Health and 
Care Excellence. Under the current remit of the MTE programme there is no 
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recognition for usability considerations in the selection and evaluation of devices for 
adoption in the NHS and endorsed by NICE.  
In order for usability to be incorporated in the MTE programme it would require 
some significant changes to the assessment process itself and the committee that 
select, evaluate and approve devices for adoption in the NHS.  
Presently the MTE programme is focused upon two primary considerations in their 
decision-making (NICE, 2011). These include:   
I. Benefit to Patients: whether the medical technology has measurable benefit 
to patients over currently available NHS technologies, measured by relevant 
outcome indicators.  
II. Benefit to the NHS: whether the impact of the medical technology is likely 
to reduce the burden on NHS staff or reduce resource use (for example staff 
or facilities) compared with current management.  
It is reported that in order to safely design for the diversity of home use medical 
device users it requires the diligent application of usability principles and the 
involvement of users through the design process (ANSI/AAMI HE75: 2009; IEC BS 
EN 62366:2007). This is supported by extensive research and literature that has 
previously addressed the application of usability towards medical devices more 
generally (Martin et al, 2008; MATCH, 2003; Martin & Barnett, 2012; Money et al, 
2011; Rose et al, 2007; Sawyer, 1996; Vincent & Blandford, 2011; Zhang et al, 
2003). In light of this, this research suggests that usability has a role to play within 
the MTE programme by NICE in that the principles of such an approach offer 
significant benefits to patients.  
The assessment of usability within the MTE programme however would require new 
expertise (i.e. usability professionals) on the programme committee. These 
professionals could then make recommendations based on the usability testing and 
evidence submitted by manufacturers to determine whether a device is worthy for 
adoption and approval. At present the selection committee for the MTE programme 
consists of approximately 25 individuals with different expertise (NICE, 2011a). 
This includes clinicians who use and are involved in the development of medical 
technologies, regulators, scientists and others experience in the medical technology 
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sector (NICE, 2011a). Given the diversity of the MTE programme committee it is 
conceivable that usability professionals could be incorporated into the panel with 
little extra costs to provide the service. Indeed, the guidance already outlines that 
such professionals can be drafted into the process. 
As previously discussed one of the recognised benefits of the MTE programme is the 
ease of entry and adoption of medical technologies into the NHS in the UK. Thus, 
the introduction of usability into the MTE programme could facilitate a change in the 
procurement decisions made by the NHS increasing the recognition of the value of 
usability considerations in design to the healthcare sector. It is believed that should 
manufacturers have an increased likelihood market adoption within the NHS by 
adopting the principles of usability engineering then the devices will be improved for 
patient users in the home environment. Devices that are more usable and 
understandable for patients are much more likely be used by patients, consequently 
reducing the likelihood of device abandonment (Batavia & Hammer, 1990).  
Despite this, Chapter eight of this research suggested that a change to the current 
MTE programme would not be sufficient in changing design practice for home use 
medical devices. The stakeholder workshop of this research indicated that 
intervention two of this research might change the way in which some companies 
operate but it would not be sufficient in changing industry wide practice. Thus, it was 
concluded that in order to change design practice of home use medical devices would 
require a change in the regulation of such devices.  
Changing the regulations of home use medical devices in the UK would have 
significant consequences on industry as a whole. As previously described, presently 
there is a major overhaul of the medical device regulations in the UK. Within the EC 
document, Proposal for a Regulation of the European Parliament and of the Council 
on Medical Devices, and amending Directive 2001/83/EC, Regulation (EC) No 
178/2002 and Regulation (EC) No 1223/2009, changes to the legal elements are 
outlined (EC, 2013).  
In light of this, a change in the regulation of home use medical devices would present 
similar implications for industry. Changes for industry would include CE marking 
(i.e. Free Movement of Devices within the EU), Device Classifications and 
Conformity Assessments, Clinical Evaluations and Investigations, Vigilance and 
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Market Surveillance, Governance and Budgetary considerations. Arguably the most 
significant of these elements on the potential to implement a change towards 
mandated requirements for usability are the budgetary implications for industry. 
Section 9.5 of this chapter addresses the barriers to implementing the proposals of 
this research.   
Notified Bodies (NBs) 
According to the European Commission (EC), proper functioning of Notified Bodies 
is crucial in ensuring a ‘high level of health and safety protection’ and confidence 
amongst citizens after recently recognised severe criticism (EC, 2013). Under the 
new regulations proposed for the UK it is outlined that national authorities 
responsible for NBs will have specific, ‘stricter and detailed criteria’ that are subject 
to ‘joint assessments’ with the commission (EC, 2013). In light of this, NBs will 
become increasingly scrutinised in their assessments of manufacturers at Union 
Level. The role of the NB therefore could be a valuable asset in the implementation 
of this research. If NBs were qualified in the assessment of the usability engineering 
process by incorporating usability professionals onto their panel of assessors then 
this would provide opportunity for a new regulation to be established and managed 
on a national level.   
Key National Issues 
 National dissemination of information and requirements for a new regulation 
for usability would require the support of organisations such as NICE, 
MHRA and the CQC to be effectively implemented. 
 Notified Bodies or an alternative national body would have to be qualified in 
assessing new mandated requirements for usability in the design of home use 
medical devices.  
 Nationwide advocacy of usability could be endorsed and promoted by 
Monitor or the CQC in the UK.  
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9.4 International Considerations 
 
Further afield there are implications from the recommendations of this research 
internationally. While the recommendations of this research propose a similar 
alignment of global requirements for usability and human factors with the 
requirements of the Food and Drug Administration (FDA) in the United States (US) 
there are practical constraints upon adopting this in practice. This section explores 
the international implications of this research in relation to the European 
Commission and the FDA.  
Centre for Devices and Radiological Health (CDRH) and the Food and Drug 
Administration (FDA) 
The Centre for Devices and Radiological Health (CDRH) is ‘responsible for 
protecting and promoting the public health’ in the US by ensuring ‘patients and 
providers have timely and continued access to safe, effective and high-quality 
medical devices and safe radiation-emitting products’ (FDA, 2013a).  
The CDRH are responsible for providing ‘understandable and accessible science-
based information’ for consumers, patients, carers and providers in relation to the 
products they oversee. The CDRH believe that making device related information 
accessible to consumers and patients assures confidence to the US market in they 
regulate (FDA, 2013a).  
It was not within the scope of this research to explore the regulatory system in the 
US as this research has been focused upon the design of home use medical devices in 
the UK. However, the findings of this research suggest that the design and regulation 
of medical devices in the UK could benefit significantly from the US market. Some 
of the designers in this research opined that the US market for home use medical 
devices is more advanced than that of the UK. This is arguably supported by the 
development of the FDA’s Home Use Initiative and the recent publication Draft 
Guidance for Industry and Food and Drug Administration Staff – Design 
Considerations for Devices Intended for Home Use (FDA, 2012). Currently, in the 
UK there have been no such recognised publications by the regulator the MHRA. As 
part of further research to be conducted by others it would be interesting to explore 
the differences in the way that the MHRA and FDA regulate the design and 
development of home use medical devices. A comparison with an exemplar device 
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designed under MHRA regulation against an FDA regulated device might reveal 
opportunities for the strengths of both regulators practices to be harmonised.  
European Commission (EC) 
The European Commission (EC) is the organisation responsible for the governance 
of the European Union (EU). According to the EC website, the EC represents the 
interests of the EU as whole (EC, 2013). The role of the EC is to propose ‘new 
legislation to the European Parliament and the council of the European Union’ to 
ensure that EU law is correctly applied by its member countries’ or states (EC, 
2013).  
With this in mind, a change in the regulatory requirements of manufacturers in the 
UK, as proposed by this research, will call for the same changes across the EU. The 
EC would be responsible to ensure that any new regulation, which would be 
applicable to all EU member states, is consistently implemented and enacted in each 
member state. This will require the harmonisation of member states to ensure that 
each competent authority is preforming and legislating as required by the regulation. 
Within the current proposals for a major regulatory overhaul in the UK this is 
addressed with the establishment of a new committee known as the Medical Device 
Coordination Group (MDCG).   
Medical Device Coordination Group (MDCG) 
Under the current proposals for a new medical device regulatory system in the UK it 
is proposed that a new committee will be established. The MDCG will be made up of 
appointed members by their Member States ‘due to their role and experience in the 
field of medical devices and chaired by the Commission’ (EC, 2013). According to 
the EC, the MDCG and various subgroups will establish forums for which 
discussions with stakeholders will be held (EC, 2013). It is believed that such a 
committee will ensure a harmonised interpretation and governance of future 
regulation across the EU.  
Usability considerations therefore could be potent at the EU level if there were to be 
representation of usability professionals within the MDCG. Appointed professionals 
experienced in usability engineering or human factors for medical devices could be 
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consulted at an EU level to ensure the guidance and mandated requirements are 
interpreted correctly across all member states.  
Key International Issues 
 Consistent implementation across all 32 member states within the European 
Union (EU) will require the support and governance of the European 
Commission (EC). 
 The appointment of usability professionals on the proposed Medical Device 
Coordination Group will ensure that usability is interpreted and enforced 
across all member states. 
 A comparative study of MHRA regulation and FDA regulation would reveal 
possible opportunities to harmonise the strength of each organisation to 
deliver safe, usable and understandable home use medical devices.  
9.5 Barriers to Implementation 
 
The purpose of this research has been to identify the practical challenges to industry 
for adopting usability principles for home use medical device design to incentivise a 
change in current practice. In the same vein there is a need to consider the challenges 
to practically implementing the proposed interventions of this research.  
This chapter has discussed the regional, national and international implications of 
this research and its propositions. Chapter eight presented a workshop, which 
explored some of the perceived constraints for different stakeholders that make up 
the home use medical device field. Aside from the barriers perceived by the 
stakeholders in the study there are other potential barriers to the proposals of this 
research, which will now be discussed.  
Increased Costs to Develop Home Use Medical Devices 
One barrier to implementing a change through mandated requirements for usability 
for home use medical devices are the additional costs imposed upon manufacturers 
and industry holistically. Changing the current regulations with respect to usability 
will increase the costs of development for manufacturers. A manufacturer may have 
to invest in training for existing employees or new staff on the implementation and 
requirements of the new regulation. There are also additional costs to manufacturers 
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in locating, recruiting and accessing device users for any necessary usability testing 
with actual end users. One must consider however that if a company is already 
adopting the principles of IEC BS EN 62366: 2008 then it is unlikely that any 
significant additional costs will be incurred.  
For companies that are not currently investing in usability it is foreseeable that they 
may have to recruit new employees with experience in usability and human factors 
issues for medical devices. This will be both difficult and expensive for small 
companies with finite resources. Alternatively companies could commission a 
reputable consultancy to conduct their user research on their behalf. There are many 
companies that currently adopt this approach and some of the design consultancies 
that offer such services were involved in this research.  
Costs of Establishing and Managing a New Regulation 
The development of a new regulatory framework is inevitably expensive for a 
government to introduce into the UK. The effective implementation of a regulation 
will require the commissioning of staff to manage and develop the framework for 
medical devices including supporting member states in the effective and efficient 
implementation across the different EU member states. As previously described there 
will be a significant cost to regional and national organisations in supporting a 
regulatory change both in terms of technical and logistical support.  
Costs of Training and Assessing for Manufacturers  
The vigilance and market surveillance of a new regulation will incur costs to assess 
the performance and conformance of manufacturers in meeting their legal 
obligations. In order to ensure the assessments performed by NBs are consistent it 
will be necessary to conduct frequent training sessions and meetings on a national 
scale. Collaboration on such a scale will by necessity result in added costs for 
manufacturers, government and the health service.   
The Accessibility of Usability 
The acceptability and accessibility of mandated requirements for usability in the 
design of home use medical devices will in itself present challenges to industry. The 
very need for this research and the work conducted by others in the field of medical 
device design is due in part to a lack of industry wide understanding about the 
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purpose, need and implementation of user research in the design and development of 
medical devices. With this in mind, it is necessary to increase the advocacy and 
knowledge of industry practitioners, outside of the design field, about the importance 
and value of usability and human factors.  
Currently the phraseology of the sector is not consistent and professionals in the field 
use many terms interchangeably which lacks a coherent message about what 
usability and human factors are trying to achieve in practice. This was highlighted in 
many of the studies of this research, which has called for a change in current design 
practice. Chapters seven and eight revealed that the designers in this research 
perceived current design guidance to lack practical value in the design of home use 
medical devices. Consequently it was opined that a new regulation for home use 
medical devices would need clearer and specific requirements for device 
manufacturers. The stakeholder workshop of this research indicated that the current 
guidance for usability towards medical device design is focused primarily on 
interface design, which is not applicable or appropriate for many of the devices 
currently used in the home environment. In light of this, it was opined that many 
manufacturers are currently uncertain about what is required by current legislation 
for usability considerations.  
This suggests that the implementation of usability in practice is currently inconsistent 
for medical devices as the requirements for manufacturers are unclear. There is a 
need for clarity in the terms, principles and requirements of usability towards home 
use medical device design. This research calls for this clarification through the 
introduction of a new regulation in the UK for mandated usability considerations.  
The following chapter will now present the conclusions of this thesis and the 
identification of possible future work.   
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Chapter 10  
Conclusions and Future 
Work 
 
10.1 Introduction 
 
This chapter presents the main contributions to knowledge that have been established 
throughout this thesis and period of study at Loughborough University. The chapter 
includes a summary of the research questions answered within this thesis and the 
recommendations for future work in the field of home use medical devices. Finally, a 
critique of the study chapters is presented before the main conclusions are drawn. 
10.2 Conclusions and Contributions to Knowledge 
 
The following section provides a summative conclusion to each research question 
addressed in this thesis and the main contributions to knowledge. 
10.2.1 An Understanding of Design Practice towards User 
Involvement in Home Use Medical Device Design. 
 
Research Question One aspired to ascertain: 
How do designers consider and involve users in home use medical device 
development? 
The research answered this research question through the following chapters: A 
literature review into existing research (Chapter Two), An idealised practice case 
study (Chapter Four), A stakeholder network case study (Chapter Five), An online 
survey study (Chapter Six) and an in-depth interview study (Chapter Seven).  
The findings of this research indicated that current design practice for involving 
users in home use medical device design was diverse and consequently comparisons 
of the approaches taken were difficult. Chapter Six of this research suggested that 
user involvement in the design process of a home use medical device was often 
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retrospective with the highest levels of involvement occurring post product 
development and during product testing.  
Chapter six of this research proposed three different scenarios to explain current 
approaches to design in industry for home use medical devices. These scenario were 
as follows: 
Scenario One: Designers are aware of the principles and methods for user needs 
research but do not apply them. 
OR 
 
Scenario Two: Designers are not aware of the relevant methods and so cannot 
apply them at all. 
OR 
 
Scenario Three: Designers are aware of the principles and methods for user needs 
research but apply them sub-optimally.  
Through exploring these issues further with participants, Chapter seven revealed that 
scenario three provided the most appropriate explanation for current design practice 
towards home use medical devices and their users. Chapter seven revealed that 
participants in this research were aware of the principles and practice of user research 
but applied the principles sub-optimally in practice based on external factors for 
home use medical device development. These factors refer to specific challenges 
towards user involvement in home use medical device design, which were addressed 
in Research Question Two of this research.   
Contribution to knowledge 
The research found that companies who reportedly did not follow usability guidance 
varied greatly in their approaches towards involving users in the design process of a 
home use medical device. In contrast, companies that reportedly followed usability 
guidance were revealed to involve users more often and more consistently 
throughout the design process.  
Due to the number of participants in this study wide assertions on the significance of 
these findings cannot be made. However, the findings of this research imply that 
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some designers, developers and manufacturers of home use medical devices have a 
perception that their experience and existing knowledge of intended users is good 
enough to omit the use of formal usability methods and principles. Furthermore in 
some cases a manufacturer may omit the involvement of the intended user population 
at all. That is not to say that one cannot perform a user centred design process 
without involving users directly, as sufficient knowledge of the intended user 
population may already exist. However, this research has identified that some 
designers and manufacturers of home use medical devices believe their knowledge to 
be sufficient in cases where more engagement with users and formal usability 
principles is required.   
Consequently this thesis positions that a notion of procedural user centred design is 
undermining the value of the established discipline which advocates the challenging 
of any preconceptions a designer or developer may have of the final product. This 
research calls for the challenging of this inherent bias we as humans all share and 
posits that the adoption of established design principles encourages one to approach 
each development in a different light and question the preconceptions brought 
forward from a previous project. 
These findings and their implications were carried forward into the second and third 
research questions of this research to ascertain how best to incentivise a change in 
current design practice. 
10.2.2 The Challenges of Involving Users in the Design Process 
of a Home Use Medical Device. 
 
Research Question Two aspired to ascertain: 
What are the challenges for industry to involving users in the design process of 
home use medical devices? 
This research question was addressed through the following chapters: A literature 
review into existing research (Chapter Two), An idealised practice case study 
(Chapter Four), An online survey study (Chapter Six) and an in-depth interview 
study (Chapter Seven).  
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The research identified and described eleven challenges towards involving users in 
the design process of a home use medical device in the United Kingdom. This 
represents a contribution to existing knowledge in the field of home use medical 
devices. Although previous studies have addressed the challenges of home use 
medical device development holistically, there was no evidence found in the 
literature that specifically focused on the challenges to industry to involving users 
and adopting usability principles in home use medical device development. The 
challenges identified in Chapter Eight of this thesis were as follows: Commerciality, 
Client Relationships, Financial Constraints, Access to Participants, Knowledge of 
Usability, Incentives for Adoption, Ethical Issues, Regulations, Hierarchy of Users, 
Diversity of Users and Intellectual Property Considerations. 
Contribution to knowledge  
The research indicated that there currently lacks an enforceable incentive for 
manufacturers and developers of home use medical devices to invest in usability in 
the UK. The application of ‘usability engineering’ set out in the internationally 
harmonised standard IEC BS EN 62366:2007 is recognised as a moral obligation 
only for companies to follow. Under current regulation in the United Kingdom 
usability considerations in home use medical device development are not mandatory 
for manufacturers. Consequently, manufacturers are able to attain regulatory 
approval for a device with limited consideration for the users and their needs within 
the home environment.   
This research suggests that some designers of home use medical devices are sceptical 
of current usability guidance and its practical value in the UK. In light of this, many 
designers and developers of home use medical devices adopt practices that are seen 
as ‘just good enough’ or sufficient to meet regulatory requirements rather than an 
approach to develop an improved device. This research posits that such an approach 
to design leads to devices on the market that may be safe to their users from a 
regulatory perspective, yet ineffective to the intended user population which is 
detrimental to patients, the manufacturer’s reputation and the economy. Furthermore, 
adopting such an approach to design could be costly to the manufacturer in the future 
in terms of device recalls and complaints. It should be added that meeting the 
requirements of ‘safety and effectiveness’ is a formal requirement by the Food and 
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Drug Administration in the United States, thus adopting an ethos of ‘just good 
enough’ design is not only dangerous but commercially restrictive to manufacturers. 
It is therefore proposed that further research in this field should explore beyond 
offering further guidance in attempt to support practicing designers and look at 
alternative routes towards changing current approaches to the design of home use 
medical devices. 
In light of these findings, research question three of this research set out to establish 
ways of incentivising a change in industry’s approach. 
10.2.3 A Proposed Intervention to Change Current Perspectives 
and Practice of Usability for Home Use Medical Devices. 
 
Research Question Three aspired to ascertain: 
How can usability for home use medical devices be incentivised for industry in the 
United Kingdom? 
This research question was addressed through the following chapters: In-depth 
interview study (Chapter Seven) and a stakeholder workshop (Chapter Eight).  
Chapter Seven of this research identified three potential interventions to change 
current designer perspectives and practice towards home use medical device 
development in the UK. Each intervention was based on the principle to offer an 
enforceable incentive to adopt usability principles in home use medical device 
development. The proposed interventions of this research were as follows: 
Intervention One: A Regulatory Update Towards Home Use Medical Device 
Design in the United Kingdom.   
Intervention Two: An Endorsement or Certification for Usability for Home Use 
Medical Devices. 
Intervention Three: A Patient User Review Forum for Home Use Medical Devices.  
Chapter Eight of this thesis presented a stakeholder workshop held with industry 
professionals from the field of home use medical devices. A group consensus 
indicated that a dual strategy (i.e. a combination of Intervention One and Three) of 
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short and long-term interventions presented the most scope for changing design 
perspectives and practice towards home use medical device design in the future.  
This research proposes a dual intervention including a change in the current 
regulations in the UK and the development of a social media platform that enables 
patient users to provide feedback and review home use medical devices.  
Contribution to knowledge 
Chapter eight highlighted that stakeholders in the study perceived a short-term 
strategy of aligning UK regulation with that of the FDA in the United States was the 
most effective strategy to change current designer perspectives and practice towards 
home use medical device development. The stakeholder workshop indicated that 
usability engineering should become a mandated requirement in the UK for home 
use medical device submissions to the MHRA. Mandating usability was identified as 
the leading incentive to change current design practice for home use medical devices. 
The stakeholder workshop presented in chapter eight, suggested that a long-term 
strategy to increase user involvement in home use medical device design would 
benefit considerably from a social media platform (review website) for patient users. 
The development of a resource for patient users would educate patients on the design 
of such devices and allow them to compare experiences and information on devices 
with other users. It was identified that manufacturers would also benefit from such a 
resource as they could access direct feedback from their device users, which was 
identified as one of the challenges within this research. The workshop indicated that 
a review platform could raise the standard of usability by introducing competition 
amongst manufacturers to deliver devices of improved usability.  
Chapter eight explored with industry professionals how the interventions would be 
implemented in practice to offer benefits to patients, manufacturers and industry as a 
whole. The study also considered the drawbacks of the proposals. This included the 
costs to implement changes in current regulations and the cost for manufacturers to 
achieve regulatory approval under the new proposals. During the period of study 
however, proposals for a major regulatory overhaul were proposed in the United 
Kingdom. Changes to the regulatory system have been criticised for increased costs 
and bureaucracy however yet they are regarded as necessary for the safety and 
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wellbeing of patients. The interventions of this research are proposed amendments to 
this regulatory update and therefore limit the costs to mandate usability. It was 
indicated that while the upfront costs for development to manufacturers may be 
higher, the opportunity costs in improved device safety could counter balance this in 
the long-term. It was not possible within the scope of this research to provide 
estimates on the cost implications for the imposing the interventions of this research. 
It is recommended as part of some future research to conduct cost-benefit analysis 
into the involvement of users in the design process of a home use medical device to 
establish the cost implications of such a change to development.  
10.3 Future Work 
 
In light of the contributions to knowledge presented within this thesis opportunities 
for potential future research have been identified. The following section describes 
possible future work to be conducted by others interested in the field of home use 
medical device design. 
10.3.1 Development of Requirements for a Usability 
Assessment for Home Use Medical Devices. 
 
In order to invoke a regulatory update for home use medical devices it is necessary to 
develop a proposal for usability requirements for home use medical devices. This 
research indicated that this proposal could be aligned with the Food and Drug 
Administration’s (FDA) pre-market approval authorisation. As part of the 
submission for regulatory approval it was proposed that manufacturers should be 
assessed upon their application of a Usability Engineering Process (UEP). This 
would then allow for manufacturers of a UEP to be certified to that affect and could 
subsequently gain an endorsement for their device. 
Further research could explore the differences in mandated requirements for home 
use medical devices between the UK and US to establish how the regulations could 
become aligned and more consistent to deliver safe, usable and understandable 
devices. This would also result in the added benefit of reduced costs to 
manufacturers too.  
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10.3.2 Development of a Social Media Platform for Patient 
Users of Home Use Medical Devices. 
 
The findings of this research indicated that the development of a social media 
resource for patient users of home use medical devices could be considerably 
valuable in changing current perspectives and practice towards home use medical 
device design. Research could explore the information that patient users would like 
to assist them in selecting a suitable medical device for their own personal needs. 
Chapter eight of this research indicated that such a resource could be affiliated to 
specific organisations such as Diabetes UK, which would then benefit from the 
established network of members.  
A patient user review forum would provide a medium between designers and users to 
share vital information relating to the use and design of a device. The forum could 
then potentially improve the quality of feedback provided by patient users of home 
use medical devices as well as allowing manufacturers to enact upon their feedback 
in future developments.  
10.3.3 Exploration of Challenges towards User Involvement 
with a Wider Population of Designers and Developers. 
 
The scope of this research was focused upon companies currently operating and 
designing home use medical devices in the UK.  With this in mind further research 
could explore the design of home use medical devices in other member states and the 
US, Canada and Australia for example. An international comparison of home use 
medical device design could reveal opportunities to improve the process of design 
and application of usability engineering worldwide.  
Further research could also address the issues and findings presented within this 
thesis on a larger scale. One of the limitations of this research is the number of 
participants recruited for each study that makes generalisations and assertions to a 
wider population inappropriate. If a population of home use medical device design 
companies based within the UK is known, then it would be possible to establish a 
suitable sample of participants to draw significant and reliable conclusions from the 
findings.  
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10.4 Critique of Study Chapters 
 
Chapter Four - Case Study One: Towards Idealised Practice 
Chapter Four of this thesis presented a case study, which aimed to ascertain a 
theoretical idealised practice towards home use medical device design. The idealised 
design process was developed in collaboration with a leading UK based design 
consultancy with research ties to a university. Despite this, it is important to 
recognise that the idealised practice is only theoretical and presents a single case 
view of design practice for home use medical devices. To make wider assertions 
about a ‘best’ practice process would require broader industry and academic input, 
arguably on an international level to understand the full extent of complexities and 
methods towards home use medical device design in practice.  
Chapter Five - Case Study Two: A Stakeholder Network 
Chapter five of this thesis presented a stakeholder network from a company 
operating in the home use medical device market in the UK. The case study 
presented the perceived stakeholders (i.e. users) involved in the process of delivering 
diabetes related devices to patients within the home environment. The process 
therefore refers to the influential stakeholders that have an influence upon the 
devices used by patients specifically. Despite this however it is important to consider 
that this case study is another example of a single case. Therefore, other companies 
operating in the home use market may perceive different stakeholders or users to be 
more important (i.e. higher in the hierarchy) in the delivery process of a medical 
device to their patients.  
Another possible criticism of the case study presented in Chapter five is that it does 
not address the process of design per se, rather the case study explores the 
prescribing model. However this approach was considered valuable for the research 
as the stakeholder network was focused upon the influential stakeholders in the 
delivery process of home use medical devices that current dominate the market 
space. If there was more time available it would be very interesting to explore how 
this process of delivery to market differs to that of a ‘consumer medical device’ 
bought by users themselves. It should be added that the process of design itself 
(holistically) was explored in much greater detail in other chapters.  
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Chapter Six – Online Survey Study: Designers and Manufacturers Perspectives 
Chapter six of this thesis presented an online survey of designers and manufacturers 
perspectives towards home use medical device design. One of the limitations for the 
study was the use of purposive and snowball sampling strategies. Participants in the 
study were self-selecting and thus it could be argued that the results of the survey 
represent the views of interested individuals only. Despite this however, the survey 
revealed a diverse set of results towards the perceptions of user involvement in home 
use medical device design. This could suggest that the respondents to the survey 
were indicative of a diverse range of the designer population however it is recognised 
that wider assertions cannot be made. 
Another limitation identified within chapter six was a restriction upon the depth 
revealed by the use of a questionnaire strategy. In hindsight, other strategies may 
have been more appropriate for the audience of this research. In particular the use of 
semi-structured interviews in Chapter seven of this research was found to be very 
useful in revealing a greater understanding of current practice towards home use 
medical device design. Paradoxically, the strategy of chapter six was essential in 
identifying and establishing a rapport with participants for chapter seven. 
Chapter Seven – In-depth Interview Study: Understanding Current Practice 
Chapter seven of this thesis presented the interviews of this research, which revealed 
a greater understanding of current designer perspectives towards home use medical 
device design in the UK. A criticism of the findings in this study however could be 
the limited number of participants that were interviewed. An extensive recruitment 
effort for companies operating in the home use market was conducted throughout the 
period of study. Despite this, participants were difficult to locate and recruit. This is 
perhaps because participation in this research was voluntary with little incentive for 
participants to take part other than to further the knowledge within academia. 
Furthermore, many of the designers and developers contacted as part of this research 
reported either to have insufficient time to participate or were restricted by 
confidentiality agreements with their clients. If this research was to be performed by 
others with a greater budget to conduct such work then perhaps participants could be 
provided with a financial incentive for participation. Despite this, Guest et al posit 
that saturation can occur within twelve interviews (Guest et al, 2006) and thus the 
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sample achieved for chapter seven was consider suitable for a population that is 
notoriously difficult to access.  
As with the previous studies of this research, the interviewees of this study were self-
selected. This was considered necessary due to the difficulty to access participants in 
the field, however it is recognised that this has implications for the results. Indeed, if 
greater quotas of participants were recruited for involvement in the research then a 
random sample of the parent population may have been selected. 
Chapter Eight – Stakeholder Workshop: Proposed Interventions  
Chapter eight of this research presented a stakeholder workshop on the proposed 
interventions of this research. The workshop explored the practicalities of applying 
the findings of this research with different practitioners in the field of home use 
medical devices. A possible criticism of the study however is the presence of three 
practitioners representing the diabetes marketplace. While diabetes represents a 
significant amount of devices currently used in the home it is important to consider 
that practitioners from this field represent a single view from a diagnosis perspective. 
To combat this other practitioners with extensive experience including a breadth of 
devices should be included in the workshop. It could also be argued that as diabetes 
management and treatments cover such a range of devices, these professionals’ 
opinions were highly relevant for the purpose of the study.  
Another criticism of the workshop presented in chapter eight could be targeted at the 
number of practitioners present. The workshop aimed to ascertain as many 
perspectives as possible to assess to the interventions of this research with the 
individuals for which the proposals were concerned. Due to the time constraints on 
project completion a single workshop was held in November 2013. This limited the 
number of participants that could attend on the day. If there were more time to 
conduct this research then participants may have been offered alternative dates that 
could have improved attendance. One must consider however that the number of 
participants for a group interview should ideally remain between six and eight in 
order for the facilitator or interviewer to be in control of the discussions. Thus the 
number of participants present at the stakeholder workshop was considered 
appropriate for the nature of the discussions and design of the study.  
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10.5 Concluding Summary 
 
To draw a conclusion on this research, submitted as a thesis for the degree of Doctor 
of Philosophy, it is proposed that the application of usability principles and 
involvement of users in the design process should become a mandated requirement 
for manufacturers of home use medical devices in the United Kingdom. 
Understanding the needs, expectations and capabilities of device users is a 
fundamental requirement to delivering safe, usable and understandable home use 
medical devices both now and in the future.  
This research has indicated that current design practice lacks an enforceable 
incentive for medical device manufacturers in the United Kingdom to invest in 
research with device users. The research indicates that the reported benefits of 
involving users in the design process are not sufficiently potent to change the ways in 
which home use medical devices are designed.  
The research has identified eleven different challenges reported by designers towards 
involving users in the design process of a home use medical device. In order to 
address these challenges a series of interventions were developed to incentivise the 
uptake of usability principles amongst industry practitioners.   
The findings of this research propose that the introduction of mandatory 
requirements for manufacturers to address usability early and throughout the design 
process of a home use medical device will lead to improved home use medical 
devices in the United Kingdom. It is believed that a change in the regulation of 
usability requirements for manufacturers will lead to reduced costs to the National 
Health Service through reduced training and device abandonment from patients and 
an improved commerciality for manufacturers through better device sales and 
reputation.  
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Appendix 2: Researcher Identity Memo 
Used as a method to explore your assumptions and experiential knowledge through 
writing down all of the expectations, beliefs and assumptions about the subject area. 
The method enables the researcher to recognise and identify the perspective he/she 
brings to the study. The following extract explores the researcher’s background in 
medical device design. 
My Background, Expectations and Beliefs 
My interest in user involvement in medical device design originates from my 
undergraduate degree studies, particularly my industrial placement with a medical 
device manufacturer. I was involved in the day-to-day issues, problems and 
solutions faced by both designers and end users. I gained valuable experience in 
the processes industry use to define their target population and their requirements, 
whilst also having the opportunity to speak with the product users in their 
environment of use. 
The industrial experience increased my commercial awareness and understanding 
of how companies operate in the medical device industry. I was exposed to the 
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challenges that companies face when attempting to deliver devices to market in 
conformance with the Medical Device Directive and supporting regulations whilst 
meeting strict budget requirements and time constraints. 
Returning to Loughborough University gave me the opportunity to reflect and 
discuss with my supervisor the theoretical and academic knowledge about the role 
of the designer-user relationship. It became apparent that ergonomics could 
provide the bridge between industry and the end user to develop quality, safe and 
usable medical devices. 
For my final year project at Loughborough University I was sponsored to work on 
a project in collaboration with my industrial placement employer. The project 
identified the usability issues involved with manual resuscitation and an upcoming 
change in CPR protocol. From the successes of this project, I applied to study for a 
PhD at Loughborough University to further explore the role of ergonomics in the 
design of medical devices. 
The focus of home-use medical devices is important to me, not only for the 
changes in population demographics and the increasing elderly population, but due 
to my exposure from a young age of insulin pens and blood glucose meters used by 
my mother as a healthcare professional in diabetes care. 
I began to recognise the diverse ways in which certain devices were prescribed and 
delivered, involving numerous teams of people leading to issues and breakdowns 
in communication. Problems with the use of the equipment within the home 
environment became increasingly evident, often requiring patients to seek 
assistance from proxies or experiencing challenges with the operation of such 
devices due to a mismatch of usability and their personal requirements. 
This identity memo has been developed for the researcher to consider his 
background and stand point on medical device design. The memo demonstrates 
some personal opinions on current medical device design and it is evident that the 
researcher feels much more can be done in this field to support the transition of 
healthcare technology into the home environment. 
The researcher’s current stance is one where usability and the real user’s needs are 
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often overlooked. In the researchers opinion the medical device industry sits on a 
continuum, between the delivery of quality medical devices for their end users and 
operating as a business, with the balance sometimes shifted towards operating 
profit. 
As this bias has been recognised it is now vital that the literature reviewed in this 
report covers the range of design successes and failures within the field, as to not 
obstruct the researcher’s view of the real problems. The researcher will reflect on 
the issues discussed in this memo throughout the research project to keep in mind 
the biases and focus of what the research is trying to achieve. 
 
Appendix 3: Survey Final Design 
User Involvement in Medical Device Design 
Survey Information 
My name is Thomas Grant and I am a PhD student at Loughborough University. 
My research is exploring user involvement in medical device design. At this stage 
of my research I want to explore current practice in incorporating the end user into 
design processes.  
 
This short survey is the first part of a larger study to explore ways in which 
industry can be supported to increase user involvement and lead to safer, more 
usable and desirable medical devices.  
 
The questionnaire is comprised of 15 questions only and should not take more than 
5 minutes of your time to complete. All of the responses you provide in this 
questionnaire are completely confidential and we can assure you that your 
company will not be identifiable in any of the published results. I am more than 
willing to share any of the results from this survey with you when they are 
available and should you be interested to receive them. 
 
On completion of the survey you will be asked to volunteer to take part in a further 
semi structured interview that will last no longer than 1 hour of your time. This 
interview is completely voluntary and you do not have to take part. If you do not 
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wish to take part please tick the allocated box at the end of the survey. Otherwise 
please leave your contact details to enable me to get in contact with you directly.  
 
You may withdraw from the survey at any time and will not be required to give a 
reason. The questionnaire is intended for anybody working within the medical 
device industry that is involved with the design and development of devices. If you 
feel you are unsuitable for this questionnaire but know or work with someone for 
whom this survey would be more appropriate please could you send this to them. 
Likewise if you feel there is someone else that this survey may be of interest to and 
they operate in the medical device sector, feel free to forward this on to them. 
 
If you would prefer a paper based version of this survey please contact me at 
t.grant2@lboro.ac.uk and I will send as many copies as you 
require together with a self-addressed envelope so that you will not be required to 
pay for postage. 
I would like to thank you in advance for your time and support with this research 
and I very much hope you will be interested to take part in a further study. 
 
Thank you. 
 
Thomas Grant 
Research Student 
Loughborough Design School 
Loughborough University 
LE11 3TU 
UK 
t.grant2@lboro.ac.uk 
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Appendix 5: Recruitment Email 
My name is Thomas Grant and I am a PhD research student at Loughborough 
University. I am contacting you to ask if you would be interested in contributing to 
my research by completing a short online survey? The survey will take no longer 
than 5 minutes to complete and your responses will be highly valuable to my 
research.  
 
I have attached a short information sheet (below) that outlines the aims of the 
study and further details on the research if you are interested.  
 
My research explores user involvement in medical device design and the methods 
industry use to meet the needs of their end users. I am particularly interested in 
home use medical device design as I believe this is a market that presents 
considerable challenges for the future and is an area that will continue to grow. 
The survey can be accessed at the following link; 
 
www.wix.com/tgrantmail/medicaldevicedesign  
 
I have developed the survey to establish the methods and processes used by 
industry to design for the needs of their end users. I would like to understand how 
company’s design medical devices to be used in the home environment and the 
challenges faced throughout the design process. 
 
I am interested to hear from anyone who is involved in the design and 
development of medical devices, particularly for home use. If you are aware of 
anyone else who may be interested in contributing to this research please feel free 
to forward this message onto them. I am keen to get as many responses as possible 
as this will really benefit my research.  
 
I would like to thank you in advance for your support and I look forward to your 
response. 
 
Kindest Regards, 
Tom 
 
Tom Grant 
Research Student 
Loughborough Design School, LDS.2.24 
Loughborough University, LE11 3TU, UK 
 
Tel +44 (0)1509 226969 
 
Loughborough Design School - Inspiring Design 
www.lboro.ac.uk/lds 
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Appendix 6: Participant Information Sheet 
 
 
Understanding the methods and processes used by 
industry to designing medical devices for the home market 
and the needs of device users.  
Primary researcher: Thomas Grant 
t.grant2@lboro.ac.uk, (Telephone: 01509 226969 Mobile: 07837942067) 
Supervisors: Laurence Clift and Richard Bibb 
Introduction 
My name is Thomas Grant and I am postgraduate research student at Loughborough 
University based in the recently established Loughborough Design School. I am 
contacting you to ask if you would be interested in contributing to my research by 
completing a short online survey. The survey consists of 15 questions and will take no 
longer than 5 minutes to complete.   
Study Rationale 
The modern shift towards home healthcare is attributable to a myriad of factors that will 
continue to grow in the future. This study forms part of a research project exploring the 
role of user involvement in medical device design and the methods industry use to meet 
the needs of their end user’s. This study aims to establish the methods and tools used to 
design for this complex user group and to identify the challenges faced by industry.   
 
Online Survey 
The online survey can be accessed at the following link: 
www.wix.com/tgrantmail/medicaldevicedesign  
This site has been developed solely for this study and all the information regarding the 
research together with the contact details can be accessed here. 
Follow up Interview (Voluntary) 
Once you have completed the survey you will be asked if you would like to take part in a 
follow up interview. It should be noted that this interview is voluntary but completion of 
the interview will greatly contribute towards my research. More information on the 
interviews can be found on the survey website under the ‘further studies’ tab. If you 
have any questions regarding any of the research please do not hesitate to contact me. 
Personal information and confidentiality 
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All information and results from the survey and interview will be treated confidential. 
The interview is voluntary and completion of the interview will be taken as your informed 
consent for the data to be used anonymously – no personal details are required. The 
views you express in this interview will be documented as your own personal views, and 
not that of the organisation you work for. The data is confidential but as a participant, if 
you have any questions or are interested in the overall outcomes of the project, please 
contact me at t.grant2@lboro.ac.uk or 01509226969. 
Appendix 7: Linked In Recruitment Advertisement 
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Appendix 8: Respondent Profiles 
Respondent Headcount Turnover (£) Company Size 
1 3000 200,000,000 LARGE 
2 12 2,500,000 SMALL 
3 70 6,000,000 MEDIUM 
4 1 125,000 MICRO 
5 12 1,000,000 SMALL 
6 3 UNKNOWN MICRO 
7 8 1,000,000 MICRO 
8 123 12,000,000 MEDIUM 
9 2 80,000 MICRO 
10 2 200,000 MICRO 
11 3 CONFIDENTIAL MICRO 
12 40 UNKNOWN SMALL 
13 30 3,000,000 SMALL 
14 9 UNKNOWN MICRO 
15 <10 UNKNOWN MICRO 
16 5 UNKNOWN MICRO 
17 11 1,300,000 SMALL 
18 1 40,000 MICRO 
19 1 50,000 MICRO 
20 7 250,000 MICRO 
21 8 2,300,000 MICRO 
22 9 UNKNOWN MICRO 
23 120 10,000,000 MEDIUM 
24 1 UNKNOWN MICRO 
25 2 150,000 MICRO 
26 120 UNKNOWN MEDIUM 
27 30 CONFIDENTIAL SMALL 
28 2 250,000 MICRO 
29 1000 UNKNOWN LARGE 
30 30 3,000,000 SMALL 
31 35-50 UNKNOWN SMALL 
32 10 £1,500,00 MICRO 
33 35 £5,000,000 SMALL 
34 2 £250,000 MICRO 
35 16 £1,800,000 SMALL 
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Appendix 9: Pairwise Comparison Results (Drivers for Development) 
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Appendix 10: Pairwise Comparison Results (Measures of Success) 
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  Appendix 11: Pairwise Comparison Results (Stages of User 
Involvement) 
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User Involvement in Home Use Medical Device Design. 
Interview Participant Information Sheet. 
 
Researcher 
Thomas Grant 
Loughborough Design School 
Loughborough University 
Loughborough 
LE11 3TU 
T.Grant2@lboro.ac.uk 
Supervisors 
Laurence Clift and Dr Richard Bibb 
L.Clift@lboro.ac.uk 
R.J.Bibb@lboro.ac.uk 
 
What is the purpose of the study? 
The modern shift towards home healthcare is attributable to a myriad of factors 
that will continue to grow in the future. This study forms part of a research project 
exploring the role of user involvement in medical device design and the methods 
industry use to meet the needs of their end users’. This study aims to establish the 
methods and tools used to design for this complex user group and to identify the 
challenges faced by industry.   
 
Who is doing this research and why? 
This study is part of a student research project funded by Loughborough University. 
The research is being conducted by Thomas Grant a postgraduate research student 
at Loughborough University’s Design School under the supervision of Laurence Clift 
and Richard Bibb.  
 
Once I take part, can I change my mind? 
Yes!  After you have read this information and asked any questions you may have 
you will be asked to complete an Informed Consent Form, however if at any time, 
before, during or after the sessions you wish to withdraw from the study please just 
contact the main investigator.  You can withdraw at any time, for any reason and 
you will not be asked to explain your reasons for withdrawing. 
 
Will I be required to attend any sessions and where will these be? 
The interview will be carried out at a time and place that is convenient for you. You 
may be asked if you would be willing to take part in a follow up interview at a later 
date, however you do not have to do this.  
Appendix 12: Participant Information Sheet (Interview Study) 
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How long will it take? 
The interview will take approximately 1 hour. 
 
Is there anything I need to do before the sessions? 
You are required to complete a short 5-10 minute questionnaire prior to the 
interview. The questionnaire is available online at 
www.wix.com/tgrantmail/medicaldevicedesign. 
 
Is there anything I need to bring with me? 
No. There isn’t anything specific you are required to bring along with you. You may 
like to bring a pen and some paper if you would like to make any notes during the 
interview. 
 
What will I be asked to do? 
The topics and format of the interview will be explained to you prior to the start. 
The interview will begin with a few profiling questions about you and then move 
onto the previous answers you provided in the online survey.  
Here the interviewer is just looking for more depth and explanations behind the 
responses you have already provided. You will be asked to sketch out and briefly 
described the design process you follow. This does not have to be a precise diagram 
it is just to identify the key stages involved in your design process. 
 
Are there any risks in participating? 
No. There are no further risks associated with your participation than can be 
expected in an office environment.  
 
Will my taking part in this study be kept confidential? 
Yes! All the information you provide in the interview will be kept confidential. No 
names, companies or places will be used in any reporting of the data. You data will 
be stored under a participant number which will be kept separate from any 
information or documents relating to personal identification.  
 
What will happen to the results of the study? 
Following the collection of all the data in this study transcriptions and thematic 
analysis of the data will begin. The data may then be presented anonymously at 
conferences, in journals and reported in the thesis of this research. As a participant I 
am happy to provide copies of these documents as and when they are available and 
if you are interested. 
 
I have some more questions who should I contact? 
If you have any questions regarding this research please feel free to contact Thomas 
Grant. 
 
What if I am not happy with how the research was conducted? 
The University has a policy relating to Research Misconduct and Whistle Blowing 
which is available online at 
http://www.lboro.ac.uk/admin/committees/ethical/Whistleblowing(2).htm.    
 
 
415 
 
 
 
 
 
User Involvement in Home Use Medical Device Design 
INFORMED CONSENT FORM 
(To be completed after Participant Information Sheet has been read) 
The purpose and details of this study have been explained to me.  I understand that this 
study is designed to further scientific knowledge and that all procedures have been 
approved by the Loughborough University Ethical Advisory Committee. 
I have read and understood the information sheet and this consent form. 
I have had an opportunity to ask questions about my participation. 
I understand that I am under no obligation to take part in the study. 
I understand that I have the right to withdraw from this study at any stage for any reason, 
and that I will not be required to explain my reasons for withdrawing. 
I understand that all the information I provide will be treated in strict confidence and will 
be kept anonymous and confidential to the researchers unless (under the statutory 
obligations of the agencies which the researchers are working with), it is judged that 
confidentiality will have to be breached for the safety of the participant or others.  
I agree to participate in this study. 
                    Your name 
 
              Your signature 
 
Signature of investigator 
 
 
                               Date 
  
Appendix 13: Informed Consent Form (Interview Study) 
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Home Use Medical Device Design  
Interview Protocol  
Participant Number:  
 
Online Survey Completed:  
 
Stage 1 – Interviewee Profile 
Question Response 
Date of Birth:  
 
Job Title: 
 
 
Experience in the position: 
 
 
Highest level of academic 
qualifications in this field: 
 
 
Any other experience you 
consider relevant: 
 
 
Stage 2 – Survey Analysis 
Question 1: Prime drivers for development 
Response in Survey: 
 
 
 
 Can you provide more detail? 
 What do you understand by this 
term? 
 When deciding which projects to go 
ahead with, who is responsible for 
that decision? 
 If I can turn to user needs, how do 
they drive project selection? 
Question 2: Barriers and Challenges 
Response in Survey: 
 
 
 
 I’d like to go through each of your 
responses here and if you can 
explain to me why this is 
considered a barrier to user 
involvement? 
 Can you provide an example of 
when these scenarios have 
restricted user involvement? 
 How do you overcome such 
barriers within your design and 
Appendix 14: Interview Protocol 
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development process?  
 Do you use any formal methods 
(focus groups, interviews etc.) to 
help you overcome these barriers? 
 If you had to choose just 3 barriers 
from the list you provided what 
would be the most significant to 
increasing user involvement in your 
design process? 
 What can practicably be done to 
help overcome these barriers? 
Question 3 – Who are your users? 
Response in Survey 
 
 
 
 How do you identify/create a 
profile for these users? 
 What methods do you use to do 
this? 
 How does the data/information 
collected come together to inform 
the design specification? 
Question 4 – Prioritising Users and Input 
Response in Survey 
 
 
 
 
 Elaborate further? 
 At what stage of the process do you 
include these users? 
 How are they included? 
 Can you provide an example of 
this? 
 Do they have equal influence on 
the final design? 
Question 5 – The Design Process 
Response in Survey 
 
 
 
 So to turn to the design process, 
could you possibly sketch out and 
briefly describe the stages 
involved? 
 Here is an A3 sheet and I would like 
you to roughly sketch out the 
process you use from initial 
concepts to final product. I am not 
looking for an exact thorough 
process, rather an indication of the 
steps involved. 
 Can you indicate on this process 
where the users are currently 
involved? 
 Could you now indicate any other 
stages where you would like to 
involve them but are restricted by 
the barriers we described earlier? 
Question 6 – Design Feedback 
Response in Survey 
 
 
 So what feedback is actually 
collected from users? 
 Is user satisfaction feedback 
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 actively collected from users? 
 How is this feedback collected? 
 What happens with the feedback? 
 Who collects this feedback? 
 If a user provides insight that could 
benefit future designs, how does 
this iterate back into the design 
process? 
 Do you have any formal methods to 
collect this data and how are user 
requirements implemented into 
design specifications? 
Question 7 – Stage of User Involvement 
Response in Survey 
 
Initial Concept:  
 
Design Stage:  
 
Product Design Specification:  
 
Product Development:  
 
Product Testing:  
 
Post Launch:  
 
 
 Are you familiar with participatory 
and co-design? 
 Do you employ these methods in 
your process? 
 Can you elaborate further? 
 Who makes the decisions on when 
to involve users within the design 
process? 
 Why do users become involved at 
this stage? Why is this different? 
 Are there any formal methods used 
to include users in the design 
process? 
Stage 3 – Design Approach 
If we turn now to stage 3 of the interview I’d like to talk about some further topics of your 
design practice. I will apologise now as there will be some slight overlap with the responses 
you have already made but if you could just provide as much information as possible and 
any examples it would be much appreciated. So if we could start with the design guidance 
available. Can you tell me: 
Topic 1: Design Approach and Guidance 
 Briefly describe the main methods you use to determine the needs of the 
user(s)? 
 Do you refer to any guidance documents or material to help you with conducting 
such work? 
 Why do you use this resource? 
 Are you aware of any other resources that are available? If so, why do you not 
use these resources? 
 Referring back to the survey responses, could any of these methods be 
practicably adapted to make the process of determining user requirements 
easier for you and your design process? 
 Before we move onto the final section, do you believe there is a need for 
alternative methods or resources to help with user centred design? If yes, what 
can practically be done? 
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Topic 2: Design Tools 
 The final topic I want to discuss is design tools. Essentially supportive material 
that has been developed to make your role easier; be it IDEO method cards, 
Spidergrams or website resources. 
 Do you use any design tools in your work? 
 Can you tell me about the models you have considered and rejected? 
 Which models have you considered and taken on board or implemented? 
 Where do you go to find out about such tools? 
 In your opinion, how could such tools practically be improved to be more 
effective? 
 Is there a need for more tools to support user centred design in this field? 
 
  
Stage 4 – Wrap up 
 Thank you very much for your time and allowing me to come and visit you today. 
I really appreciate your support for my research and all the insights you have 
provided here today have been extremely valuable. 
 Do you have any questions for me? 
 I am still recruiting participants and at present I am short on numbers so can I ask 
if there is anyone else within your company that might be willing to take part? I 
would be happy to pay another visit in the future when the time is right. 
 Do you have any comments in way of feedback that would help me improve my 
process when conducting future interviews? 
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Appendix 15: Respondent Profiles (Interview Study) 
Participant Profile 
#1 
Gender: Male 
Age: 30-39 
Background: Ergonomics 
Education Level: MSc or Above 
Job Title: Industrial Designer 
Experience: 6-10 Years 
#2 
Gender: Male 
Age: 50-59 
Background: Product Design 
Education Level: BSc/BA Level 
Job Title: Managing Director 
Experience: 16-20 Years 
#3 
Gender: Male 
Age: 50-59 
Background: Industrial Design 
Education Level: MSc or Above 
Job Title: Managing Director 
Experience: 11-15 Years 
#4 
Gender: Male 
Age: 50-59 
Background: Mechanical Engineering 
Education Level: BSc/BA Level 
Job Title: Director 
Experience: 6-10 Years 
#5 
Gender: Male 
Age: 50-59 
Background: Sports Science 
Education Level: BSc/BA Level 
Job Title: Big Leader 
Experience: 0-5 Years 
#6 
Gender: Male 
Age: 40-49 
Background: Product Design 
Education Level: BSc/BA Level 
Job Title: Director 
Experience: 6-10 Years 
#7 
Gender: Male 
Age: 50-59 
Background: Biochemistry 
Education Level: MSc or Above 
Job Title: Director 
Experience: 6-10 Years 
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#8 
Gender: Male 
Age: 40-49 
Background: Ergonomics 
Education Level: BSc/BA Level 
Job Title: Director 
Experience: 26-30 Years 
#9 
Gender: Male 
Age: 50-59 
Background: Industrial Design 
Education Level: BSc/BA Level 
Job Title: Group Leader 
Experience: 16-20 Years 
#10 
Gender: Male 
Age: 40-49 
Background: Cognitive Psychologist 
Education Level: MSc or Above 
Job Title: President 
Experience: 6-10 Years 
#11 
Gender: Male 
Age: 40-49 
Background: Mechanical Engineering 
Education Level: BSc/BA Level 
Job Title: Director 
Experience: 6-10 Years 
#12 
Gender: Male 
Age: 50-59 
Background: Engineering 
Education Level: BSc/BA Level 
Job Title: Freelance 
Experience: 26-30 Years 
#13 
Gender: Male 
Age: 30-39 
Background: Industrial Design 
Education Level: MSc or Above 
Job Title: Industrial Designer 
Experience: 0-5 Years 
 
